data_2cq0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cq0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.7 m -135.89 136.28 40.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.413 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 45.0 pt -132.67 142.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -99.88 150.38 22.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.88 141.17 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 18.3 p -141.5 163.94 31.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 29.6 t30 70.45 52.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 26.1 mt -93.93 -178.56 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.8 t -118.19 169.77 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.68 -21.47 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.89 20.26 13.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 52.8 m -113.17 99.42 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -110.15 -177.47 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -55.86 -42.14 75.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.8 t -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.111 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -28.95 47.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.6 mt -86.33 -31.15 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 11.2 tt0 -59.0 -31.67 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.33 -16.7 28.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.0 tp -82.94 -37.85 23.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.552 ' CE2' HG13 ' A' ' 300' ' ' VAL . 65.1 m-85 -98.03 10.97 39.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.9 tmt_? -76.56 -45.27 3.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 66.0 Cg_exo -48.02 -17.23 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.4 m-85 -93.38 -33.09 14.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 164.65 -162.62 35.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.0 m -90.39 117.26 28.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 266' ' ' SER . 46.9 mt -75.71 140.94 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.554 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -88.35 -45.02 10.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -150.78 153.5 35.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 44.7 mt -136.18 105.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 4.6 t80 -96.95 146.96 24.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 12.4 tp -140.95 125.84 18.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.524 ' HB1' ' CE2' ' A' ' 282' ' ' PHE . . . -62.75 119.44 9.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -130.95 149.07 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.35 163.65 13.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -101.0 -29.93 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 74.4 m -81.62 -37.75 27.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.2 p -98.96 -34.14 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.5 44.57 89.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -129.93 -175.88 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.359 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 49.9 m -86.24 106.05 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -40.65 -56.63 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.54 -23.09 0.84 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' HB1' ' A' ' 271' ' ' ALA . 14.4 p90 -115.84 159.7 21.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -147.27 168.45 21.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -136.05 113.64 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.94 133.74 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 25.3 m -108.03 123.13 48.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -98.74 169.95 9.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 12.3 m-70 -87.76 -47.09 8.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt-85 -108.37 165.3 11.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -76.65 -24.0 53.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.44 -49.98 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.14 -37.99 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.9 -43.75 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.0 91.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -48.98 -40.03 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -70.75 -64.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.559 HD13 ' CD1' ' A' ' 314' ' ' TRP . 82.7 mt -37.97 -33.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.04 38.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -77.88 -62.35 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.497 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.552 HG13 ' CE2' ' A' ' 259' ' ' PHE . 7.5 m -42.49 -27.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.4 t -70.03 109.45 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 91.1 16.61 53.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.17 158.58 33.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.81 65.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.31 127.54 34.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 4.5 m-20 46.64 50.74 12.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 35.1 p-80 46.3 44.32 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 88.7 mt -146.45 168.64 20.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -96.74 95.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 25.9 tp -60.96 146.05 48.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -119.7 129.67 54.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.456 ' CB ' HG22 ' A' ' 300' ' ' VAL . 76.6 t -141.19 147.5 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.85 149.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.559 ' CD1' HD13 ' A' ' 297' ' ' ILE . 79.8 m95 -51.18 122.72 8.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.882 0.373 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 25.7 m -139.01 147.53 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 259' ' ' PHE . 32.3 pt -141.54 143.16 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.7 ttt-85 -98.67 150.98 21.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.2 t -139.1 139.07 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 30.7 p -138.8 173.72 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 20.4 t-20 69.24 48.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.72 -178.28 3.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.952 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.9 t -126.47 179.26 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.18 -3.91 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.66 21.63 17.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.6 m -127.49 116.78 20.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 172.07 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.2 -47.47 62.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.6 t -60.4 -29.0 68.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.45 -23.35 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.04 -28.11 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -54.76 -28.01 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.31 -19.5 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.56 -36.76 44.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.553 ' CE2' HD11 ' A' ' 241' ' ' ILE . 88.4 m-85 -95.92 10.43 37.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 ttt-85 -78.87 -45.17 1.84 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.333 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -95.56 -31.94 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 167.76 -160.53 34.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.597 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.7 m -95.2 111.03 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 259' ' ' PHE . 66.5 mt -65.87 147.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 33.4 t -97.89 -46.88 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 14.1 tpp180 -147.05 146.01 29.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.409 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 39.8 mt -130.63 99.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.088 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.661 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -93.79 152.72 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.661 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 47.5 tp -141.71 143.27 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -84.9 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.19 153.98 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -99.43 157.37 16.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.31 0.3 33.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 93.4 m -111.43 -20.61 12.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 32.7 p -121.48 -16.1 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.14 37.44 80.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.57 -179.26 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 t -85.3 115.99 23.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -46.87 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.82 32.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 25.8 p90 -165.95 155.94 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -149.42 174.04 12.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.15 120.11 16.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.64 124.52 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 50.4 m -101.45 118.51 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CE2' ' O ' ' A' ' 292' ' ' ASP . 7.8 m-85 -92.62 176.02 6.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 264' ' ' SER . 9.6 m-70 -95.57 -50.03 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -108.04 149.46 28.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -69.46 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.51 -25.51 20.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.497 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 6.4 m-20 -88.57 -25.31 22.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.438 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -80.35 -33.98 36.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.31 -33.63 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -59.44 -37.79 79.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.2 -63.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 314' ' ' TRP . 61.1 mt -39.94 -35.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -72.67 -56.63 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.8 -61.41 5.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 312' ' ' VAL . 3.7 m -48.05 -35.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t -59.81 104.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.6 27.1 10.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -91.09 148.99 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -92.8 78.22 1.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.52 127.07 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 11.3 t70 52.66 48.14 23.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.565 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 46.52 32.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 45.9 mt -133.7 171.82 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.599 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -97.95 94.73 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.93 136.19 54.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -116.79 142.89 46.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 300' ' ' VAL . 99.2 t -146.67 144.78 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.37 149.02 8.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.438 ' CH2' ' HB3' ' A' ' 293' ' ' ALA . 95.6 m95 -49.59 130.3 20.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.863 0.363 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -143.29 143.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.9 pt -140.85 147.05 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.537 ' HG3' ' CE1' ' A' ' 284' ' ' PHE . 17.0 ttt180 -112.32 148.77 33.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.468 ' N ' ' HG2' ' A' ' 242' ' ' ARG . 67.3 t -127.49 148.99 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.4 p -143.24 163.11 33.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.79 38.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.8 mt -82.72 -174.97 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 248' ' ' GLU . 27.3 t -125.78 178.85 5.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.4 ' N ' ' OG ' ' A' ' 247' ' ' SER . 4.3 mm-40 -76.46 -50.47 13.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.11 -4.8 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 44.2 m -98.51 103.13 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -175.5 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -51.17 -56.21 13.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.3 t -55.31 -21.79 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.156 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -82.47 -30.4 29.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.87 -26.53 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -56.79 -33.58 66.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -89.96 -18.44 26.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.8 tp -78.64 -34.23 46.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -101.0 11.91 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 8.2 tpt180 -78.24 -45.24 2.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 0.0 110.859 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.01 -17.21 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.0 m-85 -92.56 -35.91 13.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.27 -161.45 34.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.9 m -90.31 117.28 28.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 74.9 mt -72.78 144.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.157 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.515 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.2 t -97.98 -48.09 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.0 tpt180 -145.44 151.46 38.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 65.3 mt -140.23 113.68 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 4.9 t80 -109.31 141.58 41.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 18.4 tp -129.92 121.13 26.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -61.63 122.49 15.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.122 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -134.96 149.33 50.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.27 178.82 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.29 -48.27 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 58.3 m -67.48 -42.38 83.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 -14.47 17.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 50.63 41.64 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -117.7 163.81 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.2 p -70.91 129.95 40.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -68.77 -75.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.71 32.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 24.2 p90 -165.99 157.96 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.73 171.3 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.537 ' CE1' ' HG3' ' A' ' 242' ' ' ARG . 97.7 m-85 -136.84 106.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 286' ' ' SER . 4.3 mp -94.78 136.99 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' SER . . . . . 0.423 ' N ' HG21 ' A' ' 285' ' ' ILE . 15.7 m -113.93 118.62 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -93.07 172.84 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -89.69 -43.57 10.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -116.62 168.92 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -76.89 -35.52 57.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.95 -55.29 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.86 -37.78 74.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.496 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -63.6 -44.26 94.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.56 -37.23 82.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.067 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmm-85 -50.05 -41.0 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.64 -65.86 0.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.119 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.497 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 82.5 mt -35.04 -33.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.53 -51.71 9.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -60.67 5.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.432 HG23 ' CG2' ' A' ' 312' ' ' VAL . 13.7 m -51.24 -31.58 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.3 t -61.59 119.55 8.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.32 69.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 66.9 t80 -83.71 165.42 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.442 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -110.98 82.36 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.4 120.59 41.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 21.7 t70 61.01 48.7 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 27.6 p-80 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.94 167.54 21.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -94.52 95.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 22.4 tp -60.83 143.49 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -123.93 130.86 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 313' ' ' GLU . 26.4 t -139.81 151.31 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.442 ' N ' HG11 ' A' ' 312' ' ' VAL . 7.9 pt-20 -169.39 149.82 4.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 86.2 m95 -47.89 136.08 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.125 179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.8 m -134.34 141.0 46.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 35.4 pt -140.54 145.23 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -104.39 149.17 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 73.8 t -133.09 135.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 31.0 p -130.26 171.76 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.42 51.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.7 mt -95.77 -177.52 4.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 t -122.23 164.27 18.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.48 -11.53 60.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -105.24 21.1 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 59.1 m -121.14 98.43 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -103.29 170.07 8.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -47.82 -43.4 27.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -23.67 64.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.55 -28.76 46.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.52 -30.84 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 7.1 pt20 -53.14 -33.56 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.55 -12.85 44.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.87 -37.23 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.89 10.37 39.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.4 tpt85 -76.9 -45.32 2.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.63 0.729 . . . . 0.0 110.826 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.3 Cg_exo -47.96 -17.24 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.646 2.23 . . . . 0.0 112.354 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.559 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.8 m-85 -94.22 -32.47 13.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.22 -166.66 39.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.47 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.7 m -90.32 112.86 24.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 37.1 mt -69.34 145.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 26.7 t -96.56 -44.88 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 16.7 tpp180 -148.34 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 41.5 mt -131.31 96.58 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -91.76 150.41 21.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.5 tp -142.14 120.16 12.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.5 131.8 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -134.5 174.39 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.19 164.91 13.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -107.24 -6.26 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 55.8 m -102.11 -58.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -6.84 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.83 26.87 65.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -88.09 138.73 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.5 t -47.35 127.74 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -62.22 -57.43 11.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.91 -9.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.65 149.5 52.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.78 169.4 17.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.131 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -134.21 117.56 16.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 286' ' ' SER . 3.7 mp -103.78 136.85 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' SER . . . . . 0.449 ' N ' HG23 ' A' ' 285' ' ' ILE . 3.3 m -112.02 124.85 53.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 292' ' ' ASP . 17.6 m-85 -98.78 171.74 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 12.6 m-70 -89.88 -40.26 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -118.94 158.87 24.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 17.0 ttp-105 -74.6 -13.26 60.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.91 -29.18 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.465 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -84.36 -28.55 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 287' ' ' PHE . . . -77.6 -33.77 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.97 65.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -49.14 -44.68 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -59.78 -66.65 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 314' ' ' TRP . 81.2 mt -39.86 -34.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.0 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -85.15 -57.05 2.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.455 HG22 ' CG2' ' A' ' 312' ' ' VAL . 17.2 m -47.37 -32.7 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 111.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.2 p -55.74 122.28 11.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.48 78.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.01 136.97 38.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -84.89 92.61 1.76 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.6 112.51 24.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.888 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 7.8 t70 63.62 52.94 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 33.3 p-80 45.91 27.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 30.8 mt -129.09 162.74 27.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -93.96 104.75 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.81 140.72 38.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -122.92 145.82 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.559 ' N ' HD21 ' A' ' 311' ' ' ASN . 49.6 t -145.61 136.37 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -146.68 168.1 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.551 ' CD1' HD13 ' A' ' 297' ' ' ILE . 75.8 m95 -81.06 122.29 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.0 m -140.77 124.6 17.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 28.1 pt -122.61 145.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -107.92 151.88 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.447 ' CG1' HD12 ' A' ' 310' ' ' LEU . 95.6 t -139.0 141.84 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 43.3 p -139.48 170.06 16.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 30.8 t-20 73.58 38.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.48 -175.97 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 52.6 p -127.34 175.61 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.79 -14.41 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -95.33 12.99 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 51.4 m -119.02 109.34 15.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 251' ' ' ARG . 0.0 OUTLIER -112.13 176.88 4.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -49.42 -43.33 44.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -25.42 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.38 -28.31 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.51 -25.3 16.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -61.31 -30.17 70.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.69 -16.81 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.49 -38.75 33.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.49 ' CE2' HG11 ' A' ' 300' ' ' VAL . 56.5 m-85 -95.5 8.99 41.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.4 OUTLIER -75.07 -45.44 4.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.1 Cg_exo -47.98 -18.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.385 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -93.49 -32.16 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.11 -166.39 39.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.23 113.79 25.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.09 145.09 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 39.4 t -93.95 -47.37 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -149.25 149.94 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.3 mt -130.99 104.88 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.5 t80 -98.87 136.2 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.72 127.98 39.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 282' ' ' PHE . . . -64.13 129.17 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -134.59 150.44 50.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.98 177.77 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -112.09 -56.89 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.5 m -55.26 -53.19 59.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 8.6 t -92.08 -24.11 19.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 61.85 43.59 99.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.97 176.04 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 65.3 p -80.79 129.08 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -63.58 -72.9 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.39 33.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 271' ' ' ALA . 21.5 p90 -165.74 151.92 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.844 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.32 165.06 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -131.59 111.16 11.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.02 124.37 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 18.7 m -101.04 115.47 30.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 292' ' ' ASP . 10.7 m-85 -88.22 176.29 7.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 264' ' ' SER . 14.5 m-70 -94.65 -43.76 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -114.32 168.55 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.4 ttt85 -82.93 -18.8 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -83.55 -29.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 3.5 m-20 -83.22 -27.11 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.489 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -75.09 -37.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.27 -37.84 68.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -48.28 -42.72 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.5 -70.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.489 HD12 ' CD1' ' A' ' 314' ' ' TRP . 82.6 mt -35.08 -34.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -67.01 -48.04 69.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.088 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.8 -59.85 2.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.1 m -41.81 -36.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.4 p -55.35 119.84 6.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.07 23.26 74.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -76.57 153.2 35.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.5 76.09 0.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 120.6 38.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 3.0 t70 54.57 49.63 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.494 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 24.2 p-80 47.62 29.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 38.0 mt -129.85 164.64 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -94.93 102.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.447 HD12 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -72.08 130.94 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.31 129.67 55.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 313' ' ' GLU . 55.9 t -133.78 143.27 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 312' ' ' VAL . 16.5 pt-20 -156.02 161.26 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.489 ' CD1' HD12 ' A' ' 297' ' ' ILE . 72.3 m95 -71.28 122.29 19.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.878 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.7 m -129.37 142.91 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 259' ' ' PHE . 38.2 pt -138.81 140.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.482 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 69.9 ttt180 -100.56 147.35 26.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 285' ' ' ILE . 55.8 t -129.58 145.48 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.7 p -143.27 165.54 27.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.171 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 26.5 t-20 73.32 39.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 49.9 mt -89.98 -176.95 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 m -135.56 -175.95 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -74.8 -50.11 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.16 -10.83 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 50.5 m -98.62 97.75 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -109.79 178.98 4.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.6 -41.62 31.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -67.61 -23.05 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.77 -30.32 36.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.8 mt -88.29 -24.06 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.468 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.4 tt0 -60.6 -34.5 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -94.35 -11.68 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.62 -39.7 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 241' ' ' ILE . 64.7 m-85 -98.18 12.04 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 tpt180 -79.15 -45.11 1.72 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.93 -17.23 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.621 2.214 . . . . 0.0 112.393 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.9 m-85 -95.39 -31.06 13.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.79 -166.13 39.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.1 m -90.34 108.73 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 61.4 mt -63.32 139.11 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.504 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.8 t -89.67 -43.34 10.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -148.93 153.17 37.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 85.1 mt -133.64 104.7 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -99.66 140.9 33.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 35.7 tp -133.01 125.34 29.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.516 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.41 125.55 28.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -129.08 157.7 41.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.49 -178.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -116.64 -32.32 5.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 36.7 m -80.37 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.9 t -81.8 -36.7 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.04 19.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -96.73 -177.23 3.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 86.4 p -77.42 114.98 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -52.85 -54.02 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 141.97 -6.37 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.516 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 13.6 p90 -135.26 157.2 47.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.864 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.43 163.55 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.7 m-85 -128.74 114.03 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 243' ' ' VAL . 3.7 mp -98.75 140.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.096 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.99 142.12 46.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.17 -176.31 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 8.9 m-70 -104.79 -31.58 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -129.28 148.03 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -63.71 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.837 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.86 -60.24 2.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.69 -28.41 67.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.19 78.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.4 -23.95 57.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -61.99 -37.65 85.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.8 -69.0 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.568 HD12 ' CD1' ' A' ' 314' ' ' TRP . 85.3 mt -35.88 -35.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.3 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.05 -60.9 2.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 259' ' ' PHE . 11.4 m -41.67 -42.41 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.119 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 36.7 p -53.59 127.91 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.06 68.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -83.97 134.25 34.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.63 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -105.24 115.55 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.5 m-20 57.33 54.05 7.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 36.7 p-80 48.76 36.92 8.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 90.9 mt -138.59 168.41 19.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -101.25 97.26 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.23 149.27 50.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -133.29 132.13 41.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 313' ' ' GLU . 97.8 t -139.54 143.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 312' ' ' VAL . 6.3 pt-20 -156.02 158.95 38.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.568 ' CD1' HD12 ' A' ' 297' ' ' ILE . 81.4 m95 -69.08 125.51 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.066 179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.89 0.376 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 13.4 m -140.6 131.63 26.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 259' ' ' PHE . 40.6 pt -127.6 141.08 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -99.57 153.46 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.7 t -139.64 135.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 72.6 p -132.24 163.19 29.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.4 t-20 71.59 43.77 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.2 mt -91.11 177.21 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.5 t -122.91 146.47 47.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -48.18 -49.62 32.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.11 -24.92 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.8 m -82.16 97.01 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -104.69 179.26 4.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -49.49 -56.22 10.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -55.51 -25.24 36.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.97 -31.23 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -26.06 24.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.4 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.5 tt0 -59.5 -31.71 69.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -92.87 -8.59 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.469 HD23 ' CE1' ' A' ' 259' ' ' PHE . 26.6 tp -88.05 -39.7 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 300' ' ' VAL . 79.1 m-85 -98.15 11.19 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -76.86 -45.35 2.99 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.8 Cg_exo -47.97 -17.93 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.365 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.0 m-85 -94.55 -33.79 12.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.85 -167.1 40.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 19.8 m -90.53 110.33 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.6 mt -66.24 142.49 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.4 t -92.57 -46.83 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -148.17 139.64 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 38.4 mt -120.98 102.94 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.505 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.2 t80 -93.12 143.03 26.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 24.2 tp -136.44 115.59 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.467 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.52 126.46 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.97 174.41 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -103.73 177.32 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.83 -54.74 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 26.9 m -55.14 -72.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.137 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 14.8 t -77.5 -32.26 54.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 73.97 39.37 46.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.548 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.64 169.65 8.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 45.7 m -70.94 115.61 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -48.21 -54.26 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.57 2.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 12.4 p90 -123.53 155.27 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.51 165.29 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.46 116.7 16.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 285' ' ' ILE . 4.3 mp -104.58 125.41 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.3 m -101.57 119.13 38.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -91.05 175.71 6.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.9 m-70 -92.34 -44.43 8.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -110.99 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -87.57 -20.81 25.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.58 -24.18 31.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.51 -34.44 27.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.499 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -70.44 -35.84 73.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.4 70.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -48.63 -44.07 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.83 -65.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 314' ' ' TRP . 69.1 mt -34.48 -32.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -50.09 23.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -62.51 3.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.548 HG12 ' CE2' ' A' ' 259' ' ' PHE . 16.1 m -46.59 -36.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.82 0.343 . . . . 0.0 111.125 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.8 t -57.54 114.25 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.77 26.24 56.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -82.62 153.53 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.29 71.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.37 129.55 36.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.376 . . . . 0.0 110.913 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.5 t70 45.25 52.79 8.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.547 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 44.67 31.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 30.5 mt -131.33 163.3 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -92.98 101.39 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.3 tp -76.42 139.01 40.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -119.72 140.13 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.533 ' N ' HD21 ' A' ' 311' ' ' ASN . 94.9 t -143.1 143.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.43 ' N ' HG11 ' A' ' 312' ' ' VAL . 1.2 pm0 -152.11 174.24 13.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.557 ' CD1' HD11 ' A' ' 297' ' ' ILE . 68.9 m95 -80.53 125.61 30.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.863 0.363 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.4 m -144.0 131.11 20.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.564 HD12 ' CE2' ' A' ' 259' ' ' PHE . 29.1 pt -126.0 143.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -101.81 151.84 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.71 139.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 46.9 p -141.85 165.32 27.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.9 t-20 68.42 50.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.4 mt -92.39 -175.64 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 250' ' ' THR . 5.6 t -130.42 140.24 50.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.406 ' OE1' ' C ' ' A' ' 248' ' ' GLU . 0.6 OUTLIER -47.19 -21.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.69 22.36 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 247' ' ' SER . 90.7 m -126.41 114.2 17.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.68 179.94 3.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.88 -44.77 70.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -61.18 -28.22 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.69 -33.3 64.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 43.0 mt -84.17 -28.72 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 24.0 tt0 -57.94 -42.28 84.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -83.71 -16.02 46.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 259' ' ' PHE . 14.8 tp -80.81 -38.07 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 241' ' ' ILE . 80.2 m-85 -99.15 12.01 37.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 ttt180 -77.92 -45.15 2.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.598 0.714 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.18 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.526 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.7 m-85 -92.78 -35.23 13.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.24 -163.15 36.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -91.62 109.92 21.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.95 138.9 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.477 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.4 t -88.69 -42.03 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -151.56 154.72 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 62.5 mt -133.76 101.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.48 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.4 t80 -91.4 141.56 28.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 52.9 tp -135.4 127.44 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -75.11 114.86 14.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -121.68 150.91 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.25 173.23 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 -29.77 7.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.3 m -78.59 -66.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.4 t -89.01 -13.52 38.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.25 95.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.35 157.22 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 48.0 t -58.21 115.08 2.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -51.63 -59.17 4.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.68 -13.24 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -129.03 157.2 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.68 172.72 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -139.14 116.43 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.63 132.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.43 142.02 35.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -116.23 168.35 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.0 m-70 -85.55 -35.07 21.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 288' ' ' HIS . 24.5 mmt-85 -120.82 167.27 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -78.54 -32.9 48.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.12 -54.53 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -53.93 -32.79 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -70.55 -46.0 64.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -50.78 -39.04 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.31 -69.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.46 HD12 ' CD1' ' A' ' 314' ' ' TRP . 72.8 mt -36.91 -34.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.5 55.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -80.03 -59.12 2.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.497 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 312' ' ' VAL . 28.0 m -53.97 -20.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.4 t -63.03 107.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.92 38.2 23.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -88.97 146.32 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.04 74.22 2.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -95.13 136.59 35.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 35.1 t70 42.41 53.98 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.507 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 37.8 p-80 46.05 39.03 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.1 mt -146.36 168.48 21.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.3 mp -95.55 102.79 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.64 139.96 56.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -118.52 127.82 53.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.464 ' CB ' HG23 ' A' ' 300' ' ' VAL . 44.8 t -140.72 141.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' ' 312' ' ' VAL . 15.3 pt-20 -162.22 149.96 14.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.547 ' CH2' ' HB2' ' A' ' 293' ' ' ALA . 96.1 m95 -45.01 121.4 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 179.891 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.859 0.361 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.9 m -136.02 143.52 44.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.482 HD13 ' CE2' ' A' ' 259' ' ' PHE . 42.5 pt -137.43 141.88 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -105.57 147.71 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.459 ' CG1' HD12 ' A' ' 310' ' ' LEU . 70.5 t -129.71 146.67 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 69.8 p -144.16 163.56 33.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 69.05 40.88 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 34.5 mt -85.33 -175.42 5.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 t -125.52 161.31 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.57 -9.36 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.55 -8.97 39.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 86.8 m -101.79 104.13 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -104.05 179.19 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -52.79 -51.52 60.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.4 t -62.77 -19.79 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.34 -26.92 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.87 -33.59 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 22.8 tp60 -52.49 -34.25 48.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -87.75 -20.44 26.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.411 HD22 ' CE1' ' A' ' 259' ' ' PHE . 15.3 tp -78.63 -36.79 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 241' ' ' ILE . 77.7 m-85 -98.01 11.72 36.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.585 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 2.4 ttt-85 -79.34 -45.24 1.66 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.37 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.3 m-85 -93.39 -33.76 13.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.16 -160.36 33.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 8.3 m -90.69 119.11 30.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.86 145.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -97.96 -43.71 6.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.422 ' HB2' ' NH1' ' A' ' 267' ' ' ARG . 20.2 ttm105 -150.43 149.98 30.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 54.2 mt -132.97 100.09 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -95.59 140.86 29.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.2 tp -132.93 121.7 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.549 ' HB3' ' CE2' ' A' ' 282' ' ' PHE . . . -68.79 129.87 41.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -136.98 162.16 34.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.58 178.22 7.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -108.51 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 78.0 m -73.02 -65.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 15.4 t -95.65 -18.87 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.91 37.54 92.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -91.96 160.23 15.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 28.0 t -56.0 121.16 8.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -64.88 -54.46 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.56 1.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.45 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 271' ' ' ALA . 32.6 p90 -128.61 153.86 46.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 110.857 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.46 173.08 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.6 112.4 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.83 138.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -111.27 143.91 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.39 167.25 12.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 264' ' ' SER . 6.2 m-70 -91.06 -44.12 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -104.63 155.39 18.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -78.1 -11.22 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -89.49 -41.37 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.62 -35.58 77.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.77 88.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.6 79.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -49.91 -38.63 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -70.53 -63.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.434 ' O ' ' CB ' ' A' ' 301' ' ' SER . 95.5 mt -35.97 -33.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.75 -55.43 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -54.98 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 259' ' ' PHE . 15.4 m -54.6 -30.94 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 111.161 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.0 t -61.66 106.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 84.77 21.12 56.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.01 141.93 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -85.82 93.08 1.82 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 0.53 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.2 OUTLIER -113.26 109.73 19.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.372 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 30.8 t70 67.74 53.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.523 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 17.1 p-80 47.4 26.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.51 162.08 30.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -93.09 98.02 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.459 HD12 ' CG1' ' A' ' 243' ' ' VAL . 32.3 tp -62.85 138.79 58.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -119.31 132.15 55.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.442 ' CG2' HG23 ' A' ' 300' ' ' VAL . 87.0 t -137.22 154.06 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -165.24 156.29 14.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.43 ' CD1' HD11 ' A' ' 297' ' ' ILE . 66.2 m95 -57.74 136.33 56.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.35 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 7.1 m -136.63 144.51 44.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.1 pt -144.35 141.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.472 ' HB2' ' CE2' ' A' ' 284' ' ' PHE . 69.4 ttt180 -100.56 149.03 24.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.0 t -132.06 142.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.7 p -135.14 174.52 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 3.2 m-20 64.18 48.13 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 310' ' ' LEU . 19.2 mt -103.4 168.76 8.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.3 p -118.87 154.94 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.86 -46.57 60.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -57.36 -19.25 21.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.2 m -90.08 98.93 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -106.42 -175.74 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -55.56 -55.91 26.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.8 t -55.21 -20.02 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.89 -28.69 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 mt -88.66 -27.26 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -61.92 -31.12 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.53 -18.14 28.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.59 -38.56 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -95.68 11.59 32.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 tpt180 -78.31 -45.26 2.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.598 0.714 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.5 Cg_exo -47.96 -17.16 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.415 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -93.31 -31.71 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.98 36.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -90.02 109.52 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.07 148.54 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.434 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.0 t -95.16 -43.42 8.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -154.43 149.08 26.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 72.6 mt -134.59 100.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.2 t80 -92.83 151.72 19.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.61 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 51.8 tp -140.54 145.99 37.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.683 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -97.9 132.01 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . 0.443 ' HE3' ' CD2' ' A' ' 270' ' ' LEU . 5.6 mptt -133.45 162.78 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -91.38 174.12 7.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -113.38 -52.94 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.7 m -60.38 -54.81 41.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -89.39 -18.96 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.05 82.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 279' ' ' SER . 32.1 mt-30 -118.67 126.7 52.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 278' ' ' GLN . 2.2 m -36.53 128.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -57.95 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 154.79 33.93 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.683 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 43.8 p90 -162.7 148.33 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 173.91 11.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 242' ' ' ARG . 71.1 m-85 -136.02 113.02 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 285' ' ' ILE . 4.2 mp -98.25 124.84 51.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -106.46 115.16 29.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.73 -180.0 6.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.6 m-70 -95.53 -38.72 10.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.84 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.03 167.53 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 38.4 ttp85 -73.53 -32.87 64.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.26 -64.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -48.8 -35.95 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.474 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -69.45 -42.86 74.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.29 85.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.9 mtp85 -47.05 -41.82 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 314' ' ' TRP . 89.5 mt -35.71 -32.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -68.98 -47.31 65.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.15 -62.2 2.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.4 ' CG2' ' CG2' ' A' ' 312' ' ' VAL . 22.4 m -41.26 -37.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.7 p -56.2 112.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.4 32.51 38.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.441 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -89.71 145.51 25.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -95.81 78.79 0.8 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.62 134.66 39.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 2.1 t70 44.94 52.88 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.462 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 34.0 p-80 45.59 33.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.03 167.4 21.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.2 mp -95.52 97.88 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.466 ' CD1' HD21 ' A' ' 246' ' ' LEU . 11.7 tp -73.67 138.78 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.48 144.89 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.4 ' CG2' ' CG2' ' A' ' 300' ' ' VAL . 29.6 t -143.75 145.5 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.99 171.0 17.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.56 ' CD1' HD11 ' A' ' 297' ' ' ILE . 57.9 m95 -79.25 131.78 36.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.1 m -138.61 138.27 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 259' ' ' PHE . 43.0 pt -137.28 140.15 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 14.5 ttt85 -100.96 149.23 24.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.444 ' N ' ' HG2' ' A' ' 242' ' ' ARG . 84.0 t -136.65 143.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 62.1 p -138.2 166.31 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 22.5 t-20 74.05 38.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.75 177.08 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -130.94 166.02 21.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -70.68 -16.54 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.98 9.83 11.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -132.94 111.39 10.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 -176.33 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -48.77 -59.1 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -54.66 -26.7 34.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -76.97 -30.67 56.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.69 -29.83 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.475 ' O ' ' NE2' ' A' ' 256' ' ' GLN . 21.9 tp60 -56.25 -29.48 61.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.3 -15.65 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.3 tp -84.31 -37.88 21.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 241' ' ' ILE . 83.7 m-85 -96.68 11.31 35.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.594 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -79.7 -45.24 1.56 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.712 . . . . 0.0 110.883 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.88 -17.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.08 -159.9 33.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.92 135.05 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 0.0 110.875 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 266' ' ' SER . 54.6 mt -93.61 138.88 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.452 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 48.3 t -92.6 -48.76 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.7 tpp180 -143.38 148.53 36.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.414 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 45.9 mt -132.96 108.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -95.62 144.07 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.0 tp -131.08 119.35 21.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 282' ' ' PHE . . . -62.57 113.44 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -129.14 146.66 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.29 -177.87 0.75 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -122.69 -16.65 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 92.0 m -102.23 -50.44 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -95.41 -9.05 33.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.64 56.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -99.5 178.57 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 27.6 p -89.29 121.84 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -62.13 -74.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 157.94 33.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 271' ' ' ALA . 27.6 p90 -166.13 148.34 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -139.82 165.87 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.586 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 84.8 m-85 -133.18 115.66 15.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.468 HD13 ' CE1' ' A' ' 259' ' ' PHE . 4.2 mp -101.99 131.82 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -109.05 113.05 25.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 285' ' ' ILE . 13.5 m-85 -84.48 177.11 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.452 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 13.6 m-70 -93.51 -30.54 14.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -122.8 171.37 9.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -83.72 -28.61 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.53 -56.57 5.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 292' ' ' ASP . 1.0 OUTLIER -53.18 -35.12 59.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.828 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.82 90.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.43 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -48.18 -42.59 30.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.95 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.548 HD11 ' CD1' ' A' ' 314' ' ' TRP . 86.3 mt -38.31 -32.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.49 -41.89 62.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -84.85 -63.92 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 301' ' ' SER . 14.0 m -40.55 -37.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 111.162 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 300' ' ' VAL . 75.4 p -57.04 128.59 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.94 19.06 69.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.472 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -80.89 153.14 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.36 94.27 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.68 123.62 50.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.892 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 10.6 t70 56.4 49.39 15.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 34.8 p-80 48.6 35.62 6.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.5 167.41 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -95.48 103.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.438 HD12 ' CG1' ' A' ' 243' ' ' VAL . 14.6 tp -77.12 131.22 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.52 138.98 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 99.0 t -142.87 145.73 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -163.51 149.11 11.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.548 ' CD1' HD11 ' A' ' 297' ' ' ILE . 92.5 m95 -52.38 120.0 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.869 0.366 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.8 m -137.46 145.15 42.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 17.0 pt -141.94 145.11 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.556 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 38.0 ttt180 -105.47 156.36 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.468 ' N ' ' HG2' ' A' ' 242' ' ' ARG . 97.8 t -140.47 138.71 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 76.0 p -132.69 161.99 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.8 t30 74.53 48.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 310' ' ' LEU . 31.2 mt -103.67 146.1 29.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.407 ' HB2' ' CG ' ' A' ' 306' ' ' ASP . 1.3 t -85.52 156.94 20.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.13 -6.74 18.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.6 9.34 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 54.3 m -115.6 106.8 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -105.88 174.47 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -47.61 -59.79 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.2 t -54.14 -21.86 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.8 -30.47 40.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.7 mt -90.4 -26.63 19.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.2 pt20 -56.19 -26.33 50.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -91.54 -18.01 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.551 HD21 ' CE1' ' A' ' 259' ' ' PHE . 12.2 tp -82.12 -36.58 27.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.551 ' CE1' HD21 ' A' ' 258' ' ' LEU . 68.9 m-85 -98.47 11.7 37.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -79.39 -45.3 1.65 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.893 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.2 Cg_exo -47.93 -17.59 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -93.58 -32.18 14.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.16 -166.14 39.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.485 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.9 m -90.99 106.86 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 55.9 mt -59.94 150.52 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.545 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.0 t -98.82 -46.52 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 8.4 tpp180 -149.87 146.23 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.445 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 47.1 mt -126.55 106.92 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -99.04 149.69 22.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 56.0 tp -140.75 129.08 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.65 110.51 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -131.85 135.9 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -76.57 133.12 39.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -85.32 -37.24 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 46.5 m -64.81 -34.67 78.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 7.7 p -105.4 -50.41 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.55 28.59 6.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -114.28 172.79 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.7 t -93.68 113.63 25.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.563 ' HB3' ' CE1' ' A' ' 282' ' ' PHE . 34.4 mmtt -42.58 -69.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 149.18 32.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 7.6 p90 -166.32 161.39 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -149.48 165.54 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.556 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 74.2 m-85 -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.81 129.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.3 m -106.62 118.47 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -92.24 179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.1 m-70 -95.99 -35.88 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -123.69 165.05 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -71.11 -37.96 72.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -60.38 -69.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -44.72 -34.32 2.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.434 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -66.77 -43.04 85.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.076 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.2 77.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.086 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -50.48 -40.95 52.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -66.11 -66.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.435 HD13 ' NE1' ' A' ' 314' ' ' TRP . 84.9 mt -38.83 -40.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.59 19.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -71.04 -65.25 2.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 301' ' ' SER . 7.2 m -39.93 -42.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 10.5 t -49.4 116.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.21 62.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -78.63 155.27 29.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.12 76.9 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 0.4 OUTLIER -93.31 130.25 39.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 0.8 OUTLIER 47.19 54.13 9.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.496 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 29.0 p-80 48.46 33.18 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 62.0 mt -136.4 164.05 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -95.44 95.18 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.451 ' CD1' HD22 ' A' ' 246' ' ' LEU . 11.9 tp -63.74 134.65 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -118.21 130.8 56.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 313' ' ' GLU . 91.7 t -130.6 142.29 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 312' ' ' VAL . 2.0 pp20? -145.35 172.44 13.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.435 ' NE1' HD13 ' A' ' 297' ' ' ILE . 59.0 m95 -81.47 125.18 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.882 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.893 0.378 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 241' ' ' ILE . 14.5 m -132.76 143.46 49.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.439 HG21 ' CD1' ' A' ' 297' ' ' ILE . 27.6 pt -136.98 145.98 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -107.14 147.7 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 244' ' ' THR . 54.1 t -129.45 140.46 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' THR . . . . . 0.417 ' N ' HG11 ' A' ' 243' ' ' VAL . 10.1 p -138.09 165.8 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 21.1 t30 66.21 48.26 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.2 mt -93.83 177.88 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.5 t -115.69 159.08 21.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.74 -14.18 60.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.22 19.9 15.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 49.9 m -118.98 98.57 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -100.48 177.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -52.91 -42.57 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.6 t -68.1 -25.39 65.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 -23.75 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.96 -32.57 12.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.3 pt20 -52.09 -33.91 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.56 -15.61 36.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.49 -38.72 25.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.403 ' CE2' HD13 ' A' ' 241' ' ' ILE . 95.6 m-85 -95.48 11.33 33.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.614 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 7.9 tpt180 -79.03 -43.97 1.74 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.2 Cg_exo -47.93 -18.57 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.306 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 296' ' ' ALA . 30.4 m-85 -94.76 -34.39 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.98 -161.55 34.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -94.28 117.77 30.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 54.5 mt -71.57 144.98 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.509 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.6 t -95.27 -41.9 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -152.07 149.71 29.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 52.1 mt -130.68 105.6 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -98.46 141.46 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.0 tp -132.32 131.81 42.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -71.57 125.59 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -137.01 152.14 49.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.95 -178.22 5.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -109.71 -54.11 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 62.5 m -52.49 -72.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 2.0 t -76.57 -21.42 55.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 63.56 35.72 92.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -108.25 168.5 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 42.3 t -72.4 129.35 38.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -63.38 -74.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.86 32.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 8.2 p90 -165.96 159.75 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -150.97 165.13 34.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -132.08 116.06 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.48 125.85 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 16.4 m -102.21 116.93 33.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.71 -178.61 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.3 m-70 -97.22 -37.98 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -126.37 139.98 52.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -51.23 -28.23 11.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -66.0 -68.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.0 -30.11 9.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.24 83.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.093 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.78 -35.31 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -50.74 -41.04 56.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -70.0 -66.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.439 ' CD1' HG21 ' A' ' 241' ' ' ILE . 82.9 mt -38.2 -34.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -76.15 -51.12 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -69.53 -59.56 5.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 312' ' ' VAL . 15.3 m -49.38 -26.24 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.6 t -62.42 109.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.31 27.21 31.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -83.11 154.7 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -97.06 78.94 0.68 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.22 120.77 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.1 t70 51.16 52.62 14.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 27.9 p-80 48.74 26.98 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 66.4 mt -129.55 164.0 24.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -94.96 98.0 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -120.31 138.31 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 300' ' ' VAL . 89.4 t -146.41 151.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.089 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.02 152.1 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.431 ' NE1' HD13 ' A' ' 297' ' ' ILE . 78.1 m95 -55.3 126.11 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.06 179.914 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.849 0.357 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.9 m -141.85 135.7 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.422 HD13 ' CE2' ' A' ' 259' ' ' PHE . 41.1 pt -132.77 142.28 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -102.21 149.02 24.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.446 ' CG1' HD13 ' A' ' 310' ' ' LEU . 94.7 t -135.9 139.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 53.1 p -138.55 167.63 21.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 19.7 t-20 73.13 41.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.27 -175.16 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -125.49 170.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.87 -6.7 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.98 22.14 16.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 99.6 m -131.11 96.43 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.463 ' CG ' HG23 ' A' ' 253' ' ' THR . 11.7 ptt180 -107.09 -177.38 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -45.7 -50.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' THR . . . . . 0.463 HG23 ' CG ' ' A' ' 251' ' ' ARG . 1.4 t -59.51 -28.6 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.95 -27.03 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.06 -20.35 19.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.94 -33.81 76.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -93.2 -11.68 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 28.7 tp -82.78 -41.22 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.452 ' CZ ' HG11 ' A' ' 300' ' ' VAL . 64.2 m-85 -96.76 11.91 33.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.7 ttt-85 -77.52 -45.32 2.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.729 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.87 -17.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -92.74 -31.21 15.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.72 -164.13 37.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 31.3 m -91.12 107.43 19.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.461 HG21 ' CG1' ' A' ' 268' ' ' ILE . 82.8 mt -61.35 141.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.9 t -94.05 -45.81 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -150.27 149.17 29.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.461 ' CG1' HG21 ' A' ' 265' ' ' ILE . 46.9 mt -133.47 113.2 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.103 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 5.1 t80 -104.12 147.39 27.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.5 tp -134.74 128.9 33.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -72.99 129.45 38.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -135.43 175.59 9.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.53 170.67 8.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -113.43 -5.54 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.5 m -101.31 -35.9 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -121.22 -10.52 8.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.71 84.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -104.99 163.22 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 15.0 m -69.66 142.16 53.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -82.05 -74.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 166.83 31.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 11.4 p90 -165.49 150.39 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.888 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 162.55 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -127.23 117.9 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.26 129.1 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -107.9 124.89 50.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.17 179.96 4.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.5 m-70 -93.78 -36.34 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -124.25 179.76 4.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.87 -17.56 29.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -76.52 -59.36 2.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.11 -24.77 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.412 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -73.69 -41.27 62.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.73 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -49.66 -42.05 44.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.14 -62.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.524 ' CD1' ' NE1' ' A' ' 314' ' ' TRP . 71.3 mt -39.92 -37.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.97 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -82.47 -59.46 2.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.452 HG11 ' CZ ' ' A' ' 259' ' ' PHE . 6.8 m -49.41 -30.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 p -62.97 120.86 12.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.05 20.34 79.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.18 156.39 29.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -103.52 76.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.06 120.95 40.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.872 0.368 . . . . 0.0 110.954 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 56.79 49.38 14.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.585 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 18.1 p-80 45.83 31.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 34.5 mt -132.03 166.86 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -95.41 102.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.446 HD13 ' CG1' ' A' ' 243' ' ' VAL . 15.4 tp -71.81 134.62 46.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.67 130.29 56.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.44 ' CG2' HG23 ' A' ' 300' ' ' VAL . 97.6 t -136.19 144.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.48 157.77 30.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.524 ' NE1' ' CD1' ' A' ' 297' ' ' ILE . 80.1 m95 -62.95 123.63 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.888 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.2 m -142.89 145.01 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.55 HD11 ' CE2' ' A' ' 259' ' ' PHE . 37.6 pt -140.0 142.18 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.518 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 62.5 ttt180 -105.6 153.81 21.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.461 ' CG1' HD13 ' A' ' 310' ' ' LEU . 91.4 t -138.3 142.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 61.6 p -138.16 167.5 21.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 73.59 43.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.78 177.57 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 85.3 p -121.54 -175.16 3.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.77 -1.86 58.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.24 18.8 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.508 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 53.0 m -127.61 111.56 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 179.08 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -52.1 -38.97 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -68.1 -18.91 64.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -86.6 -26.19 24.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -91.61 -22.76 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -62.31 -35.32 78.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -92.45 -10.73 36.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 259' ' ' PHE . 25.9 tp -85.79 -34.51 21.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.562 ' CZ ' HG11 ' A' ' 300' ' ' VAL . 77.6 m-85 -104.69 11.46 34.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.581 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.7 tpt180 -80.25 -45.68 1.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.6 Cg_exo -47.95 -20.43 2.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.5 m-85 -88.84 -31.26 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.97 34.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 18.7 m -91.39 118.66 30.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 266' ' ' SER . 72.9 mt -74.02 136.25 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.517 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.3 t -87.32 -42.18 13.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -154.9 160.0 40.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.71 116.06 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -113.16 148.88 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 61.0 tp -139.87 127.32 21.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 282' ' ' PHE . . . -73.2 123.45 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -136.15 146.03 46.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.17 177.22 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -114.7 -61.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.7 m -53.02 -41.41 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 t -102.01 -22.58 14.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.64 32.8 84.67 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -109.02 140.12 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 47.2 t -54.86 124.67 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -55.1 -74.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.01 33.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 271' ' ' ALA . 36.5 p90 -165.97 146.46 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.5 164.18 27.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.2 m-85 -131.06 112.63 13.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.9 mp -100.13 127.82 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 7.3 m -102.14 120.77 40.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -96.29 177.49 5.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 264' ' ' SER . 10.9 m-70 -96.5 -47.95 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -112.14 164.03 13.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 13.4 ttp-105 -71.75 -31.58 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.6 -61.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.99 -37.17 52.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.47 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -68.04 -39.13 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.65 -37.41 70.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -49.25 -42.91 42.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -63.49 -67.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 314' ' ' TRP . 85.8 mt -36.03 -32.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.127 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -70.98 -45.88 63.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -79.46 -64.96 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 259' ' ' PHE . 26.5 m -40.01 -36.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.894 0.378 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.442 ' N ' HG23 ' A' ' 300' ' ' VAL . 64.6 p -61.37 112.37 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.88 17.65 57.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -79.51 157.87 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.907 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.93 82.28 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . 0.508 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.3 OUTLIER -99.39 129.74 45.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.449 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 0.5 OUTLIER 47.77 53.69 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 31.2 p-80 45.61 39.53 5.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 77.5 mt -143.53 168.19 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -96.7 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.461 HD13 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -70.19 138.04 51.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.27 132.18 56.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 313' ' ' GLU . 79.4 t -137.06 143.4 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.43 ' N ' HG11 ' A' ' 312' ' ' VAL . 20.3 pt-20 -153.53 161.89 41.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.544 ' CD1' HD13 ' A' ' 297' ' ' ILE . 65.4 m95 -65.25 125.27 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.862 0.363 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.4 m -139.36 144.05 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 34.4 pt -138.62 144.06 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -100.79 152.84 20.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.77 140.52 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.8 p -133.65 169.47 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.62 53.12 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' A' ' 310' ' ' LEU . 19.8 mt -103.53 166.38 10.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.0 p -111.69 155.33 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.28 -5.82 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 19.59 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.0 m -131.1 99.62 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -103.57 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -51.04 -40.79 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.7 t -67.95 -30.89 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 -28.53 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.74 -26.56 20.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.56 -32.29 73.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.66 -15.13 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.79 -35.72 20.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.423 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.6 m-85 -100.92 8.57 43.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.624 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.6 OUTLIER -80.86 -42.86 1.23 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.568 0.699 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.5 Cg_exo -47.91 -17.98 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.2 m-85 -92.84 -31.8 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.15 36.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.556 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 49.0 m -91.28 116.33 28.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 34.4 mt -73.89 147.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.561 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.2 t -98.68 -43.14 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -151.57 153.89 35.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 89.1 mt -138.46 122.2 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.5 t80 -112.6 149.54 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.8 tp -135.49 127.43 29.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.567 ' HB3' ' CE2' ' A' ' 282' ' ' PHE . . . -69.42 121.59 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -128.74 150.59 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.21 -176.74 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -111.2 -62.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.9 m -47.22 -69.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 10.2 t -77.37 -34.01 55.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.76 39.46 39.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.21 -176.9 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 35.1 t -80.44 126.04 30.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -66.68 -74.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.85 32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.464 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 271' ' ' ALA . 19.8 p90 -166.02 151.26 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.923 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 246' ' ' LEU . . . -141.83 165.19 28.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -129.42 116.56 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.8 131.89 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -110.92 121.32 45.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -94.63 -178.87 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 14.3 m-70 -95.25 -35.91 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . 0.437 ' NH1' ' OD2' ' A' ' 292' ' ' ASP . 18.0 mtt85 -124.68 169.45 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -80.71 -23.48 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.5 -46.17 27.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 289' ' ' ARG . 15.7 m-20 -67.15 -35.28 79.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.504 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -69.37 -37.28 77.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.82 77.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -48.65 -42.63 35.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.85 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.484 ' CD1' ' NE1' ' A' ' 314' ' ' TRP . 89.8 mt -35.42 -37.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.95 -54.58 17.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -67.05 -66.97 2.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 312' ' ' VAL . 30.0 m -42.97 -37.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 1.7 t -50.81 113.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.47 24.85 60.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -86.3 137.78 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.41 97.06 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 116.88 30.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 14.9 t70 63.13 53.41 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 28.7 p-80 48.8 26.61 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.1 mt -129.8 165.82 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -97.98 101.1 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.445 ' CD1' HD23 ' A' ' 246' ' ' LEU . 14.0 tp -73.32 137.65 44.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.5 150.69 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 300' ' ' VAL . 48.5 t -149.1 142.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.448 ' N ' HG11 ' A' ' 312' ' ' VAL . 8.7 pt-20 -155.74 153.22 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 293' ' ' ALA . 83.5 m95 -61.79 125.95 25.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.884 0.373 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 65.1 m -143.08 140.19 30.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.0 pt -138.81 140.97 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.493 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 55.8 ttt180 -103.36 146.94 27.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 312' ' ' VAL . 89.9 t -132.74 142.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 74.3 p -136.93 167.1 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 72.28 43.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.96 176.94 6.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.401 ' CB ' ' CG ' ' A' ' 306' ' ' ASP . 15.9 t -124.63 151.99 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -54.74 -28.38 48.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.75 18.85 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 89.5 m -132.67 98.07 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.3 -174.41 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -45.57 -62.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.2 t -46.89 -34.99 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.02 -31.15 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.4 mt -86.33 -25.79 25.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.461 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 25.5 tt0 -62.72 -35.9 81.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.56 -25.65 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.465 HD21 ' CE1' ' A' ' 259' ' ' PHE . 14.2 tp -74.94 -39.52 61.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 300' ' ' VAL . 77.0 m-85 -95.96 12.02 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -77.82 -45.37 2.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.607 0.717 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.93 -17.6 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.349 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 40.0 m-85 -91.02 -40.01 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 171.27 -160.53 32.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.602 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.2 m -92.17 107.6 19.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 55.1 mt -64.86 143.05 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.569 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.3 t -91.85 -49.64 6.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -141.02 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 80.0 mt -134.99 101.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.5 t80 -92.66 142.77 27.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 53.8 tp -129.47 128.48 43.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.4 115.58 4.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.95 134.93 37.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.87 162.56 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 275' ' ' THR . 4.4 ptmt -100.37 -35.11 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.455 ' N ' ' HG3' ' A' ' 274' ' ' LYS . 93.7 m -74.95 -41.46 59.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 31.1 p -94.16 -38.55 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.23 43.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -136.18 179.26 6.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 39.9 m -85.59 109.1 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -48.92 -66.88 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 151.25 33.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 52.7 p90 -165.97 147.52 6.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -138.23 174.36 10.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.493 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.1 m-85 -139.88 115.13 9.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.3 mp -101.37 124.05 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.9 m -102.71 112.25 24.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -84.95 169.85 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -85.92 -39.89 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.37 173.19 6.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.92 -39.12 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.87 -61.59 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -49.87 -38.63 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.46 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -66.56 -45.98 77.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -48.33 -42.03 30.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.75 -71.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.468 HD11 ' NE1' ' A' ' 314' ' ' TRP . 87.4 mt -34.23 -42.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.27 81.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -76.28 -66.08 1.91 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 259' ' ' PHE . 26.1 m -42.25 -43.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.464 ' N ' HG21 ' A' ' 300' ' ' VAL . 13.0 t -48.9 104.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 90.33 33.62 8.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -96.33 130.89 43.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -79.08 52.62 4.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.47 128.03 34.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 53.9 m-20 62.2 54.35 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.91 31.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 306' ' ' ASP . 82.9 mt -140.04 168.49 19.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 309' ' ' ILE . 2.4 mp -89.58 97.96 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.14 140.15 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.92 144.47 48.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 243' ' ' VAL . 71.5 t -150.65 150.05 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -166.11 165.58 17.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.468 ' NE1' HD11 ' A' ' 297' ' ' ILE . 85.5 m95 -66.99 125.38 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.883 0.373 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 241' ' ' ILE . 20.5 m -143.68 145.48 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.447 ' N ' HG23 ' A' ' 240' ' ' THR . 30.8 pt -140.63 142.84 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.494 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 72.2 ttt180 -104.14 149.07 25.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.429 HG23 ' CD1' ' A' ' 285' ' ' ILE . 93.4 t -134.74 142.29 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 17.2 p -140.64 166.71 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 38.2 t-20 72.32 41.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.9 mt -92.11 169.6 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 306' ' ' ASP . 11.2 t -110.7 155.52 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.3 -28.92 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.89 22.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.3 m -127.92 96.77 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.173 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.4 ' HE ' ' CG2' ' A' ' 253' ' ' THR . 8.0 ptt180 -99.75 -174.33 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.06 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 254' ' ' ASP . 13.6 t -50.81 -28.07 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 253' ' ' THR . 9.8 m-20 -72.19 -27.79 62.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.64 -32.45 13.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -52.72 -30.59 33.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.93 -25.02 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.0 -36.85 56.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -96.05 11.4 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.606 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.2 OUTLIER -79.64 -44.57 1.58 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 110.888 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.94 -19.12 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 39.5 m-85 -89.71 -40.09 12.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.33 -160.22 30.63 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -93.03 113.28 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.47 HG21 ' N ' ' A' ' 266' ' ' SER . 39.9 mt -71.36 141.9 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.5 t -89.19 -46.89 8.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -147.55 156.49 42.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 53.6 mt -138.24 105.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -93.22 143.48 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 49.9 tp -127.74 132.8 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 282' ' ' PHE . . . -65.91 113.31 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -136.31 125.79 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.42 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -110.78 -40.08 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.6 m -67.08 -73.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 12.2 t -79.87 -43.21 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.52 38.24 7.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -99.66 149.7 23.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 13.5 t -57.88 116.89 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -63.72 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.62 33.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.565 ' CD2' ' HB1' ' A' ' 271' ' ' ALA . 41.7 p90 -165.98 154.57 11.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.42 174.05 11.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 91.0 m-85 -139.37 111.78 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.429 ' CD1' HG23 ' A' ' 243' ' ' VAL . 4.3 mp -95.69 123.65 47.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 67.9 m -100.38 114.18 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.48 ' CG ' ' HA ' ' A' ' 293' ' ' ALA . 12.2 m-85 -87.59 169.71 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -86.69 -40.87 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.37 173.91 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -77.91 -38.85 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.91 -62.04 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.21 -40.41 47.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 287' ' ' PHE . . . -65.78 -46.28 79.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.72 99.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -47.35 -41.54 19.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.22 -70.91 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.482 ' O ' ' CB ' ' A' ' 301' ' ' SER . 87.4 mt -34.44 -43.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.7 87.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -75.63 -66.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.509 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.405 HG21 ' CG2' ' A' ' 312' ' ' VAL . 25.6 m -43.33 -42.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 10.7 t -47.92 108.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.66 31.4 18.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -94.96 135.37 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -81.21 52.86 4.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.98 129.61 37.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 0.0 110.908 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 58.1 m-20 62.07 54.19 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 38.23 30.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 306' ' ' ASP . 91.9 mt -141.41 169.63 17.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.36 101.93 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.32 149.52 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.85 127.41 43.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 313' ' ' GLU . 93.9 t -137.33 151.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.452 ' N ' HG12 ' A' ' 312' ' ' VAL . 12.6 pt-20 -169.45 151.93 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -53.51 126.43 21.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 241' ' ' ILE . 91.2 m -135.15 150.7 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 259' ' ' PHE . 23.7 pt -142.23 144.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -107.38 152.15 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.405 ' CG1' HD11 ' A' ' 310' ' ' LEU . 99.0 t -137.11 138.02 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 60.8 p -133.27 165.29 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 16.6 t-20 73.77 49.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.52 176.33 5.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -123.75 -176.88 3.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.43 -5.14 58.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.8 19.57 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.1 m -122.29 96.43 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -105.76 173.7 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -48.69 -42.61 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -23.38 66.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.99 -30.07 35.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.3 mt -86.59 -31.94 20.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 1.3 tm0? -54.75 -50.13 69.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.03 -19.03 60.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.2 tp -80.16 -35.58 36.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 300' ' ' VAL . 59.6 m-85 -101.72 11.89 38.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -78.45 -45.21 2.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.587 0.708 . . . . 0.0 110.926 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.5 Cg_exo -48.03 -17.55 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.371 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.526 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.5 m-85 -91.41 -32.71 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.87 -162.93 36.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.25 106.25 18.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 61.8 mt -61.44 143.41 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.514 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 31.5 t -94.1 -47.67 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -149.4 153.19 36.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 74.5 mt -139.08 113.07 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.1 t80 -104.6 152.82 21.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 62.1 tp -133.14 128.44 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.559 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -66.64 121.42 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -136.91 140.13 42.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.97 170.07 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.82 -42.15 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 97.2 m -74.67 -73.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.105 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 12.9 t -70.2 -25.87 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.45 37.38 92.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -99.47 175.87 5.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.6 t -84.3 118.56 24.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -61.47 -74.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.57 34.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 22.8 p90 -165.55 151.28 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.3 169.04 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -134.58 116.06 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 285' ' ' ILE . 3.2 mp -104.29 134.55 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.9 t -106.27 144.1 33.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.433 ' HB2' ' CB ' ' A' ' 293' ' ' ALA . 18.7 m-85 -119.91 169.96 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 5.7 m-70 -94.31 -40.86 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -110.16 152.81 25.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -71.74 -16.41 62.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -85.88 -41.86 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.36 -35.81 78.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 287' ' ' PHE . . . -71.33 -35.84 71.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -74.17 -35.98 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -49.46 -43.23 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.93 -66.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 88.6 mt -34.3 -34.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -72.07 -50.63 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.79 -65.67 2.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 259' ' ' PHE . 13.6 m -43.43 -28.81 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t -62.79 114.35 3.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.92 68.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 52.1 t80 -78.23 163.29 25.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . 0.41 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -108.87 83.69 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.52 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.45 120.24 40.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.417 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 53.3 m-20 57.92 52.48 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.573 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 22.5 p-80 44.3 36.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 70.4 mt -139.09 166.63 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -93.7 101.8 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.405 HD11 ' CG1' ' A' ' 243' ' ' VAL . 14.6 tp -74.3 134.41 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.63 138.78 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 300' ' ' VAL . 68.9 t -140.47 148.34 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.07 153.05 13.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.488 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 83.3 m95 -54.52 122.0 9.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.878 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.886 0.374 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -134.92 142.71 46.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 29.5 pt -139.7 140.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.145 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 74.8 ttt180 -103.27 151.17 23.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.62 144.66 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 64.5 p -140.82 171.66 13.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m120 64.58 48.43 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.0 mt -100.9 -177.58 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.3 t -126.81 176.51 7.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.83 -24.69 48.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.38 20.16 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 97.9 m -132.75 96.41 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.538 ' NE ' ' CG2' ' A' ' 253' ' ' THR . 23.2 ptt-85 -101.48 -173.31 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -55.62 -64.3 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' THR . . . . . 0.538 ' CG2' ' NE ' ' A' ' 251' ' ' ARG . 1.8 t -50.68 -19.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.447 ' OD2' ' NH1' ' A' ' 251' ' ' ARG . 3.2 m-20 -82.82 -29.3 29.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.59 -27.83 17.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.26 -31.47 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.91 -24.91 26.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.6 tp -73.6 -35.37 65.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' PHE . . . . . 0.52 ' CE2' ' CD1' ' A' ' 241' ' ' ILE . 59.1 m-85 -97.62 10.17 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ARG . . . . . 0.601 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.3 tpt85 -75.97 -44.54 3.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.7 Cg_exo -48.0 -18.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.6 m-85 -93.37 -38.52 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.22 32.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.468 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.56 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 4.4 m -92.86 116.06 28.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 45.3 mt -74.47 140.14 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.538 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.9 t -89.97 -50.47 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -140.03 155.95 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.86 105.12 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -97.24 142.83 28.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.8 tp -126.01 131.76 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.12 119.83 11.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -136.66 122.12 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.64 -179.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -113.31 -41.74 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 89.5 m -65.94 -56.96 9.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.1 t -94.65 -15.41 24.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.6 85.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -112.07 171.22 7.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 60.5 p -77.64 113.2 15.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -68.06 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.76 34.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 39.5 p90 -162.34 146.25 11.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -136.34 167.79 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.141 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.5 m-85 -135.15 111.73 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.48 127.48 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -104.33 112.92 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -84.21 176.44 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -92.76 -41.63 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -113.4 172.65 6.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -81.31 -37.1 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.08 -54.34 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.2 -37.08 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.553 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -66.13 -46.34 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.5 98.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -46.77 -42.19 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -71.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ILE . . . . . 0.555 HD12 ' CD1' ' A' ' 314' ' ' TRP . 92.0 mt -35.81 -40.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.01 87.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.99 -62.59 1.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 259' ' ' PHE . 16.2 m -46.03 -20.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 103.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.48 29.06 9.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.89 133.51 34.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -82.25 54.38 4.87 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.03 130.07 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 110.972 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 56.6 m-20 62.08 55.03 2.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.73 31.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 306' ' ' ASP . 90.2 mt -141.52 170.64 15.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 309' ' ' ILE . 2.2 mp -89.49 100.88 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.77 143.45 56.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -125.37 129.43 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 313' ' ' GLU . 56.4 t -137.85 140.15 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 312' ' ' VAL . 12.0 pt-20 -156.6 156.02 32.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.555 ' CD1' HD12 ' A' ' 297' ' ' ILE . 80.3 m95 -57.51 128.01 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.907 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.5 m -114.43 124.17 51.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.854 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 9.6 t -47.26 147.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.59 56.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 18.0 m -85.09 156.34 21.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m -156.85 146.28 20.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -148.68 -69.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.76 101.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -57.59 97.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 74.8 mmt-85 -106.95 98.33 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -96.69 83.68 3.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -102.94 115.32 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -122.15 -17.59 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -134.03 -45.24 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -48.11 152.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -85.81 108.79 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.7 m -135.89 136.28 40.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.413 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 45.0 pt -132.67 142.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -99.88 150.38 22.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.9 t -136.88 141.17 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 18.3 p -141.5 163.94 31.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 29.6 t30 70.45 52.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 26.1 mt -93.93 -178.56 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.8 t -118.19 169.77 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.68 -21.47 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.89 20.26 13.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 52.8 m -113.17 99.42 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -110.15 -177.47 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -55.86 -42.14 75.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.8 t -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.111 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -28.95 47.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.6 mt -86.33 -31.15 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 11.2 tt0 -59.0 -31.67 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.33 -16.7 28.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.0 tp -82.94 -37.85 23.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.552 ' CE2' HG13 ' A' ' 300' ' ' VAL . 65.1 m-85 -98.03 10.97 39.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.9 tmt_? -76.56 -45.27 3.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 66.0 Cg_exo -48.02 -17.23 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.4 m-85 -93.38 -33.09 14.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 164.65 -162.62 35.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.0 m -90.39 117.26 28.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 266' ' ' SER . 46.9 mt -75.71 140.94 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.554 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -88.35 -45.02 10.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -150.78 153.5 35.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 44.7 mt -136.18 105.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 4.6 t80 -96.95 146.96 24.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 12.4 tp -140.95 125.84 18.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.524 ' HB1' ' CE2' ' A' ' 282' ' ' PHE . . . -62.75 119.44 9.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -130.95 149.07 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.35 163.65 13.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -101.0 -29.93 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 74.4 m -81.62 -37.75 27.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.2 p -98.96 -34.14 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.5 44.57 89.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -129.93 -175.88 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.359 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 49.9 m -86.24 106.05 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -40.65 -56.63 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.54 -23.09 0.84 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' HB1' ' A' ' 271' ' ' ALA . 14.4 p90 -115.84 159.7 21.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -147.27 168.45 21.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -136.05 113.64 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.94 133.74 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 25.3 m -108.03 123.13 48.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -98.74 169.95 9.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 12.3 m-70 -87.76 -47.09 8.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt-85 -108.37 165.3 11.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -76.65 -24.0 53.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.44 -49.98 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.14 -37.99 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.9 -43.75 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.0 91.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -48.98 -40.03 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -70.75 -64.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.559 HD13 ' CD1' ' A' ' 314' ' ' TRP . 82.7 mt -37.97 -33.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.04 38.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -77.88 -62.35 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.497 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.552 HG13 ' CE2' ' A' ' 259' ' ' PHE . 7.5 m -42.49 -27.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.4 t -70.03 109.45 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 91.1 16.61 53.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.17 158.58 33.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.81 65.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.31 127.54 34.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 4.5 m-20 46.64 50.74 12.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 35.1 p-80 46.3 44.32 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 88.7 mt -146.45 168.64 20.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -96.74 95.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 25.9 tp -60.96 146.05 48.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -119.7 129.67 54.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.456 ' CB ' HG22 ' A' ' 300' ' ' VAL . 76.6 t -141.19 147.5 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.85 149.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.559 ' CD1' HD13 ' A' ' 297' ' ' ILE . 79.8 m95 -51.18 122.72 8.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -53.06 -32.47 47.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -97.19 152.57 38.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.713 . . . . 0.0 110.88 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.42 157.06 32.85 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.671 2.248 . . . . 0.0 112.355 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 61.8 p -93.21 45.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.99 0.424 . . . . 0.0 110.889 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 9.4 t -63.13 -42.22 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.155 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.96 164.17 26.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.8 p -133.53 45.51 2.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 112.36 95.64 2.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.9 -177.02 3.32 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.307 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.7 m -43.95 147.68 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -104.81 112.18 25.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.544 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.6 t -58.49 155.02 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.862 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.8 t -133.96 138.09 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.61 -118.27 3.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 t 68.06 42.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.898 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 65.41 8.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 66.01 -152.5 51.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.76 168.89 22.77 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.32 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.35 142.39 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -75.77 163.87 26.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -127.25 147.83 50.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -169.71 172.2 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -159.8 134.18 7.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 48.17 38.23 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -122.57 145.52 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.39 109.34 16.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 25.7 m -139.01 147.53 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 259' ' ' PHE . 32.3 pt -141.54 143.16 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 49.7 ttt-85 -98.67 150.98 21.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.2 t -139.1 139.07 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 30.7 p -138.8 173.72 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 20.4 t-20 69.24 48.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.72 -178.28 3.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.952 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.9 t -126.47 179.26 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.18 -3.91 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.66 21.63 17.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.6 m -127.49 116.78 20.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 172.07 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.2 -47.47 62.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.6 t -60.4 -29.0 68.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.45 -23.35 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.04 -28.11 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -54.76 -28.01 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.31 -19.5 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.56 -36.76 44.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.553 ' CE2' HD11 ' A' ' 241' ' ' ILE . 88.4 m-85 -95.92 10.43 37.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 ttt-85 -78.87 -45.17 1.84 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.333 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.489 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -95.56 -31.94 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 167.76 -160.53 34.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.597 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.7 m -95.2 111.03 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 259' ' ' PHE . 66.5 mt -65.87 147.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.553 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 33.4 t -97.89 -46.88 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 14.1 tpp180 -147.05 146.01 29.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.409 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 39.8 mt -130.63 99.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.088 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.661 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -93.79 152.72 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.661 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 47.5 tp -141.71 143.27 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -84.9 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.19 153.98 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -99.43 157.37 16.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.31 0.3 33.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 93.4 m -111.43 -20.61 12.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 32.7 p -121.48 -16.1 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.14 37.44 80.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.57 -179.26 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 t -85.3 115.99 23.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -46.87 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.82 32.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 25.8 p90 -165.95 155.94 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -149.42 174.04 12.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.15 120.11 16.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.9 mp -106.64 124.52 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 50.4 m -101.45 118.51 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CE2' ' O ' ' A' ' 292' ' ' ASP . 7.8 m-85 -92.62 176.02 6.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 264' ' ' SER . 9.6 m-70 -95.57 -50.03 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -108.04 149.46 28.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -69.46 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.51 -25.51 20.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.497 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 6.4 m-20 -88.57 -25.31 22.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.438 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -80.35 -33.98 36.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.31 -33.63 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -59.44 -37.79 79.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.489 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.2 -63.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 314' ' ' TRP . 61.1 mt -39.94 -35.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -72.67 -56.63 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.8 -61.41 5.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 312' ' ' VAL . 3.7 m -48.05 -35.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t -59.81 104.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.6 27.1 10.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -91.09 148.99 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -92.8 78.22 1.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.52 127.07 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 11.3 t70 52.66 48.14 23.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.565 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 46.52 32.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 45.9 mt -133.7 171.82 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.599 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -97.95 94.73 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.93 136.19 54.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -116.79 142.89 46.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 300' ' ' VAL . 99.2 t -146.67 144.78 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.37 149.02 8.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.438 ' CH2' ' HB3' ' A' ' 293' ' ' ALA . 95.6 m95 -49.59 130.3 20.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.6 62.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -53.0 144.27 28.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.533 0.683 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.37 -41.2 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.704 2.269 . . . . 0.0 112.337 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 99.3 p -105.88 122.82 46.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 80.7 p -123.24 127.81 49.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -92.31 163.26 13.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.4 t -105.74 -56.79 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.05 94.76 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.12 135.2 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 0.0 112.311 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.9 p -139.62 146.79 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.8 m -86.97 151.59 23.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.6 p -55.04 112.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t 53.29 42.3 32.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.69 174.04 27.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 229' ' ' SER . 37.2 t -140.03 134.56 31.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.372 . . . . 0.0 110.852 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 228' ' ' SER . 99.5 p -35.75 112.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 53.65 95.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.51 133.08 12.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.712 2.275 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -100.52 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -93.03 117.72 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.34 -58.48 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -161.97 106.82 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -82.75 112.69 19.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.31 -71.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.22 179.85 6.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -106.01 92.85 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -143.29 143.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.9 pt -140.85 147.05 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.537 ' HG3' ' CE1' ' A' ' 284' ' ' PHE . 17.0 ttt180 -112.32 148.77 33.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.468 ' N ' ' HG2' ' A' ' 242' ' ' ARG . 67.3 t -127.49 148.99 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.4 p -143.24 163.11 33.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.79 38.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.8 mt -82.72 -174.97 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 248' ' ' GLU . 27.3 t -125.78 178.85 5.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.4 ' N ' ' OG ' ' A' ' 247' ' ' SER . 4.3 mm-40 -76.46 -50.47 13.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.11 -4.8 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 44.2 m -98.51 103.13 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -175.5 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -51.17 -56.21 13.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.3 t -55.31 -21.79 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.156 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -82.47 -30.4 29.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.87 -26.53 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.454 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -56.79 -33.58 66.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -89.96 -18.44 26.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.8 tp -78.64 -34.23 46.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -101.0 11.91 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 8.2 tpt180 -78.24 -45.24 2.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 0.0 110.859 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.01 -17.21 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.0 m-85 -92.56 -35.91 13.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.27 -161.45 34.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.9 m -90.31 117.28 28.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 74.9 mt -72.78 144.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.157 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.515 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.2 t -97.98 -48.09 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.0 tpt180 -145.44 151.46 38.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 65.3 mt -140.23 113.68 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 4.9 t80 -109.31 141.58 41.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 18.4 tp -129.92 121.13 26.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -61.63 122.49 15.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.122 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -134.96 149.33 50.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.27 178.82 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.29 -48.27 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 58.3 m -67.48 -42.38 83.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 -14.47 17.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 50.63 41.64 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -117.7 163.81 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.2 p -70.91 129.95 40.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -68.77 -75.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.71 32.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 24.2 p90 -165.99 157.96 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.73 171.3 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.537 ' CE1' ' HG3' ' A' ' 242' ' ' ARG . 97.7 m-85 -136.84 106.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 286' ' ' SER . 4.3 mp -94.78 136.99 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.423 ' N ' HG21 ' A' ' 285' ' ' ILE . 15.7 m -113.93 118.62 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -93.07 172.84 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -89.69 -43.57 10.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -116.62 168.92 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -76.89 -35.52 57.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.95 -55.29 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.86 -37.78 74.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.496 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -63.6 -44.26 94.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.56 -37.23 82.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.067 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmm-85 -50.05 -41.0 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.64 -65.86 0.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.119 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.497 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 82.5 mt -35.04 -33.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.53 -51.71 9.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -60.67 5.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.432 HG23 ' CG2' ' A' ' 312' ' ' VAL . 13.7 m -51.24 -31.58 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.3 t -61.59 119.55 8.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.32 69.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 66.9 t80 -83.71 165.42 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.442 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -110.98 82.36 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.4 120.59 41.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 21.7 t70 61.01 48.7 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 27.6 p-80 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.94 167.54 21.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -94.52 95.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 22.4 tp -60.83 143.49 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -123.93 130.86 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 313' ' ' GLU . 26.4 t -139.81 151.31 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.442 ' N ' HG11 ' A' ' 312' ' ' VAL . 7.9 pt-20 -169.39 149.82 4.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.876 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 86.2 m95 -47.89 136.08 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -125.44 11.13 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.125 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.61 150.35 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 44.59 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.8 p -44.49 108.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.9 t -145.12 150.85 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -106.06 151.51 24.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.7 t -148.71 147.32 28.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -84.13 168.59 44.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.535 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.53 17.67 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.35 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 41.6 p -46.67 137.3 7.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 99.6 p -100.64 159.55 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 61.2 p -69.94 -18.03 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.3 t -124.94 121.46 34.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 83.02 59.77 2.13 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.4 m -155.46 134.57 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -78.08 -69.6 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.05 -91.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.506 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.6 -21.19 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 61.24 41.65 13.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -153.12 169.27 23.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.1 mmt-85 -128.03 98.01 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -120.76 -39.8 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -57.71 131.24 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.5 40.15 3.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -147.62 173.38 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -117.82 94.58 4.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.8 m -134.34 141.0 46.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 35.4 pt -140.54 145.23 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -104.39 149.17 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 73.8 t -133.09 135.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 31.0 p -130.26 171.76 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.42 51.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.7 mt -95.77 -177.52 4.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 t -122.23 164.27 18.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.48 -11.53 60.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -105.24 21.1 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 59.1 m -121.14 98.43 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -103.29 170.07 8.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -47.82 -43.4 27.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -23.67 64.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.55 -28.76 46.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.52 -30.84 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 7.1 pt20 -53.14 -33.56 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.55 -12.85 44.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.87 -37.23 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -96.89 10.37 39.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.4 tpt85 -76.9 -45.32 2.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.63 0.729 . . . . 0.0 110.826 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.3 Cg_exo -47.96 -17.24 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.646 2.23 . . . . 0.0 112.354 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.559 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.8 m-85 -94.22 -32.47 13.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.22 -166.66 39.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.47 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.7 m -90.32 112.86 24.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 37.1 mt -69.34 145.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 26.7 t -96.56 -44.88 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 16.7 tpp180 -148.34 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 41.5 mt -131.31 96.58 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -91.76 150.41 21.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.5 tp -142.14 120.16 12.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.5 131.8 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -134.5 174.39 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.19 164.91 13.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -107.24 -6.26 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 55.8 m -102.11 -58.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -6.84 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.83 26.87 65.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -88.09 138.73 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.5 t -47.35 127.74 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -62.22 -57.43 11.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.91 -9.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.65 149.5 52.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.78 169.4 17.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.131 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -134.21 117.56 16.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 286' ' ' SER . 3.7 mp -103.78 136.85 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' SER . . . . . 0.449 ' N ' HG23 ' A' ' 285' ' ' ILE . 3.3 m -112.02 124.85 53.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 292' ' ' ASP . 17.6 m-85 -98.78 171.74 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 12.6 m-70 -89.88 -40.26 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -118.94 158.87 24.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 17.0 ttp-105 -74.6 -13.26 60.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.91 -29.18 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.465 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -84.36 -28.55 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' A' ' 287' ' ' PHE . . . -77.6 -33.77 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.97 65.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -49.14 -44.68 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -59.78 -66.65 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 314' ' ' TRP . 81.2 mt -39.86 -34.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.0 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -85.15 -57.05 2.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.455 HG22 ' CG2' ' A' ' 312' ' ' VAL . 17.2 m -47.37 -32.7 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 111.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.2 p -55.74 122.28 11.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.48 78.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.01 136.97 38.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -84.89 92.61 1.76 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.6 112.51 24.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.888 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 7.8 t70 63.62 52.94 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 33.3 p-80 45.91 27.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 30.8 mt -129.09 162.74 27.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -93.96 104.75 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.81 140.72 38.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -122.92 145.82 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.559 ' N ' HD21 ' A' ' 311' ' ' ASN . 49.6 t -145.61 136.37 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -146.68 168.1 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.551 ' CD1' HD13 ' A' ' 297' ' ' ILE . 75.8 m95 -81.06 122.29 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -113.4 177.31 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -144.32 139.99 16.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.01 156.74 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.2 m -119.87 -50.97 2.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 4.4 t -53.63 152.49 5.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -129.3 88.91 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.3 m -89.25 -48.44 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.68 -154.74 16.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.04 155.3 33.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.36 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 14.7 t -121.95 131.56 54.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.6 t -139.55 150.6 45.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 p -121.49 -0.67 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.7 m -158.13 144.26 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.33 -37.07 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 70.8 m -115.22 -59.37 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.885 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 84.2 p -97.81 128.24 44.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.82 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.99 89.01 2.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.08 165.83 27.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.687 2.258 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -92.56 -61.85 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -94.34 116.3 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.04 -54.39 4.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -55.68 142.62 33.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -166.32 157.07 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.27 -45.09 7.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -151.72 176.43 11.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.45 108.0 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.0 m -140.77 124.6 17.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 28.1 pt -122.61 145.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -107.92 151.88 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.447 ' CG1' HD12 ' A' ' 310' ' ' LEU . 95.6 t -139.0 141.84 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 43.3 p -139.48 170.06 16.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 30.8 t-20 73.58 38.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.48 -175.97 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 52.6 p -127.34 175.61 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.79 -14.41 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -95.33 12.99 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 51.4 m -119.02 109.34 15.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 251' ' ' ARG . 0.0 OUTLIER -112.13 176.88 4.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -49.42 -43.33 44.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -25.42 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.38 -28.31 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.51 -25.3 16.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -61.31 -30.17 70.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.69 -16.81 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.49 -38.75 33.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.49 ' CE2' HG11 ' A' ' 300' ' ' VAL . 56.5 m-85 -95.5 8.99 41.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.4 OUTLIER -75.07 -45.44 4.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.1 Cg_exo -47.98 -18.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.385 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -93.49 -32.16 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.11 -166.39 39.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.23 113.79 25.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 84.2 mt -68.09 145.09 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.098 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.492 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 39.4 t -93.95 -47.37 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -149.25 149.94 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.3 mt -130.99 104.88 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.5 t80 -98.87 136.2 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.72 127.98 39.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 282' ' ' PHE . . . -64.13 129.17 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -134.59 150.44 50.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.98 177.77 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -112.09 -56.89 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.5 m -55.26 -53.19 59.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 8.6 t -92.08 -24.11 19.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 61.85 43.59 99.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.97 176.04 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 65.3 p -80.79 129.08 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -63.58 -72.9 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.39 33.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 271' ' ' ALA . 21.5 p90 -165.74 151.92 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.844 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.32 165.06 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -131.59 111.16 11.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.02 124.37 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 18.7 m -101.04 115.47 30.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.464 ' CE2' ' O ' ' A' ' 292' ' ' ASP . 10.7 m-85 -88.22 176.29 7.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 264' ' ' SER . 14.5 m-70 -94.65 -43.76 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -114.32 168.55 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.4 ttt85 -82.93 -18.8 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -83.55 -29.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 3.5 m-20 -83.22 -27.11 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.489 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -75.09 -37.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.27 -37.84 68.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -48.28 -42.72 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.5 -70.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.489 HD12 ' CD1' ' A' ' 314' ' ' TRP . 82.6 mt -35.08 -34.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -67.01 -48.04 69.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.088 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.8 -59.85 2.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.1 m -41.81 -36.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.4 p -55.35 119.84 6.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.07 23.26 74.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -76.57 153.2 35.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.5 76.09 0.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 120.6 38.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 3.0 t70 54.57 49.63 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.494 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 24.2 p-80 47.62 29.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 38.0 mt -129.85 164.64 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.971 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -94.93 102.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.447 HD12 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -72.08 130.94 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.31 129.67 55.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 313' ' ' GLU . 55.9 t -133.78 143.27 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.4 ' N ' HG12 ' A' ' 312' ' ' VAL . 16.5 pt-20 -156.02 161.26 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.489 ' CD1' HD12 ' A' ' 297' ' ' ILE . 72.3 m95 -71.28 122.29 19.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -112.43 118.8 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.431 ' CG ' ' HD2' ' A' ' 317' ' ' PRO . 36.9 tttm -101.66 140.35 21.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.622 0.725 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 316' ' ' LYS . 62.6 Cg_endo -78.72 172.0 15.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -129.17 -53.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 p -98.93 107.94 20.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.66 125.16 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 85.0 p -39.9 127.35 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -106.33 96.18 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.17 129.26 12.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 9.5 m -133.72 158.21 43.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 89.4 p -130.3 165.34 22.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.47 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 12.2 m 50.94 48.36 23.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.804 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.2 m -90.8 135.36 33.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 134.7 116.69 1.67 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.1 p -174.59 151.9 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.85 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 95.3 p -72.68 168.72 18.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.902 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -153.09 -96.39 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.454 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.01 136.6 13.18 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -127.4 156.44 42.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -129.2 -42.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.7 mtp85 -45.48 -47.18 14.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.78 105.66 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.463 ' HA ' ' CE ' ' A' ' 316' ' ' LYS . 9.1 t0 -111.47 0.17 16.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -124.06 -37.05 2.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -39.85 159.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.52 108.15 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.089 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.7 m -129.37 142.91 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.57 HD12 ' CE2' ' A' ' 259' ' ' PHE . 38.2 pt -138.81 140.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.482 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 69.9 ttt180 -100.56 147.35 26.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 285' ' ' ILE . 55.8 t -129.58 145.48 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.7 p -143.27 165.54 27.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.171 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 26.5 t-20 73.32 39.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 49.9 mt -89.98 -176.95 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 m -135.56 -175.95 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -74.8 -50.11 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.16 -10.83 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 50.5 m -98.62 97.75 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -109.79 178.98 4.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.6 -41.62 31.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -67.61 -23.05 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.77 -30.32 36.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.8 mt -88.29 -24.06 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.468 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.4 tt0 -60.6 -34.5 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -94.35 -11.68 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.62 -39.7 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.57 ' CE2' HD12 ' A' ' 241' ' ' ILE . 64.7 m-85 -98.18 12.04 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 tpt180 -79.15 -45.11 1.72 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.93 -17.23 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.621 2.214 . . . . 0.0 112.393 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.9 m-85 -95.39 -31.06 13.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.79 -166.13 39.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.1 m -90.34 108.73 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 61.4 mt -63.32 139.11 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.135 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.504 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.8 t -89.67 -43.34 10.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -148.93 153.17 37.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 85.1 mt -133.64 104.7 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -99.66 140.9 33.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 35.7 tp -133.01 125.34 29.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.516 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.41 125.55 28.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -129.08 157.7 41.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.49 -178.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -116.64 -32.32 5.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 36.7 m -80.37 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.9 t -81.8 -36.7 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.159 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.04 19.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -96.73 -177.23 3.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 86.4 p -77.42 114.98 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -52.85 -54.02 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 141.97 -6.37 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.516 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 13.6 p90 -135.26 157.2 47.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.864 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.43 163.55 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.7 m-85 -128.74 114.03 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 243' ' ' VAL . 3.7 mp -98.75 140.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.096 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.99 142.12 46.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.17 -176.31 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 8.9 m-70 -104.79 -31.58 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -129.28 148.03 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -63.71 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.837 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.86 -60.24 2.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.69 -28.41 67.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.19 78.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.4 -23.95 57.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -61.99 -37.65 85.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.8 -69.0 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.568 HD12 ' CD1' ' A' ' 314' ' ' TRP . 85.3 mt -35.88 -35.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.3 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.05 -60.9 2.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 259' ' ' PHE . 11.4 m -41.67 -42.41 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.119 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.404 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 36.7 p -53.59 127.91 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.06 68.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -83.97 134.25 34.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.63 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -105.24 115.55 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.5 m-20 57.33 54.05 7.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 36.7 p-80 48.76 36.92 8.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 90.9 mt -138.59 168.41 19.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.596 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -101.25 97.26 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.23 149.27 50.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -133.29 132.13 41.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.444 HG13 ' N ' ' A' ' 313' ' ' GLU . 97.8 t -139.54 143.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.444 ' N ' HG13 ' A' ' 312' ' ' VAL . 6.3 pt-20 -156.02 158.95 38.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.568 ' CD1' HD12 ' A' ' 297' ' ' ILE . 81.4 m95 -69.08 125.51 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.51 78.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.463 ' CE ' ' HA ' ' A' ' 236' ' ' ASP . 25.6 mtmm -139.61 143.86 37.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.89 143.81 23.67 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.0 p -127.05 131.47 50.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.846 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 88.1 m -142.28 140.9 32.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -135.51 105.09 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 11.6 t -80.97 111.15 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -76.49 -70.18 1.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.02 123.18 6.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 28.6 t -84.43 134.32 34.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -124.36 97.95 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.538 -179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.6 t -139.75 141.1 36.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 19.3 m -56.76 -43.93 81.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.17 47.73 85.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.5 m -109.25 128.11 54.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.9 m -104.49 101.51 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -141.63 62.53 0.53 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.51 166.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.242 . . . . 0.0 112.395 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -105.31 120.0 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -88.52 81.5 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -124.09 144.88 49.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -94.76 11.81 30.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.466 ' CB ' ' HG3' ' A' ' 316' ' ' LYS . 19.3 p-10 -65.67 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 236' ' ' ASP . 23.5 t0 35.19 38.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -151.91 -179.56 7.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -114.07 95.35 5.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 13.4 m -140.6 131.63 26.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 259' ' ' PHE . 40.6 pt -127.6 141.08 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -99.57 153.46 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 68.7 t -139.64 135.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 72.6 p -132.24 163.19 29.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.4 t-20 71.59 43.77 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.2 mt -91.11 177.21 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.5 t -122.91 146.47 47.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -48.18 -49.62 32.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.11 -24.92 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.8 m -82.16 97.01 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -104.69 179.26 4.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -49.49 -56.22 10.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -55.51 -25.24 36.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.97 -31.23 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -26.06 24.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.4 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.5 tt0 -59.5 -31.71 69.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -92.87 -8.59 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.469 HD23 ' CE1' ' A' ' 259' ' ' PHE . 26.6 tp -88.05 -39.7 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 300' ' ' VAL . 79.1 m-85 -98.15 11.19 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -76.86 -45.35 2.99 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.8 Cg_exo -47.97 -17.93 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.365 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.535 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.0 m-85 -94.55 -33.79 12.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.85 -167.1 40.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 19.8 m -90.53 110.33 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.6 mt -66.24 142.49 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.4 t -92.57 -46.83 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -148.17 139.64 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.4 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 38.4 mt -120.98 102.94 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.505 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.2 t80 -93.12 143.03 26.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 24.2 tp -136.44 115.59 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.467 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.52 126.46 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -130.97 174.41 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -103.73 177.32 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.83 -54.74 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 26.9 m -55.14 -72.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.137 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 14.8 t -77.5 -32.26 54.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 73.97 39.37 46.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.548 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.64 169.65 8.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 45.7 m -70.94 115.61 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.3 mmtm -48.21 -54.26 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.57 2.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 12.4 p90 -123.53 155.27 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.51 165.29 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.46 116.7 16.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 285' ' ' ILE . 4.3 mp -104.58 125.41 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.3 m -101.57 119.13 38.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -91.05 175.71 6.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.9 m-70 -92.34 -44.43 8.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -110.99 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -87.57 -20.81 25.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.58 -24.18 31.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.51 -34.44 27.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.499 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -70.44 -35.84 73.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.4 70.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -48.63 -44.07 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.535 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.83 -65.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 314' ' ' TRP . 69.1 mt -34.48 -32.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -50.09 23.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -62.51 3.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.548 HG12 ' CE2' ' A' ' 259' ' ' PHE . 16.1 m -46.59 -36.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.82 0.343 . . . . 0.0 111.125 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.8 t -57.54 114.25 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.77 26.24 56.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -82.62 153.53 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.29 71.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.37 129.55 36.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.376 . . . . 0.0 110.913 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.5 t70 45.25 52.79 8.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.547 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 44.67 31.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 30.5 mt -131.33 163.3 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -92.98 101.39 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.3 tp -76.42 139.01 40.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -119.72 140.13 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.533 ' N ' HD21 ' A' ' 311' ' ' ASN . 94.9 t -143.1 143.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.43 ' N ' HG11 ' A' ' 312' ' ' VAL . 1.2 pm0 -152.11 174.24 13.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.557 ' CD1' HD11 ' A' ' 297' ' ' ILE . 68.9 m95 -80.53 125.61 30.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -119.11 162.65 18.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.466 ' HG3' ' CB ' ' A' ' 236' ' ' ASP . 35.2 ttmt -117.62 138.39 25.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.559 0.695 . . . . 0.0 110.915 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.01 109.55 2.73 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.647 2.232 . . . . 0.0 112.317 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -80.41 150.05 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 76.6 p -132.02 124.05 28.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -73.75 -48.31 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 61.8 p -160.84 150.52 17.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -87.15 145.85 20.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.75 157.49 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 28.7 t -150.14 126.61 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 m -115.59 102.28 9.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.487 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 51.6 p -140.46 138.07 34.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.8 m -44.16 -57.67 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -126.13 100.87 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 31.2 m -46.97 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -52.21 -54.1 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 151.61 97.13 0.15 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.63 111.73 3.39 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.737 2.291 . . . . 0.0 112.359 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -86.14 162.51 18.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -121.69 114.84 21.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ALA . 18.8 mtt-85 -127.69 -62.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 234' ' ' ARG . . . -35.4 -38.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 40.58 39.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -119.36 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.91 19.3 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -131.35 90.2 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.4 m -144.0 131.11 20.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.564 HD12 ' CE2' ' A' ' 259' ' ' PHE . 29.1 pt -126.0 143.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -101.81 151.84 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.71 139.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 46.9 p -141.85 165.32 27.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.9 t-20 68.42 50.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.4 mt -92.39 -175.64 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 250' ' ' THR . 5.6 t -130.42 140.24 50.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.406 ' OE1' ' C ' ' A' ' 248' ' ' GLU . 0.6 OUTLIER -47.19 -21.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.69 22.36 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 247' ' ' SER . 90.7 m -126.41 114.2 17.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.68 179.94 3.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.88 -44.77 70.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -61.18 -28.22 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.69 -33.3 64.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 43.0 mt -84.17 -28.72 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 24.0 tt0 -57.94 -42.28 84.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -83.71 -16.02 46.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.476 HD21 ' CE1' ' A' ' 259' ' ' PHE . 14.8 tp -80.81 -38.07 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 241' ' ' ILE . 80.2 m-85 -99.15 12.01 37.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 ttt180 -77.92 -45.15 2.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.598 0.714 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.18 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.526 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.7 m-85 -92.78 -35.23 13.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.24 -163.15 36.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -91.62 109.92 21.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 46.4 mt -67.95 138.9 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.477 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.4 t -88.69 -42.03 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -151.56 154.72 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 62.5 mt -133.76 101.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.48 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.4 t80 -91.4 141.56 28.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 52.9 tp -135.4 127.44 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -75.11 114.86 14.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -121.68 150.91 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.25 173.23 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 -29.77 7.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.3 m -78.59 -66.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.4 t -89.01 -13.52 38.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.103 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.25 95.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -102.35 157.22 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 48.0 t -58.21 115.08 2.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -51.63 -59.17 4.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.68 -13.24 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -129.03 157.2 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.68 172.72 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -139.14 116.43 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.63 132.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.43 142.02 35.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -116.23 168.35 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.0 m-70 -85.55 -35.07 21.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 288' ' ' HIS . 24.5 mmt-85 -120.82 167.27 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -78.54 -32.9 48.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.12 -54.53 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -53.93 -32.79 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.547 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -70.55 -46.0 64.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -50.78 -39.04 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.31 -69.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.46 HD12 ' CD1' ' A' ' 314' ' ' TRP . 72.8 mt -36.91 -34.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.5 55.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -80.03 -59.12 2.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.497 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.464 HG23 ' CB ' ' A' ' 312' ' ' VAL . 28.0 m -53.97 -20.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.4 t -63.03 107.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.92 38.2 23.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -88.97 146.32 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.04 74.22 2.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -95.13 136.59 35.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 35.1 t70 42.41 53.98 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.507 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 37.8 p-80 46.05 39.03 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.1 mt -146.36 168.48 21.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.3 mp -95.55 102.79 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.64 139.96 56.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -118.52 127.82 53.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.464 ' CB ' HG23 ' A' ' 300' ' ' VAL . 44.8 t -140.72 141.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.447 ' N ' HG13 ' A' ' 312' ' ' VAL . 15.3 pt-20 -162.22 149.96 14.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.547 ' CH2' ' HB2' ' A' ' 293' ' ' ALA . 96.1 m95 -45.01 121.4 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.89 -71.31 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 153.87 40.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.601 0.715 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.56 170.65 19.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 0.0 112.385 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 12.5 t -107.22 128.25 54.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.7 t -138.07 145.76 42.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -114.23 146.44 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 99.8 p -131.2 -48.65 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -122.41 98.01 0.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.72 123.32 7.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.638 2.225 . . . . 0.0 112.361 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 7.4 t -45.74 152.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 52.0 m -58.84 -50.19 74.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.5 t -152.17 112.06 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 29.6 t -56.12 89.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.876 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 169.96 159.08 14.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.4 m -96.65 -178.53 4.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 110.885 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.2 m -59.85 174.66 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -130.96 94.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.33 -31.72 4.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.348 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.19 100.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -104.21 113.75 27.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -173.63 166.52 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -90.5 178.76 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.466 ' N ' ' HE3' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -93.61 -18.29 22.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 236' ' ' ASP . 16.6 m-20 34.51 37.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 237' ' ' ASP . 44.5 m-80 -168.98 177.63 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -115.93 97.99 6.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.9 m -136.02 143.52 44.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.482 HD13 ' CE2' ' A' ' 259' ' ' PHE . 42.5 pt -137.43 141.88 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -105.57 147.71 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.459 ' CG1' HD12 ' A' ' 310' ' ' LEU . 70.5 t -129.71 146.67 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 69.8 p -144.16 163.56 33.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 69.05 40.88 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 34.5 mt -85.33 -175.42 5.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 t -125.52 161.31 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.57 -9.36 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.55 -8.97 39.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 86.8 m -101.79 104.13 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -104.05 179.19 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -52.79 -51.52 60.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.4 t -62.77 -19.79 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.34 -26.92 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.87 -33.59 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 22.8 tp60 -52.49 -34.25 48.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -87.75 -20.44 26.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.411 HD22 ' CE1' ' A' ' 259' ' ' PHE . 15.3 tp -78.63 -36.79 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.482 ' CE2' HD13 ' A' ' 241' ' ' ILE . 77.7 m-85 -98.01 11.72 36.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.585 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 2.4 ttt-85 -79.34 -45.24 1.66 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.37 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.476 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.3 m-85 -93.39 -33.76 13.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.16 -160.36 33.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 8.3 m -90.69 119.11 30.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.86 145.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -97.96 -43.71 6.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.422 ' HB2' ' NH1' ' A' ' 267' ' ' ARG . 20.2 ttm105 -150.43 149.98 30.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.453 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 54.2 mt -132.97 100.09 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -95.59 140.86 29.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.2 tp -132.93 121.7 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.549 ' HB3' ' CE2' ' A' ' 282' ' ' PHE . . . -68.79 129.87 41.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -136.98 162.16 34.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.58 178.22 7.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -108.51 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 78.0 m -73.02 -65.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 15.4 t -95.65 -18.87 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.91 37.54 92.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -91.96 160.23 15.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 28.0 t -56.0 121.16 8.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -64.88 -54.46 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.56 1.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.45 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.549 ' CE2' ' HB3' ' A' ' 271' ' ' ALA . 32.6 p90 -128.61 153.86 46.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 110.857 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.46 173.08 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.6 112.4 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.83 138.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -111.27 143.91 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -121.39 167.25 12.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 264' ' ' SER . 6.2 m-70 -91.06 -44.12 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -104.63 155.39 18.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -78.1 -11.22 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -89.49 -41.37 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.62 -35.58 77.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.52 -43.77 88.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.6 79.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -49.91 -38.63 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -70.53 -63.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.434 ' O ' ' CB ' ' A' ' 301' ' ' SER . 95.5 mt -35.97 -33.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.75 -55.43 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -54.98 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 259' ' ' PHE . 15.4 m -54.6 -30.94 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 111.161 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.0 t -61.66 106.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 84.77 21.12 56.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.01 141.93 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -85.82 93.08 1.82 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 0.53 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.2 OUTLIER -113.26 109.73 19.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.372 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 30.8 t70 67.74 53.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.523 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 17.1 p-80 47.4 26.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.51 162.08 30.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -93.09 98.02 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.459 HD12 ' CG1' ' A' ' 243' ' ' VAL . 32.3 tp -62.85 138.79 58.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -119.31 132.15 55.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.442 ' CG2' HG23 ' A' ' 300' ' ' VAL . 87.0 t -137.22 154.06 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -165.24 156.29 14.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.43 ' CD1' HD11 ' A' ' 297' ' ' ILE . 66.2 m95 -57.74 136.33 56.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -99.35 126.33 45.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 236' ' ' ASP . 4.6 tptt -101.74 101.43 17.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.94 167.45 27.04 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 319' ' ' THR . 12.3 t -112.66 -41.41 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.876 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 318' ' ' SER . 67.9 p 36.1 40.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.54 106.5 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.4 p -155.57 176.02 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 156.46 146.27 4.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.44 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.18 168.68 22.75 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.407 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 2.9 t -147.16 106.6 3.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 50.8 m -90.5 124.05 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.471 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 42.2 t -169.56 141.92 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 p -76.05 173.32 11.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -168.2 -52.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.466 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.6 m -40.19 106.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.893 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.7 t -166.96 150.98 6.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.35 -159.51 24.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.96 146.84 26.28 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -111.43 85.01 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -149.19 163.64 37.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.81 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -126.34 38.95 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.58 114.06 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -145.44 134.68 22.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.83 -46.66 4.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -95.23 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -79.92 90.94 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 7.1 m -136.63 144.51 44.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.1 pt -144.35 141.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.472 ' HB2' ' CE2' ' A' ' 284' ' ' PHE . 69.4 ttt180 -100.56 149.03 24.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.0 t -132.06 142.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.7 p -135.14 174.52 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 3.2 m-20 64.18 48.13 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 310' ' ' LEU . 19.2 mt -103.4 168.76 8.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.3 p -118.87 154.94 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.86 -46.57 60.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -57.36 -19.25 21.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 26.2 m -90.08 98.93 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -106.42 -175.74 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -55.56 -55.91 26.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.8 t -55.21 -20.02 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.89 -28.69 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 mt -88.66 -27.26 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.469 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -61.92 -31.12 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.53 -18.14 28.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.59 -38.56 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -95.68 11.59 32.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 tpt180 -78.31 -45.26 2.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.598 0.714 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.5 Cg_exo -47.96 -17.16 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.415 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -93.31 -31.71 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.98 36.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -90.02 109.52 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.3 mt -66.07 148.54 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.434 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.0 t -95.16 -43.42 8.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -154.43 149.08 26.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 72.6 mt -134.59 100.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.2 t80 -92.83 151.72 19.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.61 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 51.8 tp -140.54 145.99 37.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.683 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -97.9 132.01 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . 0.443 ' HE3' ' CD2' ' A' ' 270' ' ' LEU . 5.6 mptt -133.45 162.78 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -91.38 174.12 7.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -113.38 -52.94 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.7 m -60.38 -54.81 41.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -89.39 -18.96 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.05 82.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 279' ' ' SER . 32.1 mt-30 -118.67 126.7 52.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 278' ' ' GLN . 2.2 m -36.53 128.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -57.95 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 154.79 33.93 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.683 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 43.8 p90 -162.7 148.33 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 173.91 11.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 242' ' ' ARG . 71.1 m-85 -136.02 113.02 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 285' ' ' ILE . 4.2 mp -98.25 124.84 51.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -106.46 115.16 29.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.73 -180.0 6.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.6 m-70 -95.53 -38.72 10.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.84 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.03 167.53 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 38.4 ttp85 -73.53 -32.87 64.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.26 -64.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -48.8 -35.95 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.474 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -69.45 -42.86 74.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.29 85.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.9 mtp85 -47.05 -41.82 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 314' ' ' TRP . 89.5 mt -35.71 -32.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -68.98 -47.31 65.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.15 -62.2 2.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.4 ' CG2' ' CG2' ' A' ' 312' ' ' VAL . 22.4 m -41.26 -37.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.7 p -56.2 112.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.4 32.51 38.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.441 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -89.71 145.51 25.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -95.81 78.79 0.8 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.62 134.66 39.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 2.1 t70 44.94 52.88 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.462 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 34.0 p-80 45.59 33.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 59.3 mt -135.03 167.4 21.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.2 mp -95.52 97.88 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.466 ' CD1' HD21 ' A' ' 246' ' ' LEU . 11.7 tp -73.67 138.78 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.48 144.89 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.4 ' CG2' ' CG2' ' A' ' 300' ' ' VAL . 29.6 t -143.75 145.5 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.99 171.0 17.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.56 ' CD1' HD11 ' A' ' 297' ' ' ILE . 57.9 m95 -79.25 131.78 36.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -100.88 126.35 47.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -136.1 104.33 9.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.52 165.55 31.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.364 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 p -82.19 -62.58 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.4 m -70.5 133.96 47.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -95.09 109.61 21.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.8 p -81.87 116.61 21.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.73 -178.92 34.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.99 103.42 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 137.2 36.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -131.82 157.24 44.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.504 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.6 t -119.77 145.34 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.7 t -48.18 -62.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.8 -173.8 18.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 61.9 p -111.29 81.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.1 t -74.98 143.1 43.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.84 70.96 0.99 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.22 146.38 25.13 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -123.76 165.0 18.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -129.35 104.14 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -156.5 107.15 2.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.46 38.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.062 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -165.6 149.52 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.87 90.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -169.74 -179.93 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -78.75 102.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.082 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.1 m -138.61 138.27 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.546 HD11 ' CE2' ' A' ' 259' ' ' PHE . 43.0 pt -137.28 140.15 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 14.5 ttt85 -100.96 149.23 24.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.444 ' N ' ' HG2' ' A' ' 242' ' ' ARG . 84.0 t -136.65 143.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 62.1 p -138.2 166.31 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 22.5 t-20 74.05 38.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.75 177.08 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -130.94 166.02 21.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -70.68 -16.54 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.98 9.83 11.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -132.94 111.39 10.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 -176.33 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -48.77 -59.1 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -54.66 -26.7 34.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -76.97 -30.67 56.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.69 -29.83 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.475 ' O ' ' NE2' ' A' ' 256' ' ' GLN . 21.9 tp60 -56.25 -29.48 61.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.3 -15.65 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.3 tp -84.31 -37.88 21.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.546 ' CE2' HD11 ' A' ' 241' ' ' ILE . 83.7 m-85 -96.68 11.31 35.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.594 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -79.7 -45.24 1.56 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.712 . . . . 0.0 110.883 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.88 -17.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.567 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.08 -159.9 33.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.92 135.05 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 0.0 110.875 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 266' ' ' SER . 54.6 mt -93.61 138.88 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.452 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 48.3 t -92.6 -48.76 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.414 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.7 tpp180 -143.38 148.53 36.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.414 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 45.9 mt -132.96 108.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -95.62 144.07 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.0 tp -131.08 119.35 21.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 282' ' ' PHE . . . -62.57 113.44 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -129.14 146.66 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.29 -177.87 0.75 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -122.69 -16.65 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 92.0 m -102.23 -50.44 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -95.41 -9.05 33.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.64 56.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -99.5 178.57 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 27.6 p -89.29 121.84 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -62.13 -74.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 157.94 33.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 271' ' ' ALA . 27.6 p90 -166.13 148.34 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -139.82 165.87 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.586 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 84.8 m-85 -133.18 115.66 15.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.468 HD13 ' CE1' ' A' ' 259' ' ' PHE . 4.2 mp -101.99 131.82 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -109.05 113.05 25.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.445 ' CE1' HG22 ' A' ' 285' ' ' ILE . 13.5 m-85 -84.48 177.11 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.452 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 13.6 m-70 -93.51 -30.54 14.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -122.8 171.37 9.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -83.72 -28.61 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.53 -56.57 5.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 292' ' ' ASP . 1.0 OUTLIER -53.18 -35.12 59.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.828 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.82 90.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.43 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -48.18 -42.59 30.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.567 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.95 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.548 HD11 ' CD1' ' A' ' 314' ' ' TRP . 86.3 mt -38.31 -32.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.49 -41.89 62.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -84.85 -63.92 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 301' ' ' SER . 14.0 m -40.55 -37.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 111.162 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.422 ' N ' HG22 ' A' ' 300' ' ' VAL . 75.4 p -57.04 128.59 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.94 19.06 69.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.472 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -80.89 153.14 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.36 94.27 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.68 123.62 50.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.892 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 10.6 t70 56.4 49.39 15.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 34.8 p-80 48.6 35.62 6.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.8 mt -138.5 167.41 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -95.48 103.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.438 HD12 ' CG1' ' A' ' 243' ' ' VAL . 14.6 tp -77.12 131.22 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.52 138.98 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . . . . . . . . . 99.0 t -142.87 145.73 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -163.51 149.11 11.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.548 ' CD1' HD11 ' A' ' 297' ' ' ILE . 92.5 m95 -52.38 120.0 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.81 -41.22 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -104.71 142.92 25.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.04 -48.57 14.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.5 t 66.65 39.77 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -56.37 -48.77 76.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -79.93 86.89 5.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 12.2 t -111.3 86.21 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 124.33 153.12 8.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.66 149.0 2.09 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 46.6 t -59.2 99.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -133.78 141.0 47.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 226' ' ' SER . 65.3 m -59.05 118.46 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 225' ' ' SER . 30.9 t 36.3 46.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.32 53.65 16.7 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.8 t -91.85 113.62 25.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 m -135.12 145.82 48.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.836 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 173.66 80.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.1 107.84 2.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.04 -62.48 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -164.62 159.39 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.05 150.31 13.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.435 ' HB1' ' CE ' ' A' ' 316' ' ' LYS . . . -87.63 -39.6 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -38.9 134.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.04 -61.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -97.05 167.41 11.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.1 94.34 9.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.8 m -137.46 145.15 42.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 17.0 pt -141.94 145.11 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.556 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 38.0 ttt180 -105.47 156.36 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.468 ' N ' ' HG2' ' A' ' 242' ' ' ARG . 97.8 t -140.47 138.71 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 76.0 p -132.69 161.99 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.8 t30 74.53 48.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 310' ' ' LEU . 31.2 mt -103.67 146.1 29.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.407 ' HB2' ' CG ' ' A' ' 306' ' ' ASP . 1.3 t -85.52 156.94 20.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.13 -6.74 18.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.6 9.34 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 54.3 m -115.6 106.8 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -105.88 174.47 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -47.61 -59.79 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.2 t -54.14 -21.86 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.8 -30.47 40.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.7 mt -90.4 -26.63 19.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.2 pt20 -56.19 -26.33 50.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -91.54 -18.01 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.551 HD21 ' CE1' ' A' ' 259' ' ' PHE . 12.2 tp -82.12 -36.58 27.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.551 ' CE1' HD21 ' A' ' 258' ' ' LEU . 68.9 m-85 -98.47 11.7 37.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -79.39 -45.3 1.65 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.893 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.2 Cg_exo -47.93 -17.59 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -93.58 -32.18 14.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.16 -166.14 39.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.485 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.9 m -90.99 106.86 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 55.9 mt -59.94 150.52 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.545 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.0 t -98.82 -46.52 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.445 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 8.4 tpp180 -149.87 146.23 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.445 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 47.1 mt -126.55 106.92 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -99.04 149.69 22.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 56.0 tp -140.75 129.08 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.65 110.51 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -131.85 135.9 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -76.57 133.12 39.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -85.32 -37.24 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 46.5 m -64.81 -34.67 78.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 7.7 p -105.4 -50.41 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.55 28.59 6.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -114.28 172.79 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.7 t -93.68 113.63 25.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.563 ' HB3' ' CE1' ' A' ' 282' ' ' PHE . 34.4 mmtt -42.58 -69.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 149.18 32.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 7.6 p90 -166.32 161.39 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -149.48 165.54 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.556 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 74.2 m-85 -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.81 129.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.3 m -106.62 118.47 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -92.24 179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.1 m-70 -95.99 -35.88 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -123.69 165.05 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -71.11 -37.96 72.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -60.38 -69.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -44.72 -34.32 2.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.434 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -66.77 -43.04 85.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.076 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.2 77.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.086 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -50.48 -40.95 52.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -66.11 -66.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.435 HD13 ' NE1' ' A' ' 314' ' ' TRP . 84.9 mt -38.83 -40.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.59 19.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -71.04 -65.25 2.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 301' ' ' SER . 7.2 m -39.93 -42.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 300' ' ' VAL . 10.5 t -49.4 116.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.21 62.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -78.63 155.27 29.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.12 76.9 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 0.4 OUTLIER -93.31 130.25 39.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.489 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 0.8 OUTLIER 47.19 54.13 9.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.496 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 29.0 p-80 48.46 33.18 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 62.0 mt -136.4 164.05 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -95.44 95.18 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.451 ' CD1' HD22 ' A' ' 246' ' ' LEU . 11.9 tp -63.74 134.65 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -118.21 130.8 56.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 313' ' ' GLU . 91.7 t -130.6 142.29 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.455 ' N ' HG12 ' A' ' 312' ' ' VAL . 2.0 pp20? -145.35 172.44 13.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.435 ' NE1' HD13 ' A' ' 297' ' ' ILE . 59.0 m95 -81.47 125.18 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -99.89 145.34 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.435 ' CE ' ' HB1' ' A' ' 235' ' ' ALA . 1.2 tmmt? -174.84 105.01 0.26 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.866 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.57 95.77 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.366 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 99.8 p -55.0 -41.81 71.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 41.8 p -79.68 107.81 12.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -110.06 139.01 45.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 6.1 t -125.34 94.37 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -49.68 172.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.454 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.1 -175.85 2.88 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 16.2 t -134.74 87.19 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 31.3 m -116.51 155.42 28.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.2 t -167.99 158.53 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 96.1 p -137.46 177.29 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.84 -159.74 8.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 44.9 m -148.65 167.61 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 0.0 110.837 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -146.66 145.25 29.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -176.72 78.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.91 0.71 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.724 2.282 . . . . 0.0 112.35 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -81.36 -175.81 5.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -141.75 128.35 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 233' ' ' ARG . 96.9 mtt180 35.44 51.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -88.27 -48.6 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -45.08 110.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.48 -45.0 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -130.32 169.11 15.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -81.35 95.94 7.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 241' ' ' ILE . 14.5 m -132.76 143.46 49.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.439 HG21 ' CD1' ' A' ' 297' ' ' ILE . 27.6 pt -136.98 145.98 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -107.14 147.7 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 244' ' ' THR . 54.1 t -129.45 140.46 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' THR . . . . . 0.417 ' N ' HG11 ' A' ' 243' ' ' VAL . 10.1 p -138.09 165.8 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 21.1 t30 66.21 48.26 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.2 mt -93.83 177.88 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.5 t -115.69 159.08 21.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.74 -14.18 60.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.22 19.9 15.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 49.9 m -118.98 98.57 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -100.48 177.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -52.91 -42.57 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.6 t -68.1 -25.39 65.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 -23.75 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.96 -32.57 12.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.427 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.3 pt20 -52.09 -33.91 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.56 -15.61 36.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.49 -38.72 25.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.403 ' CE2' HD13 ' A' ' 241' ' ' ILE . 95.6 m-85 -95.48 11.33 33.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.614 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 7.9 tpt180 -79.03 -43.97 1.74 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.2 Cg_exo -47.93 -18.57 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.306 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 296' ' ' ALA . 30.4 m-85 -94.76 -34.39 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.98 -161.55 34.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -94.28 117.77 30.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 54.5 mt -71.57 144.98 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.509 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.6 t -95.27 -41.9 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -152.07 149.71 29.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 52.1 mt -130.68 105.6 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -98.46 141.46 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.0 tp -132.32 131.81 42.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -71.57 125.59 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -137.01 152.14 49.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.95 -178.22 5.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -109.71 -54.11 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 62.5 m -52.49 -72.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 2.0 t -76.57 -21.42 55.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 63.56 35.72 92.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -108.25 168.5 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 42.3 t -72.4 129.35 38.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -63.38 -74.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.86 32.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 8.2 p90 -165.96 159.75 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -150.97 165.13 34.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -132.08 116.06 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.7 mp -99.48 125.85 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 16.4 m -102.21 116.93 33.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.71 -178.61 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.3 m-70 -97.22 -37.98 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -126.37 139.98 52.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -51.23 -28.23 11.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -66.0 -68.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.0 -30.11 9.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.24 83.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.093 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.78 -35.31 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -50.74 -41.04 56.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.533 ' HB2' ' CD2' ' A' ' 262' ' ' PHE . . . -70.0 -66.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.439 ' CD1' HG21 ' A' ' 241' ' ' ILE . 82.9 mt -38.2 -34.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -76.15 -51.12 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -69.53 -59.56 5.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 312' ' ' VAL . 15.3 m -49.38 -26.24 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.6 t -62.42 109.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.31 27.21 31.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -83.11 154.7 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -97.06 78.94 0.68 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.22 120.77 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.1 t70 51.16 52.62 14.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 27.9 p-80 48.74 26.98 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 66.4 mt -129.55 164.0 24.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -94.96 98.0 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -120.31 138.31 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 300' ' ' VAL . 89.4 t -146.41 151.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.089 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.02 152.1 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.431 ' NE1' HD13 ' A' ' 297' ' ' ILE . 78.1 m95 -55.3 126.11 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -93.8 155.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.06 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.85 104.98 2.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.04 151.44 39.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.4 t -54.72 -49.95 69.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 76.2 p -51.33 125.39 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -80.69 -59.95 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.5 m -115.9 100.35 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -75.27 -92.45 0.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.499 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.06 129.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 t -153.8 166.57 32.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 59.5 p -140.74 134.82 30.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.541 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.7 m -133.8 136.64 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 64.3 p -122.99 -50.69 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 71.18 170.5 10.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 44.0 m -141.41 120.07 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.7 p -154.44 125.25 7.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -163.22 78.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.6 136.65 12.23 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -123.33 165.79 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -145.17 136.82 25.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -66.05 -57.45 7.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -104.29 153.33 21.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.53 127.2 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.06 -54.88 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -125.63 156.22 39.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -79.85 104.94 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.9 m -141.85 135.7 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.422 HD13 ' CE2' ' A' ' 259' ' ' PHE . 41.1 pt -132.77 142.28 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -102.21 149.02 24.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.446 ' CG1' HD13 ' A' ' 310' ' ' LEU . 94.7 t -135.9 139.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 53.1 p -138.55 167.63 21.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 19.7 t-20 73.13 41.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -92.27 -175.16 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -125.49 170.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.87 -6.7 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.98 22.14 16.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 99.6 m -131.11 96.43 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.463 ' CG ' HG23 ' A' ' 253' ' ' THR . 11.7 ptt180 -107.09 -177.38 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -45.7 -50.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.463 HG23 ' CG ' ' A' ' 251' ' ' ARG . 1.4 t -59.51 -28.6 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.95 -27.03 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.06 -20.35 19.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -64.94 -33.81 76.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -93.2 -11.68 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 28.7 tp -82.78 -41.22 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.452 ' CZ ' HG11 ' A' ' 300' ' ' VAL . 64.2 m-85 -96.76 11.91 33.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.7 ttt-85 -77.52 -45.32 2.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.729 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.87 -17.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -92.74 -31.21 15.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.72 -164.13 37.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 31.3 m -91.12 107.43 19.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.461 HG21 ' CG1' ' A' ' 268' ' ' ILE . 82.8 mt -61.35 141.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.9 t -94.05 -45.81 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -150.27 149.17 29.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.461 ' CG1' HG21 ' A' ' 265' ' ' ILE . 46.9 mt -133.47 113.2 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.103 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 5.1 t80 -104.12 147.39 27.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.5 tp -134.74 128.9 33.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -72.99 129.45 38.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -135.43 175.59 9.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.53 170.67 8.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -113.43 -5.54 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.5 m -101.31 -35.9 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -121.22 -10.52 8.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.71 84.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -104.99 163.22 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 15.0 m -69.66 142.16 53.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -82.05 -74.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 166.83 31.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 11.4 p90 -165.49 150.39 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.888 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 162.55 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -127.23 117.9 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.2 mp -103.26 129.1 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -107.9 124.89 50.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.17 179.96 4.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.5 m-70 -93.78 -36.34 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -124.25 179.76 4.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.87 -17.56 29.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -76.52 -59.36 2.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.11 -24.77 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.412 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -73.69 -41.27 62.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.73 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -49.66 -42.05 44.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.14 -62.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.524 ' CD1' ' NE1' ' A' ' 314' ' ' TRP . 71.3 mt -39.92 -37.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.97 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -82.47 -59.46 2.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.452 HG11 ' CZ ' ' A' ' 259' ' ' PHE . 6.8 m -49.41 -30.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 p -62.97 120.86 12.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.05 20.34 79.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.18 156.39 29.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -103.52 76.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.06 120.95 40.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.872 0.368 . . . . 0.0 110.954 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 56.79 49.38 14.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.585 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 18.1 p-80 45.83 31.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 34.5 mt -132.03 166.86 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -95.41 102.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.446 HD13 ' CG1' ' A' ' 243' ' ' VAL . 15.4 tp -71.81 134.62 46.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.67 130.29 56.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.44 ' CG2' HG23 ' A' ' 300' ' ' VAL . 97.6 t -136.19 144.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.48 157.77 30.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.524 ' NE1' ' CD1' ' A' ' 297' ' ' ILE . 80.1 m95 -62.95 123.63 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -112.5 103.8 11.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 112.61 37.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.558 0.694 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.64 176.33 10.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 84.3 p -144.57 166.2 25.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.0 t -145.59 129.29 17.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.107 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -121.04 83.42 2.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -163.6 139.27 6.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.0 16.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.485 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.96 161.47 32.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.345 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.7 p -110.89 -51.6 2.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 70.7 p -152.87 153.88 33.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 33.4 t -94.35 111.42 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.362 . . . . 0.0 110.849 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.7 m -118.77 107.1 13.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.35 108.02 0.25 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.1 t -115.7 41.47 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.86 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 10.1 m -89.26 119.9 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -154.61 143.07 9.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.71 179.33 6.59 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.339 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.64 -51.34 2.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.411 ' HB3' ' NH1' ' A' ' 233' ' ' ARG . 4.2 ptp180 -105.48 164.91 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -89.23 47.36 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -54.78 -49.73 70.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -51.64 138.65 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -102.37 -48.84 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -108.2 165.23 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -92.08 107.7 19.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.095 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.2 m -142.89 145.01 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.55 HD11 ' CE2' ' A' ' 259' ' ' PHE . 37.6 pt -140.0 142.18 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.518 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 62.5 ttt180 -105.6 153.81 21.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.461 ' CG1' HD13 ' A' ' 310' ' ' LEU . 91.4 t -138.3 142.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 61.6 p -138.16 167.5 21.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 73.59 43.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.78 177.57 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 85.3 p -121.54 -175.16 3.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.77 -1.86 58.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.24 18.8 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.508 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 53.0 m -127.61 111.56 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 179.08 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -52.1 -38.97 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -68.1 -18.91 64.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -86.6 -26.19 24.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -91.61 -22.76 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -62.31 -35.32 78.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -92.45 -10.73 36.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 259' ' ' PHE . 25.9 tp -85.79 -34.51 21.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.562 ' CZ ' HG11 ' A' ' 300' ' ' VAL . 77.6 m-85 -104.69 11.46 34.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.581 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.7 tpt180 -80.25 -45.68 1.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.6 Cg_exo -47.95 -20.43 2.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.5 m-85 -88.84 -31.26 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.97 34.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 18.7 m -91.39 118.66 30.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 266' ' ' SER . 72.9 mt -74.02 136.25 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.184 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.517 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.3 t -87.32 -42.18 13.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -154.9 160.0 40.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.71 116.06 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -113.16 148.88 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 61.0 tp -139.87 127.32 21.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 282' ' ' PHE . . . -73.2 123.45 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -136.15 146.03 46.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.17 177.22 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -114.7 -61.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.7 m -53.02 -41.41 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 t -102.01 -22.58 14.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.64 32.8 84.67 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -109.02 140.12 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 47.2 t -54.86 124.67 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -55.1 -74.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.01 33.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 271' ' ' ALA . 36.5 p90 -165.97 146.46 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.5 164.18 27.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.2 m-85 -131.06 112.63 13.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.9 mp -100.13 127.82 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 7.3 m -102.14 120.77 40.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -96.29 177.49 5.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 264' ' ' SER . 10.9 m-70 -96.5 -47.95 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -112.14 164.03 13.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 13.4 ttp-105 -71.75 -31.58 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.6 -61.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.99 -37.17 52.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.47 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -68.04 -39.13 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.65 -37.41 70.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -49.25 -42.91 42.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -63.49 -67.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.544 HD13 ' CD1' ' A' ' 314' ' ' TRP . 85.8 mt -36.03 -32.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.127 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -70.98 -45.88 63.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -79.46 -64.96 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 259' ' ' PHE . 26.5 m -40.01 -36.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.894 0.378 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.442 ' N ' HG23 ' A' ' 300' ' ' VAL . 64.6 p -61.37 112.37 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.88 17.65 57.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -79.51 157.87 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.907 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.93 82.28 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . 0.508 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.3 OUTLIER -99.39 129.74 45.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.449 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 0.5 OUTLIER 47.77 53.69 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 31.2 p-80 45.61 39.53 5.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 77.5 mt -143.53 168.19 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.1 mp -96.7 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.461 HD13 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -70.19 138.04 51.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.27 132.18 56.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 313' ' ' GLU . 79.4 t -137.06 143.4 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.43 ' N ' HG11 ' A' ' 312' ' ' VAL . 20.3 pt-20 -153.53 161.89 41.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.544 ' CD1' HD13 ' A' ' 297' ' ' ILE . 65.4 m95 -65.25 125.27 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -109.93 134.86 51.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.89 106.9 40.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.41 103.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.345 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.8 t -78.76 114.77 17.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.0 m -115.05 -38.9 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -158.0 173.4 16.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.6 t -122.89 119.69 31.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.15 146.08 13.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.63 2.85 7.4 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.374 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 64.3 m -90.01 122.6 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 72.9 m -75.01 162.26 28.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 26.0 m -79.75 -54.09 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 p -117.79 -41.53 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.13 54.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 40.3 t -80.56 97.56 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.5 m 48.09 48.57 18.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.857 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -80.82 -157.31 16.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.11 179.97 6.0 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.278 . . . . 0.0 112.35 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 37.35 50.91 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.29 -43.43 28.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -45.78 133.41 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.4 -45.24 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.12 126.73 44.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -111.32 -49.32 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -169.11 177.94 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -76.35 105.43 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.4 m -139.36 144.05 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 34.4 pt -138.62 144.06 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 61.6 ttt-85 -100.79 152.84 20.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.77 140.52 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.8 p -133.65 169.47 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.62 53.12 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . 0.445 HD23 ' CD1' ' A' ' 310' ' ' LEU . 19.8 mt -103.53 166.38 10.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.0 p -111.69 155.33 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.28 -5.82 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 19.59 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.0 m -131.1 99.62 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -103.57 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -51.04 -40.79 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.7 t -67.95 -30.89 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.72 -28.53 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.74 -26.56 20.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.56 -32.29 73.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.66 -15.13 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.79 -35.72 20.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.423 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.6 m-85 -100.92 8.57 43.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.624 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.6 OUTLIER -80.86 -42.86 1.23 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.568 0.699 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.5 Cg_exo -47.91 -17.98 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.2 m-85 -92.84 -31.8 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.15 36.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.556 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 49.0 m -91.28 116.33 28.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 34.4 mt -73.89 147.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.561 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.2 t -98.68 -43.14 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -151.57 153.89 35.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 89.1 mt -138.46 122.2 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.5 t80 -112.6 149.54 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.8 tp -135.49 127.43 29.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.567 ' HB3' ' CE2' ' A' ' 282' ' ' PHE . . . -69.42 121.59 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -128.74 150.59 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.21 -176.74 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -111.2 -62.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.9 m -47.22 -69.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 10.2 t -77.37 -34.01 55.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.76 39.46 39.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.21 -176.9 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 35.1 t -80.44 126.04 30.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -66.68 -74.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.85 32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.464 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 271' ' ' ALA . 19.8 p90 -166.02 151.26 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.923 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 246' ' ' LEU . . . -141.83 165.19 28.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -129.42 116.56 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 3.6 mp -105.8 131.89 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -110.92 121.32 45.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -94.63 -178.87 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 14.3 m-70 -95.25 -35.91 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . 0.437 ' NH1' ' OD2' ' A' ' 292' ' ' ASP . 18.0 mtt85 -124.68 169.45 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -80.71 -23.48 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.5 -46.17 27.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 289' ' ' ARG . 15.7 m-20 -67.15 -35.28 79.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.504 ' HB3' ' CH2' ' A' ' 314' ' ' TRP . . . -69.37 -37.28 77.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.82 77.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -48.65 -42.63 35.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.85 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.484 ' CD1' ' NE1' ' A' ' 314' ' ' TRP . 89.8 mt -35.42 -37.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.95 -54.58 17.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -67.05 -66.97 2.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 312' ' ' VAL . 30.0 m -42.97 -37.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 1.7 t -50.81 113.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.47 24.85 60.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -86.3 137.78 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.41 97.06 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 116.88 30.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 14.9 t70 63.13 53.41 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 28.7 p-80 48.8 26.61 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.1 mt -129.8 165.82 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -97.98 101.1 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.445 ' CD1' HD23 ' A' ' 246' ' ' LEU . 14.0 tp -73.32 137.65 44.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.5 150.69 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 300' ' ' VAL . 48.5 t -149.1 142.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.448 ' N ' HG11 ' A' ' 312' ' ' VAL . 8.7 pt-20 -155.74 153.22 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 293' ' ' ALA . 83.5 m95 -61.79 125.95 25.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -57.81 -31.96 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.413 ' C ' ' HD3' ' A' ' 316' ' ' LYS . 0.0 OUTLIER -104.15 153.18 39.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.905 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 318' ' ' SER . 58.8 Cg_endo -71.88 102.51 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' PRO . 96.4 p -35.63 141.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 9.5 t -153.96 147.24 24.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -63.83 105.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 t -143.72 130.92 20.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.98 85.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.455 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.31 -28.6 5.55 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.267 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 98.0 p -93.1 171.43 8.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.1 t 66.03 42.32 3.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 49.3 m -107.31 90.6 3.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -115.07 163.23 15.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.18 0.23 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 88.6 p -103.78 97.77 7.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.823 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 m -145.38 146.22 31.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.858 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.78 81.14 0.84 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.01 110.59 3.06 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -148.23 162.72 38.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.25 92.68 8.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -79.06 105.03 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.0 -42.63 47.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 t70 47.55 42.41 14.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.75 -61.13 2.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.53 166.95 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -103.96 105.64 15.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 65.1 m -143.08 140.19 30.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 30.0 pt -138.81 140.97 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.493 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 55.8 ttt180 -103.36 146.94 27.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 312' ' ' VAL . 89.9 t -132.74 142.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 74.3 p -136.93 167.1 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 72.28 43.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.96 176.94 6.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.401 ' CB ' ' CG ' ' A' ' 306' ' ' ASP . 15.9 t -124.63 151.99 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -54.74 -28.38 48.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.75 18.85 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 89.5 m -132.67 98.07 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.3 -174.41 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -45.57 -62.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.2 t -46.89 -34.99 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.02 -31.15 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.4 mt -86.33 -25.79 25.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.461 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 25.5 tt0 -62.72 -35.9 81.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.56 -25.65 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.465 HD21 ' CE1' ' A' ' 259' ' ' PHE . 14.2 tp -74.94 -39.52 61.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.568 ' CE2' HG12 ' A' ' 300' ' ' VAL . 77.0 m-85 -95.96 12.02 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -77.82 -45.37 2.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.607 0.717 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.93 -17.6 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.349 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 40.0 m-85 -91.02 -40.01 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 171.27 -160.53 32.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.602 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.2 m -92.17 107.6 19.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 55.1 mt -64.86 143.05 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.569 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.3 t -91.85 -49.64 6.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -141.02 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.461 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 80.0 mt -134.99 101.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.5 t80 -92.66 142.77 27.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 53.8 tp -129.47 128.48 43.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.4 115.58 4.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -136.95 134.93 37.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.87 162.56 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 275' ' ' THR . 4.4 ptmt -100.37 -35.11 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.455 ' N ' ' HG3' ' A' ' 274' ' ' LYS . 93.7 m -74.95 -41.46 59.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 31.1 p -94.16 -38.55 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.23 43.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -136.18 179.26 6.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 39.9 m -85.59 109.1 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -48.92 -66.88 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 151.25 33.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 52.7 p90 -165.97 147.52 6.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -138.23 174.36 10.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.493 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.1 m-85 -139.88 115.13 9.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.3 mp -101.37 124.05 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.9 m -102.71 112.25 24.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -84.95 169.85 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -85.92 -39.89 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.37 173.19 6.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.92 -39.12 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.87 -61.59 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -49.87 -38.63 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.46 ' HB2' ' CH2' ' A' ' 314' ' ' TRP . . . -66.56 -45.98 77.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -48.33 -42.03 30.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.75 -71.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.468 HD11 ' NE1' ' A' ' 314' ' ' TRP . 87.4 mt -34.23 -42.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.27 81.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -76.28 -66.08 1.91 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 259' ' ' PHE . 26.1 m -42.25 -43.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.464 ' N ' HG21 ' A' ' 300' ' ' VAL . 13.0 t -48.9 104.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 90.33 33.62 8.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -96.33 130.89 43.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -79.08 52.62 4.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -75.47 128.03 34.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 53.9 m-20 62.2 54.35 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.91 31.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 306' ' ' ASP . 82.9 mt -140.04 168.49 19.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 309' ' ' ILE . 2.4 mp -89.58 97.96 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.14 140.15 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.92 144.47 48.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 243' ' ' VAL . 71.5 t -150.65 150.05 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -166.11 165.58 17.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.468 ' NE1' HD11 ' A' ' 297' ' ' ILE . 85.5 m95 -66.99 125.38 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -118.87 117.35 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 317' ' ' PRO . 0.4 OUTLIER -163.42 133.25 3.18 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 62.1 Cg_endo -76.87 120.71 5.57 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.352 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 5.0 m -86.52 48.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 t -81.95 41.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 49.95 41.43 22.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -90.82 137.83 32.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -168.59 157.54 29.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.56 101.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 12.4 m -56.7 -58.13 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.1 p -67.52 130.02 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 8.6 t -159.45 140.09 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.9 m -153.85 166.11 33.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.91 117.29 0.65 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 16.1 m -99.19 164.99 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.899 0.38 . . . . 0.0 110.858 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.5 m -139.25 134.46 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 43.76 95.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.03 -1.55 11.73 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.681 2.254 . . . . 0.0 112.298 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -61.2 103.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 234' ' ' ARG . 0.1 OUTLIER -72.34 -39.58 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 233' ' ' ARG . 36.3 mtt85 -36.36 -48.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -60.48 109.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -168.61 114.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.74 -60.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -125.58 175.87 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.53 98.92 9.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 241' ' ' ILE . 20.5 m -143.68 145.48 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.447 ' N ' HG23 ' A' ' 240' ' ' THR . 30.8 pt -140.63 142.84 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.494 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 72.2 ttt180 -104.14 149.07 25.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.429 HG23 ' CD1' ' A' ' 285' ' ' ILE . 93.4 t -134.74 142.29 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 17.2 p -140.64 166.71 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 38.2 t-20 72.32 41.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.9 mt -92.11 169.6 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 306' ' ' ASP . 11.2 t -110.7 155.52 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.3 -28.92 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.89 22.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.3 m -127.92 96.77 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.173 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.4 ' HE ' ' CG2' ' A' ' 253' ' ' THR . 8.0 ptt180 -99.75 -174.33 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.06 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 254' ' ' ASP . 13.6 t -50.81 -28.07 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.471 ' N ' HG23 ' A' ' 253' ' ' THR . 9.8 m-20 -72.19 -27.79 62.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.64 -32.45 13.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -52.72 -30.59 33.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.93 -25.02 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.4 tp -77.0 -36.85 56.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -96.05 11.4 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.606 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.2 OUTLIER -79.64 -44.57 1.58 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 110.888 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.94 -19.12 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 39.5 m-85 -89.71 -40.09 12.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.33 -160.22 30.63 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -93.03 113.28 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.47 HG21 ' N ' ' A' ' 266' ' ' SER . 39.9 mt -71.36 141.9 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.5 t -89.19 -46.89 8.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -147.55 156.49 42.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 53.6 mt -138.24 105.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -93.22 143.48 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 49.9 tp -127.74 132.8 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.565 ' HB1' ' CD2' ' A' ' 282' ' ' PHE . . . -65.91 113.31 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -136.31 125.79 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.42 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -110.78 -40.08 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.6 m -67.08 -73.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 12.2 t -79.87 -43.21 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.52 38.24 7.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -99.66 149.7 23.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 110.871 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 13.5 t -57.88 116.89 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -63.72 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.62 33.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.565 ' CD2' ' HB1' ' A' ' 271' ' ' ALA . 41.7 p90 -165.98 154.57 11.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.42 174.05 11.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 91.0 m-85 -139.37 111.78 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.429 ' CD1' HG23 ' A' ' 243' ' ' VAL . 4.3 mp -95.69 123.65 47.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 67.9 m -100.38 114.18 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.48 ' CG ' ' HA ' ' A' ' 293' ' ' ALA . 12.2 m-85 -87.59 169.71 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -86.69 -40.87 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.37 173.91 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -77.91 -38.85 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.91 -62.04 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.21 -40.41 47.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.48 ' HA ' ' CG ' ' A' ' 287' ' ' PHE . . . -65.78 -46.28 79.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.72 99.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -47.35 -41.54 19.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.22 -70.91 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.482 ' O ' ' CB ' ' A' ' 301' ' ' SER . 87.4 mt -34.44 -43.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.7 87.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -75.63 -66.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.509 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.405 HG21 ' CG2' ' A' ' 312' ' ' VAL . 25.6 m -43.33 -42.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 10.7 t -47.92 108.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.66 31.4 18.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -94.96 135.37 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -81.21 52.86 4.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.98 129.61 37.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 0.0 110.908 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 58.1 m-20 62.07 54.19 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 38.23 30.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 306' ' ' ASP . 91.9 mt -141.41 169.63 17.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.36 101.93 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.32 149.52 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.85 127.41 43.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 313' ' ' GLU . 93.9 t -137.33 151.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.452 ' N ' HG12 ' A' ' 312' ' ' VAL . 12.6 pt-20 -169.45 151.93 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -53.51 126.43 21.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -118.25 158.43 25.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -129.54 159.2 70.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.81 161.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -105.18 -54.78 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 38.5 p -119.76 115.27 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.145 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -62.15 102.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 56.3 m -97.74 161.63 13.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 172.84 64.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.94 126.98 9.09 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.4 t -107.7 140.16 41.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.9 t -151.71 153.66 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 11.4 m -81.35 110.62 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.882 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t -120.43 110.9 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 107.15 152.45 18.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.9 p -128.42 163.99 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 16.8 m -53.17 125.5 17.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 143.59 176.52 17.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.481 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.07 -175.15 2.5 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.723 2.282 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -115.32 106.13 13.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -147.01 156.65 43.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -69.12 135.88 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -86.05 -43.65 12.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.38 144.08 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.37 -50.93 3.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -126.4 173.82 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -77.8 94.36 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 241' ' ' ILE . 91.2 m -135.15 150.7 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.417 HD12 ' CE2' ' A' ' 259' ' ' PHE . 23.7 pt -142.23 144.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -107.38 152.15 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.405 ' CG1' HD11 ' A' ' 310' ' ' LEU . 99.0 t -137.11 138.02 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 60.8 p -133.27 165.29 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 16.6 t-20 73.77 49.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.4 mt -98.52 176.33 5.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -123.75 -176.88 3.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.43 -5.14 58.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.8 19.57 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.1 m -122.29 96.43 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -105.76 173.7 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -48.69 -42.61 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -23.38 66.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.99 -30.07 35.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.3 mt -86.59 -31.94 20.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.455 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 1.3 tm0? -54.75 -50.13 69.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.03 -19.03 60.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.2 tp -80.16 -35.58 36.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 300' ' ' VAL . 59.6 m-85 -101.72 11.89 38.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -78.45 -45.21 2.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.587 0.708 . . . . 0.0 110.926 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.5 Cg_exo -48.03 -17.55 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.371 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.526 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.5 m-85 -91.41 -32.71 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.87 -162.93 36.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.25 106.25 18.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 61.8 mt -61.44 143.41 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.514 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 31.5 t -94.1 -47.67 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -149.4 153.19 36.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 74.5 mt -139.08 113.07 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.1 t80 -104.6 152.82 21.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 62.1 tp -133.14 128.44 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.559 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -66.64 121.42 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -136.91 140.13 42.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.97 170.07 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.82 -42.15 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 97.2 m -74.67 -73.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.105 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 12.9 t -70.2 -25.87 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.45 37.38 92.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -99.47 175.87 5.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.6 t -84.3 118.56 24.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -61.47 -74.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.57 34.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 22.8 p90 -165.55 151.28 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.3 169.04 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -134.58 116.06 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 285' ' ' ILE . 3.2 mp -104.29 134.55 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.9 t -106.27 144.1 33.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.433 ' HB2' ' CB ' ' A' ' 293' ' ' ALA . 18.7 m-85 -119.91 169.96 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 5.7 m-70 -94.31 -40.86 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -110.16 152.81 25.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -71.74 -16.41 62.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -85.88 -41.86 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.36 -35.81 78.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 287' ' ' PHE . . . -71.33 -35.84 71.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -74.17 -35.98 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -49.46 -43.23 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.93 -66.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 88.6 mt -34.3 -34.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -72.07 -50.63 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.79 -65.67 2.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 259' ' ' PHE . 13.6 m -43.43 -28.81 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t -62.79 114.35 3.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.92 68.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 52.1 t80 -78.23 163.29 25.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . 0.41 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -108.87 83.69 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.52 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -103.45 120.24 40.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.417 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 53.3 m-20 57.92 52.48 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.573 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 22.5 p-80 44.3 36.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 70.4 mt -139.09 166.63 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -93.7 101.8 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.405 HD11 ' CG1' ' A' ' 243' ' ' VAL . 14.6 tp -74.3 134.41 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.63 138.78 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 300' ' ' VAL . 68.9 t -140.47 148.34 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.07 153.05 13.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.488 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 83.3 m95 -54.52 122.0 9.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.76 171.1 10.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -133.81 94.4 18.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.576 0.703 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.35 97.22 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 20.9 t -98.92 78.96 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 25.6 m -116.77 148.12 41.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -90.66 114.07 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.8 t -131.04 87.49 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 61.97 170.44 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.97 -29.89 4.9 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.376 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.7 t -117.46 119.83 36.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 21.4 t -69.63 102.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 45.8 t -88.05 -60.25 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.4 m -87.96 90.95 8.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.54 -108.6 2.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 4.3 t 41.75 41.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 23.8 t -155.3 139.76 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 61.88 149.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.3 109.31 2.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -58.02 119.55 6.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -135.81 152.83 51.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -162.64 109.63 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . 0.404 ' C ' ' HE2' ' A' ' 316' ' ' LYS . . . -162.79 134.23 5.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.97 159.03 2.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -112.36 -49.38 2.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -121.86 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -77.04 97.59 4.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -134.92 142.71 46.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 29.5 pt -139.7 140.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.145 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.431 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 74.8 ttt180 -103.27 151.17 23.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 86.2 t -134.62 144.66 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 64.5 p -140.82 171.66 13.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m120 64.58 48.43 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.0 mt -100.9 -177.58 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.3 t -126.81 176.51 7.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.83 -24.69 48.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.38 20.16 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 97.9 m -132.75 96.41 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.538 ' NE ' ' CG2' ' A' ' 253' ' ' THR . 23.2 ptt-85 -101.48 -173.31 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -55.62 -64.3 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' THR . . . . . 0.538 ' CG2' ' NE ' ' A' ' 251' ' ' ARG . 1.8 t -50.68 -19.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.447 ' OD2' ' NH1' ' A' ' 251' ' ' ARG . 3.2 m-20 -82.82 -29.3 29.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.59 -27.83 17.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.26 -31.47 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.91 -24.91 26.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 11.6 tp -73.6 -35.37 65.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' PHE . . . . . 0.52 ' CE2' ' CD1' ' A' ' 241' ' ' ILE . 59.1 m-85 -97.62 10.17 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.601 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.3 tpt85 -75.97 -44.54 3.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.7 Cg_exo -48.0 -18.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.6 m-85 -93.37 -38.52 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.22 32.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.468 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.56 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 4.4 m -92.86 116.06 28.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 45.3 mt -74.47 140.14 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.538 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.9 t -89.97 -50.47 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -140.03 155.95 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.86 105.12 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -97.24 142.83 28.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.8 tp -126.01 131.76 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.556 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.12 119.83 11.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -136.66 122.12 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.64 -179.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -113.31 -41.74 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 89.5 m -65.94 -56.96 9.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.1 t -94.65 -15.41 24.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.6 85.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -112.07 171.22 7.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 60.5 p -77.64 113.2 15.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -68.06 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.76 34.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 39.5 p90 -162.34 146.25 11.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -136.34 167.79 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.141 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.5 m-85 -135.15 111.73 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ILE . . . . . . . . . . . . . 4.2 mp -100.48 127.48 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -104.33 112.92 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -84.21 176.44 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -92.76 -41.63 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -113.4 172.65 6.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -81.31 -37.1 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.08 -54.34 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.2 -37.08 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.553 ' HB1' ' CH2' ' A' ' 314' ' ' TRP . . . -66.13 -46.34 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.5 98.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -46.77 -42.19 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -71.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ILE . . . . . 0.555 HD12 ' CD1' ' A' ' 314' ' ' TRP . 92.0 mt -35.81 -40.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.01 87.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.99 -62.59 1.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 259' ' ' PHE . 16.2 m -46.03 -20.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 103.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.48 29.06 9.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.89 133.51 34.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -82.25 54.38 4.87 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.03 130.07 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 110.972 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 56.6 m-20 62.08 55.03 2.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.73 31.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 306' ' ' ASP . 90.2 mt -141.52 170.64 15.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 309' ' ' ILE . 2.2 mp -89.49 100.88 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.77 143.45 56.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -125.37 129.43 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 313' ' ' GLU . 56.4 t -137.85 140.15 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 312' ' ' VAL . 12.0 pt-20 -156.6 156.02 32.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.555 ' CD1' HD12 ' A' ' 297' ' ' ILE . 80.3 m95 -57.51 128.01 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -118.08 149.07 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.404 ' HE2' ' C ' ' A' ' 235' ' ' ALA . 15.2 mmtt -97.84 151.42 37.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.575 0.702 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.54 153.89 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.8 m -89.88 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 81.4 p -94.26 148.35 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -80.33 47.18 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.6 t -55.84 169.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.89 140.73 5.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.26 5.25 5.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 31.9 p -91.88 -48.5 6.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.6 m -118.81 112.35 19.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.7 m -135.89 136.28 40.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.744 HG22 HD11 ' A' ' 297' ' ' ILE . 45.0 pt -132.67 142.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -99.88 150.38 22.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 312' ' ' VAL . 74.9 t -136.88 141.17 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 282' ' ' PHE . 18.3 p -141.5 163.94 31.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 29.6 t30 70.45 52.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 250' ' ' THR . 26.1 mt -93.93 -178.56 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.8 t -118.19 169.77 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.68 -21.47 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.89 20.26 13.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . 1.028 HG21 HD22 ' A' ' 246' ' ' LEU . 52.8 m -113.17 99.42 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -110.15 -177.47 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.54 ' OE2' HD23 ' A' ' 270' ' ' LEU . 12.1 mp0 -55.86 -42.14 75.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.8 t -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.111 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -28.95 47.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.6 mt -86.33 -31.15 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 11.2 tt0 -59.0 -31.67 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.33 -16.7 28.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.538 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.0 tp -82.94 -37.85 23.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 265' ' ' ILE . 65.1 m-85 -98.03 10.97 39.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.9 tmt_? -76.56 -45.27 3.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 66.0 Cg_exo -48.02 -17.23 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.4 m-85 -93.38 -33.09 14.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 164.65 -162.62 35.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.0 m -90.39 117.26 28.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.9 mt -75.71 140.94 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -88.35 -45.02 10.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -150.78 153.5 35.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 44.7 mt -136.18 105.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 4.6 t80 -96.95 146.96 24.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.54 HD23 ' OE2' ' A' ' 252' ' ' GLU . 12.4 tp -140.95 125.84 18.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.75 119.44 9.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -130.95 149.07 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.35 163.65 13.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -101.0 -29.93 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 74.4 m -81.62 -37.75 27.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.2 p -98.96 -34.14 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.5 44.57 89.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -129.93 -175.88 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.359 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 49.9 m -86.24 106.05 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 271' ' ' ALA . 13.3 mmmt -40.65 -56.63 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.54 -23.09 0.84 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 244' ' ' THR . 14.4 p90 -115.84 159.7 21.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -147.27 168.45 21.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -136.05 113.64 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.0 mp -97.94 133.74 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.119 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 25.3 m -108.03 123.13 48.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.607 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.1 m-85 -98.74 169.95 9.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.556 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 12.3 m-70 -87.76 -47.09 8.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt-85 -108.37 165.3 11.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -76.65 -24.0 53.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.44 -49.98 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.14 -37.99 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.9 -43.75 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.0 91.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -48.98 -40.03 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.902 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.75 -64.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 241' ' ' ILE . 82.7 mt -37.97 -33.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.04 38.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -77.88 -62.35 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.497 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 296' ' ' ALA . 7.5 m -42.49 -27.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.4 t -70.03 109.45 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 91.1 16.61 53.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.17 158.58 33.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.81 65.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.31 127.54 34.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 4.5 m-20 46.64 50.74 12.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 35.1 p-80 46.3 44.32 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 88.7 mt -146.45 168.64 20.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.74 95.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 25.9 tp -60.96 146.05 48.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -119.7 129.67 54.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 243' ' ' VAL . 76.6 t -141.19 147.5 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.85 149.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.571 ' CD1' HD13 ' A' ' 297' ' ' ILE . 79.8 m95 -51.18 122.72 8.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.882 0.373 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 25.7 m -139.01 147.53 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 297' ' ' ILE . 32.3 pt -141.54 143.16 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 312' ' ' VAL . 49.7 ttt-85 -98.67 150.98 21.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 312' ' ' VAL . 88.2 t -139.1 139.07 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 30.7 p -138.8 173.72 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 20.4 t-20 69.24 48.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.72 -178.28 3.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.952 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.9 t -126.47 179.26 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.18 -3.91 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.66 21.63 17.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.6 m -127.49 116.78 20.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 172.07 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.2 -47.47 62.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.6 t -60.4 -29.0 68.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.45 -23.35 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.04 -28.11 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -54.76 -28.01 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.31 -19.5 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.56 -36.76 44.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.829 ' HB2' HD11 ' A' ' 265' ' ' ILE . 88.4 m-85 -95.92 10.43 37.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 ttt-85 -78.87 -45.17 1.84 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.333 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -95.56 -31.94 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 167.76 -160.53 34.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.597 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.7 m -95.2 111.03 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 259' ' ' PHE . 66.5 mt -65.87 147.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 33.4 t -97.89 -46.88 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -147.05 146.01 29.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 39.8 mt -130.63 99.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.088 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.661 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -93.79 152.72 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.674 HD23 ' HE2' ' A' ' 272' ' ' LYS . 47.5 tp -141.71 143.27 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -84.9 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.674 ' HE2' HD23 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -134.19 153.98 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -99.43 157.37 16.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.31 0.3 33.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 93.4 m -111.43 -20.61 12.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 32.7 p -121.48 -16.1 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.14 37.44 80.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.57 -179.26 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 t -85.3 115.99 23.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -46.87 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.82 32.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 25.8 p90 -165.95 155.94 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.42 174.04 12.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.15 120.11 16.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -106.64 124.52 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 50.4 m -101.45 118.51 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.785 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 7.8 m-85 -92.62 176.02 6.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 264' ' ' SER . 9.6 m-70 -95.57 -50.03 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -108.04 149.46 28.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -69.46 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.51 -25.51 20.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.497 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 6.4 m-20 -88.57 -25.31 22.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -80.35 -33.98 36.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.441 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.31 -33.63 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -59.44 -37.79 79.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.2 -63.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 241' ' ' ILE . 61.1 mt -39.94 -35.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -72.67 -56.63 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.8 -61.41 5.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.789 HG21 HG21 ' A' ' 312' ' ' VAL . 3.7 m -48.05 -35.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t -59.81 104.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.6 27.1 10.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -91.09 148.99 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -92.8 78.22 1.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.52 127.07 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 11.3 t70 52.66 48.14 23.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 21.3 p-80 46.52 32.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 309' ' ' ILE . 45.9 mt -133.7 171.82 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -97.95 94.73 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.93 136.19 54.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -116.79 142.89 46.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 243' ' ' VAL . 99.2 t -146.67 144.78 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.37 149.02 8.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.521 ' CD1' HD13 ' A' ' 297' ' ' ILE . 95.6 m95 -49.59 130.3 20.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.851 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.863 0.363 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -143.29 143.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.9 pt -140.85 147.05 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HG3' ' CE1' ' A' ' 284' ' ' PHE . 17.0 ttt180 -112.32 148.77 33.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 312' ' ' VAL . 67.3 t -127.49 148.99 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.4 p -143.24 163.11 33.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.79 38.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.8 mt -82.72 -174.97 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 248' ' ' GLU . 27.3 t -125.78 178.85 5.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.4 ' N ' ' OG ' ' A' ' 247' ' ' SER . 4.3 mm-40 -76.46 -50.47 13.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.11 -4.8 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 44.2 m -98.51 103.13 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.401 ' HA ' HD22 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -115.13 -175.5 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.625 ' OE2' HD23 ' A' ' 270' ' ' LEU . 4.3 mp0 -51.17 -56.21 13.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.3 t -55.31 -21.79 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.156 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -82.47 -30.4 29.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.87 -26.53 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -56.79 -33.58 66.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -89.96 -18.44 26.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.416 HD22 ' HE2' ' A' ' 305' ' ' TYR . 31.8 tp -78.64 -34.23 46.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 265' ' ' ILE . 81.3 m-85 -101.0 11.91 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 8.2 tpt180 -78.24 -45.24 2.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 0.0 110.859 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.01 -17.21 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.0 m-85 -92.56 -35.91 13.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.27 -161.45 34.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.9 m -90.31 117.28 28.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.531 HG21 ' CG1' ' A' ' 268' ' ' ILE . 74.9 mt -72.78 144.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.2 t -97.98 -48.09 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.0 tpt180 -145.44 151.46 38.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.531 ' CG1' HG21 ' A' ' 265' ' ' ILE . 65.3 mt -140.23 113.68 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 4.9 t80 -109.31 141.58 41.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.625 HD23 ' OE2' ' A' ' 252' ' ' GLU . 18.4 tp -129.92 121.13 26.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.948 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -61.63 122.49 15.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.122 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -134.96 149.33 50.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.27 178.82 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.29 -48.27 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 58.3 m -67.48 -42.38 83.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 -14.47 17.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 50.63 41.64 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -117.7 163.81 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.2 p -70.91 129.95 40.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -68.77 -75.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.71 32.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 24.2 p90 -165.99 157.96 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.73 171.3 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.526 ' CE1' ' HG3' ' A' ' 242' ' ' ARG . 97.7 m-85 -136.84 106.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -94.78 136.99 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.7 m -113.93 118.62 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -93.07 172.84 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -89.69 -43.57 10.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -116.62 168.92 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -76.89 -35.52 57.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.95 -55.29 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.86 -37.78 74.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.26 94.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.56 -37.23 82.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.067 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmm-85 -50.05 -41.0 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.64 -65.86 0.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.119 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.497 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 82.5 mt -35.04 -33.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.53 -51.71 9.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -60.67 5.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 ' O ' ' A' ' 296' ' ' ALA . 13.7 m -51.24 -31.58 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.3 t -61.59 119.55 8.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.32 69.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 66.9 t80 -83.71 165.42 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.442 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -110.98 82.36 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.416 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.7 OUTLIER -103.4 120.59 41.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 21.7 t70 61.01 48.7 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.493 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 27.6 p-80 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.94 167.54 21.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -94.52 95.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 22.4 tp -60.83 143.49 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -123.93 130.86 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 243' ' ' VAL . 26.4 t -139.81 151.31 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -169.39 149.82 4.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 86.2 m95 -47.89 136.08 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.125 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.8 m -134.34 141.0 46.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 35.4 pt -140.54 145.23 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -104.39 149.17 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 312' ' ' VAL . 73.8 t -133.09 135.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.437 ' O ' HD12 ' A' ' 310' ' ' LEU . 31.0 p -130.26 171.76 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.42 51.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 250' ' ' THR . 23.7 mt -95.77 -177.52 4.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 t -122.23 164.27 18.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.48 -11.53 60.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -105.24 21.1 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.542 HG21 HD22 ' A' ' 246' ' ' LEU . 59.1 m -121.14 98.43 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -103.29 170.07 8.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -47.82 -43.4 27.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -23.67 64.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.55 -28.76 46.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.52 -30.84 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 7.1 pt20 -53.14 -33.56 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.55 -12.85 44.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.87 -37.23 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.568 ' CE2' HG11 ' A' ' 300' ' ' VAL . 46.5 m-85 -96.89 10.37 39.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.4 tpt85 -76.9 -45.32 2.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.63 0.729 . . . . 0.0 110.826 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.3 Cg_exo -47.96 -17.24 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.646 2.23 . . . . 0.0 112.354 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.8 m-85 -94.22 -32.47 13.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.22 -166.66 39.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.47 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.7 m -90.32 112.86 24.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 37.1 mt -69.34 145.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 26.7 t -96.56 -44.88 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 16.7 tpp180 -148.34 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 265' ' ' ILE . 41.5 mt -131.31 96.58 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -91.76 150.41 21.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.5 tp -142.14 120.16 12.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.5 131.8 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -134.5 174.39 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.19 164.91 13.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -107.24 -6.26 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 55.8 m -102.11 -58.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -6.84 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.83 26.87 65.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -88.09 138.73 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.5 t -47.35 127.74 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -62.22 -57.43 11.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.91 -9.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.65 149.5 52.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 270' ' ' LEU . . . -133.78 169.4 17.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -134.21 117.56 16.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -103.78 136.85 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.3 m -112.02 124.85 53.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.914 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 17.6 m-85 -98.78 171.74 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 12.6 m-70 -89.88 -40.26 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -118.94 158.87 24.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 290' ' ' ARG . 17.0 ttp-105 -74.6 -13.26 60.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.91 -29.18 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.465 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -84.36 -28.55 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.914 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -77.6 -33.77 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.97 65.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -49.14 -44.68 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -59.78 -66.65 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 312' ' ' VAL . 81.2 mt -39.86 -34.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.0 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -85.15 -57.05 2.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 312' ' ' VAL . 17.2 m -47.37 -32.7 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 111.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.2 p -55.74 122.28 11.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.48 78.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.01 136.97 38.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -84.89 92.61 1.76 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.6 112.51 24.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.888 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 7.8 t70 63.62 52.94 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 33.3 p-80 45.91 27.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.451 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.8 mt -129.09 162.74 27.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -93.96 104.75 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 244' ' ' THR . 14.7 tp -78.81 140.72 38.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -122.92 145.82 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 243' ' ' VAL . 49.6 t -145.61 136.37 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -146.68 168.1 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 297' ' ' ILE . 75.8 m95 -81.06 122.29 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.0 m -140.77 124.6 17.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 28.1 pt -122.61 145.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 312' ' ' VAL . 42.9 ttt180 -107.92 151.88 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 312' ' ' VAL . 95.6 t -139.0 141.84 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 43.3 p -139.48 170.06 16.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 30.8 t-20 73.58 38.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 250' ' ' THR . 30.2 mt -90.48 -175.97 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 52.6 p -127.34 175.61 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.79 -14.41 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -95.33 12.99 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.472 HG21 HD22 ' A' ' 246' ' ' LEU . 51.4 m -119.02 109.34 15.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 251' ' ' ARG . 0.0 OUTLIER -112.13 176.88 4.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 252' ' ' GLU . 1.9 mp0 -49.42 -43.33 44.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -25.42 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.38 -28.31 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.51 -25.3 16.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -61.31 -30.17 70.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.69 -16.81 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.49 -38.75 33.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.754 ' HB2' HD11 ' A' ' 265' ' ' ILE . 56.5 m-85 -95.5 8.99 41.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.4 OUTLIER -75.07 -45.44 4.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.1 Cg_exo -47.98 -18.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.385 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -93.49 -32.16 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.11 -166.39 39.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.23 113.79 25.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.754 HD11 ' HB2' ' A' ' 259' ' ' PHE . 84.2 mt -68.09 145.09 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.498 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 39.4 t -93.95 -47.37 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -149.25 149.94 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.3 mt -130.99 104.88 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 3.5 t80 -98.87 136.2 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.72 127.98 39.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -64.13 129.17 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -134.59 150.44 50.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.98 177.77 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -112.09 -56.89 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.5 m -55.26 -53.19 59.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 8.6 t -92.08 -24.11 19.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 61.85 43.59 99.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -119.97 176.04 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 65.3 p -80.79 129.08 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -63.58 -72.9 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.39 33.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 21.5 p90 -165.74 151.92 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.844 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.32 165.06 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -131.59 111.16 11.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.1 mp -97.02 124.37 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 18.7 m -101.04 115.47 30.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.7 m-85 -88.22 176.29 7.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 264' ' ' SER . 14.5 m-70 -94.65 -43.76 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -114.32 168.55 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.4 ttt85 -82.93 -18.8 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -83.55 -29.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 3.5 m-20 -83.22 -27.11 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -75.09 -37.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.27 -37.84 68.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -48.28 -42.72 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.5 -70.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.554 HD12 ' NE1' ' A' ' 314' ' ' TRP . 82.6 mt -35.08 -34.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -67.01 -48.04 69.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.088 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.8 -59.85 2.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.1 m -41.81 -36.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.4 p -55.35 119.84 6.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.07 23.26 74.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -76.57 153.2 35.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.5 76.09 0.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 120.6 38.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 3.0 t70 54.57 49.63 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 24.2 p-80 47.62 29.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 309' ' ' ILE . 38.0 mt -129.85 164.64 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -94.93 102.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.404 HD11 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -72.08 130.94 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -111.31 129.67 55.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 243' ' ' VAL . 55.9 t -133.78 143.27 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -156.02 161.26 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.554 ' NE1' HD12 ' A' ' 297' ' ' ILE . 72.3 m95 -71.28 122.29 19.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.878 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.7 m -129.37 142.91 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 38.2 pt -138.81 140.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 69.9 ttt180 -100.56 147.35 26.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 312' ' ' VAL . 55.8 t -129.58 145.48 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.7 p -143.27 165.54 27.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.171 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 26.5 t-20 73.32 39.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 250' ' ' THR . 49.9 mt -89.98 -176.95 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 m -135.56 -175.95 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -74.8 -50.11 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.16 -10.83 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 246' ' ' LEU . 50.5 m -98.62 97.75 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -109.79 178.98 4.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.6 -41.62 31.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -67.61 -23.05 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.77 -30.32 36.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.8 mt -88.29 -24.06 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.4 tt0 -60.6 -34.5 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -94.35 -11.68 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.541 HD13 ' HE2' ' A' ' 305' ' ' TYR . 31.6 tp -80.62 -39.7 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.948 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 265' ' ' ILE . 64.7 m-85 -98.18 12.04 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 tpt180 -79.15 -45.11 1.72 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.93 -17.23 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.621 2.214 . . . . 0.0 112.393 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.9 m-85 -95.39 -31.06 13.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.79 -166.13 39.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.1 m -90.34 108.73 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 259' ' ' PHE . 61.4 mt -63.32 139.11 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.511 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.8 t -89.67 -43.34 10.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -148.93 153.17 37.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 85.1 mt -133.64 104.7 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.6 t80 -99.66 140.9 33.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 283' ' ' ALA . 35.7 tp -133.01 125.34 29.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.516 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.41 125.55 28.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -129.08 157.7 41.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.49 -178.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -116.64 -32.32 5.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 36.7 m -80.37 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 276' ' ' THR . 1.9 t -81.8 -36.7 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.159 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.04 19.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -96.73 -177.23 3.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 86.4 p -77.42 114.98 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -52.85 -54.02 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 141.97 -6.37 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.516 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 13.6 p90 -135.26 157.2 47.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.864 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.706 ' HB2' HD12 ' A' ' 270' ' ' LEU . . . -146.43 163.55 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.7 m-85 -128.74 114.03 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -98.75 140.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.096 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.99 142.12 46.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.17 -176.31 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 8.9 m-70 -104.79 -31.58 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -129.28 148.03 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -63.71 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.837 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.86 -60.24 2.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.69 -28.41 67.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.19 78.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.4 -23.95 57.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -61.99 -37.65 85.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.8 -69.0 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.54 HD12 ' NE1' ' A' ' 314' ' ' TRP . 85.3 mt -35.88 -35.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.3 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.05 -60.9 2.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 312' ' ' VAL . 11.4 m -41.67 -42.41 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.119 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 300' ' ' VAL . 36.7 p -53.59 127.91 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.06 68.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -83.97 134.25 34.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.63 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.541 ' HE2' HD13 ' A' ' 258' ' ' LEU . 1.5 t80 -105.24 115.55 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.5 m-20 57.33 54.05 7.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 36.7 p-80 48.76 36.92 8.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 309' ' ' ILE . 90.9 mt -138.59 168.41 19.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -101.25 97.26 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.23 149.27 50.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -133.29 132.13 41.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 243' ' ' VAL . 97.8 t -139.54 143.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.02 158.95 38.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.54 ' NE1' HD12 ' A' ' 297' ' ' ILE . 81.4 m95 -69.08 125.51 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.066 179.933 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.89 0.376 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 13.4 m -140.6 131.63 26.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 40.6 pt -127.6 141.08 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt180 -99.57 153.46 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 312' ' ' VAL . 68.7 t -139.64 135.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 72.6 p -132.24 163.19 29.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.4 t-20 71.59 43.77 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.2 mt -91.11 177.21 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.5 t -122.91 146.47 47.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -48.18 -49.62 32.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.11 -24.92 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.8 m -82.16 97.01 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -104.69 179.26 4.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -49.49 -56.22 10.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -55.51 -25.24 36.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.97 -31.23 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -26.06 24.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.5 tt0 -59.5 -31.71 69.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -92.87 -8.59 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 26.6 tp -88.05 -39.7 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.849 ' HB2' HD11 ' A' ' 265' ' ' ILE . 79.1 m-85 -98.15 11.19 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -76.86 -45.35 2.99 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.8 Cg_exo -47.97 -17.93 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.365 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.0 m-85 -94.55 -33.79 12.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.85 -167.1 40.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 19.8 m -90.53 110.33 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.6 mt -66.24 142.49 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.564 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.4 t -92.57 -46.83 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -148.17 139.64 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.452 ' CG1' HG21 ' A' ' 265' ' ' ILE . 38.4 mt -120.98 102.94 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.2 t80 -93.12 143.03 26.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 24.2 tp -136.44 115.59 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.446 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.52 126.46 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.442 ' HE3' HD23 ' A' ' 270' ' ' LEU . 49.4 mttp -130.97 174.41 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.429 ' HA ' ' HZ3' ' A' ' 280' ' ' LYS . 7.7 t70 -103.73 177.32 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.83 -54.74 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 26.9 m -55.14 -72.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.137 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 278' ' ' GLN . 14.8 t -77.5 -32.26 54.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 73.97 39.37 46.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.548 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 276' ' ' THR . 90.9 mt-30 -103.64 169.65 8.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 45.7 m -70.94 115.61 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 273' ' ' ASP . 19.3 mmtm -48.21 -54.26 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.57 2.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 12.4 p90 -123.53 155.27 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.51 165.29 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.46 116.7 16.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -104.58 125.41 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.3 m -101.57 119.13 38.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 14.7 m-85 -91.05 175.71 6.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.9 m-70 -92.34 -44.43 8.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -110.99 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -87.57 -20.81 25.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.58 -24.18 31.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.51 -34.44 27.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -70.44 -35.84 73.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.4 70.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -48.63 -44.07 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.83 -65.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 314' ' ' TRP . 69.1 mt -34.48 -32.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -50.09 23.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -62.51 3.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 312' ' ' VAL . 16.1 m -46.59 -36.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.82 0.343 . . . . 0.0 111.125 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.8 t -57.54 114.25 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.77 26.24 56.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -82.62 153.53 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.29 71.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.37 129.55 36.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.376 . . . . 0.0 110.913 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.5 t70 45.25 52.79 8.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.547 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 21.3 p-80 44.67 31.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.41 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.5 mt -131.33 163.3 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -92.98 101.39 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.3 tp -76.42 139.01 40.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.72 140.13 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 243' ' ' VAL . 94.9 t -143.1 143.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -152.11 174.24 13.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.602 ' CD1' HD13 ' A' ' 297' ' ' ILE . 68.9 m95 -80.53 125.61 30.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.863 0.363 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.4 m -144.0 131.11 20.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 297' ' ' ILE . 29.1 pt -126.0 143.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.0 ttt180 -101.81 151.84 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 312' ' ' VAL . 41.6 t -134.71 139.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 46.9 p -141.85 165.32 27.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.9 t-20 68.42 50.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -92.39 -175.64 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 250' ' ' THR . 5.6 t -130.42 140.24 50.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.406 ' OE1' ' C ' ' A' ' 248' ' ' GLU . 0.6 OUTLIER -47.19 -21.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.69 22.36 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 246' ' ' LEU . 90.7 m -126.41 114.2 17.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.68 179.94 3.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.88 -44.77 70.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -61.18 -28.22 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.69 -33.3 64.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.467 HD22 ' HE1' ' A' ' 259' ' ' PHE . 43.0 mt -84.17 -28.72 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 24.0 tt0 -57.94 -42.28 84.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -83.71 -16.02 46.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 259' ' ' PHE . 14.8 tp -80.81 -38.07 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' A' ' 265' ' ' ILE . 80.2 m-85 -99.15 12.01 37.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 ttt180 -77.92 -45.15 2.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.598 0.714 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.18 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.7 m-85 -92.78 -35.23 13.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.24 -163.15 36.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -91.62 109.92 21.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.4 mt -67.95 138.9 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.4 t -88.69 -42.03 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -151.56 154.72 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 62.5 mt -133.76 101.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 3.4 t80 -91.4 141.56 28.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 52.9 tp -135.4 127.44 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -75.11 114.86 14.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -121.68 150.91 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.25 173.23 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 -29.77 7.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.3 m -78.59 -66.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.417 HG21 ' OE1' ' A' ' 278' ' ' GLN . 11.4 t -89.01 -13.52 38.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.25 95.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.417 ' OE1' HG21 ' A' ' 276' ' ' THR . 84.7 mt-30 -102.35 157.22 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 48.0 t -58.21 115.08 2.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -51.63 -59.17 4.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.68 -13.24 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 31.6 p90 -129.03 157.2 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.68 172.72 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -139.14 116.43 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.5 mp -103.63 132.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.43 142.02 35.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -116.23 168.35 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.0 m-70 -85.55 -35.07 21.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 288' ' ' HIS . 24.5 mmt-85 -120.82 167.27 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -78.54 -32.9 48.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.12 -54.53 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -53.93 -32.79 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.52 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -70.55 -46.0 64.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -50.78 -39.04 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.31 -69.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 241' ' ' ILE . 72.8 mt -36.91 -34.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.5 55.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -80.03 -59.12 2.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.497 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 296' ' ' ALA . 28.0 m -53.97 -20.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.4 t -63.03 107.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.92 38.2 23.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -88.97 146.32 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.04 74.22 2.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -95.13 136.59 35.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 35.1 t70 42.41 53.98 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 37.8 p-80 46.05 39.03 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 309' ' ' ILE . 95.1 mt -146.36 168.48 21.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.3 mp -95.55 102.79 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.64 139.96 56.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -118.52 127.82 53.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 242' ' ' ARG . 44.8 t -140.72 141.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -162.22 149.96 14.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.52 ' HH2' ' HB3' ' A' ' 293' ' ' ALA . 96.1 m95 -45.01 121.4 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 179.891 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.859 0.361 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.9 m -136.02 143.52 44.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 297' ' ' ILE . 42.5 pt -137.43 141.88 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -105.57 147.71 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 312' ' ' VAL . 70.5 t -129.71 146.67 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 69.8 p -144.16 163.56 33.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 69.05 40.88 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 34.5 mt -85.33 -175.42 5.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 t -125.52 161.31 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.57 -9.36 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.55 -8.97 39.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 86.8 m -101.79 104.13 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -104.05 179.19 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -52.79 -51.52 60.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.4 t -62.77 -19.79 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.34 -26.92 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.87 -33.59 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 3.3 tp-100 -52.49 -34.25 48.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -87.75 -20.44 26.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.63 -36.79 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.7 m-85 -98.01 11.72 36.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.585 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 2.4 ttt-85 -79.34 -45.24 1.66 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.37 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.3 m-85 -93.39 -33.76 13.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.16 -160.36 33.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 8.3 m -90.69 119.11 30.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 259' ' ' PHE . 67.0 mt -73.86 145.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -97.96 -43.71 6.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 267' ' ' ARG . 20.2 ttm105 -150.43 149.98 30.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 54.2 mt -132.97 100.09 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.8 t80 -95.59 140.86 29.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.2 tp -132.93 121.7 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -68.79 129.87 41.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -136.98 162.16 34.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.58 178.22 7.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -108.51 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 78.0 m -73.02 -65.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 15.4 t -95.65 -18.87 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.91 37.54 92.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -91.96 160.23 15.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 28.0 t -56.0 121.16 8.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -64.88 -54.46 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.56 1.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.45 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 32.6 p90 -128.61 153.86 46.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 110.857 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.46 173.08 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.6 112.4 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -100.83 138.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -111.27 143.91 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 13.0 m-85 -121.39 167.25 12.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 264' ' ' SER . 6.2 m-70 -91.06 -44.12 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -104.63 155.39 18.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -78.1 -11.22 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -89.49 -41.37 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.62 -35.58 77.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.52 -43.77 88.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.6 79.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -49.91 -38.63 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.906 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.53 -63.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.514 HD11 HG22 ' A' ' 241' ' ' ILE . 95.5 mt -35.97 -33.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.75 -55.43 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -54.98 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 296' ' ' ALA . 15.4 m -54.6 -30.94 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 111.161 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.0 t -61.66 106.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 84.77 21.12 56.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.01 141.93 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -85.82 93.08 1.82 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.53 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.2 OUTLIER -113.26 109.73 19.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.372 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 30.8 t70 67.74 53.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 17.1 p-80 47.4 26.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.51 162.08 30.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -93.09 98.02 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.487 HD11 ' CG1' ' A' ' 243' ' ' VAL . 32.3 tp -62.85 138.79 58.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -119.31 132.15 55.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 243' ' ' VAL . 87.0 t -137.22 154.06 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 312' ' ' VAL . 8.7 pt-20 -165.24 156.29 14.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.502 ' CD1' HD13 ' A' ' 297' ' ' ILE . 66.2 m95 -57.74 136.33 56.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.35 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 7.1 m -136.63 144.51 44.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.1 pt -144.35 141.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.462 ' HB2' ' CE2' ' A' ' 284' ' ' PHE . 69.4 ttt180 -100.56 149.03 24.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 312' ' ' VAL . 98.0 t -132.06 142.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.7 p -135.14 174.52 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 3.2 m-20 64.18 48.13 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 250' ' ' THR . 19.2 mt -103.4 168.76 8.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.3 p -118.87 154.94 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.86 -46.57 60.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -57.36 -19.25 21.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.682 HG21 HD22 ' A' ' 246' ' ' LEU . 26.2 m -90.08 98.93 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -106.42 -175.74 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -55.56 -55.91 26.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.8 t -55.21 -20.02 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.89 -28.69 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 mt -88.66 -27.26 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.475 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -61.92 -31.12 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.53 -18.14 28.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.59 -38.56 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.783 ' HB2' HD11 ' A' ' 265' ' ' ILE . 71.8 m-85 -95.68 11.59 32.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 tpt180 -78.31 -45.26 2.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.598 0.714 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.5 Cg_exo -47.96 -17.16 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.415 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -93.31 -31.71 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.98 36.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -90.02 109.52 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.3 mt -66.07 148.54 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.434 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.0 t -95.16 -43.42 8.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -154.43 149.08 26.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 72.6 mt -134.59 100.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.2 t80 -92.83 151.72 19.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.66 HD23 ' HE3' ' A' ' 272' ' ' LYS . 51.8 tp -140.54 145.99 37.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.683 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -97.9 132.01 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.66 ' HE3' HD23 ' A' ' 270' ' ' LEU . 5.6 mptt -133.45 162.78 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -91.38 174.12 7.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -113.38 -52.94 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.7 m -60.38 -54.81 41.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -89.39 -18.96 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.05 82.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 279' ' ' SER . 32.1 mt-30 -118.67 126.7 52.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 278' ' ' GLN . 2.2 m -36.53 128.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -57.95 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 154.79 33.93 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.683 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 43.8 p90 -162.7 148.33 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -142.29 173.91 11.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 242' ' ' ARG . 71.1 m-85 -136.02 113.02 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -98.25 124.84 51.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -106.46 115.16 29.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.7 m-85 -88.73 -180.0 6.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.6 m-70 -95.53 -38.72 10.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.84 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.03 167.53 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 38.4 ttp85 -73.53 -32.87 64.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.26 -64.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -48.8 -35.95 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.45 -42.86 74.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.29 85.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.9 mtp85 -47.05 -41.82 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.601 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.5 mt -35.71 -32.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -68.98 -47.31 65.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.15 -62.2 2.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.4 m -41.26 -37.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.7 p -56.2 112.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.4 32.51 38.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.441 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -89.71 145.51 25.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -95.81 78.79 0.8 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.62 134.66 39.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 2.1 t70 44.94 52.88 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 34.0 p-80 45.59 33.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -135.03 167.4 21.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.2 mp -95.52 97.88 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.7 tp -73.67 138.78 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.48 144.89 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 243' ' ' VAL . 29.6 t -143.75 145.5 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.99 171.0 17.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.601 ' CD1' HD13 ' A' ' 297' ' ' ILE . 57.9 m95 -79.25 131.78 36.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 287' ' ' PHE . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.1 m -138.61 138.27 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 297' ' ' ILE . 43.0 pt -137.28 140.15 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 14.5 ttt85 -100.96 149.23 24.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 312' ' ' VAL . 84.0 t -136.65 143.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 62.1 p -138.2 166.31 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 22.5 t-20 74.05 38.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.75 177.08 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -130.94 166.02 21.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -70.68 -16.54 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.98 9.83 11.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -132.94 111.39 10.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 -176.33 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -48.77 -59.1 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -54.66 -26.7 34.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -76.97 -30.67 56.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.69 -29.83 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 256' ' ' GLN . 21.9 tp60 -56.25 -29.48 61.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.3 -15.65 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.3 tp -84.31 -37.88 21.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.583 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.7 m-85 -96.68 11.31 35.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.594 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -79.7 -45.24 1.56 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.712 . . . . 0.0 110.883 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.88 -17.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.08 -159.9 33.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.92 135.05 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 0.0 110.875 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.494 HG21 HG12 ' A' ' 268' ' ' ILE . 54.6 mt -93.61 138.88 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 48.3 t -92.6 -48.76 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.7 tpp180 -143.38 148.53 36.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 265' ' ' ILE . 45.9 mt -132.96 108.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.6 t80 -95.62 144.07 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.0 tp -131.08 119.35 21.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.57 113.44 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -129.14 146.66 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.29 -177.87 0.75 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -122.69 -16.65 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 92.0 m -102.23 -50.44 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -95.41 -9.05 33.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.64 56.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -99.5 178.57 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 27.6 p -89.29 121.84 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -62.13 -74.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 157.94 33.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 27.6 p90 -166.13 148.34 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -139.82 165.87 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.579 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 84.8 m-85 -133.18 115.66 15.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -101.99 131.82 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -109.05 113.05 25.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . 13.5 m-85 -84.48 177.11 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 13.6 m-70 -93.51 -30.54 14.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -122.8 171.37 9.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -83.72 -28.61 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.53 -56.57 5.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 1.0 OUTLIER -53.18 -35.12 59.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.828 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.82 90.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.43 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -48.18 -42.59 30.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.95 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 314' ' ' TRP . 86.3 mt -38.31 -32.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.49 -41.89 62.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -84.85 -63.92 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 259' ' ' PHE . 14.0 m -40.55 -37.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 111.162 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 75.4 p -57.04 128.59 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.94 19.06 69.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.472 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -80.89 153.14 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.36 94.27 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.68 123.62 50.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.892 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 10.6 t70 56.4 49.39 15.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 34.8 p-80 48.6 35.62 6.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 309' ' ' ILE . 71.8 mt -138.5 167.41 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -95.48 103.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -77.12 131.22 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.52 138.98 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 243' ' ' VAL . 99.0 t -142.87 145.73 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -163.51 149.11 11.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.558 ' CD1' HD13 ' A' ' 297' ' ' ILE . 92.5 m95 -52.38 120.0 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.869 0.366 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.8 m -137.46 145.15 42.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 297' ' ' ILE . 17.0 pt -141.94 145.11 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.54 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 38.0 ttt180 -105.47 156.36 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 312' ' ' VAL . 97.8 t -140.47 138.71 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 76.0 p -132.69 161.99 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.8 t30 74.53 48.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 250' ' ' THR . 31.2 mt -103.67 146.1 29.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.423 ' HB2' ' CG ' ' A' ' 306' ' ' ASP . 1.3 t -85.52 156.94 20.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.13 -6.74 18.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.6 9.34 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 246' ' ' LEU . 54.3 m -115.6 106.8 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -105.88 174.47 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -47.61 -59.79 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.2 t -54.14 -21.86 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.8 -30.47 40.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.7 mt -90.4 -26.63 19.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.2 pt20 -56.19 -26.33 50.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -91.54 -18.01 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.549 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.2 tp -82.12 -36.58 27.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 258' ' ' LEU . 68.9 m-85 -98.47 11.7 37.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -79.39 -45.3 1.65 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.893 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.2 Cg_exo -47.93 -17.59 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -93.58 -32.18 14.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.16 -166.14 39.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.485 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.9 m -90.99 106.86 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.9 mt -59.94 150.52 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.547 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.0 t -98.82 -46.52 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 8.4 tpp180 -149.87 146.23 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.436 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 47.1 mt -126.55 106.92 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -99.04 149.69 22.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 56.0 tp -140.75 129.08 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.65 110.51 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -131.85 135.9 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -76.57 133.12 39.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -85.32 -37.24 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 46.5 m -64.81 -34.67 78.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 7.7 p -105.4 -50.41 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.55 28.59 6.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -114.28 172.79 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.7 t -93.68 113.63 25.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 282' ' ' PHE . 34.4 mmtt -42.58 -69.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 149.18 32.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 7.6 p90 -166.32 161.39 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.48 165.54 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 74.2 m-85 -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -94.81 129.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.3 m -106.62 118.47 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -92.24 179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.1 m-70 -95.99 -35.88 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -123.69 165.05 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -71.11 -37.96 72.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -60.38 -69.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -44.72 -34.32 2.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.04 85.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.2 77.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.086 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -50.48 -40.95 52.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -66.11 -66.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 312' ' ' VAL . 84.9 mt -38.83 -40.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.59 19.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -71.04 -65.25 2.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 312' ' ' VAL . 7.2 m -39.93 -42.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.48 ' N ' HG23 ' A' ' 300' ' ' VAL . 10.5 t -49.4 116.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.21 62.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -78.63 155.27 29.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.12 76.9 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 0.4 OUTLIER -93.31 130.25 39.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.582 ' OD1' HD12 ' A' ' 308' ' ' LEU . 0.8 OUTLIER 47.19 54.13 9.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 29.0 p-80 48.46 33.18 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.582 HD12 ' OD1' ' A' ' 306' ' ' ASP . 62.0 mt -136.4 164.05 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.581 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -95.44 95.18 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.74 134.65 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -118.21 130.8 56.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 243' ' ' VAL . 91.7 t -130.6 142.29 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -145.35 172.44 13.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.416 ' CD1' HD13 ' A' ' 297' ' ' ILE . 59.0 m95 -81.47 125.18 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.882 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.893 0.378 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 315' ' ' ALA . 14.5 m -132.76 143.46 49.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 297' ' ' ILE . 27.6 pt -136.98 145.98 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -107.14 147.7 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 312' ' ' VAL . 54.1 t -129.45 140.46 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.1 p -138.09 165.8 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 21.1 t30 66.21 48.26 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.667 HD22 HG21 ' A' ' 250' ' ' THR . 22.2 mt -93.83 177.88 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.5 t -115.69 159.08 21.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.74 -14.18 60.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.22 19.9 15.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.667 HG21 HD22 ' A' ' 246' ' ' LEU . 49.9 m -118.98 98.57 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -100.48 177.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -52.91 -42.57 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.6 t -68.1 -25.39 65.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 -23.75 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.96 -32.57 12.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.3 pt20 -52.09 -33.91 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.56 -15.61 36.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.49 -38.72 25.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' A' ' 265' ' ' ILE . 95.6 m-85 -95.48 11.33 33.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.614 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 7.9 tpt180 -79.03 -43.97 1.74 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.2 Cg_exo -47.93 -18.57 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.306 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 30.4 m-85 -94.76 -34.39 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.98 -161.55 34.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -94.28 117.77 30.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 259' ' ' PHE . 54.5 mt -71.57 144.98 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.6 t -95.27 -41.9 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -152.07 149.71 29.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 52.1 mt -130.68 105.6 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.6 t80 -98.46 141.46 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.0 tp -132.32 131.81 42.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -71.57 125.59 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -137.01 152.14 49.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.95 -178.22 5.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -109.71 -54.11 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 62.5 m -52.49 -72.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 2.0 t -76.57 -21.42 55.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 63.56 35.72 92.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -108.25 168.5 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 42.3 t -72.4 129.35 38.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -63.38 -74.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.86 32.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 8.2 p90 -165.96 159.75 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -150.97 165.13 34.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -132.08 116.06 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -99.48 125.85 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 16.4 m -102.21 116.93 33.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.9 m-85 -88.71 -178.61 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.3 m-70 -97.22 -37.98 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -126.37 139.98 52.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -51.23 -28.23 11.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -66.0 -68.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.0 -30.11 9.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . . . -67.8 -38.24 83.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.78 -35.31 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -50.74 -41.04 56.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.0 -66.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.992 HD11 HG22 ' A' ' 241' ' ' ILE . 82.9 mt -38.2 -34.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -76.15 -51.12 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -69.53 -59.56 5.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 312' ' ' VAL . 15.3 m -49.38 -26.24 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.6 t -62.42 109.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.31 27.21 31.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -83.11 154.7 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -97.06 78.94 0.68 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.22 120.77 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.1 t70 51.16 52.62 14.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 27.9 p-80 48.74 26.98 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 66.4 mt -129.55 164.0 24.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -94.96 98.0 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -120.31 138.31 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 243' ' ' VAL . 89.4 t -146.41 151.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.089 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.02 152.1 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.465 ' HZ2' ' HB2' ' A' ' 294' ' ' ALA . 78.1 m95 -55.3 126.11 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 240' ' ' THR . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.06 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.849 0.357 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.9 m -141.85 135.7 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 41.1 pt -132.77 142.28 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -102.21 149.02 24.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 312' ' ' VAL . 94.7 t -135.9 139.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 53.1 p -138.55 167.63 21.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 19.7 t-20 73.13 41.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.511 HD22 HG21 ' A' ' 250' ' ' THR . 31.0 mt -92.27 -175.16 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -125.49 170.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.87 -6.7 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.98 22.14 16.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.511 HG21 HD22 ' A' ' 246' ' ' LEU . 99.6 m -131.11 96.43 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.56 ' CG ' HG22 ' A' ' 253' ' ' THR . 11.7 ptt180 -107.09 -177.38 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -45.7 -50.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' THR . . . . . 0.56 HG22 ' CG ' ' A' ' 251' ' ' ARG . 1.4 t -59.51 -28.6 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.95 -27.03 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.06 -20.35 19.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.418 ' HB2' HD12 ' A' ' 268' ' ' ILE . 11.5 tt0 -64.94 -33.81 76.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -93.2 -11.68 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.458 HD22 ' HE2' ' A' ' 305' ' ' TYR . 28.7 tp -82.78 -41.22 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.601 ' CE2' HG11 ' A' ' 300' ' ' VAL . 64.2 m-85 -96.76 11.91 33.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.7 ttt-85 -77.52 -45.32 2.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.729 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.87 -17.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -92.74 -31.21 15.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.72 -164.13 37.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 31.3 m -91.12 107.43 19.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 259' ' ' PHE . 82.8 mt -61.35 141.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.531 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.9 t -94.05 -45.81 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -150.27 149.17 29.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.525 ' CG1' HG21 ' A' ' 265' ' ' ILE . 46.9 mt -133.47 113.2 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.103 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 5.1 t80 -104.12 147.39 27.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.5 tp -134.74 128.9 33.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -72.99 129.45 38.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -135.43 175.59 9.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.53 170.67 8.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -113.43 -5.54 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.5 m -101.31 -35.9 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -121.22 -10.52 8.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.71 84.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -104.99 163.22 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 15.0 m -69.66 142.16 53.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -82.05 -74.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 166.83 31.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 11.4 p90 -165.49 150.39 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.888 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 162.55 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -127.23 117.9 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -103.26 129.1 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -107.9 124.89 50.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.17 179.96 4.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.5 m-70 -93.78 -36.34 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -124.25 179.76 4.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.87 -17.56 29.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -76.52 -59.36 2.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.11 -24.77 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.27 62.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.73 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -49.66 -42.05 44.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.847 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.14 -62.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.555 HD12 ' NE1' ' A' ' 314' ' ' TRP . 71.3 mt -39.92 -37.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.97 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -82.47 -59.46 2.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 296' ' ' ALA . 6.8 m -49.41 -30.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 p -62.97 120.86 12.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.05 20.34 79.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.18 156.39 29.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -103.52 76.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.458 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -99.06 120.95 40.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.872 0.368 . . . . 0.0 110.954 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 56.79 49.38 14.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 18.1 p-80 45.83 31.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 309' ' ' ILE . 34.5 mt -132.03 166.86 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -95.41 102.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 243' ' ' VAL . 15.4 tp -71.81 134.62 46.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.67 130.29 56.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 243' ' ' VAL . 97.6 t -136.19 144.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.48 157.77 30.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.555 ' NE1' HD12 ' A' ' 297' ' ' ILE . 80.1 m95 -62.95 123.63 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.888 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.2 m -142.89 145.01 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 37.6 pt -140.0 142.18 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 62.5 ttt180 -105.6 153.81 21.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 312' ' ' VAL . 91.4 t -138.3 142.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 61.6 p -138.16 167.5 21.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 73.59 43.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.78 177.57 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 85.3 p -121.54 -175.16 3.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.77 -1.86 58.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.24 18.8 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.508 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 53.0 m -127.61 111.56 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 179.08 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -52.1 -38.97 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -68.1 -18.91 64.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -86.6 -26.19 24.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -91.61 -22.76 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -62.31 -35.32 78.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -92.45 -10.73 36.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 259' ' ' PHE . 25.9 tp -85.79 -34.51 21.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.603 ' CE2' HG11 ' A' ' 300' ' ' VAL . 77.6 m-85 -104.69 11.46 34.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.581 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.7 tpt180 -80.25 -45.68 1.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.6 Cg_exo -47.95 -20.43 2.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.5 m-85 -88.84 -31.26 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.97 34.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 18.7 m -91.39 118.66 30.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.02 136.25 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.3 t -87.32 -42.18 13.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -154.9 160.0 40.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.71 116.06 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -113.16 148.88 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.736 HD23 ' HE3' ' A' ' 272' ' ' LYS . 61.0 tp -139.87 127.32 21.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.59 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -73.2 123.45 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.736 ' HE3' HD23 ' A' ' 270' ' ' LEU . 51.3 mttt -136.15 146.03 46.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.17 177.22 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -114.7 -61.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.7 m -53.02 -41.41 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 t -102.01 -22.58 14.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.64 32.8 84.67 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -109.02 140.12 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 47.2 t -54.86 124.67 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -55.1 -74.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.01 33.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 36.5 p90 -165.97 146.46 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.5 164.18 27.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.502 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.2 m-85 -131.06 112.63 13.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -100.13 127.82 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 7.3 m -102.14 120.77 40.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.5 m-85 -96.29 177.49 5.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 264' ' ' SER . 10.9 m-70 -96.5 -47.95 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -112.14 164.03 13.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ARG . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 290' ' ' ARG . 13.4 ttp-105 -71.75 -31.58 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.6 -61.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.99 -37.17 52.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -68.04 -39.13 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.65 -37.41 70.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -49.25 -42.91 42.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -63.49 -67.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.563 HD13 ' CD1' ' A' ' 314' ' ' TRP . 85.8 mt -36.03 -32.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.127 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -70.98 -45.88 63.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -79.46 -64.96 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.5 m -40.01 -36.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.894 0.378 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p -61.37 112.37 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.88 17.65 57.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -79.51 157.87 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.907 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.93 82.28 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.508 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.3 OUTLIER -99.39 129.74 45.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.449 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 0.5 OUTLIER 47.77 53.69 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 31.2 p-80 45.61 39.53 5.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 77.5 mt -143.53 168.19 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.7 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.19 138.04 51.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.27 132.18 56.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 243' ' ' VAL . 79.4 t -137.06 143.4 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -153.53 161.89 41.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.563 ' CD1' HD13 ' A' ' 297' ' ' ILE . 65.4 m95 -65.25 125.27 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.862 0.363 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.4 m -139.36 144.05 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 297' ' ' ILE . 34.4 pt -138.62 144.06 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.549 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt-85 -100.79 152.84 20.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -138.77 140.52 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.418 ' O ' HD12 ' A' ' 310' ' ' LEU . 70.8 p -133.65 169.47 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.62 53.12 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 19.8 mt -103.53 166.38 10.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.0 p -111.69 155.33 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.28 -5.82 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 19.59 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.0 m -131.1 99.62 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -103.57 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -51.04 -40.79 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' THR . . . . . 0.469 HG23 ' OD1' ' A' ' 254' ' ' ASP . 11.7 t -67.95 -30.89 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 253' ' ' THR . 0.9 OUTLIER -76.72 -28.53 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.74 -26.56 20.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.56 -32.29 73.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.66 -15.13 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.79 -35.72 20.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.6 m-85 -100.92 8.57 43.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.624 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.6 OUTLIER -80.86 -42.86 1.23 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.568 0.699 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.5 Cg_exo -47.91 -17.98 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.2 m-85 -92.84 -31.8 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.15 36.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.556 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 49.0 m -91.28 116.33 28.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 34.4 mt -73.89 147.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.2 t -98.68 -43.14 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -151.57 153.89 35.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 89.1 mt -138.46 122.2 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.5 t80 -112.6 149.54 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.8 tp -135.49 127.43 29.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -69.42 121.59 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -128.74 150.59 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.21 -176.74 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -111.2 -62.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.9 m -47.22 -69.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 278' ' ' GLN . 10.2 t -77.37 -34.01 55.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.76 39.46 39.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.411 ' H ' HG23 ' A' ' 276' ' ' THR . 21.6 mt-30 -111.21 -176.9 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 35.1 t -80.44 126.04 30.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -66.68 -74.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.85 32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.464 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.665 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 19.8 p90 -166.02 151.26 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.923 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.83 165.19 28.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -129.42 116.56 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.6 mp -105.8 131.89 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -110.92 121.32 45.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.7 m-85 -94.63 -178.87 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.567 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 14.3 m-70 -95.25 -35.91 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ARG . . . . . 0.437 ' NH1' ' OD2' ' A' ' 292' ' ' ASP . 18.0 mtt85 -124.68 169.45 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -80.71 -23.48 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.5 -46.17 27.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 289' ' ' ARG . 15.7 m-20 -67.15 -35.28 79.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.37 -37.28 77.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.82 77.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -48.65 -42.63 35.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.85 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.8 mt -35.42 -37.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.95 -54.58 17.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -67.05 -66.97 2.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 312' ' ' VAL . 30.0 m -42.97 -37.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 1.7 t -50.81 113.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.47 24.85 60.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -86.3 137.78 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.41 97.06 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 116.88 30.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 14.9 t70 63.13 53.41 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 28.7 p-80 48.8 26.61 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 309' ' ' ILE . 35.1 mt -129.8 165.82 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -97.98 101.1 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 244' ' ' THR . 14.0 tp -73.32 137.65 44.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.5 150.69 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 243' ' ' VAL . 48.5 t -149.1 142.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.74 153.22 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.527 ' CD1' HD13 ' A' ' 297' ' ' ILE . 83.5 m95 -61.79 125.95 25.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.884 0.373 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 65.1 m -143.08 140.19 30.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 297' ' ' ILE . 30.0 pt -138.81 140.97 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.479 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 55.8 ttt180 -103.36 146.94 27.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 312' ' ' VAL . 89.9 t -132.74 142.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 74.3 p -136.93 167.1 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 72.28 43.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.96 176.94 6.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.401 ' CB ' ' CG ' ' A' ' 306' ' ' ASP . 15.9 t -124.63 151.99 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -54.74 -28.38 48.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.75 18.85 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 89.5 m -132.67 98.07 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 253' ' ' THR . 7.5 ptt180 -109.3 -174.41 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -45.57 -62.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 251' ' ' ARG . 5.2 t -46.89 -34.99 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.02 -31.15 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.4 mt -86.33 -25.79 25.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 25.5 tt0 -62.72 -35.9 81.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.56 -25.65 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 305' ' ' TYR . 14.2 tp -74.94 -39.52 61.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.713 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.0 m-85 -95.96 12.02 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -77.82 -45.37 2.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.607 0.717 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.93 -17.6 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.349 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 40.0 m-85 -91.02 -40.01 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 171.27 -160.53 32.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.602 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.2 m -92.17 107.6 19.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.713 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.1 mt -64.86 143.05 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.566 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.3 t -91.85 -49.64 6.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -141.02 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 80.0 mt -134.99 101.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.5 t80 -92.66 142.77 27.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.639 HD23 ' CE ' ' A' ' 272' ' ' LYS . 53.8 tp -129.47 128.48 43.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.617 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.4 115.58 4.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.639 ' CE ' HD23 ' A' ' 270' ' ' LEU . 97.1 mttt -136.95 134.93 37.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.87 162.56 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 275' ' ' THR . 4.4 ptmt -100.37 -35.11 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 274' ' ' LYS . 93.7 m -74.95 -41.46 59.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 31.1 p -94.16 -38.55 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.23 43.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -136.18 179.26 6.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 39.9 m -85.59 109.1 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -48.92 -66.88 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 151.25 33.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.617 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 52.7 p90 -165.97 147.52 6.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -138.23 174.36 10.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.1 m-85 -139.88 115.13 9.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -101.37 124.05 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.9 m -102.71 112.25 24.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.1 m-85 -84.95 169.85 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -85.92 -39.89 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.37 173.19 6.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.92 -39.12 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.87 -61.59 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -49.87 -38.63 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -66.56 -45.98 77.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -48.33 -42.03 30.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.75 -71.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 301' ' ' SER . 87.4 mt -34.23 -42.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.27 81.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -76.28 -66.08 1.91 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.1 m -42.25 -43.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.483 ' N ' HG23 ' A' ' 300' ' ' VAL . 13.0 t -48.9 104.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 90.33 33.62 8.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -96.33 130.89 43.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -79.08 52.62 4.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -75.47 128.03 34.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 308' ' ' LEU . 53.9 m-20 62.2 54.35 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 5.2 p-80 37.91 31.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 306' ' ' ASP . 82.9 mt -140.04 168.49 19.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.4 mp -89.58 97.96 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.14 140.15 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.92 144.47 48.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 243' ' ' VAL . 71.5 t -150.65 150.05 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -166.11 165.58 17.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.413 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 85.5 m95 -66.99 125.38 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.883 0.373 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.5 m -143.68 145.48 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 297' ' ' ILE . 30.8 pt -140.63 142.84 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 72.2 ttt180 -104.14 149.07 25.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 312' ' ' VAL . 93.4 t -134.74 142.29 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 282' ' ' PHE . 17.2 p -140.64 166.71 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 38.2 t-20 72.32 41.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 250' ' ' THR . 28.9 mt -92.11 169.6 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 306' ' ' ASP . 11.2 t -110.7 155.52 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.3 -28.92 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.89 22.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.548 HG21 HD22 ' A' ' 246' ' ' LEU . 93.3 m -127.92 96.77 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.77 ' HG3' HG22 ' A' ' 253' ' ' THR . 8.0 ptt180 -99.75 -174.33 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.06 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' THR . . . . . 0.77 HG22 ' HG3' ' A' ' 251' ' ' ARG . 13.6 t -50.81 -28.07 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.19 -27.79 62.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.64 -32.45 13.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -52.72 -30.59 33.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.93 -25.02 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 305' ' ' TYR . 12.4 tp -77.0 -36.85 56.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 265' ' ' ILE . 84.8 m-85 -96.05 11.4 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.606 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.2 OUTLIER -79.64 -44.57 1.58 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 110.888 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.94 -19.12 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 39.5 m-85 -89.71 -40.09 12.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.33 -160.22 30.63 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -93.03 113.28 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 259' ' ' PHE . 39.9 mt -71.36 141.9 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.5 t -89.19 -46.89 8.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -147.55 156.49 42.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 53.6 mt -138.24 105.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.8 t80 -93.22 143.48 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.738 HD23 ' CE ' ' A' ' 272' ' ' LYS . 49.9 tp -127.74 132.8 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.603 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.91 113.31 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.738 ' CE ' HD23 ' A' ' 270' ' ' LEU . 86.8 mttt -136.31 125.79 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.42 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -110.78 -40.08 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.6 m -67.08 -73.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 277' ' ' GLY . 12.2 t -79.87 -43.21 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 276' ' ' THR . . . 88.52 38.24 7.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.441 ' H ' HG23 ' A' ' 276' ' ' THR . 6.5 mm100 -99.66 149.7 23.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 110.871 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 13.5 t -57.88 116.89 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -63.72 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.62 33.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 41.7 p90 -165.98 154.57 11.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -144.42 174.05 11.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 91.0 m-85 -139.37 111.78 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -95.69 123.65 47.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 67.9 m -100.38 114.18 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.729 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 12.2 m-85 -87.59 169.71 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -86.69 -40.87 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.37 173.91 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -77.91 -38.85 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.91 -62.04 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.21 -40.41 47.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.78 -46.28 79.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.72 99.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -47.35 -41.54 19.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.22 -70.91 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 241' ' ' ILE . 87.4 mt -34.44 -43.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.7 87.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -75.63 -66.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.509 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 296' ' ' ALA . 25.6 m -43.33 -42.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 10.7 t -47.92 108.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.66 31.4 18.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -94.96 135.37 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -81.21 52.86 4.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.574 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -74.98 129.61 37.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 0.0 110.908 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.431 ' CG ' ' HB3' ' A' ' 247' ' ' SER . 58.1 m-20 62.07 54.19 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.521 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 5.2 p-80 38.23 30.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 306' ' ' ASP . 91.9 mt -141.41 169.63 17.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.36 101.93 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.32 149.52 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.85 127.41 43.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 243' ' ' VAL . 93.9 t -137.33 151.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -169.45 151.93 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -53.51 126.43 21.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 315' ' ' ALA . 91.2 m -135.15 150.7 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.23 144.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -107.38 152.15 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 99.0 t -137.11 138.02 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 60.8 p -133.27 165.29 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 16.6 t-20 73.77 49.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -98.52 176.33 5.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -123.75 -176.88 3.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.43 -5.14 58.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.8 19.57 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 246' ' ' LEU . 90.1 m -122.29 96.43 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -105.76 173.7 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -48.69 -42.61 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -23.38 66.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.99 -30.07 35.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.3 mt -86.59 -31.94 20.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.468 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 1.3 tm0? -54.75 -50.13 69.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.03 -19.03 60.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 305' ' ' TYR . 35.2 tp -80.16 -35.58 36.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 300' ' ' VAL . 59.6 m-85 -101.72 11.89 38.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -78.45 -45.21 2.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.587 0.708 . . . . 0.0 110.926 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.5 Cg_exo -48.03 -17.55 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.371 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.5 m-85 -91.41 -32.71 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.87 -162.93 36.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.25 106.25 18.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 268' ' ' ILE . 61.8 mt -61.44 143.41 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.519 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 31.5 t -94.1 -47.67 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -149.4 153.19 36.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 265' ' ' ILE . 74.5 mt -139.08 113.07 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.1 t80 -104.6 152.82 21.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 62.1 tp -133.14 128.44 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -66.64 121.42 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HE3' HD23 ' A' ' 270' ' ' LEU . 31.6 mttt -136.91 140.13 42.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.97 170.07 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.82 -42.15 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 97.2 m -74.67 -73.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.105 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 278' ' ' GLN . 12.9 t -70.2 -25.87 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.45 37.38 92.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.516 ' H ' HG23 ' A' ' 276' ' ' THR . 46.0 mm-40 -99.47 175.87 5.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.6 t -84.3 118.56 24.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -61.47 -74.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.57 34.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 22.8 p90 -165.55 151.28 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.3 169.04 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -134.58 116.06 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.2 mp -104.29 134.55 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.9 t -106.27 144.1 33.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 18.7 m-85 -119.91 169.96 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 5.7 m-70 -94.31 -40.86 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -110.16 152.81 25.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -71.74 -16.41 62.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -85.88 -41.86 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.36 -35.81 78.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -71.33 -35.84 71.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ALA . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -74.17 -35.98 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -49.46 -43.23 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.93 -66.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 88.6 mt -34.3 -34.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -72.07 -50.63 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.79 -65.67 2.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 312' ' ' VAL . 13.6 m -43.43 -28.81 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t -62.79 114.35 3.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.92 68.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 52.1 t80 -78.23 163.29 25.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLY . . . . . 0.41 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -108.87 83.69 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.52 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.3 OUTLIER -103.45 120.24 40.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.417 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 53.3 m-20 57.92 52.48 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 22.5 p-80 44.3 36.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 309' ' ' ILE . 70.4 mt -139.09 166.63 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -93.7 101.8 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.3 134.41 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.63 138.78 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 243' ' ' VAL . 68.9 t -140.47 148.34 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.07 153.05 13.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.488 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 83.3 m95 -54.52 122.0 9.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 240' ' ' THR . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.886 0.374 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -134.92 142.71 46.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 29.5 pt -139.7 140.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.145 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 74.8 ttt180 -103.27 151.17 23.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 312' ' ' VAL . 86.2 t -134.62 144.66 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 64.5 p -140.82 171.66 13.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m120 64.58 48.43 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.0 mt -100.9 -177.58 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.3 t -126.81 176.51 7.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.83 -24.69 48.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.38 20.16 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 97.9 m -132.75 96.41 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.541 ' HG3' HG22 ' A' ' 253' ' ' THR . 23.2 ptt-85 -101.48 -173.31 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -55.62 -64.3 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 251' ' ' ARG . 1.8 t -50.68 -19.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.447 ' OD2' ' NH1' ' A' ' 251' ' ' ARG . 3.2 m-20 -82.82 -29.3 29.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.59 -27.83 17.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.26 -31.47 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.91 -24.91 26.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.42 HD22 ' CE2' ' A' ' 305' ' ' TYR . 11.6 tp -73.6 -35.37 65.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' PHE . . . . . 0.676 ' HB2' HD11 ' A' ' 265' ' ' ILE . 59.1 m-85 -97.62 10.17 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ARG . . . . . 0.601 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.3 tpt85 -75.97 -44.54 3.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.7 Cg_exo -48.0 -18.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.6 m-85 -93.37 -38.52 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.22 32.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.468 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.56 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 4.4 m -92.86 116.06 28.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 259' ' ' PHE . 45.3 mt -74.47 140.14 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.542 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.9 t -89.97 -50.47 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -140.03 155.95 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.86 105.12 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.6 t80 -97.24 142.83 28.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.8 tp -126.01 131.76 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.12 119.83 11.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -136.66 122.12 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.64 -179.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -113.31 -41.74 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 89.5 m -65.94 -56.96 9.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.1 t -94.65 -15.41 24.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.6 85.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -112.07 171.22 7.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 60.5 p -77.64 113.2 15.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -56.65 -68.06 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.76 34.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 39.5 p90 -162.34 146.25 11.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -136.34 167.79 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.141 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.5 m-85 -135.15 111.73 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -100.48 127.48 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -104.33 112.92 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -84.21 176.44 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -92.76 -41.63 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -113.4 172.65 6.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -81.31 -37.1 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.08 -54.34 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.2 -37.08 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.451 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -66.13 -46.34 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.5 98.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -46.77 -42.19 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.43 -71.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 314' ' ' TRP . 92.0 mt -35.81 -40.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.01 87.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.99 -62.59 1.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 296' ' ' ALA . 16.2 m -46.03 -20.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 103.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.48 29.06 9.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.89 133.51 34.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -82.25 54.38 4.87 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' TYR . . . . . 0.42 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -77.03 130.07 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 110.972 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 308' ' ' LEU . 56.6 m-20 62.08 55.03 2.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 5.2 p-80 37.73 31.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 306' ' ' ASP . 90.2 mt -141.52 170.64 15.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.49 100.88 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.77 143.45 56.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -125.37 129.43 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 243' ' ' VAL . 56.4 t -137.85 140.15 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 156.02 32.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.523 ' CD1' HD13 ' A' ' 297' ' ' ILE . 80.3 m95 -57.51 128.01 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.5 m -114.43 124.17 51.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.854 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 9.6 t -47.26 147.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.59 56.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 18.0 m -85.09 156.34 21.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m -156.85 146.28 20.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -148.68 -69.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.76 101.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -57.59 97.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 74.8 mmt-85 -106.95 98.33 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -96.69 83.68 3.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -102.94 115.32 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -122.15 -17.59 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -134.03 -45.24 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -48.11 152.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -85.81 108.79 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.7 m -135.89 136.28 40.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.744 HG22 HD11 ' A' ' 297' ' ' ILE . 45.0 pt -132.67 142.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -99.88 150.38 22.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 312' ' ' VAL . 74.9 t -136.88 141.17 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 282' ' ' PHE . 18.3 p -141.5 163.94 31.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 29.6 t30 70.45 52.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 250' ' ' THR . 26.1 mt -93.93 -178.56 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.8 t -118.19 169.77 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.68 -21.47 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.89 20.26 13.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . 1.028 HG21 HD22 ' A' ' 246' ' ' LEU . 52.8 m -113.17 99.42 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -110.15 -177.47 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' OE2' HD23 ' A' ' 270' ' ' LEU . 12.1 mp0 -55.86 -42.14 75.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.8 t -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.111 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -28.95 47.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.6 mt -86.33 -31.15 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 11.2 tt0 -59.0 -31.67 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.33 -16.7 28.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.538 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.0 tp -82.94 -37.85 23.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 265' ' ' ILE . 65.1 m-85 -98.03 10.97 39.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.9 tmt_? -76.56 -45.27 3.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 66.0 Cg_exo -48.02 -17.23 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.4 m-85 -93.38 -33.09 14.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 164.65 -162.62 35.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.0 m -90.39 117.26 28.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.9 mt -75.71 140.94 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -88.35 -45.02 10.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -150.78 153.5 35.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 44.7 mt -136.18 105.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 4.6 t80 -96.95 146.96 24.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.54 HD23 ' OE2' ' A' ' 252' ' ' GLU . 12.4 tp -140.95 125.84 18.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.75 119.44 9.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -130.95 149.07 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.35 163.65 13.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -101.0 -29.93 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 74.4 m -81.62 -37.75 27.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.2 p -98.96 -34.14 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.5 44.57 89.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -129.93 -175.88 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.359 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 49.9 m -86.24 106.05 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 271' ' ' ALA . 13.3 mmmt -40.65 -56.63 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.54 -23.09 0.84 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 244' ' ' THR . 14.4 p90 -115.84 159.7 21.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -147.27 168.45 21.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -136.05 113.64 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.0 mp -97.94 133.74 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.119 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 25.3 m -108.03 123.13 48.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.607 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.1 m-85 -98.74 169.95 9.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.556 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 12.3 m-70 -87.76 -47.09 8.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt-85 -108.37 165.3 11.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -76.65 -24.0 53.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.44 -49.98 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.14 -37.99 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.9 -43.75 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.0 91.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -48.98 -40.03 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.902 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.75 -64.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 241' ' ' ILE . 82.7 mt -37.97 -33.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.04 38.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -77.88 -62.35 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.497 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 296' ' ' ALA . 7.5 m -42.49 -27.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.4 t -70.03 109.45 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 91.1 16.61 53.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.17 158.58 33.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.81 65.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.31 127.54 34.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 4.5 m-20 46.64 50.74 12.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 35.1 p-80 46.3 44.32 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 88.7 mt -146.45 168.64 20.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.74 95.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 25.9 tp -60.96 146.05 48.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -119.7 129.67 54.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 243' ' ' VAL . 76.6 t -141.19 147.5 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.85 149.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.571 ' CD1' HD13 ' A' ' 297' ' ' ILE . 79.8 m95 -51.18 122.72 8.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -53.06 -32.47 47.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -97.19 152.57 38.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.713 . . . . 0.0 110.88 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.42 157.06 32.85 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.671 2.248 . . . . 0.0 112.355 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 61.8 p -93.21 45.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.99 0.424 . . . . 0.0 110.889 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 320' ' ' ASN . 9.4 t -63.13 -42.22 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.436 ' N ' HG23 ' A' ' 319' ' ' THR . 84.4 m-20 -74.96 164.17 26.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.8 p -133.53 45.51 2.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 112.36 95.64 2.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.9 -177.02 3.32 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.307 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.7 m -43.95 147.68 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -104.81 112.18 25.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.544 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.6 t -58.49 155.02 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.862 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.8 t -133.96 138.09 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.61 -118.27 3.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 t 68.06 42.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.898 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 65.41 8.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 66.01 -152.5 51.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.76 168.89 22.77 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.32 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.35 142.39 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -75.77 163.87 26.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -127.25 147.83 50.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -169.71 172.2 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -159.8 134.18 7.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 48.17 38.23 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -122.57 145.52 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.39 109.34 16.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 25.7 m -139.01 147.53 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 297' ' ' ILE . 32.3 pt -141.54 143.16 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 312' ' ' VAL . 49.7 ttt-85 -98.67 150.98 21.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 312' ' ' VAL . 88.2 t -139.1 139.07 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 30.7 p -138.8 173.72 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 20.4 t-20 69.24 48.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.72 -178.28 3.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.952 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.9 t -126.47 179.26 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.18 -3.91 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.66 21.63 17.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.6 m -127.49 116.78 20.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 172.07 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.2 -47.47 62.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.6 t -60.4 -29.0 68.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.45 -23.35 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.04 -28.11 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -54.76 -28.01 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.31 -19.5 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.56 -36.76 44.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.829 ' HB2' HD11 ' A' ' 265' ' ' ILE . 88.4 m-85 -95.92 10.43 37.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 ttt-85 -78.87 -45.17 1.84 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.333 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -95.56 -31.94 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 167.76 -160.53 34.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.597 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.7 m -95.2 111.03 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 259' ' ' PHE . 66.5 mt -65.87 147.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 33.4 t -97.89 -46.88 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -147.05 146.01 29.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 39.8 mt -130.63 99.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.088 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.661 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -93.79 152.72 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.674 HD23 ' HE2' ' A' ' 272' ' ' LYS . 47.5 tp -141.71 143.27 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -84.9 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.674 ' HE2' HD23 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -134.19 153.98 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -99.43 157.37 16.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.31 0.3 33.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 93.4 m -111.43 -20.61 12.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 32.7 p -121.48 -16.1 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.14 37.44 80.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.57 -179.26 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 t -85.3 115.99 23.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -46.87 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.82 32.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 25.8 p90 -165.95 155.94 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.42 174.04 12.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.15 120.11 16.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -106.64 124.52 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 50.4 m -101.45 118.51 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.785 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 7.8 m-85 -92.62 176.02 6.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 264' ' ' SER . 9.6 m-70 -95.57 -50.03 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -108.04 149.46 28.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -69.46 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.51 -25.51 20.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.497 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 6.4 m-20 -88.57 -25.31 22.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -80.35 -33.98 36.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.441 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.31 -33.63 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -59.44 -37.79 79.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.2 -63.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 241' ' ' ILE . 61.1 mt -39.94 -35.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -72.67 -56.63 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.8 -61.41 5.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.789 HG21 HG21 ' A' ' 312' ' ' VAL . 3.7 m -48.05 -35.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t -59.81 104.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.6 27.1 10.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -91.09 148.99 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -92.8 78.22 1.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.52 127.07 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 11.3 t70 52.66 48.14 23.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 21.3 p-80 46.52 32.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 309' ' ' ILE . 45.9 mt -133.7 171.82 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -97.95 94.73 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.93 136.19 54.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -116.79 142.89 46.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 243' ' ' VAL . 99.2 t -146.67 144.78 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.37 149.02 8.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.521 ' CD1' HD13 ' A' ' 297' ' ' ILE . 95.6 m95 -49.59 130.3 20.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.6 62.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -53.0 144.27 28.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.533 0.683 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.37 -41.2 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.704 2.269 . . . . 0.0 112.337 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 99.3 p -105.88 122.82 46.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 80.7 p -123.24 127.81 49.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -92.31 163.26 13.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.4 t -105.74 -56.79 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.05 94.76 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.12 135.2 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 0.0 112.311 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.9 p -139.62 146.79 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.8 m -86.97 151.59 23.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.6 p -55.04 112.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t 53.29 42.3 32.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.69 174.04 27.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 229' ' ' SER . 37.2 t -140.03 134.56 31.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.372 . . . . 0.0 110.852 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 228' ' ' SER . 99.5 p -35.75 112.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 53.65 95.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.51 133.08 12.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.712 2.275 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -100.52 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -93.03 117.72 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.34 -58.48 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -161.97 106.82 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -82.75 112.69 19.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.31 -71.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.22 179.85 6.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -106.01 92.85 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -143.29 143.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.9 pt -140.85 147.05 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HG3' ' CE1' ' A' ' 284' ' ' PHE . 17.0 ttt180 -112.32 148.77 33.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 312' ' ' VAL . 67.3 t -127.49 148.99 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.4 p -143.24 163.11 33.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.79 38.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.8 mt -82.72 -174.97 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 248' ' ' GLU . 27.3 t -125.78 178.85 5.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.4 ' N ' ' OG ' ' A' ' 247' ' ' SER . 4.3 mm-40 -76.46 -50.47 13.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.11 -4.8 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 44.2 m -98.51 103.13 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.401 ' HA ' HD22 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -115.13 -175.5 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.625 ' OE2' HD23 ' A' ' 270' ' ' LEU . 4.3 mp0 -51.17 -56.21 13.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.3 t -55.31 -21.79 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.156 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -82.47 -30.4 29.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.87 -26.53 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -56.79 -33.58 66.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -89.96 -18.44 26.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.416 HD22 ' HE2' ' A' ' 305' ' ' TYR . 31.8 tp -78.64 -34.23 46.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 265' ' ' ILE . 81.3 m-85 -101.0 11.91 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 8.2 tpt180 -78.24 -45.24 2.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 0.0 110.859 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.01 -17.21 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.0 m-85 -92.56 -35.91 13.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.27 -161.45 34.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.9 m -90.31 117.28 28.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.531 HG21 ' CG1' ' A' ' 268' ' ' ILE . 74.9 mt -72.78 144.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.2 t -97.98 -48.09 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.0 tpt180 -145.44 151.46 38.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.531 ' CG1' HG21 ' A' ' 265' ' ' ILE . 65.3 mt -140.23 113.68 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.454 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 4.9 t80 -109.31 141.58 41.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.625 HD23 ' OE2' ' A' ' 252' ' ' GLU . 18.4 tp -129.92 121.13 26.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.948 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -61.63 122.49 15.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.122 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -134.96 149.33 50.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.27 178.82 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.29 -48.27 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 58.3 m -67.48 -42.38 83.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 -14.47 17.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 50.63 41.64 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -117.7 163.81 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.2 p -70.91 129.95 40.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -68.77 -75.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.71 32.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 24.2 p90 -165.99 157.96 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.73 171.3 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.526 ' CE1' ' HG3' ' A' ' 242' ' ' ARG . 97.7 m-85 -136.84 106.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -94.78 136.99 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.7 m -113.93 118.62 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -93.07 172.84 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -89.69 -43.57 10.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -116.62 168.92 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -76.89 -35.52 57.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.95 -55.29 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.86 -37.78 74.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.26 94.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.56 -37.23 82.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.067 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmm-85 -50.05 -41.0 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.64 -65.86 0.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.119 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.497 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 82.5 mt -35.04 -33.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.53 -51.71 9.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -60.67 5.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 ' O ' ' A' ' 296' ' ' ALA . 13.7 m -51.24 -31.58 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.3 t -61.59 119.55 8.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.32 69.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 66.9 t80 -83.71 165.42 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.442 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -110.98 82.36 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.416 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.7 OUTLIER -103.4 120.59 41.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 21.7 t70 61.01 48.7 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.493 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 27.6 p-80 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.94 167.54 21.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -94.52 95.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 22.4 tp -60.83 143.49 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -123.93 130.86 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 243' ' ' VAL . 26.4 t -139.81 151.31 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -169.39 149.82 4.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 86.2 m95 -47.89 136.08 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . -125.44 11.13 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.125 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.61 150.35 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 44.59 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.8 p -44.49 108.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.9 t -145.12 150.85 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -106.06 151.51 24.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.7 t -148.71 147.32 28.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -84.13 168.59 44.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.535 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.53 17.67 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.35 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 41.6 p -46.67 137.3 7.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 99.6 p -100.64 159.55 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 61.2 p -69.94 -18.03 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.3 t -124.94 121.46 34.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 83.02 59.77 2.13 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.4 m -155.46 134.57 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -78.08 -69.6 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.05 -91.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.506 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.6 -21.19 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 61.24 41.65 13.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -153.12 169.27 23.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.1 mmt-85 -128.03 98.01 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -120.76 -39.8 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -57.71 131.24 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.5 40.15 3.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -147.62 173.38 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . -117.82 94.58 4.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.8 m -134.34 141.0 46.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 35.4 pt -140.54 145.23 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -104.39 149.17 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 312' ' ' VAL . 73.8 t -133.09 135.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.437 ' O ' HD12 ' A' ' 310' ' ' LEU . 31.0 p -130.26 171.76 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.42 51.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 250' ' ' THR . 23.7 mt -95.77 -177.52 4.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 t -122.23 164.27 18.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.48 -11.53 60.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -105.24 21.1 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.542 HG21 HD22 ' A' ' 246' ' ' LEU . 59.1 m -121.14 98.43 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -103.29 170.07 8.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -47.82 -43.4 27.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -23.67 64.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.55 -28.76 46.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.52 -30.84 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 7.1 pt20 -53.14 -33.56 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.55 -12.85 44.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.87 -37.23 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.568 ' CE2' HG11 ' A' ' 300' ' ' VAL . 46.5 m-85 -96.89 10.37 39.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.4 tpt85 -76.9 -45.32 2.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.63 0.729 . . . . 0.0 110.826 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.3 Cg_exo -47.96 -17.24 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.646 2.23 . . . . 0.0 112.354 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.8 m-85 -94.22 -32.47 13.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.22 -166.66 39.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.47 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.7 m -90.32 112.86 24.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 37.1 mt -69.34 145.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 26.7 t -96.56 -44.88 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 16.7 tpp180 -148.34 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 265' ' ' ILE . 41.5 mt -131.31 96.58 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -91.76 150.41 21.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.5 tp -142.14 120.16 12.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.5 131.8 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -134.5 174.39 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.19 164.91 13.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -107.24 -6.26 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 55.8 m -102.11 -58.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -6.84 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.83 26.87 65.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -88.09 138.73 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.5 t -47.35 127.74 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -62.22 -57.43 11.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.91 -9.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.65 149.5 52.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 270' ' ' LEU . . . -133.78 169.4 17.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -134.21 117.56 16.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -103.78 136.85 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.3 m -112.02 124.85 53.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.914 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 17.6 m-85 -98.78 171.74 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 12.6 m-70 -89.88 -40.26 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -118.94 158.87 24.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 290' ' ' ARG . 17.0 ttp-105 -74.6 -13.26 60.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.91 -29.18 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.465 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -84.36 -28.55 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.914 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -77.6 -33.77 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.97 65.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -49.14 -44.68 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -59.78 -66.65 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 312' ' ' VAL . 81.2 mt -39.86 -34.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.0 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -85.15 -57.05 2.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 312' ' ' VAL . 17.2 m -47.37 -32.7 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 111.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.2 p -55.74 122.28 11.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.48 78.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.01 136.97 38.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -84.89 92.61 1.76 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.6 112.51 24.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.888 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 7.8 t70 63.62 52.94 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 33.3 p-80 45.91 27.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.451 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.8 mt -129.09 162.74 27.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -93.96 104.75 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 244' ' ' THR . 14.7 tp -78.81 140.72 38.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -122.92 145.82 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 243' ' ' VAL . 49.6 t -145.61 136.37 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -146.68 168.1 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 297' ' ' ILE . 75.8 m95 -81.06 122.29 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -113.4 177.31 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -144.32 139.99 16.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.01 156.74 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.2 m -119.87 -50.97 2.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 4.4 t -53.63 152.49 5.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -129.3 88.91 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.3 m -89.25 -48.44 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.68 -154.74 16.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.04 155.3 33.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.36 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 14.7 t -121.95 131.56 54.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.6 t -139.55 150.6 45.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 p -121.49 -0.67 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.7 m -158.13 144.26 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.33 -37.07 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 70.8 m -115.22 -59.37 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.885 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 84.2 p -97.81 128.24 44.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.82 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.99 89.01 2.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.08 165.83 27.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.687 2.258 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -92.56 -61.85 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -94.34 116.3 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.04 -54.39 4.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -55.68 142.62 33.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -166.32 157.07 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.27 -45.09 7.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -151.72 176.43 11.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -82.45 108.0 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.0 m -140.77 124.6 17.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 28.1 pt -122.61 145.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 312' ' ' VAL . 42.9 ttt180 -107.92 151.88 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 312' ' ' VAL . 95.6 t -139.0 141.84 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 43.3 p -139.48 170.06 16.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 30.8 t-20 73.58 38.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 250' ' ' THR . 30.2 mt -90.48 -175.97 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 52.6 p -127.34 175.61 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.79 -14.41 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -95.33 12.99 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.472 HG21 HD22 ' A' ' 246' ' ' LEU . 51.4 m -119.02 109.34 15.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 251' ' ' ARG . 0.0 OUTLIER -112.13 176.88 4.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 252' ' ' GLU . 1.9 mp0 -49.42 -43.33 44.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -25.42 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.38 -28.31 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.51 -25.3 16.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -61.31 -30.17 70.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.69 -16.81 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.49 -38.75 33.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.754 ' HB2' HD11 ' A' ' 265' ' ' ILE . 56.5 m-85 -95.5 8.99 41.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.4 OUTLIER -75.07 -45.44 4.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.1 Cg_exo -47.98 -18.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.385 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -93.49 -32.16 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.11 -166.39 39.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.23 113.79 25.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.754 HD11 ' HB2' ' A' ' 259' ' ' PHE . 84.2 mt -68.09 145.09 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.498 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 39.4 t -93.95 -47.37 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -149.25 149.94 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.3 mt -130.99 104.88 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 3.5 t80 -98.87 136.2 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.72 127.98 39.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -64.13 129.17 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -134.59 150.44 50.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.98 177.77 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -112.09 -56.89 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.5 m -55.26 -53.19 59.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 8.6 t -92.08 -24.11 19.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 61.85 43.59 99.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -119.97 176.04 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 65.3 p -80.79 129.08 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -63.58 -72.9 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.39 33.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 21.5 p90 -165.74 151.92 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.844 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.32 165.06 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -131.59 111.16 11.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.1 mp -97.02 124.37 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 18.7 m -101.04 115.47 30.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.7 m-85 -88.22 176.29 7.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 264' ' ' SER . 14.5 m-70 -94.65 -43.76 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -114.32 168.55 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.4 ttt85 -82.93 -18.8 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -83.55 -29.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 3.5 m-20 -83.22 -27.11 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -75.09 -37.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.27 -37.84 68.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -48.28 -42.72 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.5 -70.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.554 HD12 ' NE1' ' A' ' 314' ' ' TRP . 82.6 mt -35.08 -34.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -67.01 -48.04 69.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.088 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.8 -59.85 2.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.1 m -41.81 -36.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.4 p -55.35 119.84 6.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.07 23.26 74.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -76.57 153.2 35.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.5 76.09 0.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 120.6 38.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 3.0 t70 54.57 49.63 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 24.2 p-80 47.62 29.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 309' ' ' ILE . 38.0 mt -129.85 164.64 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -94.93 102.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.404 HD11 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -72.08 130.94 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -111.31 129.67 55.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 243' ' ' VAL . 55.9 t -133.78 143.27 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -156.02 161.26 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.554 ' NE1' HD12 ' A' ' 297' ' ' ILE . 72.3 m95 -71.28 122.29 19.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -112.43 118.8 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.442 ' CG ' ' HD2' ' A' ' 317' ' ' PRO . 36.9 tttm -101.66 140.35 21.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.622 0.725 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 316' ' ' LYS . 62.6 Cg_endo -78.72 172.0 15.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -129.17 -53.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 p -98.93 107.94 20.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.66 125.16 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 85.0 p -39.9 127.35 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -106.33 96.18 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.17 129.26 12.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 9.5 m -133.72 158.21 43.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 89.4 p -130.3 165.34 22.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.47 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 12.2 m 50.94 48.36 23.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.804 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.2 m -90.8 135.36 33.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 134.7 116.69 1.67 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.1 p -174.59 151.9 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.85 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 95.3 p -72.68 168.72 18.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.902 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -153.09 -96.39 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.454 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.01 136.6 13.18 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -127.4 156.44 42.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -129.2 -42.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.7 mtp85 -45.48 -47.18 14.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 238' ' ' ASN . . . -136.78 105.66 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.473 ' HA ' ' CE ' ' A' ' 316' ' ' LYS . 9.1 t0 -111.47 0.17 16.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -124.06 -37.05 2.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 235' ' ' ALA . 3.0 m120 -39.85 159.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.52 108.15 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.089 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.7 m -129.37 142.91 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 38.2 pt -138.81 140.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 69.9 ttt180 -100.56 147.35 26.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 312' ' ' VAL . 55.8 t -129.58 145.48 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.7 p -143.27 165.54 27.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.171 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 26.5 t-20 73.32 39.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 250' ' ' THR . 49.9 mt -89.98 -176.95 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 m -135.56 -175.95 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -74.8 -50.11 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.16 -10.83 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 246' ' ' LEU . 50.5 m -98.62 97.75 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -109.79 178.98 4.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.6 -41.62 31.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -67.61 -23.05 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.77 -30.32 36.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.8 mt -88.29 -24.06 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.4 tt0 -60.6 -34.5 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -94.35 -11.68 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.541 HD13 ' HE2' ' A' ' 305' ' ' TYR . 31.6 tp -80.62 -39.7 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.948 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 265' ' ' ILE . 64.7 m-85 -98.18 12.04 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 tpt180 -79.15 -45.11 1.72 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.93 -17.23 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.621 2.214 . . . . 0.0 112.393 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.9 m-85 -95.39 -31.06 13.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.79 -166.13 39.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.1 m -90.34 108.73 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 259' ' ' PHE . 61.4 mt -63.32 139.11 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.511 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.8 t -89.67 -43.34 10.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -148.93 153.17 37.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 85.1 mt -133.64 104.7 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.528 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.6 t80 -99.66 140.9 33.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 283' ' ' ALA . 35.7 tp -133.01 125.34 29.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.516 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.41 125.55 28.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -129.08 157.7 41.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.49 -178.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -116.64 -32.32 5.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 36.7 m -80.37 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 276' ' ' THR . 1.9 t -81.8 -36.7 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.159 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.04 19.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -96.73 -177.23 3.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 86.4 p -77.42 114.98 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -52.85 -54.02 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 141.97 -6.37 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.516 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 13.6 p90 -135.26 157.2 47.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.864 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.706 ' HB2' HD12 ' A' ' 270' ' ' LEU . . . -146.43 163.55 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.7 m-85 -128.74 114.03 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -98.75 140.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.096 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.99 142.12 46.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.17 -176.31 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 8.9 m-70 -104.79 -31.58 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -129.28 148.03 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -63.71 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.837 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.86 -60.24 2.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.69 -28.41 67.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.19 78.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.4 -23.95 57.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -61.99 -37.65 85.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.8 -69.0 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.54 HD12 ' NE1' ' A' ' 314' ' ' TRP . 85.3 mt -35.88 -35.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.3 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.05 -60.9 2.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 312' ' ' VAL . 11.4 m -41.67 -42.41 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.119 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 300' ' ' VAL . 36.7 p -53.59 127.91 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.06 68.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -83.97 134.25 34.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.63 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.541 ' HE2' HD13 ' A' ' 258' ' ' LEU . 1.5 t80 -105.24 115.55 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.5 m-20 57.33 54.05 7.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 36.7 p-80 48.76 36.92 8.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 309' ' ' ILE . 90.9 mt -138.59 168.41 19.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -101.25 97.26 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.23 149.27 50.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -133.29 132.13 41.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 243' ' ' VAL . 97.8 t -139.54 143.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.02 158.95 38.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.54 ' NE1' HD12 ' A' ' 297' ' ' ILE . 81.4 m95 -69.08 125.51 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.51 78.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.473 ' CE ' ' HA ' ' A' ' 236' ' ' ASP . 25.6 mtmm -139.61 143.86 37.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.89 143.81 23.67 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.0 p -127.05 131.47 50.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.846 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 88.1 m -142.28 140.9 32.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -135.51 105.09 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 11.6 t -80.97 111.15 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -76.49 -70.18 1.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.02 123.18 6.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 28.6 t -84.43 134.32 34.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -124.36 97.95 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.538 -179.955 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.6 t -139.75 141.1 36.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 19.3 m -56.76 -43.93 81.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.17 47.73 85.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.5 m -109.25 128.11 54.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.9 m -104.49 101.51 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -141.63 62.53 0.53 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.51 166.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.242 . . . . 0.0 112.395 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -105.31 120.0 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -88.52 81.5 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -124.09 144.88 49.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -94.76 11.81 30.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.461 ' CB ' ' HG3' ' A' ' 316' ' ' LYS . 19.3 p-10 -65.67 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 236' ' ' ASP . 23.5 t0 35.19 38.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -151.91 -179.56 7.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -114.07 95.35 5.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 13.4 m -140.6 131.63 26.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 40.6 pt -127.6 141.08 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt180 -99.57 153.46 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 312' ' ' VAL . 68.7 t -139.64 135.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 72.6 p -132.24 163.19 29.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.4 t-20 71.59 43.77 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.2 mt -91.11 177.21 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.5 t -122.91 146.47 47.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -48.18 -49.62 32.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.11 -24.92 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.8 m -82.16 97.01 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -104.69 179.26 4.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -49.49 -56.22 10.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -55.51 -25.24 36.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.97 -31.23 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -26.06 24.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.5 tt0 -59.5 -31.71 69.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -92.87 -8.59 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 26.6 tp -88.05 -39.7 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.849 ' HB2' HD11 ' A' ' 265' ' ' ILE . 79.1 m-85 -98.15 11.19 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -76.86 -45.35 2.99 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.8 Cg_exo -47.97 -17.93 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.365 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.0 m-85 -94.55 -33.79 12.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.85 -167.1 40.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 19.8 m -90.53 110.33 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.6 mt -66.24 142.49 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.564 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.4 t -92.57 -46.83 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -148.17 139.64 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.452 ' CG1' HG21 ' A' ' 265' ' ' ILE . 38.4 mt -120.98 102.94 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.505 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.2 t80 -93.12 143.03 26.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 24.2 tp -136.44 115.59 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.446 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.52 126.46 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.442 ' HE3' HD23 ' A' ' 270' ' ' LEU . 49.4 mttp -130.97 174.41 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.429 ' HA ' ' HZ3' ' A' ' 280' ' ' LYS . 7.7 t70 -103.73 177.32 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.83 -54.74 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 26.9 m -55.14 -72.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.137 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 278' ' ' GLN . 14.8 t -77.5 -32.26 54.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 73.97 39.37 46.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.548 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 276' ' ' THR . 90.9 mt-30 -103.64 169.65 8.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 45.7 m -70.94 115.61 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 273' ' ' ASP . 19.3 mmtm -48.21 -54.26 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.57 2.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 12.4 p90 -123.53 155.27 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.51 165.29 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.46 116.7 16.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -104.58 125.41 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.3 m -101.57 119.13 38.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 14.7 m-85 -91.05 175.71 6.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.9 m-70 -92.34 -44.43 8.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -110.99 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -87.57 -20.81 25.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.58 -24.18 31.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.51 -34.44 27.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -70.44 -35.84 73.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.4 70.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -48.63 -44.07 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.83 -65.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 314' ' ' TRP . 69.1 mt -34.48 -32.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -50.09 23.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -62.51 3.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 312' ' ' VAL . 16.1 m -46.59 -36.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.82 0.343 . . . . 0.0 111.125 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.8 t -57.54 114.25 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.77 26.24 56.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -82.62 153.53 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.29 71.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.37 129.55 36.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.376 . . . . 0.0 110.913 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.5 t70 45.25 52.79 8.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.547 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 21.3 p-80 44.67 31.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.41 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.5 mt -131.33 163.3 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -92.98 101.39 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.3 tp -76.42 139.01 40.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -119.72 140.13 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 243' ' ' VAL . 94.9 t -143.1 143.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -152.11 174.24 13.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.602 ' CD1' HD13 ' A' ' 297' ' ' ILE . 68.9 m95 -80.53 125.61 30.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -119.11 162.65 18.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.461 ' HG3' ' CB ' ' A' ' 236' ' ' ASP . 35.2 ttmt -117.62 138.39 25.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.559 0.695 . . . . 0.0 110.915 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.01 109.55 2.73 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.647 2.232 . . . . 0.0 112.317 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -80.41 150.05 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 76.6 p -132.02 124.05 28.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -73.75 -48.31 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 61.8 p -160.84 150.52 17.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -87.15 145.85 20.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.75 157.49 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 28.7 t -150.14 126.61 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 m -115.59 102.28 9.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.487 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 51.6 p -140.46 138.07 34.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.8 m -44.16 -57.67 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -126.13 100.87 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 31.2 m -46.97 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -52.21 -54.1 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 151.61 97.13 0.15 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.63 111.73 3.39 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.737 2.291 . . . . 0.0 112.359 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -86.14 162.51 18.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -121.69 114.84 21.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ALA . 18.8 mtt-85 -127.69 -62.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 234' ' ' ARG . . . -35.4 -38.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 40.58 39.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -119.36 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.91 19.3 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -131.35 90.2 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.4 m -144.0 131.11 20.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 297' ' ' ILE . 29.1 pt -126.0 143.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.0 ttt180 -101.81 151.84 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 312' ' ' VAL . 41.6 t -134.71 139.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 46.9 p -141.85 165.32 27.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.9 t-20 68.42 50.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -92.39 -175.64 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 250' ' ' THR . 5.6 t -130.42 140.24 50.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.406 ' OE1' ' C ' ' A' ' 248' ' ' GLU . 0.6 OUTLIER -47.19 -21.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.69 22.36 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 246' ' ' LEU . 90.7 m -126.41 114.2 17.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.68 179.94 3.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.88 -44.77 70.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -61.18 -28.22 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.69 -33.3 64.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.467 HD22 ' HE1' ' A' ' 259' ' ' PHE . 43.0 mt -84.17 -28.72 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 24.0 tt0 -57.94 -42.28 84.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -83.71 -16.02 46.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 259' ' ' PHE . 14.8 tp -80.81 -38.07 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' A' ' 265' ' ' ILE . 80.2 m-85 -99.15 12.01 37.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 ttt180 -77.92 -45.15 2.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.598 0.714 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.18 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.7 m-85 -92.78 -35.23 13.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.24 -163.15 36.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -91.62 109.92 21.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.4 mt -67.95 138.9 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.4 t -88.69 -42.03 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -151.56 154.72 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 62.5 mt -133.76 101.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.48 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 3.4 t80 -91.4 141.56 28.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 52.9 tp -135.4 127.44 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -75.11 114.86 14.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -121.68 150.91 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.25 173.23 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 -29.77 7.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.3 m -78.59 -66.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.417 HG21 ' OE1' ' A' ' 278' ' ' GLN . 11.4 t -89.01 -13.52 38.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.25 95.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.417 ' OE1' HG21 ' A' ' 276' ' ' THR . 84.7 mt-30 -102.35 157.22 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 48.0 t -58.21 115.08 2.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -51.63 -59.17 4.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.68 -13.24 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 31.6 p90 -129.03 157.2 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.68 172.72 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -139.14 116.43 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.5 mp -103.63 132.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.43 142.02 35.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -116.23 168.35 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.0 m-70 -85.55 -35.07 21.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 288' ' ' HIS . 24.5 mmt-85 -120.82 167.27 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -78.54 -32.9 48.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.12 -54.53 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -53.93 -32.79 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.52 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -70.55 -46.0 64.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -50.78 -39.04 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.31 -69.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 241' ' ' ILE . 72.8 mt -36.91 -34.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.5 55.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -80.03 -59.12 2.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.497 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 296' ' ' ALA . 28.0 m -53.97 -20.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.4 t -63.03 107.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.92 38.2 23.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -88.97 146.32 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.04 74.22 2.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -95.13 136.59 35.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 35.1 t70 42.41 53.98 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 37.8 p-80 46.05 39.03 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 309' ' ' ILE . 95.1 mt -146.36 168.48 21.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.3 mp -95.55 102.79 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.64 139.96 56.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -118.52 127.82 53.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 242' ' ' ARG . 44.8 t -140.72 141.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -162.22 149.96 14.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.52 ' HH2' ' HB3' ' A' ' 293' ' ' ALA . 96.1 m95 -45.01 121.4 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.89 -71.31 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 153.87 40.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.601 0.715 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.56 170.65 19.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 0.0 112.385 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 12.5 t -107.22 128.25 54.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.7 t -138.07 145.76 42.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -114.23 146.44 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 99.8 p -131.2 -48.65 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -122.41 98.01 0.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.72 123.32 7.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.638 2.225 . . . . 0.0 112.361 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 7.4 t -45.74 152.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 52.0 m -58.84 -50.19 74.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.5 t -152.17 112.06 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 29.6 t -56.12 89.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.876 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 169.96 159.08 14.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.4 m -96.65 -178.53 4.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 110.885 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.2 m -59.85 174.66 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -130.96 94.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.33 -31.72 4.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.348 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.19 100.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -104.21 113.75 27.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -173.63 166.52 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -90.5 178.76 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.484 ' N ' ' HE3' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -93.61 -18.29 22.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 236' ' ' ASP . 16.6 m-20 34.51 37.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 237' ' ' ASP . 44.5 m-80 -168.98 177.63 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -115.93 97.99 6.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.9 m -136.02 143.52 44.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 297' ' ' ILE . 42.5 pt -137.43 141.88 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -105.57 147.71 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 312' ' ' VAL . 70.5 t -129.71 146.67 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 69.8 p -144.16 163.56 33.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 69.05 40.88 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 34.5 mt -85.33 -175.42 5.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 t -125.52 161.31 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.57 -9.36 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.55 -8.97 39.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 86.8 m -101.79 104.13 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -104.05 179.19 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -52.79 -51.52 60.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.4 t -62.77 -19.79 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.34 -26.92 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.87 -33.59 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 3.3 tp-100 -52.49 -34.25 48.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -87.75 -20.44 26.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.63 -36.79 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.7 m-85 -98.01 11.72 36.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.585 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 2.4 ttt-85 -79.34 -45.24 1.66 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.37 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.3 m-85 -93.39 -33.76 13.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.16 -160.36 33.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 8.3 m -90.69 119.11 30.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 259' ' ' PHE . 67.0 mt -73.86 145.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -97.96 -43.71 6.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.436 ' NH1' ' HB2' ' A' ' 267' ' ' ARG . 20.2 ttm105 -150.43 149.98 30.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 54.2 mt -132.97 100.09 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.8 t80 -95.59 140.86 29.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.2 tp -132.93 121.7 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -68.79 129.87 41.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -136.98 162.16 34.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.58 178.22 7.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -108.51 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 78.0 m -73.02 -65.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 15.4 t -95.65 -18.87 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.91 37.54 92.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -91.96 160.23 15.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 28.0 t -56.0 121.16 8.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -64.88 -54.46 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.56 1.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.45 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 32.6 p90 -128.61 153.86 46.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 110.857 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.46 173.08 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.6 112.4 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -100.83 138.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -111.27 143.91 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 13.0 m-85 -121.39 167.25 12.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 264' ' ' SER . 6.2 m-70 -91.06 -44.12 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -104.63 155.39 18.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -78.1 -11.22 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -89.49 -41.37 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.62 -35.58 77.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.52 -43.77 88.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.6 79.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -49.91 -38.63 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.906 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.53 -63.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.514 HD11 HG22 ' A' ' 241' ' ' ILE . 95.5 mt -35.97 -33.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.75 -55.43 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -54.98 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 296' ' ' ALA . 15.4 m -54.6 -30.94 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 111.161 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.0 t -61.66 106.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 84.77 21.12 56.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.01 141.93 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -85.82 93.08 1.82 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.53 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.2 OUTLIER -113.26 109.73 19.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.372 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 30.8 t70 67.74 53.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 17.1 p-80 47.4 26.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.51 162.08 30.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.589 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -93.09 98.02 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.487 HD11 ' CG1' ' A' ' 243' ' ' VAL . 32.3 tp -62.85 138.79 58.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -119.31 132.15 55.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 243' ' ' VAL . 87.0 t -137.22 154.06 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 312' ' ' VAL . 8.7 pt-20 -165.24 156.29 14.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.502 ' CD1' HD13 ' A' ' 297' ' ' ILE . 66.2 m95 -57.74 136.33 56.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 317' ' ' PRO . . . -99.35 126.33 45.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.484 ' HE3' ' N ' ' A' ' 236' ' ' ASP . 4.6 tptt -101.74 101.43 17.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 315' ' ' ALA . 61.1 Cg_endo -74.94 167.45 27.04 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.332 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 319' ' ' THR . 12.3 t -112.66 -41.41 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.876 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 318' ' ' SER . 67.9 p 36.1 40.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.54 106.5 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.4 p -155.57 176.02 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 156.46 146.27 4.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.44 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.18 168.68 22.75 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.407 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 2.9 t -147.16 106.6 3.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 50.8 m -90.5 124.05 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.471 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 42.2 t -169.56 141.92 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 p -76.05 173.32 11.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -168.2 -52.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.466 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.6 m -40.19 106.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.893 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.7 t -166.96 150.98 6.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.35 -159.51 24.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.96 146.84 26.28 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -111.43 85.01 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -149.19 163.64 37.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.81 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -126.34 38.95 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.58 114.06 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -145.44 134.68 22.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.83 -46.66 4.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -95.23 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -79.92 90.94 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 7.1 m -136.63 144.51 44.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.1 pt -144.35 141.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.462 ' HB2' ' CE2' ' A' ' 284' ' ' PHE . 69.4 ttt180 -100.56 149.03 24.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 312' ' ' VAL . 98.0 t -132.06 142.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.7 p -135.14 174.52 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 3.2 m-20 64.18 48.13 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 250' ' ' THR . 19.2 mt -103.4 168.76 8.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.3 p -118.87 154.94 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.86 -46.57 60.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -57.36 -19.25 21.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.682 HG21 HD22 ' A' ' 246' ' ' LEU . 26.2 m -90.08 98.93 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -106.42 -175.74 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -55.56 -55.91 26.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.8 t -55.21 -20.02 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.89 -28.69 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 mt -88.66 -27.26 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.475 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -61.92 -31.12 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.53 -18.14 28.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.59 -38.56 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.783 ' HB2' HD11 ' A' ' 265' ' ' ILE . 71.8 m-85 -95.68 11.59 32.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 tpt180 -78.31 -45.26 2.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.598 0.714 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.5 Cg_exo -47.96 -17.16 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.415 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -93.31 -31.71 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.98 36.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -90.02 109.52 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.3 mt -66.07 148.54 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.434 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.0 t -95.16 -43.42 8.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -154.43 149.08 26.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 72.6 mt -134.59 100.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.2 t80 -92.83 151.72 19.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.66 HD23 ' HE3' ' A' ' 272' ' ' LYS . 51.8 tp -140.54 145.99 37.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.683 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -97.9 132.01 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.66 ' HE3' HD23 ' A' ' 270' ' ' LEU . 5.6 mptt -133.45 162.78 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -91.38 174.12 7.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -113.38 -52.94 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.7 m -60.38 -54.81 41.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -89.39 -18.96 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.05 82.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 279' ' ' SER . 32.1 mt-30 -118.67 126.7 52.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 278' ' ' GLN . 2.2 m -36.53 128.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -57.95 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 154.79 33.93 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.683 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 43.8 p90 -162.7 148.33 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -142.29 173.91 11.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 242' ' ' ARG . 71.1 m-85 -136.02 113.02 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -98.25 124.84 51.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -106.46 115.16 29.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.7 m-85 -88.73 -180.0 6.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.6 m-70 -95.53 -38.72 10.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.84 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.03 167.53 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 38.4 ttp85 -73.53 -32.87 64.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.26 -64.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -48.8 -35.95 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.45 -42.86 74.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.29 85.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.9 mtp85 -47.05 -41.82 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.601 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.5 mt -35.71 -32.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -68.98 -47.31 65.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.15 -62.2 2.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.4 m -41.26 -37.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.7 p -56.2 112.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.4 32.51 38.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.441 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -89.71 145.51 25.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -95.81 78.79 0.8 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.62 134.66 39.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 2.1 t70 44.94 52.88 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 34.0 p-80 45.59 33.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -135.03 167.4 21.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.2 mp -95.52 97.88 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.7 tp -73.67 138.78 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.48 144.89 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 243' ' ' VAL . 29.6 t -143.75 145.5 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.99 171.0 17.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.601 ' CD1' HD13 ' A' ' 297' ' ' ILE . 57.9 m95 -79.25 131.78 36.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -100.88 126.35 47.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -136.1 104.33 9.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.52 165.55 31.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.364 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 p -82.19 -62.58 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.4 m -70.5 133.96 47.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -95.09 109.61 21.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.8 p -81.87 116.61 21.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.73 -178.92 34.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.99 103.42 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 137.2 36.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -131.82 157.24 44.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.504 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.6 t -119.77 145.34 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.7 t -48.18 -62.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.8 -173.8 18.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 61.9 p -111.29 81.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.1 t -74.98 143.1 43.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.84 70.96 0.99 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.22 146.38 25.13 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -123.76 165.0 18.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -129.35 104.14 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -156.5 107.15 2.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.46 38.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.062 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -165.6 149.52 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.87 90.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -169.74 -179.93 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 287' ' ' PHE . . . -78.75 102.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.082 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.1 m -138.61 138.27 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 297' ' ' ILE . 43.0 pt -137.28 140.15 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 14.5 ttt85 -100.96 149.23 24.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 312' ' ' VAL . 84.0 t -136.65 143.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 62.1 p -138.2 166.31 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 22.5 t-20 74.05 38.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.75 177.08 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -130.94 166.02 21.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -70.68 -16.54 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.98 9.83 11.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -132.94 111.39 10.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 -176.33 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -48.77 -59.1 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -54.66 -26.7 34.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -76.97 -30.67 56.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.69 -29.83 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 256' ' ' GLN . 21.9 tp60 -56.25 -29.48 61.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.3 -15.65 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.3 tp -84.31 -37.88 21.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.583 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.7 m-85 -96.68 11.31 35.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.594 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -79.7 -45.24 1.56 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.712 . . . . 0.0 110.883 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.88 -17.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.08 -159.9 33.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.92 135.05 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 0.0 110.875 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.494 HG21 HG12 ' A' ' 268' ' ' ILE . 54.6 mt -93.61 138.88 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 48.3 t -92.6 -48.76 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.7 tpp180 -143.38 148.53 36.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 265' ' ' ILE . 45.9 mt -132.96 108.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.486 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.6 t80 -95.62 144.07 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.0 tp -131.08 119.35 21.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.57 113.44 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -129.14 146.66 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.29 -177.87 0.75 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -122.69 -16.65 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 92.0 m -102.23 -50.44 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -95.41 -9.05 33.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.64 56.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -99.5 178.57 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 27.6 p -89.29 121.84 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -62.13 -74.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 157.94 33.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 27.6 p90 -166.13 148.34 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -139.82 165.87 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.579 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 84.8 m-85 -133.18 115.66 15.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -101.99 131.82 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -109.05 113.05 25.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . 13.5 m-85 -84.48 177.11 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 13.6 m-70 -93.51 -30.54 14.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -122.8 171.37 9.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -83.72 -28.61 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.53 -56.57 5.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 292' ' ' ASP . 1.0 OUTLIER -53.18 -35.12 59.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.828 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.82 90.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.43 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -48.18 -42.59 30.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.95 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 314' ' ' TRP . 86.3 mt -38.31 -32.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.49 -41.89 62.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -84.85 -63.92 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 259' ' ' PHE . 14.0 m -40.55 -37.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 111.162 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 75.4 p -57.04 128.59 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.94 19.06 69.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.472 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -80.89 153.14 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.36 94.27 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.68 123.62 50.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.892 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 10.6 t70 56.4 49.39 15.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 34.8 p-80 48.6 35.62 6.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 309' ' ' ILE . 71.8 mt -138.5 167.41 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -95.48 103.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -77.12 131.22 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.52 138.98 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 243' ' ' VAL . 99.0 t -142.87 145.73 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -163.51 149.11 11.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.558 ' CD1' HD13 ' A' ' 297' ' ' ILE . 92.5 m95 -52.38 120.0 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.81 -41.22 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -104.71 142.92 25.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.04 -48.57 14.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.5 t 66.65 39.77 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -56.37 -48.77 76.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -79.93 86.89 5.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 12.2 t -111.3 86.21 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 124.33 153.12 8.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.66 149.0 2.09 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 46.6 t -59.2 99.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -133.78 141.0 47.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 226' ' ' SER . 65.3 m -59.05 118.46 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 225' ' ' SER . 30.9 t 36.3 46.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.32 53.65 16.7 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.8 t -91.85 113.62 25.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 m -135.12 145.82 48.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.836 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 173.66 80.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.1 107.84 2.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.04 -62.48 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -164.62 159.39 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.05 150.31 13.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -87.63 -39.6 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -38.9 134.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.04 -61.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -97.05 167.41 11.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.1 94.34 9.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.8 m -137.46 145.15 42.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 297' ' ' ILE . 17.0 pt -141.94 145.11 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.54 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 38.0 ttt180 -105.47 156.36 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 312' ' ' VAL . 97.8 t -140.47 138.71 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 76.0 p -132.69 161.99 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.8 t30 74.53 48.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 250' ' ' THR . 31.2 mt -103.67 146.1 29.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.423 ' HB2' ' CG ' ' A' ' 306' ' ' ASP . 1.3 t -85.52 156.94 20.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.13 -6.74 18.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.6 9.34 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 246' ' ' LEU . 54.3 m -115.6 106.8 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -105.88 174.47 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -47.61 -59.79 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.2 t -54.14 -21.86 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.8 -30.47 40.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.7 mt -90.4 -26.63 19.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.2 pt20 -56.19 -26.33 50.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -91.54 -18.01 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.549 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.2 tp -82.12 -36.58 27.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 258' ' ' LEU . 68.9 m-85 -98.47 11.7 37.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -79.39 -45.3 1.65 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.893 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.2 Cg_exo -47.93 -17.59 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -93.58 -32.18 14.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.16 -166.14 39.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.485 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.9 m -90.99 106.86 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.9 mt -59.94 150.52 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.547 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.0 t -98.82 -46.52 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 8.4 tpp180 -149.87 146.23 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.436 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 47.1 mt -126.55 106.92 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -99.04 149.69 22.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 56.0 tp -140.75 129.08 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.65 110.51 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -131.85 135.9 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -76.57 133.12 39.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -85.32 -37.24 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 46.5 m -64.81 -34.67 78.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 7.7 p -105.4 -50.41 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.55 28.59 6.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -114.28 172.79 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.7 t -93.68 113.63 25.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 282' ' ' PHE . 34.4 mmtt -42.58 -69.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 149.18 32.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 7.6 p90 -166.32 161.39 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.48 165.54 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 74.2 m-85 -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -94.81 129.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.3 m -106.62 118.47 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -92.24 179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.1 m-70 -95.99 -35.88 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -123.69 165.05 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -71.11 -37.96 72.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -60.38 -69.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -44.72 -34.32 2.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.04 85.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.2 77.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.086 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -50.48 -40.95 52.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -66.11 -66.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 312' ' ' VAL . 84.9 mt -38.83 -40.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.59 19.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -71.04 -65.25 2.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 312' ' ' VAL . 7.2 m -39.93 -42.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.48 ' N ' HG23 ' A' ' 300' ' ' VAL . 10.5 t -49.4 116.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.21 62.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -78.63 155.27 29.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.12 76.9 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 0.4 OUTLIER -93.31 130.25 39.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.582 ' OD1' HD12 ' A' ' 308' ' ' LEU . 0.8 OUTLIER 47.19 54.13 9.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 29.0 p-80 48.46 33.18 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.582 HD12 ' OD1' ' A' ' 306' ' ' ASP . 62.0 mt -136.4 164.05 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.581 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -95.44 95.18 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.74 134.65 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -118.21 130.8 56.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 243' ' ' VAL . 91.7 t -130.6 142.29 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -145.35 172.44 13.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.416 ' CD1' HD13 ' A' ' 297' ' ' ILE . 59.0 m95 -81.47 125.18 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -99.89 145.34 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -174.84 105.01 0.26 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.57 95.77 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.366 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 99.8 p -55.0 -41.81 71.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 41.8 p -79.68 107.81 12.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -110.06 139.01 45.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 6.1 t -125.34 94.37 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -49.68 172.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.454 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.1 -175.85 2.88 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 16.2 t -134.74 87.19 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 31.3 m -116.51 155.42 28.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.2 t -167.99 158.53 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 96.1 p -137.46 177.29 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.84 -159.74 8.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 44.9 m -148.65 167.61 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 0.0 110.837 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -146.66 145.25 29.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -176.72 78.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.91 0.71 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.724 2.282 . . . . 0.0 112.35 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -81.36 -175.81 5.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -141.75 128.35 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 233' ' ' ARG . 96.9 mtt180 35.44 51.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -88.27 -48.6 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -45.08 110.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.48 -45.0 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -130.32 169.11 15.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -81.35 95.94 7.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 315' ' ' ALA . 14.5 m -132.76 143.46 49.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 297' ' ' ILE . 27.6 pt -136.98 145.98 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -107.14 147.7 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 312' ' ' VAL . 54.1 t -129.45 140.46 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.1 p -138.09 165.8 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 21.1 t30 66.21 48.26 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.667 HD22 HG21 ' A' ' 250' ' ' THR . 22.2 mt -93.83 177.88 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.5 t -115.69 159.08 21.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.74 -14.18 60.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.22 19.9 15.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.667 HG21 HD22 ' A' ' 246' ' ' LEU . 49.9 m -118.98 98.57 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -100.48 177.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -52.91 -42.57 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.6 t -68.1 -25.39 65.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 -23.75 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.96 -32.57 12.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.3 pt20 -52.09 -33.91 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.56 -15.61 36.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.49 -38.72 25.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' A' ' 265' ' ' ILE . 95.6 m-85 -95.48 11.33 33.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.614 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 7.9 tpt180 -79.03 -43.97 1.74 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.2 Cg_exo -47.93 -18.57 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.306 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 30.4 m-85 -94.76 -34.39 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.98 -161.55 34.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -94.28 117.77 30.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 259' ' ' PHE . 54.5 mt -71.57 144.98 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.6 t -95.27 -41.9 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -152.07 149.71 29.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 52.1 mt -130.68 105.6 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.6 t80 -98.46 141.46 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.0 tp -132.32 131.81 42.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -71.57 125.59 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -137.01 152.14 49.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.95 -178.22 5.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -109.71 -54.11 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 62.5 m -52.49 -72.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 2.0 t -76.57 -21.42 55.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 63.56 35.72 92.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -108.25 168.5 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 42.3 t -72.4 129.35 38.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -63.38 -74.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.86 32.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 8.2 p90 -165.96 159.75 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -150.97 165.13 34.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -132.08 116.06 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -99.48 125.85 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 16.4 m -102.21 116.93 33.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.9 m-85 -88.71 -178.61 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.3 m-70 -97.22 -37.98 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -126.37 139.98 52.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -51.23 -28.23 11.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -66.0 -68.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.0 -30.11 9.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . . . -67.8 -38.24 83.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.78 -35.31 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -50.74 -41.04 56.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.0 -66.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.992 HD11 HG22 ' A' ' 241' ' ' ILE . 82.9 mt -38.2 -34.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -76.15 -51.12 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -69.53 -59.56 5.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 312' ' ' VAL . 15.3 m -49.38 -26.24 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.6 t -62.42 109.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.31 27.21 31.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -83.11 154.7 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -97.06 78.94 0.68 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.22 120.77 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.1 t70 51.16 52.62 14.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 27.9 p-80 48.74 26.98 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 66.4 mt -129.55 164.0 24.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -94.96 98.0 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -120.31 138.31 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 243' ' ' VAL . 89.4 t -146.41 151.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.089 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.02 152.1 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.465 ' HZ2' ' HB2' ' A' ' 294' ' ' ALA . 78.1 m95 -55.3 126.11 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 240' ' ' THR . . . -93.8 155.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.06 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.85 104.98 2.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.04 151.44 39.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.4 t -54.72 -49.95 69.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 76.2 p -51.33 125.39 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -80.69 -59.95 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.5 m -115.9 100.35 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -75.27 -92.45 0.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.499 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.06 129.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 t -153.8 166.57 32.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 59.5 p -140.74 134.82 30.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.541 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.7 m -133.8 136.64 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 64.3 p -122.99 -50.69 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 71.18 170.5 10.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 44.0 m -141.41 120.07 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.7 p -154.44 125.25 7.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -163.22 78.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.6 136.65 12.23 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -123.33 165.79 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -145.17 136.82 25.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -66.05 -57.45 7.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -104.29 153.33 21.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.53 127.2 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.06 -54.88 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -125.63 156.22 39.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -79.85 104.94 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.9 m -141.85 135.7 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 41.1 pt -132.77 142.28 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -102.21 149.02 24.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 312' ' ' VAL . 94.7 t -135.9 139.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 53.1 p -138.55 167.63 21.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 19.7 t-20 73.13 41.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.511 HD22 HG21 ' A' ' 250' ' ' THR . 31.0 mt -92.27 -175.16 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -125.49 170.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.87 -6.7 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.98 22.14 16.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.511 HG21 HD22 ' A' ' 246' ' ' LEU . 99.6 m -131.11 96.43 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.56 ' CG ' HG22 ' A' ' 253' ' ' THR . 11.7 ptt180 -107.09 -177.38 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -45.7 -50.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.56 HG22 ' CG ' ' A' ' 251' ' ' ARG . 1.4 t -59.51 -28.6 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.95 -27.03 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.06 -20.35 19.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.418 ' HB2' HD12 ' A' ' 268' ' ' ILE . 11.5 tt0 -64.94 -33.81 76.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -93.2 -11.68 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.458 HD22 ' HE2' ' A' ' 305' ' ' TYR . 28.7 tp -82.78 -41.22 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.601 ' CE2' HG11 ' A' ' 300' ' ' VAL . 64.2 m-85 -96.76 11.91 33.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.7 ttt-85 -77.52 -45.32 2.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.729 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.87 -17.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -92.74 -31.21 15.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.72 -164.13 37.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 31.3 m -91.12 107.43 19.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 259' ' ' PHE . 82.8 mt -61.35 141.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.531 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.9 t -94.05 -45.81 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -150.27 149.17 29.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.525 ' CG1' HG21 ' A' ' 265' ' ' ILE . 46.9 mt -133.47 113.2 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.103 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 5.1 t80 -104.12 147.39 27.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.5 tp -134.74 128.9 33.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -72.99 129.45 38.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -135.43 175.59 9.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.53 170.67 8.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -113.43 -5.54 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.5 m -101.31 -35.9 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -121.22 -10.52 8.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.71 84.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -104.99 163.22 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 15.0 m -69.66 142.16 53.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -82.05 -74.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 166.83 31.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 11.4 p90 -165.49 150.39 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.888 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 162.55 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -127.23 117.9 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -103.26 129.1 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -107.9 124.89 50.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.17 179.96 4.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.5 m-70 -93.78 -36.34 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -124.25 179.76 4.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.87 -17.56 29.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -76.52 -59.36 2.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.11 -24.77 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.27 62.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.73 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -49.66 -42.05 44.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.847 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.14 -62.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.555 HD12 ' NE1' ' A' ' 314' ' ' TRP . 71.3 mt -39.92 -37.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.97 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -82.47 -59.46 2.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 296' ' ' ALA . 6.8 m -49.41 -30.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 p -62.97 120.86 12.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.05 20.34 79.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.18 156.39 29.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -103.52 76.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.458 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -99.06 120.95 40.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.872 0.368 . . . . 0.0 110.954 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 56.79 49.38 14.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 18.1 p-80 45.83 31.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 309' ' ' ILE . 34.5 mt -132.03 166.86 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -95.41 102.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 243' ' ' VAL . 15.4 tp -71.81 134.62 46.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.67 130.29 56.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 243' ' ' VAL . 97.6 t -136.19 144.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.48 157.77 30.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.555 ' NE1' HD12 ' A' ' 297' ' ' ILE . 80.1 m95 -62.95 123.63 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -112.5 103.8 11.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 112.61 37.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.558 0.694 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.64 176.33 10.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 84.3 p -144.57 166.2 25.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.0 t -145.59 129.29 17.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.107 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -121.04 83.42 2.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -163.6 139.27 6.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.0 16.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.485 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.96 161.47 32.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.345 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.7 p -110.89 -51.6 2.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 70.7 p -152.87 153.88 33.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 33.4 t -94.35 111.42 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.362 . . . . 0.0 110.849 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.7 m -118.77 107.1 13.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.35 108.02 0.25 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.1 t -115.7 41.47 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.86 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 10.1 m -89.26 119.9 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -154.61 143.07 9.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.71 179.33 6.59 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.339 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.64 -51.34 2.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.423 ' NH1' ' HB3' ' A' ' 233' ' ' ARG . 4.2 ptp180 -105.48 164.91 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -89.23 47.36 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -54.78 -49.73 70.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -51.64 138.65 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -102.37 -48.84 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -108.2 165.23 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -92.08 107.7 19.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.095 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.2 m -142.89 145.01 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 37.6 pt -140.0 142.18 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 62.5 ttt180 -105.6 153.81 21.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 312' ' ' VAL . 91.4 t -138.3 142.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 61.6 p -138.16 167.5 21.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 73.59 43.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.78 177.57 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 85.3 p -121.54 -175.16 3.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.77 -1.86 58.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.24 18.8 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.508 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 53.0 m -127.61 111.56 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 179.08 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -52.1 -38.97 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -68.1 -18.91 64.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -86.6 -26.19 24.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -91.61 -22.76 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -62.31 -35.32 78.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -92.45 -10.73 36.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 259' ' ' PHE . 25.9 tp -85.79 -34.51 21.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.603 ' CE2' HG11 ' A' ' 300' ' ' VAL . 77.6 m-85 -104.69 11.46 34.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.581 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.7 tpt180 -80.25 -45.68 1.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.6 Cg_exo -47.95 -20.43 2.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.5 m-85 -88.84 -31.26 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.97 34.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 18.7 m -91.39 118.66 30.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.02 136.25 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.3 t -87.32 -42.18 13.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -154.9 160.0 40.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.71 116.06 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -113.16 148.88 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.736 HD23 ' HE3' ' A' ' 272' ' ' LYS . 61.0 tp -139.87 127.32 21.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.59 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -73.2 123.45 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.736 ' HE3' HD23 ' A' ' 270' ' ' LEU . 51.3 mttt -136.15 146.03 46.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.17 177.22 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -114.7 -61.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.7 m -53.02 -41.41 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 t -102.01 -22.58 14.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.64 32.8 84.67 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -109.02 140.12 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 47.2 t -54.86 124.67 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -55.1 -74.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.01 33.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 36.5 p90 -165.97 146.46 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.5 164.18 27.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.502 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.2 m-85 -131.06 112.63 13.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -100.13 127.82 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 7.3 m -102.14 120.77 40.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.5 m-85 -96.29 177.49 5.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 264' ' ' SER . 10.9 m-70 -96.5 -47.95 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -112.14 164.03 13.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 290' ' ' ARG . 13.4 ttp-105 -71.75 -31.58 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.6 -61.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.99 -37.17 52.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -68.04 -39.13 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.65 -37.41 70.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -49.25 -42.91 42.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -63.49 -67.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.563 HD13 ' CD1' ' A' ' 314' ' ' TRP . 85.8 mt -36.03 -32.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.127 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -70.98 -45.88 63.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -79.46 -64.96 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.5 m -40.01 -36.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.894 0.378 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p -61.37 112.37 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.88 17.65 57.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -79.51 157.87 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.907 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.93 82.28 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.508 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.3 OUTLIER -99.39 129.74 45.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.449 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 0.5 OUTLIER 47.77 53.69 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 31.2 p-80 45.61 39.53 5.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 77.5 mt -143.53 168.19 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.7 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.19 138.04 51.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.27 132.18 56.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 243' ' ' VAL . 79.4 t -137.06 143.4 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -153.53 161.89 41.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.563 ' CD1' HD13 ' A' ' 297' ' ' ILE . 65.4 m95 -65.25 125.27 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -109.93 134.86 51.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.89 106.9 40.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.41 103.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.345 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.8 t -78.76 114.77 17.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.0 m -115.05 -38.9 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -158.0 173.4 16.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.6 t -122.89 119.69 31.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.15 146.08 13.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.63 2.85 7.4 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.374 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 64.3 m -90.01 122.6 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 72.9 m -75.01 162.26 28.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 26.0 m -79.75 -54.09 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 p -117.79 -41.53 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.13 54.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 40.3 t -80.56 97.56 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.5 m 48.09 48.57 18.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.857 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -80.82 -157.31 16.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.11 179.97 6.0 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.278 . . . . 0.0 112.35 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 37.35 50.91 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.29 -43.43 28.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -45.78 133.41 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.4 -45.24 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.12 126.73 44.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -111.32 -49.32 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -169.11 177.94 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -76.35 105.43 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.4 m -139.36 144.05 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 297' ' ' ILE . 34.4 pt -138.62 144.06 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.549 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt-85 -100.79 152.84 20.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -138.77 140.52 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.418 ' O ' HD12 ' A' ' 310' ' ' LEU . 70.8 p -133.65 169.47 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.62 53.12 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 19.8 mt -103.53 166.38 10.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.0 p -111.69 155.33 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.28 -5.82 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 19.59 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.0 m -131.1 99.62 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -103.57 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -51.04 -40.79 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.469 HG23 ' OD1' ' A' ' 254' ' ' ASP . 11.7 t -67.95 -30.89 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 253' ' ' THR . 0.9 OUTLIER -76.72 -28.53 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.74 -26.56 20.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.56 -32.29 73.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.66 -15.13 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.79 -35.72 20.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.6 m-85 -100.92 8.57 43.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.624 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.6 OUTLIER -80.86 -42.86 1.23 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.568 0.699 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.5 Cg_exo -47.91 -17.98 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.2 m-85 -92.84 -31.8 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.15 36.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.556 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 49.0 m -91.28 116.33 28.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 34.4 mt -73.89 147.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.2 t -98.68 -43.14 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -151.57 153.89 35.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 89.1 mt -138.46 122.2 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.5 t80 -112.6 149.54 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.8 tp -135.49 127.43 29.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -69.42 121.59 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -128.74 150.59 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.21 -176.74 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -111.2 -62.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.9 m -47.22 -69.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 278' ' ' GLN . 10.2 t -77.37 -34.01 55.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.76 39.46 39.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.411 ' H ' HG23 ' A' ' 276' ' ' THR . 21.6 mt-30 -111.21 -176.9 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 35.1 t -80.44 126.04 30.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -66.68 -74.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.85 32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.464 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.665 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 19.8 p90 -166.02 151.26 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.923 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.83 165.19 28.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -129.42 116.56 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.6 mp -105.8 131.89 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -110.92 121.32 45.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.7 m-85 -94.63 -178.87 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.567 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 14.3 m-70 -95.25 -35.91 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ARG . . . . . 0.437 ' NH1' ' OD2' ' A' ' 292' ' ' ASP . 18.0 mtt85 -124.68 169.45 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -80.71 -23.48 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.5 -46.17 27.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 289' ' ' ARG . 15.7 m-20 -67.15 -35.28 79.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.37 -37.28 77.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.82 77.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -48.65 -42.63 35.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.85 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.8 mt -35.42 -37.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.95 -54.58 17.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -67.05 -66.97 2.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 312' ' ' VAL . 30.0 m -42.97 -37.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 1.7 t -50.81 113.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.47 24.85 60.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -86.3 137.78 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.41 97.06 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 116.88 30.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 14.9 t70 63.13 53.41 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 28.7 p-80 48.8 26.61 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 309' ' ' ILE . 35.1 mt -129.8 165.82 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.602 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -97.98 101.1 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 244' ' ' THR . 14.0 tp -73.32 137.65 44.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.5 150.69 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 243' ' ' VAL . 48.5 t -149.1 142.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.74 153.22 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.527 ' CD1' HD13 ' A' ' 297' ' ' ILE . 83.5 m95 -61.79 125.95 25.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -57.81 -31.96 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.445 ' NZ ' HG22 ' A' ' 319' ' ' THR . 0.0 OUTLIER -104.15 153.18 39.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.905 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 318' ' ' SER . 58.8 Cg_endo -71.88 102.51 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' PRO . 96.4 p -35.63 141.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.445 HG22 ' NZ ' ' A' ' 316' ' ' LYS . 9.5 t -153.96 147.24 24.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -63.83 105.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 t -143.72 130.92 20.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.98 85.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.455 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.31 -28.6 5.55 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.267 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 98.0 p -93.1 171.43 8.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.1 t 66.03 42.32 3.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 49.3 m -107.31 90.6 3.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -115.07 163.23 15.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.18 0.23 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 88.6 p -103.78 97.77 7.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.823 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 m -145.38 146.22 31.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.858 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.78 81.14 0.84 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.01 110.59 3.06 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -148.23 162.72 38.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.25 92.68 8.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -79.06 105.03 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.0 -42.63 47.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 t70 47.55 42.41 14.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.75 -61.13 2.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.53 166.95 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . -103.96 105.64 15.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 65.1 m -143.08 140.19 30.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 297' ' ' ILE . 30.0 pt -138.81 140.97 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.479 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 55.8 ttt180 -103.36 146.94 27.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 312' ' ' VAL . 89.9 t -132.74 142.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 74.3 p -136.93 167.1 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 72.28 43.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.96 176.94 6.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.401 ' CB ' ' CG ' ' A' ' 306' ' ' ASP . 15.9 t -124.63 151.99 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -54.74 -28.38 48.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.75 18.85 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 89.5 m -132.67 98.07 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 253' ' ' THR . 7.5 ptt180 -109.3 -174.41 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -45.57 -62.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 251' ' ' ARG . 5.2 t -46.89 -34.99 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.02 -31.15 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.4 mt -86.33 -25.79 25.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 25.5 tt0 -62.72 -35.9 81.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.56 -25.65 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 305' ' ' TYR . 14.2 tp -74.94 -39.52 61.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.713 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.0 m-85 -95.96 12.02 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -77.82 -45.37 2.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.607 0.717 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.93 -17.6 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.349 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 40.0 m-85 -91.02 -40.01 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 171.27 -160.53 32.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.602 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.2 m -92.17 107.6 19.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.713 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.1 mt -64.86 143.05 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.566 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.3 t -91.85 -49.64 6.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -141.02 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 80.0 mt -134.99 101.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 2.5 t80 -92.66 142.77 27.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.639 HD23 ' CE ' ' A' ' 272' ' ' LYS . 53.8 tp -129.47 128.48 43.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.617 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.4 115.58 4.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.639 ' CE ' HD23 ' A' ' 270' ' ' LEU . 97.1 mttt -136.95 134.93 37.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.87 162.56 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 275' ' ' THR . 4.4 ptmt -100.37 -35.11 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 274' ' ' LYS . 93.7 m -74.95 -41.46 59.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 31.1 p -94.16 -38.55 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.23 43.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -136.18 179.26 6.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 39.9 m -85.59 109.1 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -48.92 -66.88 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 151.25 33.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.617 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 52.7 p90 -165.97 147.52 6.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -138.23 174.36 10.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.1 m-85 -139.88 115.13 9.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -101.37 124.05 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.9 m -102.71 112.25 24.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.1 m-85 -84.95 169.85 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -85.92 -39.89 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.37 173.19 6.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.92 -39.12 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.87 -61.59 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -49.87 -38.63 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -66.56 -45.98 77.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -48.33 -42.03 30.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.75 -71.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 301' ' ' SER . 87.4 mt -34.23 -42.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.27 81.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -76.28 -66.08 1.91 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.1 m -42.25 -43.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.483 ' N ' HG23 ' A' ' 300' ' ' VAL . 13.0 t -48.9 104.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 90.33 33.62 8.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -96.33 130.89 43.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -79.08 52.62 4.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -75.47 128.03 34.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 308' ' ' LEU . 53.9 m-20 62.2 54.35 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.524 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 5.2 p-80 37.91 31.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 306' ' ' ASP . 82.9 mt -140.04 168.49 19.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.4 mp -89.58 97.96 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.14 140.15 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.92 144.47 48.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 243' ' ' VAL . 71.5 t -150.65 150.05 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -166.11 165.58 17.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.413 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 85.5 m95 -66.99 125.38 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -118.87 117.35 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 317' ' ' PRO . 0.4 OUTLIER -163.42 133.25 3.18 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 62.1 Cg_endo -76.87 120.71 5.57 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.352 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 5.0 m -86.52 48.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 t -81.95 41.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 49.95 41.43 22.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -90.82 137.83 32.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -168.59 157.54 29.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.56 101.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 12.4 m -56.7 -58.13 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.1 p -67.52 130.02 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 8.6 t -159.45 140.09 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.9 m -153.85 166.11 33.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.91 117.29 0.65 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 16.1 m -99.19 164.99 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.899 0.38 . . . . 0.0 110.858 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.5 m -139.25 134.46 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 43.76 95.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.03 -1.55 11.73 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.681 2.254 . . . . 0.0 112.298 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -61.2 103.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 233' ' ' ARG . 0.1 OUTLIER -72.34 -39.58 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 233' ' ' ARG . 36.3 mtt85 -36.36 -48.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -60.48 109.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -168.61 114.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.74 -60.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -125.58 175.87 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.53 98.92 9.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.5 m -143.68 145.48 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 297' ' ' ILE . 30.8 pt -140.63 142.84 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 72.2 ttt180 -104.14 149.07 25.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 312' ' ' VAL . 93.4 t -134.74 142.29 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 282' ' ' PHE . 17.2 p -140.64 166.71 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 38.2 t-20 72.32 41.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 250' ' ' THR . 28.9 mt -92.11 169.6 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 306' ' ' ASP . 11.2 t -110.7 155.52 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.3 -28.92 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.89 22.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.548 HG21 HD22 ' A' ' 246' ' ' LEU . 93.3 m -127.92 96.77 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.77 ' HG3' HG22 ' A' ' 253' ' ' THR . 8.0 ptt180 -99.75 -174.33 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.06 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.77 HG22 ' HG3' ' A' ' 251' ' ' ARG . 13.6 t -50.81 -28.07 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.19 -27.79 62.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.64 -32.45 13.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -52.72 -30.59 33.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.93 -25.02 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 305' ' ' TYR . 12.4 tp -77.0 -36.85 56.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 265' ' ' ILE . 84.8 m-85 -96.05 11.4 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.606 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.2 OUTLIER -79.64 -44.57 1.58 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 110.888 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.94 -19.12 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 39.5 m-85 -89.71 -40.09 12.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.33 -160.22 30.63 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -93.03 113.28 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 259' ' ' PHE . 39.9 mt -71.36 141.9 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.5 t -89.19 -46.89 8.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -147.55 156.49 42.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 53.6 mt -138.24 105.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.8 t80 -93.22 143.48 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.738 HD23 ' CE ' ' A' ' 272' ' ' LYS . 49.9 tp -127.74 132.8 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.603 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.91 113.31 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.738 ' CE ' HD23 ' A' ' 270' ' ' LEU . 86.8 mttt -136.31 125.79 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.42 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -110.78 -40.08 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.6 m -67.08 -73.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 277' ' ' GLY . 12.2 t -79.87 -43.21 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 276' ' ' THR . . . 88.52 38.24 7.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.441 ' H ' HG23 ' A' ' 276' ' ' THR . 6.5 mm100 -99.66 149.7 23.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 110.871 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 13.5 t -57.88 116.89 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -63.72 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.62 33.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 41.7 p90 -165.98 154.57 11.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -144.42 174.05 11.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 91.0 m-85 -139.37 111.78 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -95.69 123.65 47.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 67.9 m -100.38 114.18 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.729 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 12.2 m-85 -87.59 169.71 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -86.69 -40.87 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.37 173.91 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -77.91 -38.85 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.91 -62.04 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.21 -40.41 47.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.78 -46.28 79.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.72 99.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -47.35 -41.54 19.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.22 -70.91 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 241' ' ' ILE . 87.4 mt -34.44 -43.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.7 87.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -75.63 -66.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.509 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 296' ' ' ALA . 25.6 m -43.33 -42.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 10.7 t -47.92 108.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.66 31.4 18.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -94.96 135.37 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -81.21 52.86 4.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.574 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -74.98 129.61 37.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 0.0 110.908 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.431 ' CG ' ' HB3' ' A' ' 247' ' ' SER . 58.1 m-20 62.07 54.19 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.521 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 5.2 p-80 38.23 30.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 306' ' ' ASP . 91.9 mt -141.41 169.63 17.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.36 101.93 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.32 149.52 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.85 127.41 43.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 243' ' ' VAL . 93.9 t -137.33 151.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -169.45 151.93 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -53.51 126.43 21.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . -118.25 158.43 25.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.412 ' HD2' ' C ' ' A' ' 315' ' ' ALA . 11.0 mptt -129.54 159.2 70.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.81 161.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -105.18 -54.78 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 38.5 p -119.76 115.27 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.145 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -62.15 102.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 56.3 m -97.74 161.63 13.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 172.84 64.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.94 126.98 9.09 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.4 t -107.7 140.16 41.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.9 t -151.71 153.66 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 11.4 m -81.35 110.62 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.882 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t -120.43 110.9 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 107.15 152.45 18.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.9 p -128.42 163.99 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 16.8 m -53.17 125.5 17.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 143.59 176.52 17.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.481 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.07 -175.15 2.5 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.723 2.282 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -115.32 106.13 13.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -147.01 156.65 43.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -69.12 135.88 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -86.05 -43.65 12.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.38 144.08 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.37 -50.93 3.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -126.4 173.82 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -77.8 94.36 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 315' ' ' ALA . 91.2 m -135.15 150.7 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.23 144.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -107.38 152.15 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 99.0 t -137.11 138.02 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 60.8 p -133.27 165.29 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 16.6 t-20 73.77 49.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -98.52 176.33 5.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -123.75 -176.88 3.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.43 -5.14 58.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.8 19.57 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 246' ' ' LEU . 90.1 m -122.29 96.43 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -105.76 173.7 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -48.69 -42.61 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -23.38 66.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.99 -30.07 35.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.3 mt -86.59 -31.94 20.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.468 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 1.3 tm0? -54.75 -50.13 69.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.03 -19.03 60.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 305' ' ' TYR . 35.2 tp -80.16 -35.58 36.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 300' ' ' VAL . 59.6 m-85 -101.72 11.89 38.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -78.45 -45.21 2.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.587 0.708 . . . . 0.0 110.926 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.5 Cg_exo -48.03 -17.55 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.371 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.5 m-85 -91.41 -32.71 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.87 -162.93 36.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.25 106.25 18.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 268' ' ' ILE . 61.8 mt -61.44 143.41 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.519 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 31.5 t -94.1 -47.67 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -149.4 153.19 36.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 265' ' ' ILE . 74.5 mt -139.08 113.07 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.1 t80 -104.6 152.82 21.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 62.1 tp -133.14 128.44 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -66.64 121.42 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HE3' HD23 ' A' ' 270' ' ' LEU . 31.6 mttt -136.91 140.13 42.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.97 170.07 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.82 -42.15 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 97.2 m -74.67 -73.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.105 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 278' ' ' GLN . 12.9 t -70.2 -25.87 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.45 37.38 92.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.516 ' H ' HG23 ' A' ' 276' ' ' THR . 46.0 mm-40 -99.47 175.87 5.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.6 t -84.3 118.56 24.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -61.47 -74.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.57 34.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 22.8 p90 -165.55 151.28 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.3 169.04 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -134.58 116.06 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.2 mp -104.29 134.55 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.9 t -106.27 144.1 33.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 18.7 m-85 -119.91 169.96 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 5.7 m-70 -94.31 -40.86 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -110.16 152.81 25.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -71.74 -16.41 62.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -85.88 -41.86 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.36 -35.81 78.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -71.33 -35.84 71.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ALA . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -74.17 -35.98 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -49.46 -43.23 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.93 -66.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 88.6 mt -34.3 -34.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -72.07 -50.63 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.79 -65.67 2.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 312' ' ' VAL . 13.6 m -43.43 -28.81 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t -62.79 114.35 3.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.92 68.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 52.1 t80 -78.23 163.29 25.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . 0.41 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -108.87 83.69 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.52 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.3 OUTLIER -103.45 120.24 40.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.417 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 53.3 m-20 57.92 52.48 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.573 ' CD2' ' O ' ' A' ' 307' ' ' HIS . 22.5 p-80 44.3 36.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 309' ' ' ILE . 70.4 mt -139.09 166.63 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -93.7 101.8 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.3 134.41 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.63 138.78 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 243' ' ' VAL . 68.9 t -140.47 148.34 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.07 153.05 13.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.488 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 83.3 m95 -54.52 122.0 9.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 240' ' ' THR . . . -88.76 171.1 10.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -133.81 94.4 18.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.576 0.703 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.35 97.22 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 20.9 t -98.92 78.96 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 25.6 m -116.77 148.12 41.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -90.66 114.07 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.8 t -131.04 87.49 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 61.97 170.44 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.97 -29.89 4.9 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.376 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.7 t -117.46 119.83 36.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 21.4 t -69.63 102.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 45.8 t -88.05 -60.25 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.4 m -87.96 90.95 8.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.54 -108.6 2.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 4.3 t 41.75 41.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 23.8 t -155.3 139.76 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 61.88 149.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.3 109.31 2.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -58.02 119.55 6.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -135.81 152.83 51.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -162.64 109.63 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.417 ' C ' ' HE2' ' A' ' 316' ' ' LYS . . . -162.79 134.23 5.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.97 159.03 2.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -112.36 -49.38 2.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -121.86 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -77.04 97.59 4.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -134.92 142.71 46.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 29.5 pt -139.7 140.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.145 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 74.8 ttt180 -103.27 151.17 23.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 312' ' ' VAL . 86.2 t -134.62 144.66 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 64.5 p -140.82 171.66 13.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m120 64.58 48.43 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.0 mt -100.9 -177.58 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.3 t -126.81 176.51 7.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.83 -24.69 48.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.38 20.16 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 97.9 m -132.75 96.41 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.541 ' HG3' HG22 ' A' ' 253' ' ' THR . 23.2 ptt-85 -101.48 -173.31 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -55.62 -64.3 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 251' ' ' ARG . 1.8 t -50.68 -19.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.447 ' OD2' ' NH1' ' A' ' 251' ' ' ARG . 3.2 m-20 -82.82 -29.3 29.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.59 -27.83 17.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.26 -31.47 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.91 -24.91 26.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.42 HD22 ' CE2' ' A' ' 305' ' ' TYR . 11.6 tp -73.6 -35.37 65.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' PHE . . . . . 0.676 ' HB2' HD11 ' A' ' 265' ' ' ILE . 59.1 m-85 -97.62 10.17 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.601 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.3 tpt85 -75.97 -44.54 3.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.7 Cg_exo -48.0 -18.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.6 m-85 -93.37 -38.52 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.22 32.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.468 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.56 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 4.4 m -92.86 116.06 28.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 259' ' ' PHE . 45.3 mt -74.47 140.14 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.542 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.9 t -89.97 -50.47 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -140.03 155.95 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.86 105.12 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 1.6 t80 -97.24 142.83 28.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.8 tp -126.01 131.76 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.12 119.83 11.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -136.66 122.12 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.64 -179.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -113.31 -41.74 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 89.5 m -65.94 -56.96 9.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.1 t -94.65 -15.41 24.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.6 85.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -112.07 171.22 7.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 60.5 p -77.64 113.2 15.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -56.65 -68.06 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.76 34.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 39.5 p90 -162.34 146.25 11.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -136.34 167.79 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.141 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.5 m-85 -135.15 111.73 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -100.48 127.48 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -104.33 112.92 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -84.21 176.44 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -92.76 -41.63 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -113.4 172.65 6.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -81.31 -37.1 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.08 -54.34 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.2 -37.08 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.451 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -66.13 -46.34 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.5 98.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -46.77 -42.19 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.43 -71.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 314' ' ' TRP . 92.0 mt -35.81 -40.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.01 87.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.99 -62.59 1.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 296' ' ' ALA . 16.2 m -46.03 -20.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 103.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.48 29.06 9.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.89 133.51 34.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -82.25 54.38 4.87 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' TYR . . . . . 0.42 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -77.03 130.07 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 110.972 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 308' ' ' LEU . 56.6 m-20 62.08 55.03 2.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' HIS . . . . . 0.541 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 5.2 p-80 37.73 31.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 306' ' ' ASP . 90.2 mt -141.52 170.64 15.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.49 100.88 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.77 143.45 56.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -125.37 129.43 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 243' ' ' VAL . 56.4 t -137.85 140.15 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 156.02 32.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.523 ' CD1' HD13 ' A' ' 297' ' ' ILE . 80.3 m95 -57.51 128.01 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . -118.08 149.07 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 235' ' ' ALA . 15.2 mmtt -97.84 151.42 37.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.575 0.702 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.54 153.89 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.8 m -89.88 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 81.4 p -94.26 148.35 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -80.33 47.18 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.6 t -55.84 169.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.89 140.73 5.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.26 5.25 5.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 31.9 p -91.88 -48.5 6.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.6 m -118.81 112.35 19.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.874 0.369 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.7 m -135.89 136.28 40.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.744 HG22 HD11 ' A' ' 297' ' ' ILE . 45.0 pt -132.67 142.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -99.88 150.38 22.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 312' ' ' VAL . 74.9 t -136.88 141.17 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 282' ' ' PHE . 18.3 p -141.5 163.94 31.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 29.6 t30 70.45 52.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 250' ' ' THR . 26.1 mt -93.93 -178.56 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.8 t -118.19 169.77 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.68 -21.47 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.89 20.26 13.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 1.028 HG21 HD22 ' A' ' 246' ' ' LEU . 52.8 m -113.17 99.42 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -110.15 -177.47 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.54 ' OE2' HD23 ' A' ' 270' ' ' LEU . 12.1 mp0 -55.86 -42.14 75.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.8 t -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.111 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -28.95 47.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.6 mt -86.33 -31.15 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 11.2 tt0 -59.0 -31.67 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.33 -16.7 28.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.538 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.0 tp -82.94 -37.85 23.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 265' ' ' ILE . 65.1 m-85 -98.03 10.97 39.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.9 tmt_? -76.56 -45.27 3.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 66.0 Cg_exo -48.02 -17.23 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.4 m-85 -93.38 -33.09 14.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 164.65 -162.62 35.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.0 m -90.39 117.26 28.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.9 mt -75.71 140.94 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -88.35 -45.02 10.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -150.78 153.5 35.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 44.7 mt -136.18 105.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 4.6 t80 -96.95 146.96 24.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.54 HD23 ' OE2' ' A' ' 252' ' ' GLU . 12.4 tp -140.95 125.84 18.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.75 119.44 9.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -130.95 149.07 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.35 163.65 13.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -101.0 -29.93 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 74.4 m -81.62 -37.75 27.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.2 p -98.96 -34.14 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.5 44.57 89.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -129.93 -175.88 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.359 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 49.9 m -86.24 106.05 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 271' ' ' ALA . 13.3 mmmt -40.65 -56.63 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.54 -23.09 0.84 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 244' ' ' THR . 14.4 p90 -115.84 159.7 21.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -147.27 168.45 21.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -136.05 113.64 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.0 mp -97.94 133.74 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.119 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 25.3 m -108.03 123.13 48.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.607 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.1 m-85 -98.74 169.95 9.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.556 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 12.3 m-70 -87.76 -47.09 8.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt-85 -108.37 165.3 11.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -76.65 -24.0 53.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.44 -49.98 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.14 -37.99 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.9 -43.75 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.0 91.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -48.98 -40.03 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.902 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.75 -64.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 241' ' ' ILE . 82.7 mt -37.97 -33.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.04 38.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -77.88 -62.35 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.497 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 296' ' ' ALA . 7.5 m -42.49 -27.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.4 t -70.03 109.45 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 91.1 16.61 53.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.17 158.58 33.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.81 65.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.31 127.54 34.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 4.5 m-20 46.64 50.74 12.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 35.1 p-80 46.3 44.32 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 88.7 mt -146.45 168.64 20.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.74 95.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 25.9 tp -60.96 146.05 48.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -119.7 129.67 54.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 243' ' ' VAL . 76.6 t -141.19 147.5 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.85 149.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.571 ' CD1' HD13 ' A' ' 297' ' ' ILE . 79.8 m95 -51.18 122.72 8.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.882 0.373 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 25.7 m -139.01 147.53 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 297' ' ' ILE . 32.3 pt -141.54 143.16 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 312' ' ' VAL . 49.7 ttt-85 -98.67 150.98 21.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 312' ' ' VAL . 88.2 t -139.1 139.07 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 30.7 p -138.8 173.72 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 20.4 t-20 69.24 48.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.72 -178.28 3.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.952 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.9 t -126.47 179.26 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.18 -3.91 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.66 21.63 17.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.6 m -127.49 116.78 20.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 172.07 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.2 -47.47 62.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.6 t -60.4 -29.0 68.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.45 -23.35 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.04 -28.11 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -54.76 -28.01 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.31 -19.5 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.56 -36.76 44.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.829 ' HB2' HD11 ' A' ' 265' ' ' ILE . 88.4 m-85 -95.92 10.43 37.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 ttt-85 -78.87 -45.17 1.84 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.333 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -95.56 -31.94 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 167.76 -160.53 34.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.597 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.7 m -95.2 111.03 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 259' ' ' PHE . 66.5 mt -65.87 147.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 33.4 t -97.89 -46.88 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -147.05 146.01 29.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 39.8 mt -130.63 99.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.088 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.661 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -93.79 152.72 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.674 HD23 ' HE2' ' A' ' 272' ' ' LYS . 47.5 tp -141.71 143.27 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -84.9 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.674 ' HE2' HD23 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -134.19 153.98 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -99.43 157.37 16.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.31 0.3 33.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 93.4 m -111.43 -20.61 12.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 32.7 p -121.48 -16.1 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.14 37.44 80.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.57 -179.26 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 t -85.3 115.99 23.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -46.87 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.82 32.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 25.8 p90 -165.95 155.94 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.42 174.04 12.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.15 120.11 16.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -106.64 124.52 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 50.4 m -101.45 118.51 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.785 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 7.8 m-85 -92.62 176.02 6.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 264' ' ' SER . 9.6 m-70 -95.57 -50.03 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -108.04 149.46 28.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -69.46 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.51 -25.51 20.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.497 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 6.4 m-20 -88.57 -25.31 22.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -80.35 -33.98 36.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.441 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.31 -33.63 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -59.44 -37.79 79.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.2 -63.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 241' ' ' ILE . 61.1 mt -39.94 -35.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -72.67 -56.63 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.8 -61.41 5.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.789 HG21 HG21 ' A' ' 312' ' ' VAL . 3.7 m -48.05 -35.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t -59.81 104.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.6 27.1 10.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -91.09 148.99 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -92.8 78.22 1.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.52 127.07 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 11.3 t70 52.66 48.14 23.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.565 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 46.52 32.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 309' ' ' ILE . 45.9 mt -133.7 171.82 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -97.95 94.73 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.93 136.19 54.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -116.79 142.89 46.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 243' ' ' VAL . 99.2 t -146.67 144.78 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.37 149.02 8.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.521 ' CD1' HD13 ' A' ' 297' ' ' ILE . 95.6 m95 -49.59 130.3 20.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.851 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.863 0.363 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -143.29 143.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.9 pt -140.85 147.05 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HG3' ' CE1' ' A' ' 284' ' ' PHE . 17.0 ttt180 -112.32 148.77 33.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 312' ' ' VAL . 67.3 t -127.49 148.99 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.4 p -143.24 163.11 33.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.79 38.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.8 mt -82.72 -174.97 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 248' ' ' GLU . 27.3 t -125.78 178.85 5.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.4 ' N ' ' OG ' ' A' ' 247' ' ' SER . 4.3 mm-40 -76.46 -50.47 13.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.11 -4.8 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 44.2 m -98.51 103.13 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.401 ' HA ' HD22 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -115.13 -175.5 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.625 ' OE2' HD23 ' A' ' 270' ' ' LEU . 4.3 mp0 -51.17 -56.21 13.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.3 t -55.31 -21.79 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.156 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -82.47 -30.4 29.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.87 -26.53 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -56.79 -33.58 66.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -89.96 -18.44 26.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.416 HD22 ' HE2' ' A' ' 305' ' ' TYR . 31.8 tp -78.64 -34.23 46.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 265' ' ' ILE . 81.3 m-85 -101.0 11.91 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 8.2 tpt180 -78.24 -45.24 2.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 0.0 110.859 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.01 -17.21 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.0 m-85 -92.56 -35.91 13.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.27 -161.45 34.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.9 m -90.31 117.28 28.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.531 HG21 ' CG1' ' A' ' 268' ' ' ILE . 74.9 mt -72.78 144.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.2 t -97.98 -48.09 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.0 tpt180 -145.44 151.46 38.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.531 ' CG1' HG21 ' A' ' 265' ' ' ILE . 65.3 mt -140.23 113.68 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 4.9 t80 -109.31 141.58 41.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.625 HD23 ' OE2' ' A' ' 252' ' ' GLU . 18.4 tp -129.92 121.13 26.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.948 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -61.63 122.49 15.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.122 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -134.96 149.33 50.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.27 178.82 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.29 -48.27 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 58.3 m -67.48 -42.38 83.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 -14.47 17.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 50.63 41.64 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -117.7 163.81 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.2 p -70.91 129.95 40.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -68.77 -75.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.71 32.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 24.2 p90 -165.99 157.96 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.73 171.3 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.526 ' CE1' ' HG3' ' A' ' 242' ' ' ARG . 97.7 m-85 -136.84 106.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -94.78 136.99 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.7 m -113.93 118.62 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -93.07 172.84 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -89.69 -43.57 10.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -116.62 168.92 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -76.89 -35.52 57.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.95 -55.29 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.86 -37.78 74.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.26 94.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.56 -37.23 82.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.067 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmm-85 -50.05 -41.0 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.64 -65.86 0.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.119 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.497 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 82.5 mt -35.04 -33.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.53 -51.71 9.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -60.67 5.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 ' O ' ' A' ' 296' ' ' ALA . 13.7 m -51.24 -31.58 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.3 t -61.59 119.55 8.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.32 69.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 66.9 t80 -83.71 165.42 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.442 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -110.98 82.36 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.416 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.7 OUTLIER -103.4 120.59 41.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 21.7 t70 61.01 48.7 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 27.6 p-80 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.94 167.54 21.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -94.52 95.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 22.4 tp -60.83 143.49 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -123.93 130.86 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 243' ' ' VAL . 26.4 t -139.81 151.31 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -169.39 149.82 4.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 86.2 m95 -47.89 136.08 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.125 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.792 0.329 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.8 m -134.34 141.0 46.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 35.4 pt -140.54 145.23 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -104.39 149.17 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 312' ' ' VAL . 73.8 t -133.09 135.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.437 ' O ' HD12 ' A' ' 310' ' ' LEU . 31.0 p -130.26 171.76 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.42 51.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 250' ' ' THR . 23.7 mt -95.77 -177.52 4.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 t -122.23 164.27 18.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.48 -11.53 60.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -105.24 21.1 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.542 HG21 HD22 ' A' ' 246' ' ' LEU . 59.1 m -121.14 98.43 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -103.29 170.07 8.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -47.82 -43.4 27.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -23.67 64.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.55 -28.76 46.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.52 -30.84 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 7.1 pt20 -53.14 -33.56 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.55 -12.85 44.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.87 -37.23 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.568 ' CE2' HG11 ' A' ' 300' ' ' VAL . 46.5 m-85 -96.89 10.37 39.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.4 tpt85 -76.9 -45.32 2.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.63 0.729 . . . . 0.0 110.826 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.3 Cg_exo -47.96 -17.24 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.646 2.23 . . . . 0.0 112.354 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.8 m-85 -94.22 -32.47 13.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.22 -166.66 39.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.47 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.7 m -90.32 112.86 24.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 37.1 mt -69.34 145.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 26.7 t -96.56 -44.88 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 16.7 tpp180 -148.34 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 265' ' ' ILE . 41.5 mt -131.31 96.58 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -91.76 150.41 21.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.5 tp -142.14 120.16 12.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.5 131.8 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -134.5 174.39 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.19 164.91 13.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -107.24 -6.26 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 55.8 m -102.11 -58.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -6.84 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.83 26.87 65.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -88.09 138.73 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.5 t -47.35 127.74 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -62.22 -57.43 11.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.91 -9.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.65 149.5 52.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 270' ' ' LEU . . . -133.78 169.4 17.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -134.21 117.56 16.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -103.78 136.85 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.3 m -112.02 124.85 53.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.914 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 17.6 m-85 -98.78 171.74 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 12.6 m-70 -89.88 -40.26 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -118.94 158.87 24.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 17.0 ttp-105 -74.6 -13.26 60.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.91 -29.18 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.465 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -84.36 -28.55 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.914 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -77.6 -33.77 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.97 65.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -49.14 -44.68 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -59.78 -66.65 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 312' ' ' VAL . 81.2 mt -39.86 -34.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.0 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -85.15 -57.05 2.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 312' ' ' VAL . 17.2 m -47.37 -32.7 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 111.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.2 p -55.74 122.28 11.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.48 78.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.01 136.97 38.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -84.89 92.61 1.76 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.6 112.51 24.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.888 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 7.8 t70 63.62 52.94 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 33.3 p-80 45.91 27.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.451 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.8 mt -129.09 162.74 27.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -93.96 104.75 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 244' ' ' THR . 14.7 tp -78.81 140.72 38.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -122.92 145.82 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 243' ' ' VAL . 49.6 t -145.61 136.37 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -146.68 168.1 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 297' ' ' ILE . 75.8 m95 -81.06 122.29 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.903 0.382 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.0 m -140.77 124.6 17.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 28.1 pt -122.61 145.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 312' ' ' VAL . 42.9 ttt180 -107.92 151.88 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 312' ' ' VAL . 95.6 t -139.0 141.84 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 43.3 p -139.48 170.06 16.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 30.8 t-20 73.58 38.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 250' ' ' THR . 30.2 mt -90.48 -175.97 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 52.6 p -127.34 175.61 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.79 -14.41 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -95.33 12.99 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.472 HG21 HD22 ' A' ' 246' ' ' LEU . 51.4 m -119.02 109.34 15.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 251' ' ' ARG . 0.0 OUTLIER -112.13 176.88 4.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 252' ' ' GLU . 1.9 mp0 -49.42 -43.33 44.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -25.42 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.38 -28.31 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.51 -25.3 16.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -61.31 -30.17 70.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.69 -16.81 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.49 -38.75 33.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.754 ' HB2' HD11 ' A' ' 265' ' ' ILE . 56.5 m-85 -95.5 8.99 41.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.4 OUTLIER -75.07 -45.44 4.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.1 Cg_exo -47.98 -18.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.385 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -93.49 -32.16 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.11 -166.39 39.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.23 113.79 25.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.754 HD11 ' HB2' ' A' ' 259' ' ' PHE . 84.2 mt -68.09 145.09 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.498 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 39.4 t -93.95 -47.37 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -149.25 149.94 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.3 mt -130.99 104.88 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.5 t80 -98.87 136.2 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.72 127.98 39.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -64.13 129.17 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -134.59 150.44 50.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.98 177.77 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -112.09 -56.89 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.5 m -55.26 -53.19 59.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 8.6 t -92.08 -24.11 19.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 61.85 43.59 99.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.97 176.04 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 65.3 p -80.79 129.08 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -63.58 -72.9 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.39 33.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 21.5 p90 -165.74 151.92 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.844 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.32 165.06 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -131.59 111.16 11.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.1 mp -97.02 124.37 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 18.7 m -101.04 115.47 30.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.7 m-85 -88.22 176.29 7.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 264' ' ' SER . 14.5 m-70 -94.65 -43.76 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -114.32 168.55 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.4 ttt85 -82.93 -18.8 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -83.55 -29.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 3.5 m-20 -83.22 -27.11 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -75.09 -37.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.27 -37.84 68.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -48.28 -42.72 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.5 -70.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.554 HD12 ' NE1' ' A' ' 314' ' ' TRP . 82.6 mt -35.08 -34.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -67.01 -48.04 69.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.088 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.8 -59.85 2.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.1 m -41.81 -36.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.4 p -55.35 119.84 6.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.07 23.26 74.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -76.57 153.2 35.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.5 76.09 0.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 120.6 38.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 3.0 t70 54.57 49.63 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.494 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 24.2 p-80 47.62 29.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 309' ' ' ILE . 38.0 mt -129.85 164.64 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -94.93 102.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.404 HD11 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -72.08 130.94 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.31 129.67 55.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 243' ' ' VAL . 55.9 t -133.78 143.27 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -156.02 161.26 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.554 ' NE1' HD12 ' A' ' 297' ' ' ILE . 72.3 m95 -71.28 122.29 19.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.878 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.861 0.362 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.7 m -129.37 142.91 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 38.2 pt -138.81 140.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 69.9 ttt180 -100.56 147.35 26.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 312' ' ' VAL . 55.8 t -129.58 145.48 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.7 p -143.27 165.54 27.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.171 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 26.5 t-20 73.32 39.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 250' ' ' THR . 49.9 mt -89.98 -176.95 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 m -135.56 -175.95 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -74.8 -50.11 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.16 -10.83 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 246' ' ' LEU . 50.5 m -98.62 97.75 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -109.79 178.98 4.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.6 -41.62 31.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -67.61 -23.05 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.77 -30.32 36.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.8 mt -88.29 -24.06 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.4 tt0 -60.6 -34.5 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -94.35 -11.68 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.541 HD13 ' HE2' ' A' ' 305' ' ' TYR . 31.6 tp -80.62 -39.7 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.948 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 265' ' ' ILE . 64.7 m-85 -98.18 12.04 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 tpt180 -79.15 -45.11 1.72 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.93 -17.23 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.621 2.214 . . . . 0.0 112.393 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.9 m-85 -95.39 -31.06 13.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.79 -166.13 39.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.1 m -90.34 108.73 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 259' ' ' PHE . 61.4 mt -63.32 139.11 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.511 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.8 t -89.67 -43.34 10.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -148.93 153.17 37.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 85.1 mt -133.64 104.7 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -99.66 140.9 33.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 283' ' ' ALA . 35.7 tp -133.01 125.34 29.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.516 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.41 125.55 28.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -129.08 157.7 41.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.49 -178.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -116.64 -32.32 5.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 36.7 m -80.37 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 276' ' ' THR . 1.9 t -81.8 -36.7 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.159 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.04 19.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -96.73 -177.23 3.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 86.4 p -77.42 114.98 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -52.85 -54.02 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 141.97 -6.37 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.516 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 13.6 p90 -135.26 157.2 47.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.864 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.706 ' HB2' HD12 ' A' ' 270' ' ' LEU . . . -146.43 163.55 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.7 m-85 -128.74 114.03 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -98.75 140.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.096 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.99 142.12 46.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.17 -176.31 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 8.9 m-70 -104.79 -31.58 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -129.28 148.03 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -63.71 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.837 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.86 -60.24 2.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.69 -28.41 67.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.19 78.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.4 -23.95 57.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -61.99 -37.65 85.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.8 -69.0 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.54 HD12 ' NE1' ' A' ' 314' ' ' TRP . 85.3 mt -35.88 -35.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.3 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.05 -60.9 2.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 312' ' ' VAL . 11.4 m -41.67 -42.41 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.119 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 300' ' ' VAL . 36.7 p -53.59 127.91 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.06 68.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -83.97 134.25 34.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.63 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.541 ' HE2' HD13 ' A' ' 258' ' ' LEU . 1.5 t80 -105.24 115.55 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.5 m-20 57.33 54.05 7.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 36.7 p-80 48.76 36.92 8.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 309' ' ' ILE . 90.9 mt -138.59 168.41 19.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -101.25 97.26 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.23 149.27 50.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -133.29 132.13 41.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 243' ' ' VAL . 97.8 t -139.54 143.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.02 158.95 38.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.54 ' NE1' HD12 ' A' ' 297' ' ' ILE . 81.4 m95 -69.08 125.51 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.066 179.933 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.89 0.376 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 13.4 m -140.6 131.63 26.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 40.6 pt -127.6 141.08 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt180 -99.57 153.46 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 312' ' ' VAL . 68.7 t -139.64 135.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 72.6 p -132.24 163.19 29.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.4 t-20 71.59 43.77 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.2 mt -91.11 177.21 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.5 t -122.91 146.47 47.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -48.18 -49.62 32.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.11 -24.92 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.8 m -82.16 97.01 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -104.69 179.26 4.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -49.49 -56.22 10.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -55.51 -25.24 36.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.97 -31.23 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -26.06 24.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.5 tt0 -59.5 -31.71 69.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -92.87 -8.59 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 26.6 tp -88.05 -39.7 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.849 ' HB2' HD11 ' A' ' 265' ' ' ILE . 79.1 m-85 -98.15 11.19 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -76.86 -45.35 2.99 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.8 Cg_exo -47.97 -17.93 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.365 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.0 m-85 -94.55 -33.79 12.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.85 -167.1 40.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 19.8 m -90.53 110.33 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.6 mt -66.24 142.49 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.564 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.4 t -92.57 -46.83 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -148.17 139.64 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.452 ' CG1' HG21 ' A' ' 265' ' ' ILE . 38.4 mt -120.98 102.94 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.505 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.2 t80 -93.12 143.03 26.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 24.2 tp -136.44 115.59 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.446 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.52 126.46 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.442 ' HE3' HD23 ' A' ' 270' ' ' LEU . 49.4 mttp -130.97 174.41 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.429 ' HA ' ' HZ3' ' A' ' 280' ' ' LYS . 7.7 t70 -103.73 177.32 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.83 -54.74 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 26.9 m -55.14 -72.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.137 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 278' ' ' GLN . 14.8 t -77.5 -32.26 54.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 73.97 39.37 46.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.548 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 276' ' ' THR . 90.9 mt-30 -103.64 169.65 8.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 45.7 m -70.94 115.61 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 273' ' ' ASP . 19.3 mmtm -48.21 -54.26 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.57 2.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 12.4 p90 -123.53 155.27 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.51 165.29 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.46 116.7 16.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -104.58 125.41 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.3 m -101.57 119.13 38.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 14.7 m-85 -91.05 175.71 6.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.9 m-70 -92.34 -44.43 8.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -110.99 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -87.57 -20.81 25.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.58 -24.18 31.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.51 -34.44 27.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -70.44 -35.84 73.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.4 70.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -48.63 -44.07 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.83 -65.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 314' ' ' TRP . 69.1 mt -34.48 -32.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -50.09 23.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -62.51 3.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 312' ' ' VAL . 16.1 m -46.59 -36.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.82 0.343 . . . . 0.0 111.125 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.8 t -57.54 114.25 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.77 26.24 56.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -82.62 153.53 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.29 71.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.37 129.55 36.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.376 . . . . 0.0 110.913 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.5 t70 45.25 52.79 8.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.547 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 44.67 31.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.41 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.5 mt -131.33 163.3 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -92.98 101.39 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.3 tp -76.42 139.01 40.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -119.72 140.13 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 243' ' ' VAL . 94.9 t -143.1 143.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -152.11 174.24 13.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.602 ' CD1' HD13 ' A' ' 297' ' ' ILE . 68.9 m95 -80.53 125.61 30.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.863 0.363 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.4 m -144.0 131.11 20.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 297' ' ' ILE . 29.1 pt -126.0 143.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.0 ttt180 -101.81 151.84 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 312' ' ' VAL . 41.6 t -134.71 139.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 46.9 p -141.85 165.32 27.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.9 t-20 68.42 50.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -92.39 -175.64 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 250' ' ' THR . 5.6 t -130.42 140.24 50.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.406 ' OE1' ' C ' ' A' ' 248' ' ' GLU . 0.6 OUTLIER -47.19 -21.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.69 22.36 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 246' ' ' LEU . 90.7 m -126.41 114.2 17.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.68 179.94 3.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.88 -44.77 70.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -61.18 -28.22 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.69 -33.3 64.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.467 HD22 ' HE1' ' A' ' 259' ' ' PHE . 43.0 mt -84.17 -28.72 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 24.0 tt0 -57.94 -42.28 84.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -83.71 -16.02 46.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 259' ' ' PHE . 14.8 tp -80.81 -38.07 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' A' ' 265' ' ' ILE . 80.2 m-85 -99.15 12.01 37.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 ttt180 -77.92 -45.15 2.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.598 0.714 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.18 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.7 m-85 -92.78 -35.23 13.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.24 -163.15 36.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -91.62 109.92 21.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.4 mt -67.95 138.9 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.4 t -88.69 -42.03 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -151.56 154.72 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 62.5 mt -133.76 101.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.48 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.4 t80 -91.4 141.56 28.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 52.9 tp -135.4 127.44 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -75.11 114.86 14.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -121.68 150.91 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.25 173.23 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 -29.77 7.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.3 m -78.59 -66.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.417 HG21 ' OE1' ' A' ' 278' ' ' GLN . 11.4 t -89.01 -13.52 38.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.25 95.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.417 ' OE1' HG21 ' A' ' 276' ' ' THR . 84.7 mt-30 -102.35 157.22 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 48.0 t -58.21 115.08 2.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -51.63 -59.17 4.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.68 -13.24 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 31.6 p90 -129.03 157.2 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.68 172.72 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -139.14 116.43 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.5 mp -103.63 132.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.43 142.02 35.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -116.23 168.35 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.0 m-70 -85.55 -35.07 21.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 288' ' ' HIS . 24.5 mmt-85 -120.82 167.27 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -78.54 -32.9 48.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.12 -54.53 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -53.93 -32.79 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.52 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -70.55 -46.0 64.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -50.78 -39.04 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.31 -69.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 241' ' ' ILE . 72.8 mt -36.91 -34.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.5 55.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -80.03 -59.12 2.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.497 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 296' ' ' ALA . 28.0 m -53.97 -20.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.4 t -63.03 107.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.92 38.2 23.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -88.97 146.32 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.04 74.22 2.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -95.13 136.59 35.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 35.1 t70 42.41 53.98 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.507 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 37.8 p-80 46.05 39.03 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 309' ' ' ILE . 95.1 mt -146.36 168.48 21.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.3 mp -95.55 102.79 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.64 139.96 56.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -118.52 127.82 53.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 242' ' ' ARG . 44.8 t -140.72 141.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -162.22 149.96 14.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.52 ' HH2' ' HB3' ' A' ' 293' ' ' ALA . 96.1 m95 -45.01 121.4 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 179.891 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.859 0.361 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.9 m -136.02 143.52 44.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 297' ' ' ILE . 42.5 pt -137.43 141.88 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -105.57 147.71 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 312' ' ' VAL . 70.5 t -129.71 146.67 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 69.8 p -144.16 163.56 33.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 69.05 40.88 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 34.5 mt -85.33 -175.42 5.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 t -125.52 161.31 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.57 -9.36 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.55 -8.97 39.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 86.8 m -101.79 104.13 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -104.05 179.19 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -52.79 -51.52 60.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.4 t -62.77 -19.79 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.34 -26.92 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.87 -33.59 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.512 ' NE2' HD12 ' A' ' 265' ' ' ILE . 22.8 tp60 -52.49 -34.25 48.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -87.75 -20.44 26.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.63 -36.79 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.7 m-85 -98.01 11.72 36.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.585 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 2.4 ttt-85 -79.34 -45.24 1.66 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.37 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.3 m-85 -93.39 -33.76 13.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.16 -160.36 33.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 8.3 m -90.69 119.11 30.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 259' ' ' PHE . 67.0 mt -73.86 145.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -97.96 -43.71 6.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.436 ' HB2' ' NH1' ' A' ' 267' ' ' ARG . 20.2 ttm105 -150.43 149.98 30.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 54.2 mt -132.97 100.09 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -95.59 140.86 29.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.2 tp -132.93 121.7 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -68.79 129.87 41.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -136.98 162.16 34.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.58 178.22 7.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -108.51 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 78.0 m -73.02 -65.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 15.4 t -95.65 -18.87 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.91 37.54 92.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -91.96 160.23 15.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 28.0 t -56.0 121.16 8.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -64.88 -54.46 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.56 1.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.45 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 32.6 p90 -128.61 153.86 46.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 110.857 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.46 173.08 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.6 112.4 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -100.83 138.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -111.27 143.91 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 13.0 m-85 -121.39 167.25 12.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 264' ' ' SER . 6.2 m-70 -91.06 -44.12 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -104.63 155.39 18.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -78.1 -11.22 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -89.49 -41.37 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.62 -35.58 77.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.52 -43.77 88.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.6 79.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -49.91 -38.63 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.906 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.53 -63.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.514 HD11 HG22 ' A' ' 241' ' ' ILE . 95.5 mt -35.97 -33.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.75 -55.43 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -54.98 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 296' ' ' ALA . 15.4 m -54.6 -30.94 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 111.161 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.0 t -61.66 106.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 84.77 21.12 56.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.01 141.93 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -85.82 93.08 1.82 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.53 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.2 OUTLIER -113.26 109.73 19.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.372 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 30.8 t70 67.74 53.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.523 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 17.1 p-80 47.4 26.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.51 162.08 30.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -93.09 98.02 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.487 HD11 ' CG1' ' A' ' 243' ' ' VAL . 32.3 tp -62.85 138.79 58.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -119.31 132.15 55.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 243' ' ' VAL . 87.0 t -137.22 154.06 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 312' ' ' VAL . 8.7 pt-20 -165.24 156.29 14.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.502 ' CD1' HD13 ' A' ' 297' ' ' ILE . 66.2 m95 -57.74 136.33 56.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.834 0.35 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 7.1 m -136.63 144.51 44.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.1 pt -144.35 141.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.462 ' HB2' ' CE2' ' A' ' 284' ' ' PHE . 69.4 ttt180 -100.56 149.03 24.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 312' ' ' VAL . 98.0 t -132.06 142.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.7 p -135.14 174.52 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 3.2 m-20 64.18 48.13 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 250' ' ' THR . 19.2 mt -103.4 168.76 8.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.3 p -118.87 154.94 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.86 -46.57 60.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -57.36 -19.25 21.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.682 HG21 HD22 ' A' ' 246' ' ' LEU . 26.2 m -90.08 98.93 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -106.42 -175.74 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -55.56 -55.91 26.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.8 t -55.21 -20.02 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.89 -28.69 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 mt -88.66 -27.26 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.475 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -61.92 -31.12 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.53 -18.14 28.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.59 -38.56 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.783 ' HB2' HD11 ' A' ' 265' ' ' ILE . 71.8 m-85 -95.68 11.59 32.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 tpt180 -78.31 -45.26 2.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.598 0.714 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.5 Cg_exo -47.96 -17.16 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.415 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -93.31 -31.71 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.98 36.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -90.02 109.52 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.3 mt -66.07 148.54 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.434 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.0 t -95.16 -43.42 8.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -154.43 149.08 26.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 72.6 mt -134.59 100.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.2 t80 -92.83 151.72 19.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.66 HD23 ' HE3' ' A' ' 272' ' ' LYS . 51.8 tp -140.54 145.99 37.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.683 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -97.9 132.01 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.66 ' HE3' HD23 ' A' ' 270' ' ' LEU . 5.6 mptt -133.45 162.78 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -91.38 174.12 7.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -113.38 -52.94 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.7 m -60.38 -54.81 41.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -89.39 -18.96 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.05 82.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 279' ' ' SER . 32.1 mt-30 -118.67 126.7 52.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 278' ' ' GLN . 2.2 m -36.53 128.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -57.95 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 154.79 33.93 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.683 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 43.8 p90 -162.7 148.33 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -142.29 173.91 11.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 242' ' ' ARG . 71.1 m-85 -136.02 113.02 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -98.25 124.84 51.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -106.46 115.16 29.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.7 m-85 -88.73 -180.0 6.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.6 m-70 -95.53 -38.72 10.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.84 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.03 167.53 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 38.4 ttp85 -73.53 -32.87 64.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.26 -64.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -48.8 -35.95 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.45 -42.86 74.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.29 85.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.9 mtp85 -47.05 -41.82 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.601 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.5 mt -35.71 -32.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -68.98 -47.31 65.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.15 -62.2 2.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.4 m -41.26 -37.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.7 p -56.2 112.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.4 32.51 38.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.441 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -89.71 145.51 25.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -95.81 78.79 0.8 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.62 134.66 39.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 2.1 t70 44.94 52.88 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.462 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 34.0 p-80 45.59 33.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -135.03 167.4 21.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.2 mp -95.52 97.88 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.7 tp -73.67 138.78 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.48 144.89 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 243' ' ' VAL . 29.6 t -143.75 145.5 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.99 171.0 17.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.601 ' CD1' HD13 ' A' ' 297' ' ' ILE . 57.9 m95 -79.25 131.78 36.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 287' ' ' PHE . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.1 m -138.61 138.27 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 297' ' ' ILE . 43.0 pt -137.28 140.15 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 14.5 ttt85 -100.96 149.23 24.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 312' ' ' VAL . 84.0 t -136.65 143.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 62.1 p -138.2 166.31 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 22.5 t-20 74.05 38.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.75 177.08 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -130.94 166.02 21.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -70.68 -16.54 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.98 9.83 11.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -132.94 111.39 10.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 -176.33 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -48.77 -59.1 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -54.66 -26.7 34.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -76.97 -30.67 56.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.69 -29.83 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.475 ' O ' ' NE2' ' A' ' 256' ' ' GLN . 21.9 tp60 -56.25 -29.48 61.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.3 -15.65 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.3 tp -84.31 -37.88 21.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.583 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.7 m-85 -96.68 11.31 35.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.594 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -79.7 -45.24 1.56 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.712 . . . . 0.0 110.883 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.88 -17.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.08 -159.9 33.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.92 135.05 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 0.0 110.875 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.494 HG21 HG12 ' A' ' 268' ' ' ILE . 54.6 mt -93.61 138.88 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 48.3 t -92.6 -48.76 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.7 tpp180 -143.38 148.53 36.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 265' ' ' ILE . 45.9 mt -132.96 108.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -95.62 144.07 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.0 tp -131.08 119.35 21.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.57 113.44 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -129.14 146.66 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.29 -177.87 0.75 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -122.69 -16.65 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 92.0 m -102.23 -50.44 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -95.41 -9.05 33.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.64 56.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -99.5 178.57 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 27.6 p -89.29 121.84 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -62.13 -74.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 157.94 33.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 27.6 p90 -166.13 148.34 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -139.82 165.87 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.579 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 84.8 m-85 -133.18 115.66 15.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -101.99 131.82 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -109.05 113.05 25.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . 13.5 m-85 -84.48 177.11 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 13.6 m-70 -93.51 -30.54 14.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -122.8 171.37 9.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -83.72 -28.61 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.53 -56.57 5.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 292' ' ' ASP . 1.0 OUTLIER -53.18 -35.12 59.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.828 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.82 90.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.43 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -48.18 -42.59 30.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.95 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 314' ' ' TRP . 86.3 mt -38.31 -32.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.49 -41.89 62.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -84.85 -63.92 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 259' ' ' PHE . 14.0 m -40.55 -37.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 111.162 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 75.4 p -57.04 128.59 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.94 19.06 69.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.472 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -80.89 153.14 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.36 94.27 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.68 123.62 50.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.892 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 10.6 t70 56.4 49.39 15.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 34.8 p-80 48.6 35.62 6.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 309' ' ' ILE . 71.8 mt -138.5 167.41 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -95.48 103.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -77.12 131.22 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.52 138.98 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 243' ' ' VAL . 99.0 t -142.87 145.73 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -163.51 149.11 11.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.558 ' CD1' HD13 ' A' ' 297' ' ' ILE . 92.5 m95 -52.38 120.0 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.869 0.366 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.8 m -137.46 145.15 42.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 297' ' ' ILE . 17.0 pt -141.94 145.11 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.54 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 38.0 ttt180 -105.47 156.36 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 312' ' ' VAL . 97.8 t -140.47 138.71 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 76.0 p -132.69 161.99 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.8 t30 74.53 48.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 250' ' ' THR . 31.2 mt -103.67 146.1 29.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.423 ' HB2' ' CG ' ' A' ' 306' ' ' ASP . 1.3 t -85.52 156.94 20.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.13 -6.74 18.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.6 9.34 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 246' ' ' LEU . 54.3 m -115.6 106.8 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -105.88 174.47 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -47.61 -59.79 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.2 t -54.14 -21.86 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.8 -30.47 40.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.7 mt -90.4 -26.63 19.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.2 pt20 -56.19 -26.33 50.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -91.54 -18.01 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.549 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.2 tp -82.12 -36.58 27.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 258' ' ' LEU . 68.9 m-85 -98.47 11.7 37.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -79.39 -45.3 1.65 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.893 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.2 Cg_exo -47.93 -17.59 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -93.58 -32.18 14.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.16 -166.14 39.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.485 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.9 m -90.99 106.86 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.9 mt -59.94 150.52 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.547 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.0 t -98.82 -46.52 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 8.4 tpp180 -149.87 146.23 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.436 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 47.1 mt -126.55 106.92 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -99.04 149.69 22.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 56.0 tp -140.75 129.08 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.65 110.51 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -131.85 135.9 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -76.57 133.12 39.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -85.32 -37.24 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 46.5 m -64.81 -34.67 78.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 7.7 p -105.4 -50.41 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.55 28.59 6.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -114.28 172.79 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.7 t -93.68 113.63 25.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 282' ' ' PHE . 34.4 mmtt -42.58 -69.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 149.18 32.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 7.6 p90 -166.32 161.39 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.48 165.54 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 74.2 m-85 -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -94.81 129.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.3 m -106.62 118.47 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -92.24 179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.1 m-70 -95.99 -35.88 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -123.69 165.05 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -71.11 -37.96 72.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -60.38 -69.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -44.72 -34.32 2.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.04 85.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.2 77.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.086 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -50.48 -40.95 52.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -66.11 -66.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 312' ' ' VAL . 84.9 mt -38.83 -40.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.59 19.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -71.04 -65.25 2.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 312' ' ' VAL . 7.2 m -39.93 -42.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.48 ' N ' HG23 ' A' ' 300' ' ' VAL . 10.5 t -49.4 116.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.21 62.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -78.63 155.27 29.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.12 76.9 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 0.4 OUTLIER -93.31 130.25 39.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.582 ' OD1' HD12 ' A' ' 308' ' ' LEU . 0.8 OUTLIER 47.19 54.13 9.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.496 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 29.0 p-80 48.46 33.18 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.582 HD12 ' OD1' ' A' ' 306' ' ' ASP . 62.0 mt -136.4 164.05 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -95.44 95.18 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.74 134.65 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -118.21 130.8 56.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 243' ' ' VAL . 91.7 t -130.6 142.29 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -145.35 172.44 13.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.416 ' CD1' HD13 ' A' ' 297' ' ' ILE . 59.0 m95 -81.47 125.18 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.882 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.893 0.378 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 315' ' ' ALA . 14.5 m -132.76 143.46 49.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 297' ' ' ILE . 27.6 pt -136.98 145.98 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -107.14 147.7 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 312' ' ' VAL . 54.1 t -129.45 140.46 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.1 p -138.09 165.8 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 21.1 t30 66.21 48.26 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.667 HD22 HG21 ' A' ' 250' ' ' THR . 22.2 mt -93.83 177.88 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.5 t -115.69 159.08 21.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.74 -14.18 60.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.22 19.9 15.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.667 HG21 HD22 ' A' ' 246' ' ' LEU . 49.9 m -118.98 98.57 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -100.48 177.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -52.91 -42.57 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.6 t -68.1 -25.39 65.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 -23.75 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.96 -32.57 12.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.3 pt20 -52.09 -33.91 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.56 -15.61 36.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.49 -38.72 25.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' A' ' 265' ' ' ILE . 95.6 m-85 -95.48 11.33 33.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.614 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 7.9 tpt180 -79.03 -43.97 1.74 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.2 Cg_exo -47.93 -18.57 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.306 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 30.4 m-85 -94.76 -34.39 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.98 -161.55 34.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -94.28 117.77 30.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 259' ' ' PHE . 54.5 mt -71.57 144.98 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.6 t -95.27 -41.9 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -152.07 149.71 29.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 52.1 mt -130.68 105.6 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -98.46 141.46 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.0 tp -132.32 131.81 42.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -71.57 125.59 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -137.01 152.14 49.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.95 -178.22 5.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -109.71 -54.11 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 62.5 m -52.49 -72.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 2.0 t -76.57 -21.42 55.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 63.56 35.72 92.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -108.25 168.5 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 42.3 t -72.4 129.35 38.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -63.38 -74.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.86 32.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 8.2 p90 -165.96 159.75 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -150.97 165.13 34.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -132.08 116.06 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -99.48 125.85 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 16.4 m -102.21 116.93 33.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.9 m-85 -88.71 -178.61 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.3 m-70 -97.22 -37.98 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -126.37 139.98 52.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -51.23 -28.23 11.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -66.0 -68.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.0 -30.11 9.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . . . -67.8 -38.24 83.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.78 -35.31 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -50.74 -41.04 56.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.0 -66.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.992 HD11 HG22 ' A' ' 241' ' ' ILE . 82.9 mt -38.2 -34.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -76.15 -51.12 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -69.53 -59.56 5.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 312' ' ' VAL . 15.3 m -49.38 -26.24 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.6 t -62.42 109.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.31 27.21 31.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -83.11 154.7 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -97.06 78.94 0.68 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.22 120.77 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.1 t70 51.16 52.62 14.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 27.9 p-80 48.74 26.98 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 66.4 mt -129.55 164.0 24.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -94.96 98.0 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -120.31 138.31 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 243' ' ' VAL . 89.4 t -146.41 151.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.089 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.02 152.1 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.465 ' HZ2' ' HB2' ' A' ' 294' ' ' ALA . 78.1 m95 -55.3 126.11 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 240' ' ' THR . . . . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.06 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.849 0.357 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.9 m -141.85 135.7 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 41.1 pt -132.77 142.28 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -102.21 149.02 24.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 312' ' ' VAL . 94.7 t -135.9 139.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 53.1 p -138.55 167.63 21.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 19.7 t-20 73.13 41.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.511 HD22 HG21 ' A' ' 250' ' ' THR . 31.0 mt -92.27 -175.16 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -125.49 170.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.87 -6.7 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.98 22.14 16.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.511 HG21 HD22 ' A' ' 246' ' ' LEU . 99.6 m -131.11 96.43 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.56 ' CG ' HG22 ' A' ' 253' ' ' THR . 11.7 ptt180 -107.09 -177.38 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -45.7 -50.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . 0.56 HG22 ' CG ' ' A' ' 251' ' ' ARG . 1.4 t -59.51 -28.6 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.95 -27.03 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.06 -20.35 19.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.418 ' HB2' HD12 ' A' ' 268' ' ' ILE . 11.5 tt0 -64.94 -33.81 76.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -93.2 -11.68 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.458 HD22 ' HE2' ' A' ' 305' ' ' TYR . 28.7 tp -82.78 -41.22 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.601 ' CE2' HG11 ' A' ' 300' ' ' VAL . 64.2 m-85 -96.76 11.91 33.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.7 ttt-85 -77.52 -45.32 2.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.729 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.87 -17.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -92.74 -31.21 15.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.72 -164.13 37.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 31.3 m -91.12 107.43 19.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 259' ' ' PHE . 82.8 mt -61.35 141.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.531 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.9 t -94.05 -45.81 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -150.27 149.17 29.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.525 ' CG1' HG21 ' A' ' 265' ' ' ILE . 46.9 mt -133.47 113.2 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.103 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 5.1 t80 -104.12 147.39 27.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.5 tp -134.74 128.9 33.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -72.99 129.45 38.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -135.43 175.59 9.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.53 170.67 8.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -113.43 -5.54 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.5 m -101.31 -35.9 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -121.22 -10.52 8.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.71 84.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -104.99 163.22 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 15.0 m -69.66 142.16 53.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -82.05 -74.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 166.83 31.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 11.4 p90 -165.49 150.39 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.888 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 162.55 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -127.23 117.9 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -103.26 129.1 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -107.9 124.89 50.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.17 179.96 4.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.5 m-70 -93.78 -36.34 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -124.25 179.76 4.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.87 -17.56 29.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -76.52 -59.36 2.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.11 -24.77 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.27 62.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.73 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -49.66 -42.05 44.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.847 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.14 -62.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.555 HD12 ' NE1' ' A' ' 314' ' ' TRP . 71.3 mt -39.92 -37.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.97 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -82.47 -59.46 2.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 296' ' ' ALA . 6.8 m -49.41 -30.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 p -62.97 120.86 12.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.05 20.34 79.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.18 156.39 29.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -103.52 76.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.458 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -99.06 120.95 40.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.872 0.368 . . . . 0.0 110.954 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 56.79 49.38 14.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.585 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 18.1 p-80 45.83 31.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 309' ' ' ILE . 34.5 mt -132.03 166.86 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -95.41 102.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 243' ' ' VAL . 15.4 tp -71.81 134.62 46.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.67 130.29 56.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 243' ' ' VAL . 97.6 t -136.19 144.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.48 157.77 30.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.555 ' NE1' HD12 ' A' ' 297' ' ' ILE . 80.1 m95 -62.95 123.63 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.888 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.2 m -142.89 145.01 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 37.6 pt -140.0 142.18 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 62.5 ttt180 -105.6 153.81 21.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 312' ' ' VAL . 91.4 t -138.3 142.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 61.6 p -138.16 167.5 21.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 73.59 43.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.78 177.57 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 85.3 p -121.54 -175.16 3.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.77 -1.86 58.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.24 18.8 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.508 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 53.0 m -127.61 111.56 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 179.08 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -52.1 -38.97 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -68.1 -18.91 64.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -86.6 -26.19 24.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -91.61 -22.76 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -62.31 -35.32 78.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -92.45 -10.73 36.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 259' ' ' PHE . 25.9 tp -85.79 -34.51 21.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.603 ' CE2' HG11 ' A' ' 300' ' ' VAL . 77.6 m-85 -104.69 11.46 34.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.581 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.7 tpt180 -80.25 -45.68 1.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.6 Cg_exo -47.95 -20.43 2.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.5 m-85 -88.84 -31.26 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.97 34.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 18.7 m -91.39 118.66 30.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.02 136.25 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.3 t -87.32 -42.18 13.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -154.9 160.0 40.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.71 116.06 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -113.16 148.88 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.736 HD23 ' HE3' ' A' ' 272' ' ' LYS . 61.0 tp -139.87 127.32 21.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.59 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -73.2 123.45 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.736 ' HE3' HD23 ' A' ' 270' ' ' LEU . 51.3 mttt -136.15 146.03 46.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.17 177.22 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -114.7 -61.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.7 m -53.02 -41.41 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 t -102.01 -22.58 14.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.64 32.8 84.67 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -109.02 140.12 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 47.2 t -54.86 124.67 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -55.1 -74.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.01 33.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 36.5 p90 -165.97 146.46 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.5 164.18 27.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.502 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.2 m-85 -131.06 112.63 13.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -100.13 127.82 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 7.3 m -102.14 120.77 40.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.5 m-85 -96.29 177.49 5.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 264' ' ' SER . 10.9 m-70 -96.5 -47.95 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -112.14 164.03 13.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 13.4 ttp-105 -71.75 -31.58 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.6 -61.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.99 -37.17 52.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -68.04 -39.13 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.65 -37.41 70.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -49.25 -42.91 42.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -63.49 -67.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.563 HD13 ' CD1' ' A' ' 314' ' ' TRP . 85.8 mt -36.03 -32.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.127 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -70.98 -45.88 63.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -79.46 -64.96 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.5 m -40.01 -36.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.894 0.378 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p -61.37 112.37 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.88 17.65 57.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -79.51 157.87 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.907 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.93 82.28 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.508 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.3 OUTLIER -99.39 129.74 45.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.449 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 0.5 OUTLIER 47.77 53.69 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 31.2 p-80 45.61 39.53 5.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 77.5 mt -143.53 168.19 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.7 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.19 138.04 51.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.27 132.18 56.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 243' ' ' VAL . 79.4 t -137.06 143.4 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -153.53 161.89 41.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.563 ' CD1' HD13 ' A' ' 297' ' ' ILE . 65.4 m95 -65.25 125.27 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.862 0.363 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.4 m -139.36 144.05 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 297' ' ' ILE . 34.4 pt -138.62 144.06 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.549 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt-85 -100.79 152.84 20.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -138.77 140.52 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.418 ' O ' HD12 ' A' ' 310' ' ' LEU . 70.8 p -133.65 169.47 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.62 53.12 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 19.8 mt -103.53 166.38 10.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.0 p -111.69 155.33 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.28 -5.82 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 19.59 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.0 m -131.1 99.62 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -103.57 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -51.04 -40.79 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . 0.469 HG23 ' OD1' ' A' ' 254' ' ' ASP . 11.7 t -67.95 -30.89 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 253' ' ' THR . 0.9 OUTLIER -76.72 -28.53 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.74 -26.56 20.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.56 -32.29 73.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.66 -15.13 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.79 -35.72 20.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.6 m-85 -100.92 8.57 43.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.624 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.6 OUTLIER -80.86 -42.86 1.23 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.568 0.699 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.5 Cg_exo -47.91 -17.98 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.2 m-85 -92.84 -31.8 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.15 36.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.556 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 49.0 m -91.28 116.33 28.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 34.4 mt -73.89 147.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.2 t -98.68 -43.14 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -151.57 153.89 35.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 89.1 mt -138.46 122.2 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.5 t80 -112.6 149.54 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.8 tp -135.49 127.43 29.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -69.42 121.59 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -128.74 150.59 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.21 -176.74 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -111.2 -62.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.9 m -47.22 -69.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 278' ' ' GLN . 10.2 t -77.37 -34.01 55.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.76 39.46 39.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.411 ' H ' HG23 ' A' ' 276' ' ' THR . 21.6 mt-30 -111.21 -176.9 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 35.1 t -80.44 126.04 30.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -66.68 -74.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.85 32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.464 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.665 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 19.8 p90 -166.02 151.26 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.923 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.83 165.19 28.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -129.42 116.56 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.6 mp -105.8 131.89 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -110.92 121.32 45.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.7 m-85 -94.63 -178.87 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.567 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 14.3 m-70 -95.25 -35.91 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . 0.437 ' NH1' ' OD2' ' A' ' 292' ' ' ASP . 18.0 mtt85 -124.68 169.45 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -80.71 -23.48 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.5 -46.17 27.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 289' ' ' ARG . 15.7 m-20 -67.15 -35.28 79.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.37 -37.28 77.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.82 77.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -48.65 -42.63 35.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.85 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.8 mt -35.42 -37.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.95 -54.58 17.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -67.05 -66.97 2.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 312' ' ' VAL . 30.0 m -42.97 -37.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 1.7 t -50.81 113.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.47 24.85 60.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -86.3 137.78 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.41 97.06 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 116.88 30.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 14.9 t70 63.13 53.41 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 28.7 p-80 48.8 26.61 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 309' ' ' ILE . 35.1 mt -129.8 165.82 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -97.98 101.1 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 244' ' ' THR . 14.0 tp -73.32 137.65 44.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.5 150.69 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 243' ' ' VAL . 48.5 t -149.1 142.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.74 153.22 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.527 ' CD1' HD13 ' A' ' 297' ' ' ILE . 83.5 m95 -61.79 125.95 25.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.901 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.884 0.373 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 65.1 m -143.08 140.19 30.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 297' ' ' ILE . 30.0 pt -138.81 140.97 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.479 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 55.8 ttt180 -103.36 146.94 27.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 312' ' ' VAL . 89.9 t -132.74 142.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 74.3 p -136.93 167.1 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 72.28 43.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.96 176.94 6.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.401 ' CB ' ' CG ' ' A' ' 306' ' ' ASP . 15.9 t -124.63 151.99 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -54.74 -28.38 48.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.75 18.85 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 89.5 m -132.67 98.07 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 253' ' ' THR . 7.5 ptt180 -109.3 -174.41 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -45.57 -62.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 251' ' ' ARG . 5.2 t -46.89 -34.99 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.02 -31.15 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.4 mt -86.33 -25.79 25.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 25.5 tt0 -62.72 -35.9 81.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.56 -25.65 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 305' ' ' TYR . 14.2 tp -74.94 -39.52 61.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.713 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.0 m-85 -95.96 12.02 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -77.82 -45.37 2.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.607 0.717 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.93 -17.6 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.349 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 40.0 m-85 -91.02 -40.01 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 171.27 -160.53 32.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.602 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.2 m -92.17 107.6 19.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.713 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.1 mt -64.86 143.05 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.566 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.3 t -91.85 -49.64 6.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -141.02 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 80.0 mt -134.99 101.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.5 t80 -92.66 142.77 27.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.639 HD23 ' CE ' ' A' ' 272' ' ' LYS . 53.8 tp -129.47 128.48 43.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.617 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.4 115.58 4.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.639 ' CE ' HD23 ' A' ' 270' ' ' LEU . 97.1 mttt -136.95 134.93 37.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.87 162.56 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 275' ' ' THR . 4.4 ptmt -100.37 -35.11 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 274' ' ' LYS . 93.7 m -74.95 -41.46 59.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 31.1 p -94.16 -38.55 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.23 43.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -136.18 179.26 6.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 39.9 m -85.59 109.1 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -48.92 -66.88 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 151.25 33.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.617 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 52.7 p90 -165.97 147.52 6.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -138.23 174.36 10.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.1 m-85 -139.88 115.13 9.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -101.37 124.05 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.9 m -102.71 112.25 24.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.1 m-85 -84.95 169.85 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -85.92 -39.89 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.37 173.19 6.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.92 -39.12 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.87 -61.59 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -49.87 -38.63 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -66.56 -45.98 77.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -48.33 -42.03 30.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.75 -71.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 301' ' ' SER . 87.4 mt -34.23 -42.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.27 81.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -76.28 -66.08 1.91 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.1 m -42.25 -43.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.483 ' N ' HG23 ' A' ' 300' ' ' VAL . 13.0 t -48.9 104.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 90.33 33.62 8.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -96.33 130.89 43.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -79.08 52.62 4.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -75.47 128.03 34.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 53.9 m-20 62.2 54.35 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.91 31.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 306' ' ' ASP . 82.9 mt -140.04 168.49 19.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.4 mp -89.58 97.96 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.14 140.15 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.92 144.47 48.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 243' ' ' VAL . 71.5 t -150.65 150.05 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -166.11 165.58 17.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.413 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 85.5 m95 -66.99 125.38 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.883 0.373 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.5 m -143.68 145.48 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 297' ' ' ILE . 30.8 pt -140.63 142.84 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 72.2 ttt180 -104.14 149.07 25.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 312' ' ' VAL . 93.4 t -134.74 142.29 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 282' ' ' PHE . 17.2 p -140.64 166.71 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 38.2 t-20 72.32 41.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 250' ' ' THR . 28.9 mt -92.11 169.6 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 306' ' ' ASP . 11.2 t -110.7 155.52 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.3 -28.92 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.89 22.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.548 HG21 HD22 ' A' ' 246' ' ' LEU . 93.3 m -127.92 96.77 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.77 ' HG3' HG22 ' A' ' 253' ' ' THR . 8.0 ptt180 -99.75 -174.33 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.06 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . 0.77 HG22 ' HG3' ' A' ' 251' ' ' ARG . 13.6 t -50.81 -28.07 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.19 -27.79 62.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.64 -32.45 13.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -52.72 -30.59 33.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.93 -25.02 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 305' ' ' TYR . 12.4 tp -77.0 -36.85 56.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 265' ' ' ILE . 84.8 m-85 -96.05 11.4 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.606 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.2 OUTLIER -79.64 -44.57 1.58 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 110.888 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.94 -19.12 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 39.5 m-85 -89.71 -40.09 12.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.33 -160.22 30.63 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -93.03 113.28 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 259' ' ' PHE . 39.9 mt -71.36 141.9 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.5 t -89.19 -46.89 8.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -147.55 156.49 42.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 53.6 mt -138.24 105.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -93.22 143.48 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.738 HD23 ' CE ' ' A' ' 272' ' ' LYS . 49.9 tp -127.74 132.8 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.603 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.91 113.31 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.738 ' CE ' HD23 ' A' ' 270' ' ' LEU . 86.8 mttt -136.31 125.79 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.42 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -110.78 -40.08 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.6 m -67.08 -73.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 277' ' ' GLY . 12.2 t -79.87 -43.21 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 276' ' ' THR . . . 88.52 38.24 7.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.441 ' H ' HG23 ' A' ' 276' ' ' THR . 6.5 mm100 -99.66 149.7 23.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 110.871 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 13.5 t -57.88 116.89 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -63.72 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.62 33.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 41.7 p90 -165.98 154.57 11.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -144.42 174.05 11.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 91.0 m-85 -139.37 111.78 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -95.69 123.65 47.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 67.9 m -100.38 114.18 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.729 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 12.2 m-85 -87.59 169.71 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -86.69 -40.87 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.37 173.91 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -77.91 -38.85 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.91 -62.04 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.21 -40.41 47.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.78 -46.28 79.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.72 99.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -47.35 -41.54 19.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.22 -70.91 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 241' ' ' ILE . 87.4 mt -34.44 -43.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.7 87.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -75.63 -66.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.509 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 296' ' ' ALA . 25.6 m -43.33 -42.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 10.7 t -47.92 108.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.66 31.4 18.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -94.96 135.37 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -81.21 52.86 4.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.574 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -74.98 129.61 37.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 0.0 110.908 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 58.1 m-20 62.07 54.19 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 38.23 30.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 306' ' ' ASP . 91.9 mt -141.41 169.63 17.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.36 101.93 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.32 149.52 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.85 127.41 43.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 243' ' ' VAL . 93.9 t -137.33 151.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -169.45 151.93 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -53.51 126.43 21.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.859 0.361 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 315' ' ' ALA . 91.2 m -135.15 150.7 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.23 144.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -107.38 152.15 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 99.0 t -137.11 138.02 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 60.8 p -133.27 165.29 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 16.6 t-20 73.77 49.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -98.52 176.33 5.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -123.75 -176.88 3.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.43 -5.14 58.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.8 19.57 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 246' ' ' LEU . 90.1 m -122.29 96.43 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -105.76 173.7 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -48.69 -42.61 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -23.38 66.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.99 -30.07 35.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.3 mt -86.59 -31.94 20.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.468 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 1.3 tm0? -54.75 -50.13 69.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.03 -19.03 60.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 305' ' ' TYR . 35.2 tp -80.16 -35.58 36.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 300' ' ' VAL . 59.6 m-85 -101.72 11.89 38.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -78.45 -45.21 2.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.587 0.708 . . . . 0.0 110.926 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.5 Cg_exo -48.03 -17.55 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.371 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.5 m-85 -91.41 -32.71 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.87 -162.93 36.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.25 106.25 18.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 268' ' ' ILE . 61.8 mt -61.44 143.41 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.519 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 31.5 t -94.1 -47.67 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -149.4 153.19 36.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 265' ' ' ILE . 74.5 mt -139.08 113.07 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.1 t80 -104.6 152.82 21.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 62.1 tp -133.14 128.44 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -66.64 121.42 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HE3' HD23 ' A' ' 270' ' ' LEU . 31.6 mttt -136.91 140.13 42.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.97 170.07 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.82 -42.15 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 97.2 m -74.67 -73.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.105 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 278' ' ' GLN . 12.9 t -70.2 -25.87 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.45 37.38 92.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.516 ' H ' HG23 ' A' ' 276' ' ' THR . 46.0 mm-40 -99.47 175.87 5.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.6 t -84.3 118.56 24.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -61.47 -74.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.57 34.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 22.8 p90 -165.55 151.28 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.3 169.04 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -134.58 116.06 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.2 mp -104.29 134.55 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.9 t -106.27 144.1 33.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 18.7 m-85 -119.91 169.96 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 5.7 m-70 -94.31 -40.86 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -110.16 152.81 25.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -71.74 -16.41 62.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -85.88 -41.86 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.36 -35.81 78.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -71.33 -35.84 71.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -74.17 -35.98 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -49.46 -43.23 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.93 -66.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 88.6 mt -34.3 -34.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -72.07 -50.63 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.79 -65.67 2.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 312' ' ' VAL . 13.6 m -43.43 -28.81 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t -62.79 114.35 3.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.92 68.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 52.1 t80 -78.23 163.29 25.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . 0.41 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -108.87 83.69 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.52 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.3 OUTLIER -103.45 120.24 40.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.417 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 53.3 m-20 57.92 52.48 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.573 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 22.5 p-80 44.3 36.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 309' ' ' ILE . 70.4 mt -139.09 166.63 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -93.7 101.8 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.3 134.41 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.63 138.78 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 243' ' ' VAL . 68.9 t -140.47 148.34 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.07 153.05 13.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.488 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 83.3 m95 -54.52 122.0 9.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 240' ' ' THR . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.886 0.374 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -134.92 142.71 46.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 29.5 pt -139.7 140.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.145 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 74.8 ttt180 -103.27 151.17 23.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 312' ' ' VAL . 86.2 t -134.62 144.66 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 64.5 p -140.82 171.66 13.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m120 64.58 48.43 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.0 mt -100.9 -177.58 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.3 t -126.81 176.51 7.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.83 -24.69 48.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.38 20.16 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 97.9 m -132.75 96.41 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.541 ' HG3' HG22 ' A' ' 253' ' ' THR . 23.2 ptt-85 -101.48 -173.31 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -55.62 -64.3 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 251' ' ' ARG . 1.8 t -50.68 -19.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.447 ' OD2' ' NH1' ' A' ' 251' ' ' ARG . 3.2 m-20 -82.82 -29.3 29.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.59 -27.83 17.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.26 -31.47 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.91 -24.91 26.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.42 HD22 ' CE2' ' A' ' 305' ' ' TYR . 11.6 tp -73.6 -35.37 65.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' PHE . . . . . 0.676 ' HB2' HD11 ' A' ' 265' ' ' ILE . 59.1 m-85 -97.62 10.17 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ARG . . . . . 0.601 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.3 tpt85 -75.97 -44.54 3.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.7 Cg_exo -48.0 -18.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.6 m-85 -93.37 -38.52 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.22 32.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.468 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.56 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 4.4 m -92.86 116.06 28.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 259' ' ' PHE . 45.3 mt -74.47 140.14 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.542 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.9 t -89.97 -50.47 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -140.03 155.95 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.86 105.12 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -97.24 142.83 28.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.8 tp -126.01 131.76 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.12 119.83 11.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -136.66 122.12 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.64 -179.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -113.31 -41.74 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 89.5 m -65.94 -56.96 9.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.1 t -94.65 -15.41 24.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.6 85.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -112.07 171.22 7.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 60.5 p -77.64 113.2 15.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -56.65 -68.06 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.76 34.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 39.5 p90 -162.34 146.25 11.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -136.34 167.79 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.141 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.5 m-85 -135.15 111.73 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -100.48 127.48 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -104.33 112.92 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -84.21 176.44 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -92.76 -41.63 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -113.4 172.65 6.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -81.31 -37.1 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.08 -54.34 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.2 -37.08 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.451 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -66.13 -46.34 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.5 98.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -46.77 -42.19 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.43 -71.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 314' ' ' TRP . 92.0 mt -35.81 -40.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.01 87.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.99 -62.59 1.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 296' ' ' ALA . 16.2 m -46.03 -20.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 103.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.48 29.06 9.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.89 133.51 34.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -82.25 54.38 4.87 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . 0.42 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -77.03 130.07 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 110.972 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 56.6 m-20 62.08 55.03 2.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.73 31.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 306' ' ' ASP . 90.2 mt -141.52 170.64 15.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.49 100.88 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.77 143.45 56.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -125.37 129.43 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 243' ' ' VAL . 56.4 t -137.85 140.15 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 156.02 32.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.523 ' CD1' HD13 ' A' ' 297' ' ' ILE . 80.3 m95 -57.51 128.01 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 53.5 m -114.43 124.17 51.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.888 0.375 . . . . 0.0 110.854 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 9.6 t -47.26 147.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.59 56.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 18.0 m -85.09 156.34 21.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.892 0.377 . . . . 0.0 110.843 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.0 m -156.85 146.28 20.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -148.68 -69.89 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.53 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.76 101.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -57.59 97.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 74.8 mmt-85 -106.95 98.33 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -96.69 83.68 3.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -102.94 115.32 30.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.105 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -122.15 -17.59 7.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -134.03 -45.24 0.78 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -48.11 152.26 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -85.81 108.79 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.114 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 2.7 m -135.89 136.28 40.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.744 HG22 HD11 ' A' ' 297' ' ' ILE . 45.0 pt -132.67 142.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.1 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -99.88 150.38 22.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 312' ' ' VAL . 74.9 t -136.88 141.17 41.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 282' ' ' PHE . 18.3 p -141.5 163.94 31.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 29.6 t30 70.45 52.07 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 250' ' ' THR . 26.1 mt -93.93 -178.56 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 30.8 t -118.19 169.77 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -70.68 -21.47 62.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.893 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.89 20.26 13.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 1.028 HG21 HD22 ' A' ' 246' ' ' LEU . 52.8 m -113.17 99.42 7.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -110.15 -177.47 3.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' OE2' HD23 ' A' ' 270' ' ' LEU . 12.1 mp0 -55.86 -42.14 75.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.8 t -66.26 -26.26 67.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.111 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -28.95 47.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.6 mt -86.33 -31.15 21.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.933 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 11.2 tt0 -59.0 -31.67 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.33 -16.7 28.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.538 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.0 tp -82.94 -37.85 23.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.883 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 265' ' ' ILE . 65.1 m-85 -98.03 10.97 39.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.9 tmt_? -76.56 -45.27 3.3 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 0.0 110.882 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 66.0 Cg_exo -48.02 -17.23 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.733 2.289 . . . . 0.0 112.333 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.4 m-85 -93.38 -33.09 14.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.869 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 164.65 -162.62 35.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.484 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.0 m -90.39 117.26 28.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.819 0.343 . . . . 0.0 110.822 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.622 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.9 mt -75.71 140.94 16.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -88.35 -45.02 10.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -150.78 153.5 35.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.828 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 44.7 mt -136.18 105.23 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 4.6 t80 -96.95 146.96 24.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.54 HD23 ' OE2' ' A' ' 252' ' ' GLU . 12.4 tp -140.95 125.84 18.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.536 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.75 119.44 9.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.11 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -130.95 149.07 52.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.916 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.35 163.65 13.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -101.0 -29.93 11.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 74.4 m -81.62 -37.75 27.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.132 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.2 p -98.96 -34.14 10.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.5 44.57 89.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.506 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -129.93 -175.88 3.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.359 . . . . 0.0 110.891 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 49.9 m -86.24 106.05 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 271' ' ' ALA . 13.3 mmmt -40.65 -56.63 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 152.54 -23.09 0.84 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.436 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.562 ' HB3' HG22 ' A' ' 244' ' ' THR . 14.4 p90 -115.84 159.7 21.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -147.27 168.45 21.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -136.05 113.64 10.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.0 mp -97.94 133.74 38.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.119 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 25.3 m -108.03 123.13 48.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.607 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.1 m-85 -98.74 169.95 9.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.92 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.556 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 12.3 m-70 -87.76 -47.09 8.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt-85 -108.37 165.3 11.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -76.65 -24.0 53.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.44 -49.98 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -57.14 -37.99 72.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.9 -43.75 87.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.121 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.0 91.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 41.1 mtt-85 -48.98 -40.03 28.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.902 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.75 -64.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.073 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 241' ' ' ILE . 82.7 mt -37.97 -33.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.95 -46.04 38.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -77.88 -62.35 2.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.497 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 296' ' ' ALA . 7.5 m -42.49 -27.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.163 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 35.4 t -70.03 109.45 4.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 91.1 16.61 53.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.545 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -74.17 158.58 33.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.942 0.401 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.81 65.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -84.31 127.54 34.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.865 0.364 . . . . 0.0 110.901 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.436 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 4.5 m-20 46.64 50.74 12.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 35.1 p-80 46.3 44.32 12.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 88.7 mt -146.45 168.64 20.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.74 95.89 5.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.177 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 25.9 tp -60.96 146.05 48.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 -119.7 129.67 54.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.93 HG22 HG22 ' A' ' 243' ' ' VAL . 76.6 t -141.19 147.5 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.85 149.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.571 ' CD1' HD13 ' A' ' 297' ' ' ILE . 79.8 m95 -51.18 122.72 8.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -53.06 -32.47 47.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -97.19 152.57 38.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.596 0.713 . . . . 0.0 110.88 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.42 157.06 32.85 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.671 2.248 . . . . 0.0 112.355 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 61.8 p -93.21 45.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.99 0.424 . . . . 0.0 110.889 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 320' ' ' ASN . 9.4 t -63.13 -42.22 99.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.155 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.436 ' N ' HG23 ' A' ' 319' ' ' THR . 84.4 m-20 -74.96 164.17 26.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 53.8 p -133.53 45.51 2.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 112.36 95.64 2.24 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.9 -177.02 3.32 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.676 2.251 . . . . 0.0 112.307 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.7 m -43.95 147.68 0.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 4.8 t -104.81 112.18 25.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.893 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.544 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 38.6 t -58.49 155.02 12.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.862 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.8 t -133.96 138.09 45.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -115.61 -118.27 3.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 1.9 t 68.06 42.63 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.857 0.36 . . . . 0.0 110.898 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 p -87.73 65.41 8.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 66.01 -152.5 51.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.76 168.89 22.77 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.32 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -94.35 142.39 27.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -75.77 163.87 26.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -127.25 147.83 50.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -169.71 172.2 6.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -159.8 134.18 7.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 48.17 38.23 9.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -122.57 145.52 48.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.39 109.34 16.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 25.7 m -139.01 147.53 42.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.121 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 297' ' ' ILE . 32.3 pt -141.54 143.16 27.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.415 ' O ' HG13 ' A' ' 312' ' ' VAL . 49.7 ttt-85 -98.67 150.98 21.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 312' ' ' VAL . 88.2 t -139.1 139.07 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 30.7 p -138.8 173.72 11.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 20.4 t-20 69.24 48.0 0.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 31.0 mt -98.72 -178.28 3.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.952 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 43.9 t -126.47 179.26 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -86.18 -3.91 59.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.89 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -106.66 21.63 17.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 90.6 m -127.49 116.78 20.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.181 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.68 172.07 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -51.2 -47.47 62.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 7.6 t -60.4 -29.0 68.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -74.45 -23.35 58.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.04 -28.11 14.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -54.76 -28.01 45.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.31 -19.5 22.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.56 -36.76 44.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.829 ' HB2' HD11 ' A' ' 265' ' ' ILE . 88.4 m-85 -95.92 10.43 37.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.904 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 ttt-85 -78.87 -45.17 1.84 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.872 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.0 -17.14 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.674 2.249 . . . . 0.0 112.333 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -95.56 -31.94 13.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 167.76 -160.53 34.15 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.597 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.7 m -95.2 111.03 22.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 0.0 110.856 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.829 HD11 ' HB2' ' A' ' 259' ' ' PHE . 66.5 mt -65.87 147.75 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 33.4 t -97.89 -46.88 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -147.05 146.01 29.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 39.8 mt -130.63 99.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.088 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.661 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -93.79 152.72 18.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.932 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.674 HD23 ' HE2' ' A' ' 272' ' ' LYS . 47.5 tp -141.71 143.27 33.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.622 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -84.9 129.79 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.674 ' HE2' HD23 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -134.19 153.98 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -99.43 157.37 16.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.31 0.3 33.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 93.4 m -111.43 -20.61 12.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 32.7 p -121.48 -16.1 7.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.126 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.14 37.44 80.1 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.474 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -129.57 -179.26 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.4 t -85.3 115.99 23.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -46.87 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.82 32.4 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.622 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 25.8 p90 -165.95 155.94 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.42 174.04 12.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -137.15 120.11 16.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -106.64 124.52 62.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 50.4 m -101.45 118.51 37.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.785 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 7.8 m-85 -92.62 176.02 6.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 264' ' ' SER . 9.6 m-70 -95.57 -50.03 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -108.04 149.46 28.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.2 ttt180 -69.46 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.51 -25.51 20.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.497 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 6.4 m-20 -88.57 -25.31 22.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.828 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -80.35 -33.98 36.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.441 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.31 -33.63 69.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.066 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -59.44 -37.79 79.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.2 -63.97 1.01 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 241' ' ' ILE . 61.1 mt -39.94 -35.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -72.67 -56.63 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.044 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.8 -61.41 5.89 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.789 HG21 HG21 ' A' ' 312' ' ' VAL . 3.7 m -48.05 -35.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.5 t -59.81 104.47 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.6 27.1 10.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -91.09 148.99 22.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.873 0.368 . . . . 0.0 110.89 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -92.8 78.22 1.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.52 127.07 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.868 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.407 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 11.3 t70 52.66 48.14 23.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.565 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 46.52 32.08 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 309' ' ' ILE . 45.9 mt -133.7 171.82 13.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.938 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -97.95 94.73 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.112 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.1 tp -66.93 136.19 54.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -116.79 142.89 46.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.831 HG22 HG22 ' A' ' 243' ' ' VAL . 99.2 t -146.67 144.78 20.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -165.37 149.02 8.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.521 ' CD1' HD13 ' A' ' 297' ' ' ILE . 95.6 m95 -49.59 130.3 20.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.6 62.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -53.0 144.27 28.02 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.533 0.683 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.37 -41.2 0.28 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.704 2.269 . . . . 0.0 112.337 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 99.3 p -105.88 122.82 46.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 80.7 p -123.24 127.81 49.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.156 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -92.31 163.26 13.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.4 t -105.74 -56.79 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.05 94.76 2.0 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.12 135.2 18.55 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 0.0 112.311 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.9 p -139.62 146.79 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.8 m -86.97 151.59 23.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.6 p -55.04 112.3 1.03 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.934 0.397 . . . . 0.0 110.847 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.1 t 53.29 42.3 32.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.69 174.04 27.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 229' ' ' SER . 37.2 t -140.03 134.56 31.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.372 . . . . 0.0 110.852 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 228' ' ' SER . 99.5 p -35.75 112.76 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.844 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 53.65 95.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.506 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.51 133.08 12.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.712 2.275 . . . . 0.0 112.344 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -100.52 42.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -93.03 117.72 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.847 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -92.34 -58.48 2.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -161.97 106.82 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.5 p-10 -82.75 112.69 19.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -121.31 -71.33 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -87.22 179.85 6.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -106.01 92.85 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.7 m -143.29 143.46 31.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.142 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 31.9 pt -140.85 147.05 23.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HG3' ' CE1' ' A' ' 284' ' ' PHE . 17.0 ttt180 -112.32 148.77 33.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 312' ' ' VAL . 67.3 t -127.49 148.99 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 13.4 p -143.24 163.11 33.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 70.79 38.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 23.8 mt -82.72 -174.97 5.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 248' ' ' GLU . 27.3 t -125.78 178.85 5.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.4 ' N ' ' OG ' ' A' ' 247' ' ' SER . 4.3 mm-40 -76.46 -50.47 13.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.11 -4.8 8.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 44.2 m -98.51 103.13 15.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.401 ' HA ' HD22 ' A' ' 270' ' ' LEU . 0.0 OUTLIER -115.13 -175.5 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.625 ' OE2' HD23 ' A' ' 270' ' ' LEU . 4.3 mp0 -51.17 -56.21 13.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.856 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.3 t -55.31 -21.79 16.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.156 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -82.47 -30.4 29.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 mt -88.87 -26.53 21.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -56.79 -33.58 66.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.931 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -89.96 -18.44 26.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.416 HD22 ' HE2' ' A' ' 305' ' ' TYR . 31.8 tp -78.64 -34.23 46.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.919 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 265' ' ' ILE . 81.3 m-85 -101.0 11.91 38.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 8.2 tpt180 -78.24 -45.24 2.18 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 0.0 110.859 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.4 Cg_exo -48.01 -17.21 0.75 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.0 m-85 -92.56 -35.91 13.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.27 -161.45 34.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.549 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.9 m -90.31 117.28 28.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.531 HG21 ' CG1' ' A' ' 268' ' ' ILE . 74.9 mt -72.78 144.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.157 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.2 t -97.98 -48.09 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.0 tpt180 -145.44 151.46 38.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.531 ' CG1' HG21 ' A' ' 265' ' ' ILE . 65.3 mt -140.23 113.68 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.133 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 4.9 t80 -109.31 141.58 41.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.625 HD23 ' OE2' ' A' ' 252' ' ' GLU . 18.4 tp -129.92 121.13 26.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.948 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -61.63 122.49 15.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.122 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 19.3 mttm -134.96 149.33 50.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.27 178.82 7.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.5 mtmm -114.29 -48.27 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 58.3 m -67.48 -42.38 83.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 -14.47 17.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 50.63 41.64 42.9 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.533 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -117.7 163.81 15.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.2 p -70.91 129.95 40.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -68.77 -75.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.71 32.39 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 24.2 p90 -165.99 157.96 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -146.73 171.3 15.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.526 ' CE1' ' HG3' ' A' ' 242' ' ' ARG . 97.7 m-85 -136.84 106.58 6.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -94.78 136.99 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.7 m -113.93 118.62 34.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -93.07 172.84 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.825 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -89.69 -43.57 10.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -116.62 168.92 9.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -76.89 -35.52 57.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.837 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -60.95 -55.29 34.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.86 -37.78 74.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -63.6 -44.26 94.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.56 -37.23 82.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.067 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 9.3 mmm-85 -50.05 -41.0 46.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.64 -65.86 0.65 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.119 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.497 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 82.5 mt -35.04 -33.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.53 -51.71 9.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.127 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -60.67 5.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.85 HG22 ' O ' ' A' ' 296' ' ' ALA . 13.7 m -51.24 -31.58 11.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.145 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.3 t -61.59 119.55 8.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.32 69.07 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 66.9 t80 -83.71 165.42 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.442 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -110.98 82.36 0.3 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.416 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.7 OUTLIER -103.4 120.59 41.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.373 . . . . 0.0 110.95 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.485 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 21.7 t70 61.01 48.7 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 27.6 p-80 47.94 32.59 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 71.2 mt -135.94 167.54 21.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -94.52 95.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 22.4 tp -60.83 143.49 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -123.93 130.86 53.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.658 HG22 HG22 ' A' ' 243' ' ' VAL . 26.4 t -139.81 151.31 22.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.125 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -169.39 149.82 4.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.876 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.497 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 86.2 m95 -47.89 136.08 11.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.953 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . -125.44 11.13 8.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.125 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.61 150.35 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.593 0.711 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.07 44.59 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.684 2.256 . . . . 0.0 112.325 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 88.8 p -44.49 108.18 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.872 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 12.9 t -145.12 150.85 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -106.06 151.51 24.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.7 t -148.71 147.32 28.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -84.13 168.59 44.97 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.535 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.53 17.67 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.35 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 41.6 p -46.67 137.3 7.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 99.6 p -100.64 159.55 15.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 61.2 p -69.94 -18.03 63.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 22.3 t -124.94 121.46 34.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 83.02 59.77 2.13 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.473 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.4 m -155.46 134.57 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.7 t -78.08 -69.6 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 121.05 -91.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.506 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.6 -21.19 0.77 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.691 2.261 . . . . 0.0 112.359 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 61.24 41.65 13.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -153.12 169.27 23.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 32.1 mmt-85 -128.03 98.01 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -120.76 -39.8 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 10.3 p30 -57.71 131.24 49.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -126.5 40.15 3.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -147.62 173.38 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . -117.82 94.58 4.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.095 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 8.8 m -134.34 141.0 46.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 35.4 pt -140.54 145.23 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -104.39 149.17 25.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 312' ' ' VAL . 73.8 t -133.09 135.58 56.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.079 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.437 ' O ' HD12 ' A' ' 310' ' ' LEU . 31.0 p -130.26 171.76 12.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.139 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.42 51.93 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.542 HD22 HG21 ' A' ' 250' ' ' THR . 23.7 mt -95.77 -177.52 4.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.4 t -122.23 164.27 18.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -70.48 -11.53 60.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -105.24 21.1 17.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.542 HG21 HD22 ' A' ' 246' ' ' LEU . 59.1 m -121.14 98.43 5.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 24.3 mmm-85 -103.29 170.07 8.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -47.82 -43.4 27.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -23.67 64.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.185 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -78.55 -28.76 46.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 86.9 mt -87.52 -30.84 20.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 7.1 pt20 -53.14 -33.56 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -87.55 -12.85 44.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 13.5 tp -87.87 -37.23 16.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.568 ' CE2' HG11 ' A' ' 300' ' ' VAL . 46.5 m-85 -96.89 10.37 39.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.4 tpt85 -76.9 -45.32 2.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.63 0.729 . . . . 0.0 110.826 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.3 Cg_exo -47.96 -17.24 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.646 2.23 . . . . 0.0 112.354 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.8 m-85 -94.22 -32.47 13.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.22 -166.66 39.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.47 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.7 m -90.32 112.86 24.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.833 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.459 ' CD1' ' HA ' ' A' ' 256' ' ' GLN . 37.1 mt -69.34 145.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.156 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 26.7 t -96.56 -44.88 6.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.917 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.426 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 16.7 tpp180 -148.34 146.89 28.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 265' ' ' ILE . 41.5 mt -131.31 96.58 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.141 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -91.76 150.41 21.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.928 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.615 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.5 tp -142.14 120.16 12.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -62.5 131.8 50.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -134.5 174.39 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.19 164.91 13.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -107.24 -6.26 17.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 55.8 m -102.11 -58.22 1.92 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -6.84 21.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.83 26.87 65.82 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.442 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -88.09 138.73 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 7.5 t -47.35 127.74 11.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -62.22 -57.43 11.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 147.91 -9.65 1.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -132.65 149.5 52.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.818 0.342 . . . . 0.0 110.904 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 270' ' ' LEU . . . -133.78 169.4 17.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.131 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -134.21 117.56 16.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -103.78 136.85 34.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 3.3 m -112.02 124.85 53.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.914 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 17.6 m-85 -98.78 171.74 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 12.6 m-70 -89.88 -40.26 12.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 13.8 mtt180 -118.94 158.87 24.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 17.0 ttp-105 -74.6 -13.26 60.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -88.91 -29.18 19.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.465 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -84.36 -28.55 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.914 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -77.6 -33.77 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.101 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.97 65.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.121 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -49.14 -44.68 42.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -59.78 -66.65 0.48 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 312' ' ' VAL . 81.2 mt -39.86 -34.65 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.48 -44.0 72.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -85.15 -57.05 2.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.473 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.702 HG21 HG21 ' A' ' 312' ' ' VAL . 17.2 m -47.37 -32.7 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.878 0.37 . . . . 0.0 111.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 14.2 p -55.74 122.28 11.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 72.11 19.48 78.52 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -78.01 136.97 38.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -84.89 92.61 1.76 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.6 112.51 24.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 0.0 110.888 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 7.8 t70 63.62 52.94 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 33.3 p-80 45.91 27.25 0.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.451 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.8 mt -129.09 162.74 27.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -93.96 104.75 16.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.155 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 244' ' ' THR . 14.7 tp -78.81 140.72 38.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -122.92 145.82 48.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.816 HG22 HG22 ' A' ' 243' ' ' VAL . 49.6 t -145.61 136.37 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.118 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -146.68 168.1 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.545 ' CD1' HD13 ' A' ' 297' ' ' ILE . 75.8 m95 -81.06 122.29 27.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.896 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -113.4 177.31 4.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -144.32 139.99 16.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.61 0.719 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.01 156.74 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.259 . . . . 0.0 112.365 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 35.2 m -119.87 -50.97 2.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 4.4 t -53.63 152.49 5.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.136 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -129.3 88.91 2.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.3 m -89.25 -48.44 7.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 115.68 -154.74 16.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.453 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.04 155.3 33.65 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.708 2.272 . . . . 0.0 112.36 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 14.7 t -121.95 131.56 54.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.894 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.6 t -139.55 150.6 45.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.468 179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 15.9 p -121.49 -0.67 9.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 18.7 m -158.13 144.26 17.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.877 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 120.33 -37.07 3.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.472 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 70.8 m -115.22 -59.37 2.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.885 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 84.2 p -97.81 128.24 44.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.82 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.99 89.01 2.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.08 165.83 27.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.687 2.258 . . . . 0.0 112.321 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -92.56 -61.85 1.52 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -94.34 116.3 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.04 -54.39 4.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -55.68 142.62 33.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -166.32 157.07 12.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.27 -45.09 7.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -151.72 176.43 11.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -82.45 108.0 15.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 4.0 m -140.77 124.6 17.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.165 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.435 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 28.1 pt -122.61 145.9 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.122 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.49 ' O ' HG13 ' A' ' 312' ' ' VAL . 42.9 ttt180 -107.92 151.88 25.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.843 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 312' ' ' VAL . 95.6 t -139.0 141.84 35.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 43.3 p -139.48 170.06 16.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 30.8 t-20 73.58 38.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 250' ' ' THR . 30.2 mt -90.48 -175.97 4.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 52.6 p -127.34 175.61 8.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -78.79 -14.41 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -95.33 12.99 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.472 HG21 HD22 ' A' ' 246' ' ' LEU . 51.4 m -119.02 109.34 15.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.138 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.44 ' HD2' ' N ' ' A' ' 251' ' ' ARG . 0.0 OUTLIER -112.13 176.88 4.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 252' ' ' GLU . 1.9 mp0 -49.42 -43.33 44.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.79 -25.42 67.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.38 -28.31 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.2 mt -95.51 -25.3 16.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -61.31 -30.17 70.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.69 -16.81 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 31.3 tp -79.49 -38.75 33.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.754 ' HB2' HD11 ' A' ' 265' ' ' ILE . 56.5 m-85 -95.5 8.99 41.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.4 OUTLIER -75.07 -45.44 4.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.549 0.69 . . . . 0.0 110.859 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.1 Cg_exo -47.98 -18.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.385 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.572 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -93.49 -32.16 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.11 -166.39 39.43 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.23 113.79 25.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.754 HD11 ' HB2' ' A' ' 259' ' ' PHE . 84.2 mt -68.09 145.09 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.098 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.498 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 39.4 t -93.95 -47.37 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -149.25 149.94 31.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.865 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.3 mt -130.99 104.88 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.5 t80 -98.87 136.2 39.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.965 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.72 127.98 39.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.531 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -64.13 129.17 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -134.59 150.44 50.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -90.98 177.77 6.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -112.09 -56.89 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.5 m -55.26 -53.19 59.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 8.6 t -92.08 -24.11 19.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.201 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 61.85 43.59 99.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.97 176.04 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 65.3 p -80.79 129.08 34.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -63.58 -72.9 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.39 33.08 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.476 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 21.5 p90 -165.74 151.92 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.844 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.32 165.06 28.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -131.59 111.16 11.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.563 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.1 mp -97.02 124.37 49.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.172 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 18.7 m -101.04 115.47 30.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.7 m-85 -88.22 176.29 7.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 264' ' ' SER . 14.5 m-70 -94.65 -43.76 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -114.32 168.55 9.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 19.4 ttt85 -82.93 -18.8 38.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -83.55 -29.83 27.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.464 ' O ' ' CE2' ' A' ' 287' ' ' PHE . 3.5 m-20 -83.22 -27.11 30.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -75.09 -37.09 61.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.27 -37.84 68.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.081 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -48.28 -42.72 31.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.5 -70.51 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.554 HD12 ' NE1' ' A' ' 314' ' ' TRP . 82.6 mt -35.08 -34.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.154 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -67.01 -48.04 69.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.088 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.8 -59.85 2.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.584 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.1 m -41.81 -36.69 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.374 . . . . 0.0 111.142 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 57.4 p -55.35 119.84 6.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.07 23.26 74.92 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.483 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -76.57 153.2 35.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.865 0.364 . . . . 0.0 110.909 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.5 76.09 0.49 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -98.2 120.6 38.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.856 0.36 . . . . 0.0 110.932 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.456 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 3.0 t70 54.57 49.63 17.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.494 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 24.2 p-80 47.62 29.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.826 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 309' ' ' ILE . 38.0 mt -129.85 164.64 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.971 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -94.93 102.15 13.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.404 HD11 ' CG1' ' A' ' 243' ' ' VAL . 14.2 tp -72.08 130.94 42.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.899 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.31 129.67 55.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.903 HG22 HG22 ' A' ' 243' ' ' VAL . 55.9 t -133.78 143.27 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -156.02 161.26 40.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.554 ' NE1' HD12 ' A' ' 297' ' ' ILE . 72.3 m95 -71.28 122.29 19.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -112.43 118.8 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.442 ' CG ' ' HD2' ' A' ' 317' ' ' PRO . 36.9 tttm -101.66 140.35 21.15 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.622 0.725 . . . . 0.0 110.877 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 316' ' ' LYS . 62.6 Cg_endo -78.72 172.0 15.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -129.17 -53.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 p -98.93 107.94 20.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -133.66 125.16 28.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 85.0 p -39.9 127.35 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -106.33 96.18 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.17 129.26 12.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.704 2.269 . . . . 0.0 112.369 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 9.5 m -133.72 158.21 43.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 89.4 p -130.3 165.34 22.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.47 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 12.2 m 50.94 48.36 23.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.804 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 43.2 m -90.8 135.36 33.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 134.7 116.69 1.67 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.1 p -174.59 151.9 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.886 0.374 . . . . 0.0 110.85 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 95.3 p -72.68 168.72 18.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.902 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -153.09 -96.39 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.454 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.01 136.6 13.18 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.722 2.281 . . . . 0.0 112.339 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -127.4 156.44 42.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -129.2 -42.61 1.35 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.7 mtp85 -45.48 -47.18 14.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 238' ' ' ASN . . . -136.78 105.66 5.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.473 ' HA ' ' CE ' ' A' ' 316' ' ' LYS . 9.1 t0 -111.47 0.17 16.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -124.06 -37.05 2.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' HB2' ' HB1' ' A' ' 235' ' ' ALA . 3.0 m120 -39.85 159.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.891 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.52 108.15 15.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.089 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.7 m -129.37 142.91 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 38.2 pt -138.81 140.28 39.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.135 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 69.9 ttt180 -100.56 147.35 26.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 312' ' ' VAL . 55.8 t -129.58 145.48 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.7 p -143.27 165.54 27.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.171 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 26.5 t-20 73.32 39.06 0.62 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.733 HD22 HG21 ' A' ' 250' ' ' THR . 49.9 mt -89.98 -176.95 5.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.8 m -135.56 -175.95 4.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -74.8 -50.11 18.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -59.16 -10.83 3.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.733 HG21 HD22 ' A' ' 246' ' ' LEU . 50.5 m -98.62 97.75 8.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -109.79 178.98 4.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -48.6 -41.62 31.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -67.61 -23.05 65.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.146 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.77 -30.32 36.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.812 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.8 mt -88.29 -24.06 23.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.4 tt0 -60.6 -34.5 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.935 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -94.35 -11.68 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.541 HD13 ' HE2' ' A' ' 305' ' ' TYR . 31.6 tp -80.62 -39.7 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.948 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.552 ' HB2' HD11 ' A' ' 265' ' ' ILE . 64.7 m-85 -98.18 12.04 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.59 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.8 tpt180 -79.15 -45.11 1.72 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.591 0.71 . . . . 0.0 110.853 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.93 -17.23 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.621 2.214 . . . . 0.0 112.393 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.9 m-85 -95.39 -31.06 13.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.79 -166.13 39.42 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.496 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.1 m -90.34 108.73 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 259' ' ' PHE . 61.4 mt -63.32 139.11 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.135 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.511 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 27.8 t -89.67 -43.34 10.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.835 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -148.93 153.17 37.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 85.1 mt -133.64 104.7 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.169 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -99.66 140.9 33.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 283' ' ' ALA . 35.7 tp -133.01 125.34 29.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.516 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.41 125.55 28.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -129.08 157.7 41.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.49 -178.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.912 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -116.64 -32.32 5.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 36.7 m -80.37 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 276' ' ' THR . 1.9 t -81.8 -36.7 28.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.159 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.04 19.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -96.73 -177.23 3.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.928 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 86.4 p -77.42 114.98 16.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -52.85 -54.02 40.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.932 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 141.97 -6.37 2.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.479 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.516 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 13.6 p90 -135.26 157.2 47.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 0.0 110.864 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.706 ' HB2' HD12 ' A' ' 270' ' ' LEU . . . -146.43 163.55 35.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.7 m-85 -128.74 114.03 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.605 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -98.75 140.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.096 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.99 142.12 46.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -116.17 -176.31 2.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.837 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 8.9 m-70 -104.79 -31.58 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -129.28 148.03 51.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.863 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -63.71 -21.39 66.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.837 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.86 -60.24 2.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.69 -28.41 67.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -69.25 -38.19 78.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -75.4 -23.95 57.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.095 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -61.99 -37.65 85.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.857 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -68.8 -69.0 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.54 HD12 ' NE1' ' A' ' 314' ' ' TRP . 85.3 mt -35.88 -35.95 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.3 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -78.05 -60.9 2.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.51 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 312' ' ' VAL . 11.4 m -41.67 -42.41 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 111.119 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.471 ' N ' HG23 ' A' ' 300' ' ' VAL . 36.7 p -53.59 127.91 27.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.848 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.06 68.67 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.46 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -83.97 134.25 34.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -80.91 91.63 1.42 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.541 ' HE2' HD13 ' A' ' 258' ' ' LEU . 1.5 t80 -105.24 115.55 30.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.832 0.348 . . . . 0.0 110.886 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.54 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.5 m-20 57.33 54.05 7.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 36.7 p-80 48.76 36.92 8.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 309' ' ' ILE . 90.9 mt -138.59 168.41 19.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.69 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.0 OUTLIER -101.25 97.26 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.156 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 21.4 tp -65.23 149.27 50.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -133.29 132.13 41.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.873 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.872 HG22 HG22 ' A' ' 243' ' ' VAL . 97.8 t -139.54 143.97 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.092 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -156.02 158.95 38.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.54 ' NE1' HD12 ' A' ' 297' ' ' ILE . 81.4 m95 -69.08 125.51 26.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.51 78.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.066 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.473 ' CE ' ' HA ' ' A' ' 236' ' ' ASP . 25.6 mtmm -139.61 143.86 37.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.588 0.708 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.89 143.81 23.67 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 68.0 p -127.05 131.47 50.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.846 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 88.1 m -142.28 140.9 32.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.161 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -135.51 105.09 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 11.6 t -80.97 111.15 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -76.49 -70.18 1.31 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.02 123.18 6.6 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 28.6 t -84.43 134.32 34.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -124.36 97.95 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.538 -179.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.6 t -139.75 141.1 36.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 19.3 m -56.76 -43.93 81.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 57.17 47.73 85.42 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.495 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.5 m -109.25 128.11 54.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.9 m -104.49 101.51 11.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -141.63 62.53 0.53 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.499 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.51 166.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.662 2.242 . . . . 0.0 112.395 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 234' ' ' ARG . 38.0 t30 -105.31 120.0 40.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -88.52 81.5 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.411 ' HB2' ' ND2' ' A' ' 232' ' ' ASN . 5.1 tpm_? -124.09 144.88 49.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -94.76 11.81 30.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.461 ' CB ' ' HG3' ' A' ' 316' ' ' LYS . 19.3 p-10 -65.67 -18.32 65.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 236' ' ' ASP . 23.5 t0 35.19 38.79 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -151.91 -179.56 7.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -114.07 95.35 5.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 13.4 m -140.6 131.63 26.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 40.6 pt -127.6 141.08 47.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt180 -99.57 153.46 19.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 312' ' ' VAL . 68.7 t -139.64 135.64 39.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 72.6 p -132.24 163.19 29.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.4 t-20 71.59 43.77 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.929 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 28.2 mt -91.11 177.21 6.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.5 t -122.91 146.47 47.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.8 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -48.18 -49.62 32.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.11 -24.92 43.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 93.8 m -82.16 97.01 8.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 21.5 mmm-85 -104.69 179.26 4.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -49.49 -56.22 10.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -55.51 -25.24 36.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.126 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.97 -31.23 44.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 23.8 mt -86.45 -26.06 24.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 16.5 tt0 -59.5 -31.71 69.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -92.87 -8.59 42.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 26.6 tp -88.05 -39.7 14.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.849 ' HB2' HD11 ' A' ' 265' ' ' ILE . 79.1 m-85 -98.15 11.19 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.861 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.586 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -76.86 -45.35 2.99 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.601 0.715 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.8 Cg_exo -47.97 -17.93 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.365 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 31.0 m-85 -94.55 -33.79 12.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.85 -167.1 40.24 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 19.8 m -90.53 110.33 21.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.849 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.6 mt -66.24 142.49 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.564 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.4 t -92.57 -46.83 7.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.844 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 46.8 ttt180 -148.17 139.64 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.452 ' CG1' HG21 ' A' ' 265' ' ' ILE . 38.4 mt -120.98 102.94 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.505 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.2 t80 -93.12 143.03 26.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 24.2 tp -136.44 115.59 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.446 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.52 126.46 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.093 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.442 ' HE3' HD23 ' A' ' 270' ' ' LEU . 49.4 mttp -130.97 174.41 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.429 ' HA ' ' HZ3' ' A' ' 280' ' ' LYS . 7.7 t70 -103.73 177.32 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.83 -54.74 2.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 26.9 m -55.14 -72.38 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.137 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.454 HG23 ' H ' ' A' ' 278' ' ' GLN . 14.8 t -77.5 -32.26 54.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 73.97 39.37 46.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.548 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.454 ' H ' HG23 ' A' ' 276' ' ' THR . 90.9 mt-30 -103.64 169.65 8.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.916 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 45.7 m -70.94 115.61 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 273' ' ' ASP . 19.3 mmtm -48.21 -54.26 14.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 143.58 -15.57 2.24 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.499 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 12.4 p90 -123.53 155.27 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.851 0.358 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.51 165.29 27.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.46 116.7 16.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -104.58 125.41 59.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 34.3 m -101.57 119.13 38.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 14.7 m-85 -91.05 175.71 6.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.9 m-70 -92.34 -44.43 8.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -110.99 173.71 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -87.57 -20.81 25.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -83.58 -24.18 31.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -82.51 -34.44 27.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -70.44 -35.84 73.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.7 -38.4 70.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.113 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -48.63 -44.07 37.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.83 -65.21 0.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.602 HD13 ' CD1' ' A' ' 314' ' ' TRP . 69.1 mt -34.48 -32.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -50.09 23.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.09 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.49 -62.51 3.03 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 312' ' ' VAL . 16.1 m -46.59 -36.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.82 0.343 . . . . 0.0 111.125 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.8 t -57.54 114.25 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.77 26.24 56.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.484 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -82.62 153.53 25.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 0.0 110.876 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -99.29 71.71 0.52 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.37 129.55 36.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.376 . . . . 0.0 110.913 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.5 t70 45.25 52.79 8.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.877 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.547 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 21.3 p-80 44.67 31.44 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.41 ' C ' HD12 ' A' ' 309' ' ' ILE . 30.5 mt -131.33 163.3 28.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -92.98 101.39 12.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.083 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 10.3 tp -76.42 139.01 40.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 312' ' ' VAL . 0.1 OUTLIER -119.72 140.13 51.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 1.019 HG22 HG22 ' A' ' 243' ' ' VAL . 94.9 t -143.1 143.4 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -152.11 174.24 13.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.602 ' CD1' HD13 ' A' ' 297' ' ' ILE . 68.9 m95 -80.53 125.61 30.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -119.11 162.65 18.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.461 ' HG3' ' CB ' ' A' ' 236' ' ' ASP . 35.2 ttmt -117.62 138.39 25.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.559 0.695 . . . . 0.0 110.915 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.01 109.55 2.73 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.647 2.232 . . . . 0.0 112.317 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 49.2 m -80.41 150.05 29.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 76.6 p -132.02 124.05 28.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.119 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -73.75 -48.31 32.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 61.8 p -160.84 150.52 17.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -87.15 145.85 20.02 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -77.75 157.49 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.338 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 28.7 t -150.14 126.61 10.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.859 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.7 m -115.59 102.28 9.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.909 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.487 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 51.6 p -140.46 138.07 34.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.876 0.37 . . . . 0.0 110.833 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.8 m -44.16 -57.67 3.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -126.13 100.87 0.59 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.466 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 31.2 m -46.97 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.9 m -52.21 -54.1 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 151.61 97.13 0.15 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -74.63 111.73 3.39 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.737 2.291 . . . . 0.0 112.359 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -86.14 162.51 18.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -121.69 114.84 21.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 235' ' ' ALA . 18.8 mtt-85 -127.69 -62.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 234' ' ' ARG . . . -35.4 -38.84 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 40.58 39.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -119.36 174.87 6.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -98.91 19.3 15.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -131.35 90.2 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 5.4 m -144.0 131.11 20.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.186 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 297' ' ' ILE . 29.1 pt -126.0 143.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.733 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.0 ttt180 -101.81 151.84 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.722 HG22 HG22 ' A' ' 312' ' ' VAL . 41.6 t -134.71 139.59 47.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.16 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 46.9 p -141.85 165.32 27.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.164 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 28.9 t-20 68.42 50.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -92.39 -175.64 4.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.922 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 250' ' ' THR . 5.6 t -130.42 140.24 50.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.406 ' OE1' ' C ' ' A' ' 248' ' ' GLU . 0.6 OUTLIER -47.19 -21.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -91.69 22.36 4.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.47 HG21 HD22 ' A' ' 246' ' ' LEU . 90.7 m -126.41 114.2 17.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.165 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.68 179.94 3.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -53.88 -44.77 70.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.1 t -61.18 -28.22 68.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.149 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.69 -33.3 64.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.467 HD22 ' HE1' ' A' ' 259' ' ' PHE . 43.0 mt -84.17 -28.72 27.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.911 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 24.0 tt0 -57.94 -42.28 84.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -83.71 -16.02 46.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 259' ' ' PHE . 14.8 tp -80.81 -38.07 29.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.598 ' HB2' HD11 ' A' ' 265' ' ' ILE . 80.2 m-85 -99.15 12.01 37.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 ttt180 -77.92 -45.15 2.36 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.598 0.714 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.18 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.678 2.252 . . . . 0.0 112.37 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.7 m-85 -92.78 -35.23 13.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.836 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.24 -163.15 36.84 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -91.62 109.92 21.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.902 0.382 . . . . 0.0 110.843 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 259' ' ' PHE . 46.4 mt -67.95 138.9 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.48 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.4 t -88.69 -42.03 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -151.56 154.72 37.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.824 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 62.5 mt -133.76 101.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.48 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 3.4 t80 -91.4 141.56 28.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 52.9 tp -135.4 127.44 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.402 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -75.11 114.86 14.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -121.68 150.91 41.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.25 173.23 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.4 -29.77 7.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.3 m -78.59 -66.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.139 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.417 HG21 ' OE1' ' A' ' 278' ' ' GLN . 11.4 t -89.01 -13.52 38.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.103 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 60.92 38.25 95.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.417 ' OE1' HG21 ' A' ' 276' ' ' THR . 84.7 mt-30 -102.35 157.22 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.33 . . . . 0.0 110.922 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 48.0 t -58.21 115.08 2.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.823 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -51.63 -59.17 4.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.883 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 150.68 -13.24 0.89 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 31.6 p90 -129.03 157.2 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -144.68 172.72 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.079 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -139.14 116.43 11.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.621 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.5 mp -103.63 132.08 50.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.43 142.02 35.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -116.23 168.35 10.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.908 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.0 m-70 -85.55 -35.07 21.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.409 ' NH1' ' O ' ' A' ' 288' ' ' HIS . 24.5 mmt-85 -120.82 167.27 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -78.54 -32.9 48.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.12 -54.53 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.912 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -53.93 -32.79 54.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.52 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -70.55 -46.0 64.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.7 88.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -50.78 -39.04 51.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.872 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.657 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -68.31 -69.78 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 241' ' ' ILE . 72.8 mt -36.91 -34.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.52 -43.5 55.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.086 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -80.03 -59.12 2.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.497 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 296' ' ' ALA . 28.0 m -53.97 -20.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.145 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.4 t -63.03 107.71 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.92 38.2 23.8 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -88.97 146.32 24.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 0.0 110.882 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.04 74.22 2.2 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -95.13 136.59 35.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.942 0.401 . . . . 0.0 110.91 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.455 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 35.1 t70 42.41 53.98 4.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.507 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 37.8 p-80 46.05 39.03 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 309' ' ' ILE . 95.1 mt -146.36 168.48 21.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.928 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.3 mp -95.55 102.79 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.108 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.7 tp -67.64 139.96 56.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.942 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -118.52 127.82 53.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 242' ' ' ARG . 44.8 t -140.72 141.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.143 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -162.22 149.96 14.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.52 ' HH2' ' HB3' ' A' ' 293' ' ' ALA . 96.1 m95 -45.01 121.4 2.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.89 -71.31 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 153.87 40.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.601 0.715 . . . . 0.0 110.935 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.56 170.65 19.82 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.69 2.26 . . . . 0.0 112.385 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 12.5 t -107.22 128.25 54.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.819 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.7 t -138.07 145.76 42.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.139 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -114.23 146.44 40.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 99.8 p -131.2 -48.65 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -122.41 98.01 0.61 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.72 123.32 7.94 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.638 2.225 . . . . 0.0 112.361 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 7.4 t -45.74 152.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 52.0 m -58.84 -50.19 74.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.851 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 43.5 t -152.17 112.06 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 29.6 t -56.12 89.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.876 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 169.96 159.08 14.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.467 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.4 m -96.65 -178.53 4.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 110.885 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 73.2 m -59.85 174.66 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -130.96 94.54 0.31 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.516 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.33 -31.72 4.41 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 0.0 112.348 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.19 100.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -104.21 113.75 27.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -173.63 166.52 4.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -90.5 178.76 6.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.08 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.484 ' N ' ' HE3' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -93.61 -18.29 22.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 236' ' ' ASP . 16.6 m-20 34.51 37.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 237' ' ' ASP . 44.5 m-80 -168.98 177.63 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -115.93 97.99 6.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.9 m -136.02 143.52 44.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 297' ' ' ILE . 42.5 pt -137.43 141.88 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.114 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -105.57 147.71 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 312' ' ' VAL . 70.5 t -129.71 146.67 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 69.8 p -144.16 163.56 33.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 69.05 40.88 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 34.5 mt -85.33 -175.42 5.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 t -125.52 161.31 27.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.853 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -71.57 -9.36 58.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.55 -8.97 39.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 86.8 m -101.79 104.13 14.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -104.05 179.19 4.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -52.79 -51.52 60.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.4 t -62.77 -19.79 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.179 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -82.34 -26.92 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.87 -33.59 18.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.512 ' NE2' HD12 ' A' ' 265' ' ' ILE . 22.8 tp60 -52.49 -34.25 48.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -87.75 -20.44 26.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 15.3 tp -78.63 -36.79 43.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.631 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.7 m-85 -98.01 11.72 36.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.585 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 2.4 ttt-85 -79.34 -45.24 1.66 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.617 0.722 . . . . 0.0 110.872 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.1 Cg_exo -47.94 -17.37 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.333 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.3 m-85 -93.39 -33.76 13.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.16 -160.36 33.86 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.457 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.458 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 8.3 m -90.69 119.11 30.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.631 HD11 ' HB2' ' A' ' 259' ' ' PHE . 67.0 mt -73.86 145.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.41 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 8.6 t -97.96 -43.71 6.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.436 ' HB2' ' NH1' ' A' ' 267' ' ' ARG . 20.2 ttm105 -150.43 149.98 30.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.867 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 54.2 mt -132.97 100.09 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.521 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -95.59 140.86 29.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 36.2 tp -132.93 121.7 23.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -68.79 129.87 41.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -136.98 162.16 34.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.58 178.22 7.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -108.51 -32.51 7.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 78.0 m -73.02 -65.4 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 15.4 t -95.65 -18.87 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.125 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.91 37.54 92.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.516 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -91.96 160.23 15.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 28.0 t -56.0 121.16 8.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -64.88 -54.46 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.56 1.74 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.45 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 32.6 p90 -128.61 153.86 46.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.867 0.365 . . . . 0.0 110.857 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.46 173.08 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -138.6 112.4 8.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.862 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -100.83 138.67 24.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.1 t -111.27 143.91 41.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 13.0 m-85 -121.39 167.25 12.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.458 ' CD2' ' O ' ' A' ' 264' ' ' SER . 6.2 m-70 -91.06 -44.12 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -104.63 155.39 18.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.3 ttt-85 -78.1 -11.22 59.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.903 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -89.49 -41.37 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.906 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.62 -35.58 77.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.645 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.52 -43.77 88.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.6 79.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.1 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -49.91 -38.63 36.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.906 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.53 -63.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.145 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.514 HD11 HG22 ' A' ' 241' ' ' ILE . 95.5 mt -35.97 -33.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.137 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.75 -55.43 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.73 -54.98 12.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.501 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.906 HG22 ' O ' ' A' ' 296' ' ' ALA . 15.4 m -54.6 -30.94 22.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.82 0.343 . . . . 0.0 111.161 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 3.0 t -61.66 106.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.842 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 84.77 21.12 56.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -80.01 141.93 35.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.932 0.396 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -85.82 93.08 1.82 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.476 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.53 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.2 OUTLIER -113.26 109.73 19.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.88 0.372 . . . . 0.0 110.918 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.408 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 30.8 t70 67.74 53.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.523 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 17.1 p-80 47.4 26.6 0.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.51 162.08 30.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.589 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -93.09 98.02 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.487 HD11 ' CG1' ' A' ' 243' ' ' VAL . 32.3 tp -62.85 138.79 58.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.861 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -119.31 132.15 55.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.82 HG22 HG22 ' A' ' 243' ' ' VAL . 87.0 t -137.22 154.06 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.128 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 312' ' ' VAL . 8.7 pt-20 -165.24 156.29 14.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.502 ' CD1' HD13 ' A' ' 297' ' ' ILE . 66.2 m95 -57.74 136.33 56.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 317' ' ' PRO . . . -99.35 126.33 45.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.134 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.484 ' HE3' ' N ' ' A' ' 236' ' ' ASP . 4.6 tptt -101.74 101.43 17.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 315' ' ' ALA . 61.1 Cg_endo -74.94 167.45 27.04 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.332 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 319' ' ' THR . 12.3 t -112.66 -41.41 3.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.876 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.42 ' C ' ' O ' ' A' ' 318' ' ' SER . 67.9 p 36.1 40.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.158 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -113.54 106.5 14.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.4 p -155.57 176.02 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.822 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 156.46 146.27 4.42 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.44 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -77.18 168.68 22.75 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.694 2.263 . . . . 0.0 112.407 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 2.9 t -147.16 106.6 3.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 50.8 m -90.5 124.05 34.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.471 -179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 42.2 t -169.56 141.92 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 110.842 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.0 p -76.05 173.32 11.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -168.2 -52.84 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.466 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 58.6 m -40.19 106.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.838 0.351 . . . . 0.0 110.893 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.7 t -166.96 150.98 6.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 93.35 -159.51 24.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.506 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.96 146.84 26.28 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.672 2.248 . . . . 0.0 112.37 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -111.43 85.01 2.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -149.19 163.64 37.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.81 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -126.34 38.95 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -128.58 114.06 16.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -145.44 134.68 22.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.83 -46.66 4.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -95.23 145.79 24.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -79.92 90.94 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 7.1 m -136.63 144.51 44.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 36.1 pt -144.35 141.52 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.462 ' HB2' ' CE2' ' A' ' 284' ' ' PHE . 69.4 ttt180 -100.56 149.03 24.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 312' ' ' VAL . 98.0 t -132.06 142.92 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 70.7 p -135.14 174.52 10.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 3.2 m-20 64.18 48.13 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.682 HD22 HG21 ' A' ' 250' ' ' THR . 19.2 mt -103.4 168.76 8.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 44.3 p -118.87 154.94 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -50.86 -46.57 60.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -57.36 -19.25 21.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.682 HG21 HD22 ' A' ' 246' ' ' LEU . 26.2 m -90.08 98.93 12.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.1 mtt-85 -106.42 -175.74 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -55.56 -55.91 26.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.8 t -55.21 -20.02 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.142 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.89 -28.69 25.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 mt -88.66 -27.26 21.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.475 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 12.6 tt0 -61.92 -31.12 71.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -88.53 -18.14 28.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.59 -38.56 23.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.783 ' HB2' HD11 ' A' ' 265' ' ' ILE . 71.8 m-85 -95.68 11.59 32.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.5 tpt180 -78.31 -45.26 2.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.598 0.714 . . . . 0.0 110.849 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.5 Cg_exo -47.96 -17.16 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.639 2.226 . . . . 0.0 112.415 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.565 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -93.31 -31.71 14.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 163.59 -163.98 36.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.537 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -90.02 109.52 20.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.797 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 259' ' ' PHE . 72.3 mt -66.07 148.54 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.434 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.0 t -95.16 -43.42 8.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -154.43 149.08 26.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 72.6 mt -134.59 100.78 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.2 t80 -92.83 151.72 19.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.66 HD23 ' HE3' ' A' ' 272' ' ' LYS . 51.8 tp -140.54 145.99 37.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.683 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -97.9 132.01 43.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.66 ' HE3' HD23 ' A' ' 270' ' ' LEU . 5.6 mptt -133.45 162.78 30.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -91.38 174.12 7.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -113.38 -52.94 2.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.7 m -60.38 -54.81 41.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.156 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -89.39 -18.96 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.05 82.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.452 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 279' ' ' SER . 32.1 mt-30 -118.67 126.7 52.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.81 0.338 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 278' ' ' GLN . 2.2 m -36.53 128.01 0.81 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -57.95 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.926 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 154.79 33.93 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.683 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 43.8 p90 -162.7 148.33 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.889 0.376 . . . . 0.0 110.891 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -142.29 173.91 11.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 242' ' ' ARG . 71.1 m-85 -136.02 113.02 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -98.25 124.84 51.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -106.46 115.16 29.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 15.7 m-85 -88.73 -180.0 6.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.6 m-70 -95.53 -38.72 10.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.84 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.03 167.53 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 38.4 ttp85 -73.53 -32.87 64.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -66.26 -64.25 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -48.8 -35.95 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.45 -42.86 74.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -67.45 -39.29 85.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 15.9 mtp85 -47.05 -41.82 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -64.43 -67.95 0.39 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.601 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.5 mt -35.71 -32.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -68.98 -47.31 65.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.15 -62.2 2.02 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.475 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 259' ' ' PHE . 22.4 m -41.26 -37.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 0.0 111.135 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 36.7 p -56.2 112.27 1.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.858 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.4 32.51 38.1 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.441 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -89.71 145.51 25.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.879 0.371 . . . . 0.0 110.856 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -95.81 78.79 0.8 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -96.62 134.66 39.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.872 0.368 . . . . 0.0 110.904 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 2.1 t70 44.94 52.88 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.462 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 34.0 p-80 45.59 33.77 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 309' ' ' ILE . 59.3 mt -135.03 167.4 21.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.2 mp -95.52 97.88 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.7 tp -73.67 138.78 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -123.48 144.89 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.676 HG22 HG22 ' A' ' 243' ' ' VAL . 29.6 t -143.75 145.5 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -150.99 171.0 17.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.601 ' CD1' HD13 ' A' ' 297' ' ' ILE . 57.9 m95 -79.25 131.78 36.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -100.88 126.35 47.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -136.1 104.33 9.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.616 0.722 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.52 165.55 31.42 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.364 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 50.7 p -82.19 -62.58 1.59 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.4 m -70.5 133.96 47.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 45.1 p-10 -95.09 109.61 21.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.8 p -81.87 116.61 21.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -159.73 -178.92 34.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.448 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.99 103.42 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 137.2 36.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.6 t -131.82 157.24 44.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.504 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.6 t -119.77 145.34 46.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.868 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.7 t -48.18 -62.24 1.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.865 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.8 -173.8 18.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.518 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 61.9 p -111.29 81.87 1.51 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.881 0.372 . . . . 0.0 110.811 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 43.1 t -74.98 143.1 43.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.831 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 98.84 70.96 0.99 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.507 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.22 146.38 25.13 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -123.76 165.0 18.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.836 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -129.35 104.14 7.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -156.5 107.15 2.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.46 38.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.062 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -165.6 149.52 8.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -65.87 90.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -169.74 -179.93 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 287' ' ' PHE . . . -78.75 102.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.082 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.1 m -138.61 138.27 37.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 297' ' ' ILE . 43.0 pt -137.28 140.15 42.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.579 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 14.5 ttt85 -100.96 149.23 24.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.878 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 312' ' ' VAL . 84.0 t -136.65 143.56 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 62.1 p -138.2 166.31 24.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 22.5 t-20 74.05 38.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 32.3 mt -90.75 177.08 6.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -130.94 166.02 21.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -70.68 -16.54 62.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.98 9.83 11.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -132.94 111.39 10.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.66 -176.33 2.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -48.77 -59.1 3.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -54.66 -26.7 34.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -76.97 -30.67 56.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 36.1 mt -86.69 -29.83 22.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.475 ' O ' ' NE2' ' A' ' 256' ' ' GLN . 21.9 tp60 -56.25 -29.48 61.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -90.3 -15.65 30.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.3 tp -84.31 -37.88 21.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.962 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.583 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.7 m-85 -96.68 11.31 35.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.858 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.594 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.8 OUTLIER -79.7 -45.24 1.56 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.712 . . . . 0.0 110.883 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.88 -17.34 0.75 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.698 2.265 . . . . 0.0 112.386 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.571 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 32.3 m-85 -95.31 -34.27 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.08 -159.9 33.28 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.92 135.05 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.342 . . . . 0.0 110.875 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.494 HG21 HG12 ' A' ' 268' ' ' ILE . 54.6 mt -93.61 138.88 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 48.3 t -92.6 -48.76 6.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 15.7 tpp180 -143.38 148.53 36.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 265' ' ' ILE . 45.9 mt -132.96 108.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.486 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -95.62 144.07 26.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 58.0 tp -131.08 119.35 21.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.546 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.57 113.44 2.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 10.2 mmtp -129.14 146.66 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.29 -177.87 0.75 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -122.69 -16.65 7.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.896 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 92.0 m -102.23 -50.44 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -95.41 -9.05 33.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 54.79 33.64 56.03 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -99.5 178.57 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 27.6 p -89.29 121.84 31.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -62.13 -74.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 157.94 33.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.488 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 27.6 p90 -166.13 148.34 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -139.82 165.87 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.579 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 84.8 m-85 -133.18 115.66 15.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -101.99 131.82 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.167 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 4.4 m -109.05 113.05 25.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.456 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . 13.5 m-85 -84.48 177.11 8.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.461 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 13.6 m-70 -93.51 -30.54 14.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -122.8 171.37 9.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -83.72 -28.61 28.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -72.53 -56.57 5.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 292' ' ' ASP . 1.0 OUTLIER -53.18 -35.12 59.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.828 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -65.65 -38.82 90.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.127 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.43 72.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -48.18 -42.59 30.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.95 -63.81 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.081 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 314' ' ' TRP . 86.3 mt -38.31 -32.22 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.167 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.49 -41.89 62.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -84.85 -63.92 1.58 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.514 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.583 HG11 ' CE2' ' A' ' 259' ' ' PHE . 14.0 m -40.55 -37.98 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 111.162 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 75.4 p -57.04 128.59 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.851 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 66.94 19.06 69.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.472 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -80.89 153.14 27.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 0.0 110.904 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -101.36 94.27 1.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.68 123.62 50.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.894 0.378 . . . . 0.0 110.892 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 10.6 t70 56.4 49.39 15.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 34.8 p-80 48.6 35.62 6.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 309' ' ' ILE . 71.8 mt -138.5 167.41 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -95.48 103.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -77.12 131.22 38.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.52 138.98 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.994 HG22 HG22 ' A' ' 243' ' ' VAL . 99.0 t -142.87 145.73 22.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.108 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -163.51 149.11 11.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.558 ' CD1' HD13 ' A' ' 297' ' ' ILE . 92.5 m95 -52.38 120.0 5.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.81 -41.22 23.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.153 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -104.71 142.92 25.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.621 0.724 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.04 -48.57 14.3 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.5 t 66.65 39.77 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -56.37 -48.77 76.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.149 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -79.93 86.89 5.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 12.2 t -111.3 86.21 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.91 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 124.33 153.12 8.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.66 149.0 2.09 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 46.6 t -59.2 99.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.8 t -133.78 141.0 47.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.846 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 226' ' ' SER . 65.3 m -59.05 118.46 5.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.849 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 225' ' ' SER . 30.9 t 36.3 46.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.86 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 69.32 53.65 16.7 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.466 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.8 t -91.85 113.62 25.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.2 m -135.12 145.82 48.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.836 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 173.66 80.76 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.1 107.84 2.51 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.681 2.254 . . . . 0.0 112.345 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.04 -62.48 1.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -164.62 159.39 18.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.05 150.31 13.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -87.63 -39.6 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -38.9 134.16 1.03 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -123.04 -61.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -97.05 167.41 11.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -88.1 94.34 9.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 9.8 m -137.46 145.15 42.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 297' ' ' ILE . 17.0 pt -141.94 145.11 24.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.54 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 38.0 ttt180 -105.47 156.36 18.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 312' ' ' VAL . 97.8 t -140.47 138.71 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 76.0 p -132.69 161.99 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 25.8 t30 74.53 48.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 250' ' ' THR . 31.2 mt -103.67 146.1 29.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.423 ' HB2' ' CG ' ' A' ' 306' ' ' ASP . 1.3 t -85.52 156.94 20.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.13 -6.74 18.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -98.6 9.34 43.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.417 HG21 HD22 ' A' ' 246' ' ' LEU . 54.3 m -115.6 106.8 14.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.173 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 13.2 mtp180 -105.88 174.47 5.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.831 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -47.61 -59.79 3.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.2 t -54.14 -21.86 9.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -79.8 -30.47 40.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.892 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 32.7 mt -90.4 -26.63 19.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.2 pt20 -56.19 -26.33 50.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -91.54 -18.01 24.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.549 HD23 ' CE1' ' A' ' 259' ' ' PHE . 12.2 tp -82.12 -36.58 27.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 258' ' ' LEU . 68.9 m-85 -98.47 11.7 37.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.591 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -79.39 -45.3 1.65 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.604 0.716 . . . . 0.0 110.893 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.2 Cg_exo -47.93 -17.59 0.84 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.694 2.263 . . . . 0.0 112.363 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.568 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.0 m-85 -93.58 -32.18 14.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.16 -166.14 39.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.485 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.9 m -90.99 106.86 18.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.9 mt -59.94 150.52 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.547 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.0 t -98.82 -46.52 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 268' ' ' ILE . 8.4 tpp180 -149.87 146.23 26.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.436 ' N ' ' HG3' ' A' ' 267' ' ' ARG . 47.1 mt -126.55 106.92 16.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.4 t80 -99.04 149.69 22.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.58 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 56.0 tp -140.75 129.08 22.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.651 ' CB ' ' CE2' ' A' ' 282' ' ' PHE . . . -74.65 110.51 9.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.1 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -131.85 135.9 47.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -76.57 133.12 39.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -85.32 -37.24 20.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 46.5 m -64.81 -34.67 78.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 7.7 p -105.4 -50.41 3.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.129 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 101.55 28.59 6.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -114.28 172.79 6.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.93 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 31.7 t -93.68 113.63 25.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.581 ' HB3' ' CE1' ' A' ' 282' ' ' PHE . 34.4 mmtt -42.58 -69.26 0.14 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 149.18 32.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.452 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.651 ' CE2' ' CB ' ' A' ' 271' ' ' ALA . 7.6 p90 -166.32 161.39 16.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.885 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -149.48 165.54 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 74.2 m-85 -132.03 111.52 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -94.81 129.05 45.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.3 m -106.62 118.47 36.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.864 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -92.24 179.48 5.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.591 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.1 m-70 -95.99 -35.88 11.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -123.69 165.05 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -71.11 -37.96 72.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.829 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -60.38 -69.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -44.72 -34.32 2.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.04 85.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.076 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.04 -36.2 77.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.086 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -50.48 -40.95 52.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -66.11 -66.79 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.066 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 312' ' ' VAL . 84.9 mt -38.83 -40.53 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.1 -56.59 19.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -71.04 -65.25 2.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.446 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.732 HG21 HG21 ' A' ' 312' ' ' VAL . 7.2 m -39.93 -42.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.812 0.339 . . . . 0.0 111.104 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.48 ' N ' HG23 ' A' ' 300' ' ' VAL . 10.5 t -49.4 116.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.21 62.78 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.478 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -78.63 155.27 29.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.847 0.356 . . . . 0.0 110.908 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.12 76.9 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 0.4 OUTLIER -93.31 130.25 39.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.582 ' OD1' HD12 ' A' ' 308' ' ' LEU . 0.8 OUTLIER 47.19 54.13 9.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.496 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 29.0 p-80 48.46 33.18 3.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.851 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.582 HD12 ' OD1' ' A' ' 306' ' ' ASP . 62.0 mt -136.4 164.05 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.903 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.581 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.8 OUTLIER -95.44 95.18 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 11.9 tp -63.74 134.65 55.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -118.21 130.8 56.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.999 HG22 HG22 ' A' ' 243' ' ' VAL . 91.7 t -130.6 142.29 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.101 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -145.35 172.44 13.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.863 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.416 ' CD1' HD13 ' A' ' 297' ' ' ILE . 59.0 m95 -81.47 125.18 30.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -99.89 145.34 27.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -174.84 105.01 0.26 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.589 0.709 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.57 95.77 1.02 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.366 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 99.8 p -55.0 -41.81 71.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.844 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 41.8 p -79.68 107.81 12.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -110.06 139.01 45.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 6.1 t -125.34 94.37 4.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -49.68 172.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.454 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.1 -175.85 2.88 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.727 2.284 . . . . 0.0 112.358 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 16.2 t -134.74 87.19 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 31.3 m -116.51 155.42 28.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.857 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.508 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.2 t -167.99 158.53 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.869 0.366 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 96.1 p -137.46 177.29 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.84 -159.74 8.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 44.9 m -148.65 167.61 25.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 0.0 110.837 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.2 t -146.66 145.25 29.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -176.72 78.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.91 0.71 9.38 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.724 2.282 . . . . 0.0 112.35 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -81.36 -175.81 5.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 233' ' ' ARG . 0.0 OUTLIER -141.75 128.35 20.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.829 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 233' ' ' ARG . 96.9 mtt180 35.44 51.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -88.27 -48.6 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -45.08 110.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.48 -45.0 48.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.865 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -130.32 169.11 15.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -81.35 95.94 7.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 315' ' ' ALA . 14.5 m -132.76 143.46 49.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 297' ' ' ILE . 27.6 pt -136.98 145.98 29.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -107.14 147.7 29.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 312' ' ' VAL . 54.1 t -129.45 140.46 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.1 p -138.09 165.8 25.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.18 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 21.1 t30 66.21 48.26 1.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.667 HD22 HG21 ' A' ' 250' ' ' THR . 22.2 mt -93.83 177.88 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.905 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 29.5 t -115.69 159.08 21.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -65.74 -14.18 60.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.22 19.9 15.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.667 HG21 HD22 ' A' ' 246' ' ' LEU . 49.9 m -118.98 98.57 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.144 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -100.48 177.0 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -52.91 -42.57 65.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.6 t -68.1 -25.39 65.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.67 -23.75 53.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.8 mt -95.96 -32.57 12.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 5.3 pt20 -52.09 -33.91 41.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -87.56 -15.61 36.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 12.2 tp -81.49 -38.72 25.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.947 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.62 ' HB2' HD11 ' A' ' 265' ' ' ILE . 95.6 m-85 -95.48 11.33 33.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.614 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 7.9 tpt180 -79.03 -43.97 1.74 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.625 0.726 . . . . 0.0 110.874 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.2 Cg_exo -47.93 -18.57 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.741 2.294 . . . . 0.0 112.306 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 30.4 m-85 -94.76 -34.39 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 170.98 -161.55 34.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.519 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.577 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 15.1 m -94.28 117.77 30.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.62 HD11 ' HB2' ' A' ' 259' ' ' PHE . 54.5 mt -71.57 144.98 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.512 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.6 t -95.27 -41.9 8.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.801 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -152.07 149.71 29.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 52.1 mt -130.68 105.6 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.6 t80 -98.46 141.46 31.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.0 tp -132.32 131.81 42.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.646 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -71.57 125.59 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -137.01 152.14 49.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -87.95 -178.22 5.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -109.71 -54.11 2.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 62.5 m -52.49 -72.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 2.0 t -76.57 -21.42 55.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.174 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 63.56 35.72 92.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -108.25 168.5 9.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.847 0.356 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 42.3 t -72.4 129.35 38.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -63.38 -74.94 0.09 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.9 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.86 32.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.646 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 8.2 p90 -165.96 159.75 16.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.476 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -150.97 165.13 34.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -132.08 116.06 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.599 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.7 mp -99.48 125.85 52.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 16.4 m -102.21 116.93 33.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.9 m-85 -88.71 -178.61 5.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.891 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 264' ' ' SER . 11.3 m-70 -97.22 -37.98 9.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 23.9 mtt180 -126.37 139.98 52.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 31.8 ttp85 -51.23 -28.23 11.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -66.0 -68.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.0 -30.11 9.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.569 ' HB2' ' HB1' ' A' ' 239' ' ' ALA . . . -67.8 -38.24 83.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.093 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -71.78 -35.31 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.067 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -50.74 -41.04 56.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.566 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -70.0 -66.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.992 HD11 HG22 ' A' ' 241' ' ' ILE . 82.9 mt -38.2 -34.52 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.123 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -76.15 -51.12 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -69.53 -59.56 5.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.701 HG21 HG21 ' A' ' 312' ' ' VAL . 15.3 m -49.38 -26.24 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.6 t -62.42 109.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.31 27.21 31.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.524 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -83.11 154.7 24.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.888 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -97.06 78.94 0.68 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.49 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.22 120.77 38.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.946 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.532 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 4.1 t70 51.16 52.62 14.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.842 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 27.9 p-80 48.74 26.98 1.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 66.4 mt -129.55 164.0 24.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.7 OUTLIER -94.96 98.0 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.02 146.07 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -120.31 138.31 53.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.765 HG22 HG22 ' A' ' 243' ' ' VAL . 89.4 t -146.41 151.06 14.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.089 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -167.02 152.1 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.465 ' HZ2' ' HB2' ' A' ' 294' ' ' ALA . 78.1 m95 -55.3 126.11 23.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' A' ' 240' ' ' THR . . . -93.8 155.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.06 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.85 104.98 2.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 110.859 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.04 151.44 39.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.259 . . . . 0.0 112.345 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.4 t -54.72 -49.95 69.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 76.2 p -51.33 125.39 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -80.69 -59.95 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.5 m -115.9 100.35 7.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -75.27 -92.45 0.18 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.499 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.06 129.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.1 t -153.8 166.57 32.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 59.5 p -140.74 134.82 30.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.541 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 58.7 m -133.8 136.64 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 64.3 p -122.99 -50.69 1.92 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 71.18 170.5 10.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 44.0 m -141.41 120.07 12.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.7 p -154.44 125.25 7.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.828 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -163.22 78.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.481 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.6 136.65 12.23 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.684 2.256 . . . . 0.0 112.323 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -123.33 165.79 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -145.17 136.82 25.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 76.9 mtm-85 -66.05 -57.45 7.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -104.29 153.33 21.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.53 127.2 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -120.06 -54.88 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.809 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -125.63 156.22 39.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -79.85 104.94 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 6.9 m -141.85 135.7 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 41.1 pt -132.77 142.28 42.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -102.21 149.02 24.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 312' ' ' VAL . 94.7 t -135.9 139.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 53.1 p -138.55 167.63 21.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 19.7 t-20 73.13 41.96 0.47 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.511 HD22 HG21 ' A' ' 250' ' ' THR . 31.0 mt -92.27 -175.16 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.5 t -125.49 170.3 11.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -74.87 -6.7 50.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.98 22.14 16.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.511 HG21 HD22 ' A' ' 246' ' ' LEU . 99.6 m -131.11 96.43 4.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.149 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.56 ' CG ' HG22 ' A' ' 253' ' ' THR . 11.7 ptt180 -107.09 -177.38 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -45.7 -50.33 13.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.56 HG22 ' CG ' ' A' ' 251' ' ' ARG . 1.4 t -59.51 -28.6 67.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.95 -27.03 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 13.7 mt -95.06 -20.35 19.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.418 ' HB2' HD12 ' A' ' 268' ' ' ILE . 11.5 tt0 -64.94 -33.81 76.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -93.2 -11.68 32.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.93 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.458 HD22 ' HE2' ' A' ' 305' ' ' TYR . 28.7 tp -82.78 -41.22 19.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.601 ' CE2' HG11 ' A' ' 300' ' ' VAL . 64.2 m-85 -96.76 11.91 33.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.588 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 3.7 ttt-85 -77.52 -45.32 2.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.632 0.729 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.87 -17.42 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.705 2.27 . . . . 0.0 112.395 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.8 m-85 -92.74 -31.21 15.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.72 -164.13 37.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.594 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 31.3 m -91.12 107.43 19.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 259' ' ' PHE . 82.8 mt -61.35 141.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.133 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.531 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.9 t -94.05 -45.81 7.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -150.27 149.17 29.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.905 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.525 ' CG1' HG21 ' A' ' 265' ' ' ILE . 46.9 mt -133.47 113.2 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.103 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 5.1 t80 -104.12 147.39 27.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.5 tp -134.74 128.9 33.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.587 ' CB ' ' CZ ' ' A' ' 282' ' ' PHE . . . -72.99 129.45 38.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -135.43 175.59 9.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.53 170.67 8.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -113.43 -5.54 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.5 m -101.31 -35.9 9.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.164 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.8 t -121.22 -10.52 8.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.46 32.71 84.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.454 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -104.99 163.22 12.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.885 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 15.0 m -69.66 142.16 53.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -82.05 -74.9 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 166.83 31.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.499 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.587 ' CZ ' ' CB ' ' A' ' 271' ' ' ALA . 11.4 p90 -165.49 150.39 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.351 . . . . 0.0 110.888 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -142.29 162.55 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -127.23 117.9 23.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -103.26 129.1 55.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -107.9 124.89 50.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -98.17 179.96 4.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.594 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.5 m-70 -93.78 -36.34 12.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -124.25 179.76 4.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -88.87 -17.56 29.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -76.52 -59.36 2.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.843 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.11 -24.77 64.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.27 62.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.1 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -72.03 -35.73 69.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -49.66 -42.05 44.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.847 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.14 -62.78 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.073 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.555 HD12 ' NE1' ' A' ' 314' ' ' TRP . 71.3 mt -39.92 -37.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -71.76 -39.97 69.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.101 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -82.47 -59.46 2.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.528 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 296' ' ' ALA . 6.8 m -49.41 -30.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.351 . . . . 0.0 111.123 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 11.3 p -62.97 120.86 12.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 75.05 20.34 79.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.542 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -78.18 156.39 29.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -103.52 76.97 0.28 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.458 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.2 OUTLIER -99.06 120.95 40.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.872 0.368 . . . . 0.0 110.954 -179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 56.79 49.38 14.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.585 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 18.1 p-80 45.83 31.12 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.454 ' C ' HD12 ' A' ' 309' ' ' ILE . 34.5 mt -132.03 166.86 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.569 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -95.41 102.12 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.413 HD11 ' CG1' ' A' ' 243' ' ' VAL . 15.4 tp -71.81 134.62 46.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -114.67 130.29 56.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 243' ' ' VAL . 97.6 t -136.19 144.9 31.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.138 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -159.48 157.77 30.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.555 ' NE1' HD12 ' A' ' 297' ' ' ILE . 80.1 m95 -62.95 123.63 19.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -112.5 103.8 11.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -82.22 112.61 37.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.558 0.694 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.64 176.33 10.23 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 0.0 112.343 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 84.3 p -144.57 166.2 25.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.829 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.0 t -145.59 129.29 17.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.107 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -121.04 83.42 2.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -163.6 139.27 6.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -120.85 155.0 16.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.485 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.96 161.47 32.95 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.345 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 86.7 p -110.89 -51.6 2.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.897 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 70.7 p -152.87 153.88 33.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.481 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 33.4 t -94.35 111.42 23.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.859 0.362 . . . . 0.0 110.849 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.7 m -118.77 107.1 13.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.864 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.35 108.02 0.25 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.483 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.1 t -115.7 41.47 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.371 . . . . 0.0 110.86 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 10.1 m -89.26 119.9 30.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -154.61 143.07 9.59 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.71 179.33 6.59 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.733 2.289 . . . . 0.0 112.339 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.64 -51.34 2.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.423 ' HB3' ' NH1' ' A' ' 233' ' ' ARG . 4.2 ptp180 -105.48 164.91 11.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -89.23 47.36 1.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -54.78 -49.73 70.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -51.64 138.65 22.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -102.37 -48.84 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -108.2 165.23 11.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 293' ' ' ALA . . . -92.08 107.7 19.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.095 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 19.2 m -142.89 145.01 32.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.159 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 37.6 pt -140.0 142.18 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.085 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 62.5 ttt180 -105.6 153.81 21.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 312' ' ' VAL . 91.4 t -138.3 142.76 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 61.6 p -138.16 167.5 21.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.13 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 73.59 43.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.78 177.57 6.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 85.3 p -121.54 -175.16 3.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.77 -1.86 58.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.24 18.8 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.508 ' OG1' ' CE1' ' A' ' 305' ' ' TYR . 53.0 m -127.61 111.56 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.117 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.92 179.08 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -52.1 -38.97 59.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -68.1 -18.91 64.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.182 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -86.6 -26.19 24.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.0 mt -91.61 -22.76 20.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -62.31 -35.32 78.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -92.45 -10.73 36.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' ' 259' ' ' PHE . 25.9 tp -85.79 -34.51 21.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.603 ' CE2' HG11 ' A' ' 300' ' ' VAL . 77.6 m-85 -104.69 11.46 34.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.581 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 1.7 tpt180 -80.25 -45.68 1.4 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 0.0 110.859 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.6 Cg_exo -47.95 -20.43 2.05 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 34.5 m-85 -88.84 -31.26 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 168.32 -160.97 34.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.486 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 18.7 m -91.39 118.66 30.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.02 136.25 25.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.184 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.3 t -87.32 -42.18 13.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -154.9 160.0 40.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.863 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.71 116.06 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.7 t80 -113.16 148.88 34.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.736 HD23 ' HE3' ' A' ' 272' ' ' LYS . 61.0 tp -139.87 127.32 21.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.59 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -73.2 123.45 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.11 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.736 ' HE3' HD23 ' A' ' 270' ' ' LEU . 51.3 mttt -136.15 146.03 46.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.891 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -73.17 177.22 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -114.7 -61.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 90.7 m -53.02 -41.41 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.172 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 t -102.01 -22.58 14.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.119 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 62.64 32.8 84.67 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.471 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -109.02 140.12 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 47.2 t -54.86 124.67 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.865 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -55.1 -74.86 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.01 33.15 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 36.5 p90 -165.97 146.46 6.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 110.868 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -133.5 164.18 27.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.131 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.502 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.2 m-85 -131.06 112.63 13.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.9 mp -100.13 127.82 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 7.3 m -102.14 120.77 40.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 10.5 m-85 -96.29 177.49 5.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 264' ' ' SER . 10.9 m-70 -96.5 -47.95 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -112.14 164.03 13.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 290' ' ' ARG . 13.4 ttp-105 -71.75 -31.58 66.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -66.6 -61.67 1.86 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.99 -37.17 52.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -68.04 -39.13 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.129 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -71.65 -37.41 70.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -49.25 -42.91 42.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.827 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -63.49 -67.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.086 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.563 HD13 ' CD1' ' A' ' 314' ' ' TRP . 85.8 mt -36.03 -32.42 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.127 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -70.98 -45.88 63.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.112 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -79.46 -64.96 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.487 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.5 m -40.01 -36.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.894 0.378 . . . . 0.0 111.164 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 64.6 p -61.37 112.37 2.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 87.88 17.65 57.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -79.51 157.87 27.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.907 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -105.93 82.28 0.33 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.508 ' CE1' ' OG1' ' A' ' 250' ' ' THR . 0.3 OUTLIER -99.39 129.74 45.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 110.929 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.449 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 0.5 OUTLIER 47.77 53.69 10.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.833 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 31.2 p-80 45.61 39.53 5.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 309' ' ' ILE . 77.5 mt -143.53 168.19 20.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 309' ' ' ILE . 1.1 mp -96.7 102.14 13.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.2 tp -70.19 138.04 51.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -118.27 132.18 56.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 1.081 HG22 HG22 ' A' ' 243' ' ' VAL . 79.4 t -137.06 143.4 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.157 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -153.53 161.89 41.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.866 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.563 ' CD1' HD13 ' A' ' 297' ' ' ILE . 65.4 m95 -65.25 125.27 24.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -109.93 134.86 51.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.115 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.89 106.9 40.54 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 0.0 110.928 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.41 103.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.345 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.8 t -78.76 114.77 17.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 22.0 m -115.05 -38.9 3.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -158.0 173.4 16.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.6 t -122.89 119.69 31.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -156.15 146.08 13.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.519 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -77.63 2.85 7.4 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.679 2.253 . . . . 0.0 112.374 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 64.3 m -90.01 122.6 33.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 72.9 m -75.01 162.26 28.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.488 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 26.0 m -79.75 -54.09 6.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 p -117.79 -41.53 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 73.64 -166.13 54.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 40.3 t -80.56 97.56 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.87 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.5 m 48.09 48.57 18.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.857 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -80.82 -157.31 16.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.511 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.11 179.97 6.0 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.718 2.278 . . . . 0.0 112.35 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 37.35 50.91 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -78.29 -43.43 28.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -45.78 133.41 8.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -40.4 -45.24 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.08 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -99.12 126.73 44.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -111.32 -49.32 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -169.11 177.94 4.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -76.35 105.43 7.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 3.4 m -139.36 144.05 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 297' ' ' ILE . 34.4 pt -138.62 144.06 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.549 ' O ' HG13 ' A' ' 312' ' ' VAL . 61.6 ttt-85 -100.79 152.84 20.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 312' ' ' VAL . 54.6 t -138.77 140.52 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.418 ' O ' HD12 ' A' ' 310' ' ' LEU . 70.8 p -133.65 169.47 16.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.62 53.12 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 19.8 mt -103.53 166.38 10.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 21.0 p -111.69 155.33 23.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.28 -5.82 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.911 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 19.59 16.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 24.0 m -131.1 99.62 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -103.57 -175.29 2.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -51.04 -40.79 59.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.469 HG23 ' OD1' ' A' ' 254' ' ' ASP . 11.7 t -67.95 -30.89 70.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.152 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 253' ' ' THR . 0.9 OUTLIER -76.72 -28.53 55.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 11.0 mt -89.74 -26.56 20.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.56 -32.29 73.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -89.66 -15.13 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 14.4 tp -85.79 -35.72 20.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 300' ' ' VAL . 83.6 m-85 -100.92 8.57 43.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.624 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.6 OUTLIER -80.86 -42.86 1.23 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.568 0.699 . . . . 0.0 110.843 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 63.5 Cg_exo -47.91 -17.98 0.96 Allowed 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.688 2.259 . . . . 0.0 112.365 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.2 m-85 -92.84 -31.8 14.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 169.92 -163.15 36.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.556 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 49.0 m -91.28 116.33 28.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.862 0.363 . . . . 0.0 110.841 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . . . . . . . . . 34.4 mt -73.89 147.96 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.567 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 23.2 t -98.68 -43.14 6.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 56.8 ttp85 -151.57 153.89 35.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 89.1 mt -138.46 122.2 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 3.5 t80 -112.6 149.54 32.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 68.8 tp -135.49 127.43 29.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -69.42 121.59 17.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -128.74 150.59 50.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.21 -176.74 6.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -111.2 -62.7 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 28.9 m -47.22 -69.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 278' ' ' GLN . 10.2 t -77.37 -34.01 55.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.76 39.46 39.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.411 ' H ' HG23 ' A' ' 276' ' ' THR . 21.6 mt-30 -111.21 -176.9 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.351 . . . . 0.0 110.921 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 35.1 t -80.44 126.04 30.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 22.2 mmmt -66.68 -74.66 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 163.85 32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.464 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.665 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 19.8 p90 -166.02 151.26 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.923 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.83 165.19 28.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.104 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -129.42 116.56 19.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.6 mp -105.8 131.89 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 2.1 m -110.92 121.32 45.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.673 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.7 m-85 -94.63 -178.87 4.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.567 ' CD2' ' HB2' ' A' ' 266' ' ' SER . 14.3 m-70 -95.25 -35.91 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . 0.437 ' NH1' ' OD2' ' A' ' 292' ' ' ASP . 18.0 mtt85 -124.68 169.45 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 28.2 ttt85 -80.71 -23.48 39.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.5 -46.17 27.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.437 ' OD2' ' NH1' ' A' ' 289' ' ' ARG . 15.7 m-20 -67.15 -35.28 79.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.673 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -69.37 -37.28 77.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.106 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -69.55 -38.82 77.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -48.65 -42.63 35.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -65.85 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.083 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 314' ' ' TRP . 89.8 mt -35.42 -37.73 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.95 -54.58 17.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -67.05 -66.97 2.15 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 312' ' ' VAL . 30.0 m -42.97 -37.6 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 1.7 t -50.81 113.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.47 24.85 60.03 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.538 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -86.3 137.78 32.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -88.41 97.06 2.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.2 116.88 30.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.522 ' O ' ' CG ' ' A' ' 307' ' ' HIS . 14.9 t70 63.13 53.41 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 306' ' ' ASP . 28.7 p-80 48.8 26.61 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 309' ' ' ILE . 35.1 mt -129.8 165.82 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 0.9 OUTLIER -97.98 101.1 11.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 244' ' ' THR . 14.0 tp -73.32 137.65 44.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -122.5 150.69 42.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.945 HG22 HG22 ' A' ' 243' ' ' VAL . 48.5 t -149.1 142.01 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.74 153.22 29.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.527 ' CD1' HD13 ' A' ' 297' ' ' ILE . 83.5 m95 -61.79 125.95 25.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -57.81 -31.96 67.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.086 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.445 ' NZ ' HG22 ' A' ' 319' ' ' THR . 0.0 OUTLIER -104.15 153.18 39.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.581 0.705 . . . . 0.0 110.905 179.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 318' ' ' SER . 58.8 Cg_endo -71.88 102.51 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' PRO . 96.4 p -35.63 141.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.445 HG22 ' NZ ' ' A' ' 316' ' ' LYS . 9.5 t -153.96 147.24 24.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.166 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -63.83 105.93 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 19.7 t -143.72 130.92 20.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.98 85.02 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.455 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.31 -28.6 5.55 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.267 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 98.0 p -93.1 171.43 8.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.1 t 66.03 42.32 3.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 49.3 m -107.31 90.6 3.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 0.0 110.869 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.0 t -115.07 163.23 15.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 128.98 79.18 0.23 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.509 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 88.6 p -103.78 97.77 7.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.823 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.5 m -145.38 146.22 31.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.858 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.78 81.14 0.84 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.01 110.59 3.06 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -148.23 162.72 38.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.25 92.68 8.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -79.06 105.03 10.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -76.0 -42.63 47.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 7.0 t70 47.55 42.41 14.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.854 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.75 -61.13 2.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.53 166.95 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 287' ' ' PHE . . . -103.96 105.64 15.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 65.1 m -143.08 140.19 30.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 297' ' ' ILE . 30.0 pt -138.81 140.97 37.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.479 ' HG3' ' CE2' ' A' ' 284' ' ' PHE . 55.8 ttt180 -103.36 146.94 27.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 312' ' ' VAL . 89.9 t -132.74 142.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 74.3 p -136.93 167.1 22.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.121 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 72.28 43.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 24.8 mt -90.96 176.94 6.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.893 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.401 ' CB ' ' CG ' ' A' ' 306' ' ' ASP . 15.9 t -124.63 151.99 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.861 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -54.74 -28.38 48.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.75 18.85 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 89.5 m -132.67 98.07 4.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.563 ' HG3' HG22 ' A' ' 253' ' ' THR . 7.5 ptt180 -109.3 -174.41 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -45.57 -62.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.921 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.563 HG22 ' HG3' ' A' ' 251' ' ' ARG . 5.2 t -46.89 -34.99 5.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.02 -31.15 65.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.822 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.4 mt -86.33 -25.79 25.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 268' ' ' ILE . 25.5 tt0 -62.72 -35.9 81.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.882 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.56 -25.65 30.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.495 HD22 ' CE2' ' A' ' 305' ' ' TYR . 14.2 tp -74.94 -39.52 61.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.713 ' HB2' HD11 ' A' ' 265' ' ' ILE . 77.0 m-85 -95.96 12.02 31.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -77.82 -45.37 2.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.607 0.717 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.4 Cg_exo -47.93 -17.6 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.677 2.251 . . . . 0.0 112.349 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.569 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 40.0 m-85 -91.02 -40.01 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 171.27 -160.53 32.78 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.602 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.2 m -92.17 107.6 19.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 0.0 110.858 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.713 HD11 ' HB2' ' A' ' 259' ' ' PHE . 55.1 mt -64.86 143.05 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.566 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 10.3 t -91.85 -49.64 6.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -141.02 150.29 42.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 256' ' ' GLN . 80.0 mt -134.99 101.29 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.491 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 2.5 t80 -92.66 142.77 27.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.639 HD23 ' CE ' ' A' ' 272' ' ' LYS . 53.8 tp -129.47 128.48 43.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.617 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -62.4 115.58 4.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.106 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.639 ' CE ' HD23 ' A' ' 270' ' ' LEU . 97.1 mttt -136.95 134.93 37.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -89.87 162.56 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 275' ' ' THR . 4.4 ptmt -100.37 -35.11 9.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.459 ' N ' ' HG3' ' A' ' 274' ' ' LYS . 93.7 m -74.95 -41.46 59.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 31.1 p -94.16 -38.55 11.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.17 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 72.28 44.23 43.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -136.18 179.26 6.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 39.9 m -85.59 109.1 18.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -48.92 -66.88 0.32 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 151.25 33.79 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.502 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.617 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 52.7 p90 -165.97 147.52 6.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -138.23 174.36 10.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.077 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 78.1 m-85 -139.88 115.13 9.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -101.37 124.05 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 13.9 m -102.71 112.25 24.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.866 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 11.1 m-85 -84.95 169.85 13.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.893 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -85.92 -39.89 16.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.798 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -118.37 173.19 6.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -78.92 -39.12 35.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -60.87 -61.59 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -49.87 -38.63 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -66.56 -45.98 77.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.27 98.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.078 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -48.33 -42.03 30.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.75 -71.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 301' ' ' SER . 87.4 mt -34.23 -42.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.27 81.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.074 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -76.28 -66.08 1.91 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.622 HG11 ' CE2' ' A' ' 259' ' ' PHE . 26.1 m -42.25 -43.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.483 ' N ' HG23 ' A' ' 300' ' ' VAL . 13.0 t -48.9 104.47 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 90.33 33.62 8.59 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.516 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -96.33 130.89 43.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -79.08 52.62 4.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.495 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -75.47 128.03 34.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.85 0.357 . . . . 0.0 110.907 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.514 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 53.9 m-20 62.2 54.35 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.882 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.91 31.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 306' ' ' ASP . 82.9 mt -140.04 168.49 19.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.4 mp -89.58 97.96 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.14 140.15 52.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.92 144.47 48.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.853 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.98 HG22 HG22 ' A' ' 243' ' ' VAL . 71.5 t -150.65 150.05 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -166.11 165.58 17.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.413 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 85.5 m95 -66.99 125.38 25.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.887 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -118.87 117.35 28.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.49 ' HD2' ' N ' ' A' ' 317' ' ' PRO . 0.4 OUTLIER -163.42 133.25 3.18 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 0.0 110.89 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.49 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 62.1 Cg_endo -76.87 120.71 5.57 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.722 2.281 . . . . 0.0 112.352 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 5.0 m -86.52 48.8 1.69 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.893 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 t -81.95 41.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.13 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 49.95 41.43 22.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 14.1 t -90.82 137.83 32.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -168.59 157.54 29.73 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.448 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.56 101.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 12.4 m -56.7 -58.13 9.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.87 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.1 p -67.52 130.02 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 8.6 t -159.45 140.09 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 110.869 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.9 m -153.85 166.11 33.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.842 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -172.91 117.29 0.65 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.48 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 16.1 m -99.19 164.99 11.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.899 0.38 . . . . 0.0 110.858 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.5 m -139.25 134.46 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.859 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 43.76 95.24 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.03 -1.55 11.73 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.681 2.254 . . . . 0.0 112.298 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -61.2 103.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.87 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 233' ' ' ARG . 0.1 OUTLIER -72.34 -39.58 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 233' ' ' ARG . 36.3 mtt85 -36.36 -48.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -60.48 109.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -168.61 114.36 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -100.74 -60.61 1.49 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -125.58 175.87 7.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -82.53 98.92 9.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 20.5 m -143.68 145.48 32.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.197 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.772 HG22 HD11 ' A' ' 297' ' ' ILE . 30.8 pt -140.63 142.84 29.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.551 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 72.2 ttt180 -104.14 149.07 25.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 312' ' ' VAL . 93.4 t -134.74 142.29 40.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 282' ' ' PHE . 17.2 p -140.64 166.71 23.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.12 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 38.2 t-20 72.32 41.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 250' ' ' THR . 28.9 mt -92.11 169.6 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.431 ' HB3' ' CG ' ' A' ' 306' ' ' ASP . 11.2 t -110.7 155.52 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.3 -28.92 65.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -85.89 22.42 1.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.548 HG21 HD22 ' A' ' 246' ' ' LEU . 93.3 m -127.92 96.77 4.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.173 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.77 ' HG3' HG22 ' A' ' 253' ' ' THR . 8.0 ptt180 -99.75 -174.33 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.888 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.06 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.77 HG22 ' HG3' ' A' ' 251' ' ' ARG . 13.6 t -50.81 -28.07 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.19 -27.79 62.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.64 -32.45 13.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -52.72 -30.59 33.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -82.93 -25.02 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.874 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.574 HD22 ' CE2' ' A' ' 305' ' ' TYR . 12.4 tp -77.0 -36.85 56.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.537 ' HB2' HD11 ' A' ' 265' ' ' ILE . 84.8 m-85 -96.05 11.4 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.855 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.606 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.2 OUTLIER -79.64 -44.57 1.58 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 110.888 -179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 64.0 Cg_exo -47.94 -19.12 1.36 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.645 2.23 . . . . 0.0 112.352 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 39.5 m-85 -89.71 -40.09 12.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.882 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 173.33 -160.22 30.63 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.478 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.583 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 14.3 m -93.03 113.28 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.859 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 259' ' ' PHE . 39.9 mt -71.36 141.9 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.524 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 22.5 t -89.19 -46.89 8.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.894 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 21.3 ttp180 -147.55 156.49 42.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 53.6 mt -138.24 105.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.8 t80 -93.22 143.48 26.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.738 HD23 ' CE ' ' A' ' 272' ' ' LYS . 49.9 tp -127.74 132.8 49.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.603 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.91 113.31 4.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.738 ' CE ' HD23 ' A' ' 270' ' ' LEU . 86.8 mttt -136.31 125.79 25.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.42 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.888 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -110.78 -40.08 4.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 98.6 m -67.08 -73.59 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.471 HG23 ' N ' ' A' ' 277' ' ' GLY . 12.2 t -79.87 -43.21 22.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.141 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 276' ' ' THR . . . 88.52 38.24 7.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.517 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.441 ' H ' HG23 ' A' ' 276' ' ' THR . 6.5 mm100 -99.66 149.7 23.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.88 0.371 . . . . 0.0 110.871 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 13.5 t -57.88 116.89 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -63.72 -65.83 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.62 33.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.603 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 41.7 p90 -165.98 154.57 11.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 269' ' ' TYR . . . -144.42 174.05 11.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.479 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 91.0 m-85 -139.37 111.78 7.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.3 mp -95.69 123.65 47.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 67.9 m -100.38 114.18 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.876 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.729 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 12.2 m-85 -87.59 169.71 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.583 ' CD2' ' O ' ' A' ' 264' ' ' SER . 15.0 m-70 -86.69 -40.87 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -120.37 173.91 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.863 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -77.91 -38.85 44.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.849 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.91 -62.04 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.21 -40.41 47.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.852 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.729 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -65.78 -46.28 79.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -62.91 -41.72 99.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -47.35 -41.54 19.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.565 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.22 -70.91 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.093 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 241' ' ' ILE . 87.4 mt -34.44 -43.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.11 -46.7 87.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.137 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -75.63 -66.93 1.8 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.509 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 296' ' ' ALA . 25.6 m -43.33 -42.46 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 297' ' ' ILE . 10.7 t -47.92 108.47 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.856 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 86.66 31.4 18.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -94.96 135.37 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -81.21 52.86 4.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.514 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.574 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -74.98 129.61 37.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.917 0.389 . . . . 0.0 110.908 -179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.515 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 58.1 m-20 62.07 54.19 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 38.23 30.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 306' ' ' ASP . 91.9 mt -141.41 169.63 17.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.36 101.93 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.129 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 18.2 tp -65.32 149.52 49.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -127.85 127.41 43.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.762 HG22 HG22 ' A' ' 243' ' ' VAL . 93.9 t -137.33 151.9 27.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -169.45 151.93 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -53.51 126.43 21.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.93 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.551 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . -118.25 158.43 25.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.098 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.412 ' HD2' ' C ' ' A' ' 315' ' ' ALA . 11.0 mptt -129.54 159.2 70.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -44.81 161.66 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 23.2 t -105.18 -54.78 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.832 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 38.5 p -119.76 115.27 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.145 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -62.15 102.31 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.925 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 56.3 m -97.74 161.63 13.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 172.84 64.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.94 126.98 9.09 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.4 t -107.7 140.16 41.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 7.9 t -151.71 153.66 34.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 11.4 m -81.35 110.62 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.882 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t -120.43 110.9 17.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 107.15 152.45 18.48 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.478 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.9 p -128.42 163.99 23.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.819 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 16.8 m -53.17 125.5 17.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.832 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 143.59 176.52 17.7 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.481 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.07 -175.15 2.5 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.723 2.282 . . . . 0.0 112.331 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -115.32 106.13 13.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -147.01 156.65 43.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 55.0 mtm-85 -69.12 135.88 51.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -86.05 -43.65 12.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -84.38 144.08 29.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.37 -50.93 3.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -126.4 173.82 9.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -77.8 94.36 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 315' ' ' ALA . 91.2 m -135.15 150.7 50.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . . . . . . . . . 23.7 pt -142.23 144.97 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -107.38 152.15 24.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 312' ' ' VAL . 99.0 t -137.11 138.02 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.14 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 60.8 p -133.27 165.29 25.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.089 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 309' ' ' ILE . 16.6 t-20 73.77 49.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 250' ' ' THR . 31.4 mt -98.52 176.33 5.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 6.8 t -123.75 -176.88 3.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.43 -5.14 58.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.8 19.57 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 246' ' ' LEU . 90.1 m -122.29 96.43 5.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -105.76 173.7 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -48.69 -42.61 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.14 -23.38 66.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.106 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.99 -30.07 35.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.3 mt -86.59 -31.94 20.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.468 ' HA ' ' CD1' ' A' ' 265' ' ' ILE . 1.3 tm0? -54.75 -50.13 69.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -75.03 -19.03 60.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 305' ' ' TYR . 35.2 tp -80.16 -35.58 36.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.591 ' CE2' HG11 ' A' ' 300' ' ' VAL . 59.6 m-85 -101.72 11.89 38.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.595 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 0.0 OUTLIER -78.45 -45.21 2.06 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.587 0.708 . . . . 0.0 110.926 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.5 Cg_exo -48.03 -17.55 0.87 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.253 . . . . 0.0 112.371 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 36.5 m-85 -91.41 -32.71 15.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 166.87 -162.93 36.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.531 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.592 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 16.3 m -90.25 106.25 18.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.501 HD13 HD11 ' A' ' 268' ' ' ILE . 61.8 mt -61.44 143.41 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.122 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.519 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 31.5 t -94.1 -47.67 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -149.4 153.19 36.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 265' ' ' ILE . 74.5 mt -139.08 113.07 7.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 270' ' ' LEU . 2.1 t80 -104.6 152.82 21.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.527 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 62.1 tp -133.14 128.44 36.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.542 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -66.64 121.42 15.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . 0.5 ' HE3' HD23 ' A' ' 270' ' ' LEU . 31.6 mttt -136.91 140.13 42.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.97 170.07 4.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.832 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -100.82 -42.15 6.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 97.2 m -74.67 -73.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.105 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 278' ' ' GLN . 12.9 t -70.2 -25.87 63.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 66.45 37.38 92.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.516 ' H ' HG23 ' A' ' 276' ' ' THR . 46.0 mm-40 -99.47 175.87 5.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 8.6 t -84.3 118.56 24.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -61.47 -74.38 0.08 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 156.57 34.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 22.8 p90 -165.55 151.28 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.3 169.04 18.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -134.58 116.06 14.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 285' ' ' ILE . 3.2 mp -104.29 134.55 45.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 1.9 t -106.27 144.1 33.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.877 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.918 ' HB2' ' HB2' ' A' ' 293' ' ' ALA . 18.7 m-85 -119.91 169.96 9.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.592 ' CD2' ' O ' ' A' ' 264' ' ' SER . 5.7 m-70 -94.31 -40.86 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 16.5 mmt85 -110.16 152.81 25.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -71.74 -16.41 62.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -85.88 -41.86 14.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.36 -35.81 78.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.918 ' HB2' ' HB2' ' A' ' 287' ' ' PHE . . . -71.33 -35.84 71.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . 0.467 ' HB2' ' HZ2' ' A' ' 314' ' ' TRP . . . -74.17 -35.98 64.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -49.46 -43.23 44.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.856 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 262' ' ' PHE . . . -60.93 -66.18 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 314' ' ' TRP . 88.6 mt -34.3 -34.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -72.07 -50.63 26.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -73.79 -65.67 2.16 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 312' ' ' VAL . 13.6 m -43.43 -28.81 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 0.0 111.101 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 1.7 t -62.79 114.35 3.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 79.42 20.92 68.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.41 ' CG ' ' N ' ' A' ' 304' ' ' GLY . 52.1 t80 -78.23 163.29 25.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.915 0.388 . . . . 0.0 110.863 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . 0.41 ' N ' ' CG ' ' A' ' 303' ' ' PHE . . . -108.87 83.69 0.34 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.52 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.467 ' HE2' HD22 ' A' ' 258' ' ' LEU . 0.3 OUTLIER -103.45 120.24 40.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.417 ' O ' ' ND1' ' A' ' 307' ' ' HIS . 53.3 m-20 57.92 52.48 7.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.573 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 22.5 p-80 44.3 36.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 309' ' ' ILE . 70.4 mt -139.09 166.63 24.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.556 ' CD1' ' N ' ' A' ' 309' ' ' ILE . 1.0 OUTLIER -93.7 101.8 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.165 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.3 134.41 42.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -115.63 138.78 50.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 1.024 HG22 HG22 ' A' ' 243' ' ' VAL . 68.9 t -140.47 148.34 22.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -164.07 153.05 13.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.488 ' CD1' ' CD1' ' A' ' 297' ' ' ILE . 83.3 m95 -54.52 122.0 9.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.954 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.651 ' HB3' HG22 ' A' ' 240' ' ' THR . . . -88.76 171.1 10.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -133.81 94.4 18.93 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.576 0.703 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.35 97.22 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 20.9 t -98.92 78.96 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 25.6 m -116.77 148.12 41.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -90.66 114.07 26.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.8 t -131.04 87.49 2.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 61.97 170.44 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.97 -29.89 4.9 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.702 2.268 . . . . 0.0 112.376 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.7 t -117.46 119.83 36.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.822 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 21.4 t -69.63 102.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 45.8 t -88.05 -60.25 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.4 m -87.96 90.95 8.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.859 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -116.54 -108.6 2.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.463 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 4.3 t 41.75 41.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.895 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 23.8 t -155.3 139.76 16.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.863 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 61.88 149.13 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.485 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.3 109.31 2.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.694 2.263 . . . . 0.0 112.369 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -58.02 119.55 6.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -135.81 152.83 51.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.953 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -162.64 109.63 1.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.862 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.417 ' C ' ' HE2' ' A' ' 316' ' ' LYS . . . -162.79 134.23 5.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -174.97 159.03 2.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -112.36 -49.38 2.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -121.86 171.44 8.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -77.04 97.59 4.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 33.3 m -134.92 142.71 46.61 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.105 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 0.52 ' CD1' ' CE2' ' A' ' 259' ' ' PHE . 29.5 pt -139.7 140.92 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.145 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 315' ' ' ALA . 74.8 ttt180 -103.27 151.17 23.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 312' ' ' VAL . 86.2 t -134.62 144.66 34.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 64.5 p -140.82 171.66 13.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.132 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASN . . . . . . . . . . . . . 2.3 m120 64.58 48.43 2.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LEU . . . . . . . . . . . . . 22.0 mt -100.9 -177.58 3.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.3 t -126.81 176.51 7.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.83 -24.69 48.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.38 20.16 2.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 97.9 m -132.75 96.41 3.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.541 ' HG3' HG22 ' A' ' 253' ' ' THR . 23.2 ptt-85 -101.48 -173.31 2.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.876 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -55.62 -64.3 0.89 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 251' ' ' ARG . 1.8 t -50.68 -19.85 1.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.175 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.447 ' OD2' ' NH1' ' A' ' 251' ' ' ARG . 3.2 m-20 -82.82 -29.3 29.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.86 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.5 mt -92.59 -27.83 17.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -53.26 -31.47 43.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.91 -24.91 26.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.42 HD22 ' CE2' ' A' ' 305' ' ' TYR . 11.6 tp -73.6 -35.37 65.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' PHE . . . . . 0.676 ' HB2' HD11 ' A' ' 265' ' ' ILE . 59.1 m-85 -97.62 10.17 40.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.601 ' N ' ' CD ' ' A' ' 261' ' ' PRO . 6.3 tpt85 -75.97 -44.54 3.85 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.618 0.723 . . . . 0.0 110.898 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 260' ' ' ARG . 65.7 Cg_exo -48.0 -18.01 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.63 2.22 . . . . 0.0 112.338 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 296' ' ' ALA . 33.6 m-85 -93.37 -38.52 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.22 32.9 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.468 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.56 ' O ' ' CD2' ' A' ' 288' ' ' HIS . 4.4 m -92.86 116.06 28.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.864 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ILE . . . . . 0.676 HD11 ' HB2' ' A' ' 259' ' ' PHE . 45.3 mt -74.47 140.14 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.542 ' HB2' ' CD2' ' A' ' 288' ' ' HIS . 18.9 t -89.97 -50.47 6.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.816 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -140.03 155.95 46.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.86 105.12 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.159 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 1.6 t80 -97.24 142.83 28.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 269' ' ' TYR . 33.8 tp -126.01 131.76 52.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.63 ' HB2' ' CE2' ' A' ' 282' ' ' PHE . . . -65.12 119.83 11.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.108 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -136.66 122.12 19.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -61.64 -179.92 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -113.31 -41.74 3.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 89.5 m -65.94 -56.96 9.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 11.1 t -94.65 -15.41 24.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 56.08 41.6 85.77 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -112.07 171.22 7.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.771 0.32 . . . . 0.0 110.885 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 60.5 p -77.64 113.2 15.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.404 ' HA ' ' NZ ' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -56.65 -68.06 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.907 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 153.76 34.14 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.446 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.63 ' CE2' ' HB2' ' A' ' 271' ' ' ALA . 39.5 p90 -162.34 146.25 11.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.873 0.368 . . . . 0.0 110.918 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -136.34 167.79 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.141 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 242' ' ' ARG . 97.5 m-85 -135.15 111.73 9.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.854 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 285' ' ' ILE . 4.2 mp -100.48 127.48 53.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' SER . . . . . . . . . . . . . 15.1 m -104.33 112.92 26.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -84.21 176.44 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' HIS . . . . . 0.56 ' CD2' ' O ' ' A' ' 264' ' ' SER . 13.2 m-70 -92.76 -41.63 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -113.4 172.65 6.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -81.31 -37.1 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.889 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.08 -54.34 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -51.2 -37.08 44.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.451 ' HB3' ' HH2' ' A' ' 314' ' ' TRP . . . -66.13 -46.34 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.5 98.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.097 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -46.77 -42.19 16.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.772 ' O ' HG22 ' A' ' 300' ' ' VAL . . . -64.43 -71.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 314' ' ' TRP . 92.0 mt -35.81 -40.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.01 87.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 296' ' ' ALA . . . -81.99 -62.59 1.9 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.545 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' VAL . . . . . 0.772 HG22 ' O ' ' A' ' 296' ' ' ALA . 16.2 m -46.03 -20.85 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.112 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 103.65 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.48 29.06 9.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.89 133.51 34.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -82.25 54.38 4.87 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . 0.42 ' CE2' HD22 ' A' ' 258' ' ' LEU . 0.5 OUTLIER -77.03 130.07 36.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 110.972 -179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 307' ' ' HIS . 56.6 m-20 62.08 55.03 2.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' HIS . . . . . 0.541 ' CG ' ' O ' ' A' ' 307' ' ' HIS . 1.6 p80 37.73 31.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.842 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 306' ' ' ASP . 90.2 mt -141.52 170.64 15.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . 0.62 ' N ' HD12 ' A' ' 309' ' ' ILE . 2.2 mp -89.49 100.88 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 23.8 tp -66.77 143.45 56.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -125.37 129.43 49.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' VAL . . . . . 0.717 HG22 HG22 ' A' ' 243' ' ' VAL . 56.4 t -137.85 140.15 41.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.6 156.02 32.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.523 ' CD1' HD13 ' A' ' 297' ' ' ILE . 80.3 m95 -57.51 128.01 34.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' A' ' 242' ' ' ARG . . . -118.08 149.07 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.074 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.417 ' HE2' ' C ' ' A' ' 235' ' ' ALA . 15.2 mmtt -97.84 151.42 37.57 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.575 0.702 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.54 153.89 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.349 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' SER . . . . . . . . . . . . . 1.8 m -89.88 -62.5 1.46 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 81.4 p -94.26 148.35 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -80.33 47.18 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 3.6 t -55.84 169.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 125.89 140.73 5.39 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.26 5.25 5.58 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.715 2.277 . . . . 0.0 112.335 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 31.9 p -91.88 -48.5 6.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 16.6 m -118.81 112.35 19.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.47 -179.983 . . . . . . . . 0 0 . 1 stop_ save_